# EDGAR Filing Document

**Accession Number:** 0000002969
**File Stem:** 0000002969-25-000055
**Filing Date:** 2025-11
**Character Count:** 788341
**Document Hash:** 26db308743447a456e1314573ca50a82
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000002969-25-000055.hdr.sgml**: 20251120

**ACCESSION NUMBER**: 0000002969-25-000055

**CONFORMED SUBMISSION TYPE**: 10-K

**PUBLIC DOCUMENT COUNT**: 199

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251120

**DATE AS OF CHANGE**: 20251120

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Air Products & Chemicals, Inc.
- **CENTRAL INDEX KEY:** 0000002969
- **STANDARD INDUSTRIAL CLASSIFICATION:** INDUSTRIAL INORGANIC CHEMICALS [2810]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 231274455
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-04534
- **FILM NUMBER:** 251501490

**BUSINESS ADDRESS:**
- **STREET 1:** 1940 AIR PRODUCTS BLVD.
- **CITY:** ALLENTOWN
- **STATE:** PA
- **ZIP:** 18106-5500
- **BUSINESS PHONE:** 6104814911

**MAIL ADDRESS:**
- **STREET 1:** 1940 AIR PRODUCTS BLVD.
- **CITY:** ALLENTOWN
- **STATE:** PA
- **ZIP:** 18106-5500

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AIR PRODUCTS & CHEMICALS, INC.
- **DATE OF NAME CHANGE:** 20220408

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AIR PRODUCTS & CHEMICALS INC /DE/
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? apd-20250930

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u> 

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-K**

---

| | |
|:---|:---|
| **☒** | **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
| | For the fiscal year ended 30 September 2025 |

---

or

---

| | |
|:---|:---|
| ☐ | **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
| | For the transition period from _______________________ to ______________________  |

---

Commission file number **001-04534**![airproductslogoa16.jpg](apd-20250930_g1.jpg)

**AIR PRODUCTS AND CHEMICALS, INC.** 

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| **Delaware** | **23-1274455** |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |

---

**1940 Air Products Boulevard** 

**Allentown, Pennsylvania 18106-5500** 

(Address of principal executive offices) (Zip Code)

**610-481-4911** 

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, par value $1.00 per share | APD | New York Stock Exchange |
| 0.500% Euro Notes due 2028 | APD28 | New York Stock Exchange |
| 2.950% Euro Notes due 2031 | APD31 | New York Stock Exchange |
| 0.800% Euro Notes due 2032 | APD32 | New York Stock Exchange |
| 3.250% Euro Notes due 2032 | APD32B | New York Stock Exchange |
| 4.000% Euro Notes due 2035 | APD35 | New York Stock Exchange |
| 3.450% Euro Notes due 2037 | APD37 | New York Stock Exchange |

---

Securities registered pursuant to Section 12(g) of the Act: None

---

| | | | | |
|:---|:---|:---|:---|:---|
| Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. | Yes | ☒ | No | ☐ |
| Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. | Yes | ☐ | No | ☒ |
| Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. | Yes | ☒ | No | ☐ |
| Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). | Yes | ☒ | No | ☐ |
| Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. |  |  |  |  |

---

Large accelerated filer ☒ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company ☐

---

| | | | | |
|:---|:---|:---|:---|:---|
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. |  | ☐ |
| Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of<br>the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. | Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of<br>the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. | Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of<br>the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. |  | ☒ |
| If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. | If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. | If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. |  | ☐ |
| Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). | Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). | Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). |  | ☐ |
| Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). | Yes | ☐ | No | ☒ |

---

The aggregate market value of the voting stock held by non-affiliates of the registrant on 31 March 2025 was approximately $65.6 billion. For purposes of the foregoing calculations, all directors and/or executive officers have been deemed to be affiliates, but the registrant disclaims that any such director and/or executive officer is an affiliate.

The number of shares of common stock issued and outstanding as of 31 October 2025 was 222,590,241.

**DOCUMENTS INCORPORATED BY REFERENCE**

Portions of the registrant's definitive Proxy Statement for the 2026 Annual Meeting of Shareholders are incorporated by reference into Part III.

------

**AIR PRODUCTS AND CHEMICALS, INC. and Subsidiaries**

**ANNUAL REPORT ON FORM 10-K**

**For the fiscal year ended 30 September 2025**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| **PART I** | **PART I** | **PART I** |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 1. | <u>[BUSINESS](#i6c5d80e205be49368cbb0bd080310540_16)</u> | [5](#i6c5d80e205be49368cbb0bd080310540_16) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 1A. | <u>[RISK FACTORS](#i6c5d80e205be49368cbb0bd080310540_19)</u> | [12](#i6c5d80e205be49368cbb0bd080310540_19) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 1B. | <u>[UNRESOLVED STAFF COMMENTS](#i6c5d80e205be49368cbb0bd080310540_22)</u> | [21](#i6c5d80e205be49368cbb0bd080310540_22) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 1C. | <u>[CYBERSECURITY](#i6c5d80e205be49368cbb0bd080310540_25)</u> | [22](#i6c5d80e205be49368cbb0bd080310540_25) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 2. | <u>[PROPERTIES](#i6c5d80e205be49368cbb0bd080310540_28)</u> | [24](#i6c5d80e205be49368cbb0bd080310540_28) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 3. | <u>[LEGAL PROCEEDINGS](#i6c5d80e205be49368cbb0bd080310540_31)</u> | [25](#i6c5d80e205be49368cbb0bd080310540_31) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 4. | <u>[MINE SAFETY DISCLOSURES](#i6c5d80e205be49368cbb0bd080310540_34)</u> | [25](#i6c5d80e205be49368cbb0bd080310540_34) |
| **PART II** | **PART II** | **PART II** |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 5. | <u>[MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES](#i6c5d80e205be49368cbb0bd080310540_40)</u> | [26](#i6c5d80e205be49368cbb0bd080310540_40) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 6. | <u>[RESERVED](#i6c5d80e205be49368cbb0bd080310540_43)</u> | [27](#i6c5d80e205be49368cbb0bd080310540_43) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 7. | <u>[MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS](#i6c5d80e205be49368cbb0bd080310540_46)</u> | [28](#i6c5d80e205be49368cbb0bd080310540_46) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 7A. | <u>[QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK](#i6c5d80e205be49368cbb0bd080310540_85)</u> | [63](#i6c5d80e205be49368cbb0bd080310540_85) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 8. | <u>[FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA](#i6c5d80e205be49368cbb0bd080310540_88)</u> | [65](#i6c5d80e205be49368cbb0bd080310540_88) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 9. | <u>[CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE](#i6c5d80e205be49368cbb0bd080310540_211)</u> | [148](#i6c5d80e205be49368cbb0bd080310540_211) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 9A. | <u>[CONTROLS AND PROCEDURES](#i6c5d80e205be49368cbb0bd080310540_214)</u> | [148](#i6c5d80e205be49368cbb0bd080310540_214) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 9B. | <u>[OTHER INFORMATION](#i6c5d80e205be49368cbb0bd080310540_217)</u> | [149](#i6c5d80e205be49368cbb0bd080310540_217) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 9C. | <u>[DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS](#i6c5d80e205be49368cbb0bd080310540_220)</u> | [149](#i6c5d80e205be49368cbb0bd080310540_220) |
| **PART III** | **PART III** | **PART III** |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 10. | <u>[DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE](#i6c5d80e205be49368cbb0bd080310540_226)</u> | [150](#i6c5d80e205be49368cbb0bd080310540_226) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 11. | <u>[EXECUTIVE COMPENSATION](#i6c5d80e205be49368cbb0bd080310540_229)</u> | [150](#i6c5d80e205be49368cbb0bd080310540_229) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 12. | <u>[SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS](#i6c5d80e205be49368cbb0bd080310540_232)</u> | [150](#i6c5d80e205be49368cbb0bd080310540_232) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 13. | <u>[CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE](#i6c5d80e205be49368cbb0bd080310540_235)</u> | [150](#i6c5d80e205be49368cbb0bd080310540_235) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 14. | <u>[PRINCIPAL ACCOUNTANT FEES AND SERVICES](#i6c5d80e205be49368cbb0bd080310540_238)</u> | [150](#i6c5d80e205be49368cbb0bd080310540_238) |
| **PART IV** | **PART IV** | **PART IV** |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 15. | <u>[EXHIBITS AND FINANCIAL STATEMENT SCHEDULES](#i6c5d80e205be49368cbb0bd080310540_244)</u> | [151](#i6c5d80e205be49368cbb0bd080310540_244) |
| &nbsp;&nbsp;&nbsp;&nbsp;ITEM 16. | <u>[FORM 10-K SUMMARY](#i6c5d80e205be49368cbb0bd080310540_247)</u> | [151](#i6c5d80e205be49368cbb0bd080310540_247) |
| <u>[INDEX TO EXHIBITS](#i6c5d80e205be49368cbb0bd080310540_250)</u> | <u>[INDEX TO EXHIBITS](#i6c5d80e205be49368cbb0bd080310540_250)</u> | [152](#i6c5d80e205be49368cbb0bd080310540_250) |
| <u>[SIGNATURES](#i6c5d80e205be49368cbb0bd080310540_253)</u> | <u>[SIGNATURES](#i6c5d80e205be49368cbb0bd080310540_253)</u> | [155](#i6c5d80e205be49368cbb0bd080310540_253) |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**FORWARD-LOOKING STATEMENTS**

This Annual Report on Form 10-K contains "forward-looking statements" within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and can generally be identified by words such as "anticipate," "believe," "could," "estimate," "expect," "forecast," "future," "goal," "intend," "may," "outlook," "plan," "position," "possible," "potential," "project," "should," "target," "will," "would," and similar expressions or variations thereof, or the negative thereof, but these terms are not the exclusive means of identifying such statements. Forward-looking statements are based on management's expectations and assumptions as of the date of this report and are not guarantees of future performance. You are cautioned not to place undue reliance on our forward-looking statements.

Forward-looking statements may relate to a number of matters, including expectations regarding revenue, margins, expenses, earnings, tax provisions, cash flows, pension obligations, share repurchases or other statements regarding economic conditions or our business outlook; statements regarding capital expenditures and plans, projects, investment opportunities, strategies and objectives for our future operations, including our ability to win new projects and execute the projects in our backlog; and statements regarding our expectations with respect to pending legal claims or disputes. While forward-looking statements are made in good faith and based on assumptions, expectations and projections that management believes are reasonable based on currently available information, actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors, including, without limitation:

&nbsp;&nbsp;&nbsp;&nbsp;• changes in global or regional economic conditions, inflation, and supply and demand dynamics in the market segments we serve, including demand for technologies and projects to limit the impact of global climate change;

&nbsp;&nbsp;&nbsp;&nbsp;• changes in the financial markets that may affect the availability and terms on which we may obtain financing;

&nbsp;&nbsp;&nbsp;&nbsp;• the ability to execute agreements with customers and implement price increases to offset cost increases;

&nbsp;&nbsp;&nbsp;&nbsp;• disruptions to our supply chain and related distribution delays and cost increases;

&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with having extensive international operations, including political risks, risks associated with unanticipated government actions and risks of investing in developing markets;

&nbsp;&nbsp;&nbsp;&nbsp;• project delays, scope changes, cost escalations, contract terminations, customer cancellations, or postponement of projects and sales;

&nbsp;&nbsp;&nbsp;&nbsp;• our ability to safely develop, operate, and manage costs of large-scale and technically complex projects;

&nbsp;&nbsp;&nbsp;&nbsp;• the future financial and operating performance of major customers, joint ventures, and equity affiliates;

&nbsp;&nbsp;&nbsp;&nbsp;• our ability to safely and effectively develop, implement, and operate new technologies and to market products produced utilizing new technologies;

&nbsp;&nbsp;&nbsp;&nbsp;• our ability to execute the projects in our backlog and refresh our pipeline of new projects;

&nbsp;&nbsp;&nbsp;&nbsp;• tariffs, economic sanctions and regulatory activities in jurisdictions in which we and our affiliates and joint ventures operate;

&nbsp;&nbsp;&nbsp;&nbsp;• the impact of environmental, tax, safety, or other legislation, as well as regulations and other public policy initiatives affecting our business and the business of our affiliates and related compliance requirements, including legislation, regulations, or policies intended to address global climate change;

&nbsp;&nbsp;&nbsp;&nbsp;• changes in tax rates and other changes in tax law;

&nbsp;&nbsp;&nbsp;&nbsp;• safety incidents relating to our operations;

&nbsp;&nbsp;&nbsp;&nbsp;• the timing, impact, and other uncertainties relating to acquisitions, divestitures, and joint venture activities, as well as our ability to integrate acquisitions and separate divested businesses, respectively;

&nbsp;&nbsp;&nbsp;&nbsp;• risks relating to cybersecurity incidents, including risks from the interruption, failure or compromise of our information systems or those of our business partners or service providers;

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**FORWARD-LOOKING STATEMENTS (CONTINUED)**

&nbsp;&nbsp;&nbsp;&nbsp;• catastrophic events, such as natural disasters and extreme weather events, pandemics and other public health crises, acts of war, including Russia's invasion of Ukraine and new and ongoing conflicts in the Middle East, or terrorism;

&nbsp;&nbsp;&nbsp;&nbsp;• the impact on our business and customers of price fluctuations in oil and natural gas and disruptions in markets and the economy due to oil and natural gas price volatility;

&nbsp;&nbsp;&nbsp;&nbsp;• costs and outcomes of legal or regulatory proceedings and investigations;

&nbsp;&nbsp;&nbsp;&nbsp;• asset impairments due to economic conditions or specific events;

&nbsp;&nbsp;&nbsp;&nbsp;• significant fluctuations in inflation, interest rates and foreign currency exchange rates from those currently anticipated;

&nbsp;&nbsp;&nbsp;&nbsp;• damage to facilities, pipelines or delivery systems, including those we are constructing or that we own or operate for third parties;

&nbsp;&nbsp;&nbsp;&nbsp;• availability and cost of electric power, natural gas, and other raw materials; and

&nbsp;&nbsp;&nbsp;&nbsp;• the commencement and success of any productivity and operational improvement programs.

In addition to the foregoing factors, forward-looking statements contained herein are qualified with respect to the risks disclosed elsewhere in this document, including in Item *1A, Risk Factors,* Item 7, *Management's Discussion and Analysis of Financial Condition and Results of Operations*, and Item 7A, *Quantitative and Qualitative Disclosures About Market Risk.* Any of these factors, as well as those not currently anticipated by management, could cause our results of operations, financial condition, or liquidity to differ materially from what is expressed or implied by any forward-looking statement. Except as required by law, we disclaim any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect any change in assumptions, beliefs, or expectations or any change in events, conditions, or circumstances upon which any such forward-looking statements are based.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**PART I**

**Item 1. Business**

As used in this report, unless the context indicates otherwise, the terms "we," "our," "us," the "Company," "Air Products," or "registrant" include our controlled subsidiaries and affiliates.

Additional information about Air Products is available on our website at www.airproducts.com. References to our website within this report are inactive textual references only. The content of our website is not incorporated by reference into, and does not form part of, this Annual Report on Form 10-K.

Air Products trades on the New York Stock Exchange under the symbol "APD". All periodic and current reports, registration statements, proxy statements, and other filings that we are required to file with the Securities and Exchange Commission ("SEC"), including our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) of the Securities Exchange Act of 1934 (the "Exchange Act"), are available free of charge through our website as soon as reasonably practicable after electronic filing of the material with the SEC. All such reports filed during the period covered by this report were available on our website on the same day as filing. Additionally, these filings are available free of charge on the SEC's website, www.sec.gov.

Notes to the consolidated financial statements that are referenced in the disclosures that follow can be found under Item 8, *Financial Statements and Supplementary Data*, of this Annual Report on Form 10-K.

**About Air Products**

Air Products and Chemicals, Inc., a Delaware corporation founded in 1940, is a world-leading industrial gases company that has built a reputation for its innovation, operational excellence, and commitment to safety and environmental stewardship. Focused on serving energy, environmental, and emerging markets and generating a cleaner future, we offer products and services that improve our customers' operations and sustainability.

We serve a broad range of industries, including refining, chemicals, metals, electronics, manufacturing, medical, and food, providing essential industrial gases, related equipment, and applications expertise. We also develop, engineer, build, own, and operate some of the world's largest clean hydrogen projects supporting the transition to low- and zero-carbon energy, particularly in industrial applications and the heavy-duty transportation sector. Additionally, our sale of equipment businesses provide specialized products such as turbomachinery, membrane systems, and cryogenic containers to customers worldwide.

We manage our operations, assess performance, and report earnings under five reportable segments: Americas, Asia, Europe, Middle East and India, and Corporate and other. Refer to Note 26, *Business Segment and Geographic Information*, to the consolidated financial statements for additional information.

**Our Businesses**

<u>Regional Industrial Gases</u>

Our industrial gases business, which is organized and operated regionally in the Americas, Asia, Europe, and Middle East and India segments, produces and sells atmospheric gases such as oxygen, nitrogen, and argon (primarily recovered by the cryogenic distillation of air); process gases such as hydrogen, helium, carbon dioxide ("CO2"), carbon monoxide, and syngas (a mixture of hydrogen and carbon monoxide); and specialty gases. Overall regional industrial gases sales constituted over 90% of consolidated sales in fiscal years 2025, 2024, and 2023, approximately half of which were attributable to atmospheric gases.

Each of the regional industrial gases segments competes against three global industrial gas companies: Air Liquide S.A., Linde plc, and Messer Group GmbH, as well as regional competitors. Competition in industrial gases is based primarily on price, reliability of supply, and the development of industrial gas applications. We derive a competitive advantage in locations where we have pipeline networks, which enable us to provide a reliable and economic supply of products to our larger customers.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

*Production*

Industrial gases are generally produced at or near the point of use due to the complexity and inefficiency of storing molecules at low temperatures. The industrial gases business develops, builds, and operates equipment for the production and processing of gases. Atmospheric gases are produced through various air separation processes, with cryogenic distillation being the most prevalent, while process gases are produced by methods other than air separation.

Hydrogen is a process gas that is typically produced by purifying byproduct sources obtained from chemical and petrochemical industries without carbon capture, commonly referred to as "gray hydrogen." We primarily produce gray hydrogen. In addition, we are advancing projects that produce low-carbon hydrogen from hydrocarbons with carbon capture ("blue hydrogen") and carbon-free hydrogen from renewable energy ("green hydrogen"), such as the NEOM Green Hydrogen Project in Saudi Arabia. In fiscal year 2025, we exited certain clean energy projects as discussed in Note 5, *Business and Asset Actions*, to the consolidated financial statements. Despite these actions, we continue to see opportunity in clean energy and are pursuing focused investments in scalable, economically viable solutions that support long-term shareholder value.

Electricity is the largest cost component in the production of atmospheric gases. To produce hydrogen, carbon monoxide, and syngas, steam methane reformers use natural gas as the primary raw material, while gasifiers use liquid and solid hydrocarbons. We mitigate electricity, natural gas, and hydrocarbon price fluctuations contractually through pricing formulas, surcharges, cost pass-through provisions, and tolling arrangements. During fiscal year 2025, we did not encounter significant difficulties in obtaining adequate supplies of power and natural gas.

Helium is produced as a byproduct of gases extracted from underground reservoirs, primarily natural gas and CO2 purified before resale. Because helium is generally sourced globally at long distances from point of sale, we maintain an inventory of helium in our fleet of ISO containers as well as in underground storage facilities in Amarillo, Texas and Beaumont, Texas.

*Supply Modes*

We distribute product to our industrial gas customers through either our on-site or merchant supply mode depending on various factors, including the customer's volume requirements and location. Each sale of gas supply mode is described below:

&nbsp;&nbsp;&nbsp;&nbsp;• *On-site Gases*— This supply mode serves customers primarily in the energy production and refining, chemical, metals, and electronics industries worldwide, where large and relatively consistent volumes of industrial gases are required. Gases are produced and supplied through large facilities constructed or acquired on or near customer facilities, or by pipeline systems from centralized production locations. These sale of gas arrangements are generally governed by long-term contracts ranging from 15- to 20-years. We also deliver smaller quantities of product through small on-site plants (cryogenic or non-cryogenic generators), generally under 10- to 15-year contracts. Contracts in this supply mode commonly include fixed monthly charges and/or minimum purchase requirements with price escalation provisions that are typically based on external indices. Our on-site supply mode generates approximately half our total company sales.

&nbsp;&nbsp;&nbsp;&nbsp;• *Merchant Gases*— This supply mode includes liquid bulk and packaged gas products. Liquid bulk gases are delivered in either liquid or gaseous form via tanker or tube trailer and stored, usually in its liquid state, in equipment that we typically design and install at the customer's site for vaporizing into a gaseous state as needed. Packaged gases customers receive small quantities of product delivered in either cylinders or dewars, with operations in Europe, Asia, and Latin America. Sales of both liquid bulk and packaged gases do not include minimum purchase requirements, as they are governed by contracts and/or purchase orders that reflect the customer's specific needs. These contracts contain stated terms that are generally five years or less.

We maintain inventory in locations that facilitate supply of products to customers on a reasonable delivery schedule. Inventory consists primarily of crude helium, specialty gases, and other industrial gases supplied via the merchant gases supply mode.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

*End Use*

The refining industry uses hydrogen to facilitate the conversion of heavy crude feedstock and lower the sulfur content of gasoline and diesel fuels. This produces cleaner transportation fuels that can be used with other equipment to significantly reduce emissions that contribute to climate change. Many other industries that already benefit from hydrogen's unique properties to improve quality, optimize performance, and reduce costs are also looking to hydrogen as a fuel that can help decarbonize their manufacturing processes.

The chemicals industry uses hydrogen, oxygen, nitrogen, carbon monoxide, and syngas as feedstocks in the production of many basic chemicals. The energy production industry uses nitrogen injection for enhanced recovery of oil and natural gas and oxygen for gasification. Oxygen is used in combustion and industrial heating applications, including in the steel, certain nonferrous metals, glass, and cement industries. Nitrogen applications are used in food processing for freezing and preserving flavor, and nitrogen is used for inerting in various fields, including the metals, chemical, and semiconductor industries. Helium is used for its unique properties as an inert gas with an extremely low boiling point. It is widely used in semiconductor and fiber optics manufacturing, MRI magnet cooling, and for purging and pressurizing rocket fuel systems in aerospace launches. Additional applications include use in laboratories, cryogenics, and as a shielding gas in arc welding. Argon is used in the metals and other industries for its unique inerting, thermal conductivity, and other properties. Industrial gases are also used in welding and providing healthcare and are utilized in various manufacturing processes to make them more efficient and to optimize performance.

**Industrial Gases Equipment**

We design and manufacture equipment for air separation, hydrocarbon recovery and purification, and liquid helium and liquid hydrogen transport and storage. The Corporate and other segment includes activity related to the sale of cryogenic and gas processing equipment for air separation. The equipment is sold worldwide to customers in a variety of industries, including chemical and petrochemical manufacturing, oil and gas recovery and processing, and steel and primary metals processing. The Corporate and other segment also includes the results of our Rotoflow business, which manufactures turboexpanders and other precision rotating equipment, and our Gardner Cryogenics business, which fabricates helium and hydrogen transport and storage containers.

Steel, aluminum, and capital equipment subcomponents such as compressors are the principal raw materials in the manufacturing of equipment. Raw materials for individual projects typically are acquired under firm purchase agreements. Equipment is produced at our manufacturing sites with certain components procured from subcontractors and vendors.

Competition in the equipment business is based primarily on plant efficiency and technological performance, service, technical know-how, and price, as well as schedule and plant performance guarantees. Our sale of equipment supply mode constituted less than 10% of consolidated sales in fiscal years 2025, 2024, and 2023.

Our former liquefied natural gas ("LNG") process technology and equipment business was included in the Corporate and other segment until its sale to Honeywell International Inc. on 30 September 2024. The LNG business generated operating income of approximately $135 million in fiscal year 2024 and $120 million in fiscal year 2023. As a result of the sale, we recognized a pre-tax gain of approximately $1.6 billion during the fourth quarter of fiscal year 2024, reported within "Gain on sale of business" on our consolidated income statements. This gain was not recorded in the results of the Corporate and other segment. Refer to Note 4, *Gain on Sale of Business*, to the consolidated financial statements for additional information.

**Customers**

We do not have a homogeneous customer base or end market, and no single customer accounts for more than 10% of our consolidated sales. We do have concentrations of customers in specific industries, primarily refining, chemicals, and electronics. Within each of these industries, we have several large-volume customers with long-term contracts. A negative trend affecting one of these industries, or the loss of one of these major customers, although not material to our consolidated sales, could have an adverse impact on our financial results.

**Seasonality**

While seasonality does not materially affect our long-term performance, it may result in variability in quarterly financial results.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Governmental Contracts**

Our business is not subject to a government entity's renegotiation of profits or termination of contracts that would be material to our business as a whole.

**Equity Affiliates**

Our reporting segments include our share of the results of joint ventures accounted for under the equity method. Our share of our investees' net earnings is primarily presented net of income taxes within "Equity affiliates' income" on our consolidated income statements. The carrying value of our equity method investments is reflected as "Investment in net assets of and advances to equity affiliates" on our consolidated balance sheets. All of our equity method investments are in foreign industrial gas producers, the largest of which operate in Algeria, China, India, Italy, Mexico, and Saudi Arabia. For additional information regarding these investments, refer to Note 10, *Equity Affiliates*, to the consolidated financial statements.

**International Operations**

Through our subsidiaries, affiliates, and joint ventures accounted for using the equity method, we conduct business in approximately 50 countries and regions outside the United States. Our international businesses are subject to risks customarily encountered in foreign operations, including fluctuations in foreign currency exchange rates and controls, tariffs, trade sanctions, import and export controls, and other economic, political, and regulatory policies of local governments described in Item 1A, *Risk Factors*, of this Annual Report on Form 10-K.

We have controlling interests in foreign subsidiaries that operate in Canada and approximately 10 countries in Latin America (primarily Chile and Brazil); approximately 10 countries and regions in Asia (primarily China, South Korea, and Taiwan); approximately 25 countries in the Europe and Africa region (primarily the Netherlands, the countries of the United Kingdom, and Spain); and approximately five countries in the Middle East, primarily Saudi Arabia. As discussed under "Equity Affiliates" above, we also own non-controlling interests in entities operating in Asia, Europe, Latin America, and the Middle East.

Financial information related to our foreign operations and investments can be found in the consolidated financial statements under Note 10, *Equity Affiliates*; Note 24, *Income Taxes*; and Note 26, *Business Segment and Geographic Information*.

Details regarding foreign currency translation are provided in Note 1, *Basis of Presentation and Major Accounting Policies*, to the consolidated financial statements, under "Foreign Currency".

Our exposure to currency fluctuations is discussed in Note 15, *Financial Instruments*, to the consolidated financial statements and Item 7A, *Quantitative and Qualitative Disclosures About Market Risk*, under "Foreign Currency Exchange Rate Risk".

**Technology Development**

We pursue a market-oriented approach to technology development through research and development, engineering, and commercial development processes. We conduct research and development principally in our laboratories located in the United States (Allentown, Pennsylvania), the United Kingdom (Basingstoke and Carrington), Spain (Barcelona), China (Shanghai), and Saudi Arabia (Dhahran). We also fund and cooperate in research and development programs conducted by a number of major universities and undertake research work funded by others, including the United States government.

Development of technology for use within the industrial gases business focuses primarily on new and improved processes and equipment for the production and delivery of industrial gases and new or improved applications for industrial gas products.

During fiscal year 2025, we owned approximately 560 United States patents, approximately 2,650 foreign patents, and were a licensee under certain patents owned by others. While the patents and licenses are considered important, we do not consider our business as a whole to be materially dependent upon any particular patent, patent license, or group of patents or licenses.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Environmental Regulation**

We are subject to various environmental laws, regulations, and public policies in the countries in which we have operations. Compliance with these measures often results in higher capital expenditures and costs. In the normal course of business, we are involved in legal proceedings under the Comprehensive Environmental Response, Compensation, and Liability Act ("CERCLA," the federal Superfund law); Resource Conservation and Recovery Act ("RCRA"); and similar state and foreign environmental laws relating to the designation of certain sites for investigation or remediation. Our accounting policy for environmental expenditures is discussed in Note 1, *Basis of Presentation and Major Accounting Policies*, and environmental loss contingencies are discussed in Note 19, *Commitments and Contingencies*, to the consolidated financial statements.

Some of our operations are within jurisdictions that have or are developing regulatory regimes governing emissions of greenhouse gases ("GHG"), including CO2. These include the European Union Emission Trading System, the California Cap-and-Trade Program, China's Emission Trading Scheme, and South Korea's Emission Trading Scheme. In the Netherlands, a CO2 emissions tax was enacted on 1 January 2021. In Canada, Alberta's Technology Innovation and Emission Reduction System went into effect 1 January 2020. In Ontario, Environment & Climate Change Canada's Output Based Pricing System was replaced by the GHG Emissions Performance Standards program beginning 1 January 2022. In Taiwan, enforcement of the Climate Change Response Act began in 2023. A carbon fee framework pursuant to that law has also been announced, with collections thereunder first scheduled for 2026, covering emissions generated in 2025. In September 2025, the U.S. Environmental Protection Agency ("EPA") issued a proposed rule to end federal mandatory GHG reporting for almost all sectors (including Subpart P that we are subject to); however, the rule is not yet final and timing is uncertain. Additionally, in August 2025, the EPA issued a proposed rule to reconsider its 2009 Endangerment Finding rule (and a 2016 agency affirmation of that rule) that was the basis for subsequent actions to regulate certain GHGs under the federal Clean Air Act, including for new constructions and major modifications to existing facilities, as well as new motor vehicles. The European Union has issued the Corporate Sustainability Reporting Directive as well as the Corporate Sustainability Due Diligence Directive, and California has enacted the Climate Corporate Data Accountability Act and the Climate Related Financial Risk Act that will require GHG emissions and climate-related financial risk reporting for certain entities. Furthermore, some jurisdictions have various mechanisms to target the power sector to achieve emission reductions, which often result in higher power costs.

Increased public concern may result in more international and/or regional requirements to reduce or mitigate the effects of GHG emissions. Although uncertain, these developments could increase our costs related to consumption of electric power, hydrogen production and application of our gasification technology. We will be able to mitigate costs related to the consumption of electric power through the use of renewable electricity and some of the other increased costs through contractual terms. However, the lack of definitive legislation or regulatory requirements prevents an accurate estimate of the long-term impact these measures will have on our operations. Any legislation that limits or taxes GHG emissions could negatively impact our growth, increase our operating costs, or reduce demand for certain of our products.

Regulation of GHG may also produce new opportunities for us. We continue to develop technologies to help our facilities and our customers lower energy consumption, improve efficiency, and lower emissions.

Expenditures for capital projects intended to control pollution from existing operating facilities as required under current environmental regulations were not material in fiscal years 2025, 2024, and 2023. We do not expect material expenditures for these projects in fiscal year 2026.

For additional information regarding environmental matters, refer to Note 19, *Commitments and Contingencies*, to the consolidated financial statements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Sustainability**

We pursue opportunities to improve energy efficiency and lower emissions across our operations. Additionally, our customers rely on our expertise to enhance their operations, boost efficiency, improve yields, and reduce their environmental footprint. Our offerings include gases, equipment, technologies, and applications that enable our customers, and their customers, to improve their sustainability performance by avoiding GHG emissions, improving efficiency, allowing the use of by-product gases, and recycling resources between facilities.

Our latest Sustainability Report is available at www.airproducts.com/company/sustainability/sustainability-report.

**Human Capital Management**

We are focused on attracting, developing, and retaining a highly-skilled workforce that will deliver excellent service to our customers. We strive to create a workforce that reflects our customers and the communities where we do business. By embracing the experiences and perspectives within our talent pool and nurturing a culture grounded in respect and collaboration, we empower employees to confidently share ideas. This approach is central to our corporate strategy, which is supported by our leaders and enabled by a positive organizational culture.

As of 30 September 2025, we had approximately 21,300 employees, with over 99% working full-time and approximately 75% based outside the United States. We maintain collective bargaining agreements with unions and works councils at certain locations, which expire at various times over the next four years. Approximately 15% of our global workforce is covered by these agreements.

We offer a variety of opportunities for employees to develop their capabilities, talents, and careers. Employees choose learning and development goals aligned to roles and responsibilities that support current and expected future business needs. We continue to invest in new learning platforms and learner-centric experiences that encourage employee development and skills retention.

<u>Safety</u>

Safety is a core operating principle at Air Products. We view it as a fundamental responsibility to ensure that every employee returns home safe and healthy each day. Our goal is zero accidents and incidents, and we are committed to continuously improving the safety and health of our employees, contractors, customers, and the communities where we operate.

We use a multidisciplinary approach to safety and health, which includes a global Environment, Health and Safety ("EHS") policy; goals for employee, contractor, and transportation safety; a Global EHS Management System that supports the principles of ISO 45001; employee training based on job function; risk assessment processes for workers, operations, products, transportation, and regulatory requirements, including an escalation process for engaging our EHS Risk Council; compliance audits conducted by our EHS Assurance Team; review of performance by our Board of Directors, Sustainability Leadership Council, businesses and operations, and members of our Safety and Health Centers of Excellence at least annually; internal reporting of results on a monthly basis; and external reporting on safety performance through our annual Sustainability Report, public website, and responses to various stakeholders.

<u>Compensation</u>

By aligning our pay practices with business goals, we support the financial well-being of our workforce and reinforce our commitment to responsible corporate citizenship. Sustainable and equitable pay is essential to fostering a workplace where employees feel valued and supported. Our compensation practices are designed to ensure fairness and promote long-term economic stability for our workforce. We are committed to ethical pay practices that align with our values of social responsibility, ensuring that all employees receive equitable compensation regardless of gender, race, religion, disability, age, or any other personal characteristic.

We strive to offer competitive pay in the local markets where we operate, balancing financial sustainability with our ability to attract and retain talent. To support this, we benchmark our compensation to remain aligned with market conditions and provide competitive pay and benefits. Our compensation programs generally include base pay, annual variable pay (bonus), and long-term incentives (stock awards under the Air Products Long-Term Incentive Plan) for eligible employees.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Our Executive Officers**

The table below identifies each executive officer by name, age, and offices held as of 20 November 2025. Information with respect to offices held is stated in fiscal years.

---

| | | |
|:---|:---|:---|
| **Name** | **Age** | **Office** |
| Eduardo Menezes | 62 | Chief Executive Officer and Director (Principal Executive Officer) since February 2025. Prior to joining Air Products, Mr. Menezes served as Executive Vice President of Linde plc from 2018 to 2021, with responsibility for Europe, Middle East and Africa. Mr. Menezes previously served for over three decades in progressively senior roles at Praxair, Inc., prior to its acquisition by Linde in 2018. From 2012 through the time of the merger, Mr. Menezes served as an Executive Vice President of Praxair, with responsibility for its businesses in Asia, Europe, Mexico and South America, as well as for global hydrogen operations. Mr. Menezes also served from 2010 to 2011 as head of the North American Industrial Gases business and Praxair's packaged gas business and from 2007 to 2010 as President of Praxair Europe. Mr. Menezes is a member of the Board of Directors and a member of the Executive Committee of the Board of Directors. |
| Melissa N. Schaeffer | 46 | Executive Vice President and Chief Financial Officer (became Senior Vice President and Chief Financial Officer in August 2021 and Executive Vice President in October 2024). Ms. Schaeffer joined the Company in 2016 and most recently served as Vice President, Finance – GEMTE, Americas, Middle East, and India from 2020 to 2021 and previously served as Vice President, Chief Audit Executive from 2016 to 2020. Before joining the Company, Ms. Schaeffer was global director, Internal Audit at Trinseo S.A. and worked for 10 years at Ernst & Young LLP. Ms. Schaeffer also serves on the board of directors of Trane Technologies plc. |
| Ivo Bols | 64 | President, Europe and Africa since 2017. Mr. Bols previously served as President, EMEA from 2014 to 2016, Vice President and General Manager, Merchant Gases–Europe from 2012 to 2014, General Manager, Global Liquid Bulk, Generated Gases and Helium from 2011 to 2012 and Vice President and General Manager, Merchant Gases-Asia from 2007 to 2011. Mr. Bols joined the Company in 1988. |
| Kurt Lefevere | 55 | President, Asia since June 2024. Mr. Lefevere previously served as Vice President, Northern Continent, Europe from 2015 to June 2024, Manager, Strategy Development and Performance Enhancement for the Company's Global Merchant division from 2013 until 2014, and General Manager for the Packaged Gases division in Asia from 2011 until 2013. Mr. Lefevere joined the Company in 1994. |
| Matthew Lepore | 55 | Executive Vice President, General Counsel, Chief Compliance Officer and Secretary since August 2025. Mr. Lepore previously served as Group General Counsel, President for Legal, Compliance and Insurance, Chief Compliance Officer, Chief Human Rights Officer and Corporate Secretary at BASF SE (Ludwigshafen am Rhein, Germany) since 2021, Senior Vice President and Global Head of Legal at BASF SE from 2018 to 2021, Senior Vice President and General Counsel, Chief Compliance Officer and Corporate Secretary of BASF Corporation (New Jersey) from 2014 to 2018, and Corporate Secretary and Chief Governance Officer at Pfizer Inc. from 2008 to 2014. |
| Francesco Maione | 56 | President, Americas since December 2020 and Global Helium & Rare Gases since June 2025. Mr. Maione previously served as President, Atmospheric Gases, Americas during 2020, as Vice President and General Manager, South America from 2019 until early 2020, as Vice President, Northern Region Americas, from 2018 to 2019 and Vice President, Southern Region, Americas, from 2016 to 2018. Mr. Maione joined the Company in 1998. |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Item 1A. Risk Factors**

Our operations are affected by various risks, many of which are beyond our control. In evaluating investment in the Company and the forward-looking information contained in this Annual Report on Form 10-K or presented elsewhere from time to time, readers should carefully consider the risk factors discussed below. Any of these risks could have a material adverse effect on our business, operating results, financial condition, and the actual outcome of matters as to which forward-looking statements are made and could adversely affect the value of an investment in our securities. The risks described below are not all inclusive but are designed to highlight what we believe are important factors to consider when evaluating our expectations. In addition to such risks, there may be additional risks and uncertainties that adversely affect our business, performance, or financial condition in the future that are not presently known, are not currently believed to be significant, or are not identified below because they are common to all businesses.

**Risks Related to Economic Conditions**

<u>Changes in global and regional economic conditions, the markets we serve, or the financial markets may adversely affect our results of operations and cash flows.</u>

Unfavorable conditions in the global economy or regional economies, the markets we serve, or financial markets may decrease the demand for our goods and services and adversely impact our revenues, operating results, and cash flows.

Demand for our products and services depends in part on the general economic conditions affecting the regions and markets in which we do business. Weak economic conditions and changing supply and demand balances in the markets we serve have negatively impacted demand for our products and services in the past and may do so in the future. In addition, certain of our green and blue hydrogen projects are largely based on expected demand for technologies and projects to limit the impact of global climate change. Demand for our solutions could be negatively impacted if the public and private sectors reduce their focus on reducing carbon emissions. Reduced demand for our products and services would have a negative impact on our revenues and earnings and could decrease our margins, constrain our operating flexibility, reduce efficient utilization of our manufacturing capacity, or result in unexpected charges. Excess capacity in our manufacturing facilities or those of our competitors could decrease our ability to maintain pricing and generate profits.

In addition, our operating results in one or more segments have in the past, and may in the future, be affected by uncertain or deteriorating economic conditions for particular customer markets within a segment. A decline in the industries served by our customers or adverse events or circumstances affecting individual customers can reduce demand for our products and services and impair the ability of such customers to satisfy their obligations to us, resulting in uncollected receivables, unanticipated contract terminations, project delays or the inability to recover plant investments, any of which may negatively impact our financial results.

Weak overall demand or specific customer conditions may also cause customer shutdowns or defaults or otherwise make us unable to operate facilities profitably and may force sale or abandonment of facilities and equipment or prevent projects from coming on-stream when expected. These or other events associated with weak economic conditions or specific market, industry, product, or customer events may require us to record an impairment on tangible assets, such as facilities and equipment, or intangible assets, such as customer relationships, intellectual property, or goodwill. Any charges relating to such impairments could be significant and could have a material adverse impact on our financial condition and results of operations.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Our extensive international operations can be adversely impacted by operational, economic, political, security, legal, and currency translation risks that could decrease profitability.</u>

In fiscal year 2025, approximately 60% of our sales were derived from customers outside the United States and many of our operations, suppliers, customers, and employees are located outside the United States. Our operations in foreign jurisdictions may be subject to risks including exchange control regulations, import and trade restrictions, tariffs, trade policy and other potentially detrimental domestic and foreign governmental practices or policies affecting U.S. companies doing business abroad. Changing economic and political conditions within foreign jurisdictions, strained relations between countries, or the imposition, extension, or expansion of tariffs or international sanctions can cause fluctuations in demand, price volatility, supply disruptions, or loss of property. We have experienced these events in the past and the occurrence of any of these risks in the future could have a material adverse impact on our financial condition, results of operations, and cash flows.

Certain of our larger and more complex projects are located in markets outside the United States, such as China, India, the Middle East, and Uzbekistan, including in locations where there is the potential for significant economic and political disruptions. We are actively investing large amounts of capital and other resources, in some cases through joint ventures, in developing markets, which we believe to have high growth potential. Our operations in these markets may be subject to greater risks than those faced by our operations in mature economies, including political and economic instability, project delay or abandonment due to unanticipated government actions, inadequate investment in infrastructure, undeveloped property rights and legal systems, unfamiliar regulatory environments, relationships with local partners, language and cultural differences and increased difficulty recruiting, training and retaining qualified employees. In addition, our properties and contracts in these locations may be subject to seizure and cancellation, respectively, without full compensation for loss. Successful operation of particular facilities or execution of projects may be disrupted by civil unrest, acts of war, sabotage or terrorism, and other local security concerns. Such concerns may require us to incur greater costs for security or require us to shut down operations for a period of time.

Furthermore, because the majority of our revenue is generated from sales outside the United States, we are exposed to fluctuations in foreign currency exchange rates. Our business is primarily exposed to translational currency risk as the results of our foreign operations are translated into U.S. dollars at current exchange rates throughout the fiscal period. Our policy is to minimize cash flow volatility from changes in currency exchange rates. We choose not to hedge the translation of our foreign subsidiaries' earnings into dollars. Accordingly, reported sales, net earnings, cash flows, and fair values have been, and in the future will be, affected by changes in foreign exchange rates. For a more detailed discussion of currency exposure, see Item 7A, *Quantitative and Qualitative Disclosures About Market Risk*, below.

<u>Changes in global and regional economic conditions may impact our ability to obtain financing or increase the cost of obtaining financing which may adversely impact our operations and financial results.</u>

Volatility and disruption in the U.S., European and global credit, capital, and money markets could increase the costs for or make it more difficult for us to obtain financing for our operations, potentially impacting our cash flows or creating financial risks. In addition, our borrowing costs can be affected by short and long-term debt ratings assigned by independent rating agencies. A decrease in these debt ratings could increase the cost of borrowing or make it more difficult to obtain financing.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Risks Related to Our Business**

<u>Risks related to the approval, execution, and operation of our projects, particularly with respect to our largest projects, may adversely affect our operations or financial results.</u>

A significant portion of our business involves clean hydrogen, carbon capture, gasification, and other large-scale projects that involve challenging engineering, permitting, procurement, and construction phases that may last several years and involve the investment of billions of dollars. These projects are technically complex, often reliant on significant interaction with government authorities, and face significant financing, development, operational, and reputational risks. These projects may also be subject to complex government approvals, as well as legal or regulatory challenges by government authorities or third parties. Delays in receiving required approvals, litigation and execution difficulties have required us and could in the future require us to delay or abandon certain projects, which may result in higher costs, lower returns, the loss of invested proceeds, and reputational damage.

We have in the past and may in the future encounter difficulties related to the development of projects that may result in delays, scope changes and additional costs, or project cancellations. Such difficulties may relate to engineering, delays in designs or materials provided by the customer or a third party, equipment and materials delivery delays, schedule changes, customer scope changes, delays related to obtaining regulatory permits and rights-of-way, inability to find adequate sources of labor in the locations where we are building new plants, weather-related delays, delays by customers' contractors in completing their portion of a project, technical or transportation difficulties, cost overruns, supply difficulties, geopolitical risks, and other factors, many of which are beyond our control, that may impact our ability to complete a project within the original delivery schedule. In some cases, delays and additional costs have been and may in the future be substantial and could have a material adverse effect on our financial condition and results of operations. We also may be required to cancel a project and/or compensate the customer for the delay, which may also cause us to incur material costs that we may be unable to recover. In addition, in some cases we seek financing for large projects and face market risk associated with the availability and terms of such financing. These financing arrangements may require that we comply with certain performance requirements which, if not met, could result in default and restructuring costs or other losses, as well as potential acceleration of cash outflows. All of these factors could also negatively impact our reputation or relationships with our customers, suppliers and other third parties, any of which could adversely affect our ability to secure new projects in the future.

In addition, our large-scale clean hydrogen projects are being built before finalization of offtake agreements for a substantial percentage of expected production, which may create uncertainty regarding future demand, pricing, and other commercial terms. If we are unable to enter into favorable commercial agreements with prospective customers, our projected returns could be adversely impacted, which may harm our business and financial performance. In addition, uncertainty regarding future offtake agreements for our clean hydrogen projects may lead to greater uncertainty regarding our prospects, which may adversely affect the market prices for our securities and our credit ratings.

The operation of our facilities, pipelines, and delivery systems inherently entails hazards that require continuous oversight and control, such as pipeline leaks and ruptures, fire, explosions, toxic releases, mechanical failures, vehicle accidents, or cyber incidents. If operational risks materialize, they could result in loss of life, damage to the environment, or loss of production, all of which could negatively impact our ongoing operations, reputation, financial results, and cash flows. In addition, our operating results are dependent on the continued operation of our production facilities and our ability to meet customer requirements, which depend, in part, on our ability to properly maintain and replace aging assets.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>We are subject to extensive government regulation in the jurisdictions in which we do business. Regulations addressing, among other things, import/export restrictions, anti-bribery and corruption, and taxes, can negatively impact our financial condition, results of operation, and cash flows.</u>

We are subject to government regulation in the United States and in the foreign jurisdictions where we conduct business. The application of laws and regulations to our business is sometimes unclear. Compliance with laws and regulations may involve significant costs or require changes in business practices that could result in reduced profitability. If there is a determination that we have failed to comply with applicable laws or regulations, we may be subject to penalties or sanctions that could adversely impact our reputation and financial results. Compliance with changes in laws or regulations can result in increased operating costs and require additional, unplanned capital expenditures. Export controls or other regulatory restrictions could prevent us from shipping our products to and from some markets or increase the cost of doing so. Changes in tax laws and regulations and international tax treaties could affect the financial results of our businesses. Increasingly aggressive enforcement of anti-bribery and anti-corruption requirements, including the U.S. Foreign Corrupt Practices Act, the United Kingdom Bribery Act and the China Anti-Unfair Competition Law, could subject us to criminal or civil sanctions if a violation is deemed to have occurred. In addition, we are subject to laws and sanctions imposed by the U.S. and other jurisdictions where we do business that may prohibit us, or certain of our affiliates, from doing business in certain countries or with certain customers or restricting the kind of business that we may conduct. Such restrictions may provide a competitive advantage to competitors who are not subject to comparable restrictions or prevent us from taking advantage of growth opportunities.

Further, we cannot guarantee that our internal controls and compliance systems will always protect us from acts committed by employees, agents, business partners or that businesses that we acquire would not violate U.S. and/or non-U.S. laws, including the laws governing payments to government officials, bribery, fraud, kickbacks and false claims, pricing, sales and marketing practices, conflicts of interest, competition, export and import compliance, money laundering, and data privacy. Any such improper actions or allegations of such acts could damage our reputation and subject us to civil or criminal investigations in the U.S. and in other jurisdictions and related shareholder lawsuits, could lead to substantial civil and criminal, monetary and non-monetary penalties, and could cause us to incur significant legal and investigatory fees. In addition, the government may seek to hold us liable as a successor for violations committed by companies in which we invest or that we acquire.

<u>We may be unable to successfully identify, execute or effectively integrate acquisitions, manage our joint ventures, or effectively disentangle divested businesses.</u>

Our ability to grow revenue, earnings, and cash flow at anticipated rates depends in part on our ability to identify, successfully acquire and integrate businesses and assets at appropriate prices, and realize expected growth, synergies, and operating efficiencies. We may not be able to complete transactions on favorable terms, on a timely basis or at all. In addition, our results of operations and cash flows may be adversely impacted by the failure of acquired businesses or assets to meet expected returns, the failure to integrate acquired businesses, the inability to dispose of non-core assets and businesses on satisfactory terms and conditions, and the discovery of unanticipated liabilities or other problems in acquired businesses or assets for which we lack adequate contractual protections or insurance. In addition, we may incur asset impairment charges related to acquisitions that do not meet expectations.

In addition, some of our largest projects involve joint ventures. These arrangements may involve significant risks and uncertainties, including our ability to cooperate with our strategic partners, our strategic partners having interests or goals that are inconsistent with ours, and the potential that our strategic partners may be unable to meet their economic or other obligations to the joint venture, which may negatively impact the expected benefits of the joint venture and cause us to incur additional expense or suffer reputational damage. In addition, due to the nature of these arrangements, we may have limited ability to direct or influence the management of the joint venture, which may limit our ability to assist and oversee the design and implementation of the joint venture's business as well as its accounting, legal, governance, human resources, information technology, and other administrative systems. This may expose us to additional risks and uncertainties because we may be dependent upon and subject to liability, losses, or reputational damage relating to systems, controls, and personnel that are not under our control. These risks may be augmented when the joint venture is operating outside the United States due to differences in language, culture, and regulation, as well as the factors listed above that are relevant to our international operations.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

We continually assess the strategic fit of our existing businesses and may divest businesses that are deemed not to fit with our strategic plan or are not achieving the desired return on investment. These transactions pose risks and challenges that could negatively impact our business and financial statements. For example, when we decide to sell or otherwise dispose of a business or assets, we may be unable to do so on satisfactory terms within our anticipated time frame or at all. In addition, divestitures or other dispositions may dilute our earnings per share, have other adverse financial and accounting impacts, distract management, and give rise to disputes with buyers or others. In addition, we have agreed, and may in the future agree, to indemnify buyers against known and unknown contingent liabilities. Our financial results could be impacted adversely by claims under these indemnification provisions.

<u>The security of our information technology systems could be compromised, which could adversely affect our ability to operate.</u>

We depend on information technology to enable us to operate safely and efficiently and interface with our customers as well as to maintain our internal control environment and financial reporting accuracy and efficiency. Our information technology capabilities are delivered through a combination of internal and external services and service providers. If we do not allocate and effectively manage the resources necessary to build and sustain the proper technology infrastructure, we could be subject to transaction errors, processing inefficiencies, the loss of customers, business disruptions, property damage, or the loss of or damage to our confidential business information due to a security breach. In addition, our information technology systems may be damaged, disrupted or shut down due to attacks by computer hackers, computer viruses, employee error or malfeasance, power outages, hardware failures, telecommunication or utility failures, catastrophes or other unforeseen events, and in any such circumstances our system redundancy and other disaster recovery planning may be ineffective or inadequate. Security breaches of our systems (or the systems of our customers, suppliers or other business partners) could result in the misappropriation, destruction or unauthorized access or disclosure of confidential information or personal data belonging to us or to our employees, partners, customers or suppliers, and may subject us to legal liability.

As with most large systems, our information technology systems have in the past been, and in the future likely will be subject to computer viruses, malicious codes, unauthorized access and other cyber-attacks, and we expect the sophistication and frequency of such attacks to continue to increase. In addition, advancements in, and the deployment of, intelligent automation, including artificial intelligence tooling and "bots", may increase our and our vendors' vulnerability to such attacks. To date, we are not aware of any significant impact on our operations or financial results from such attempts; however, unauthorized access could disrupt our business operations, result in the loss of assets, and have a material adverse effect on our business, financial condition, or results of operations. Any of the attacks, breaches or other disruptions or damage described above could: interrupt our operations at one or more sites; delay production and shipments; result in the theft of our and our customers' intellectual property and trade secrets; damage customer and business partner relationships and our reputation; result in defective products or services, physical damage to facilities, pipelines or delivery systems, including those we own or operate for third parties; result in legal claims and proceedings, including liability and penalties under applicable privacy laws; lead to increased costs for security and remediation; or raise concerns regarding our internal control environment and internal control over financial reporting. Each of these consequences could adversely affect our business, reputation and our financial statements.

Our business involves the use, storage, and transmission of information about our employees, vendors, and customers. The protection of such information, as well as our proprietary information, is critical to us. The regulatory environment surrounding information security and privacy is increasingly demanding, with the frequent imposition of new and constantly changing requirements. We have established policies and procedures to help protect the security and privacy of this information. We also, from time to time, export sensitive customer data and technical information to recipients outside the United States. Breaches of our security measures or the accidental loss, inadvertent disclosure, or unapproved dissemination of proprietary information or sensitive or confidential data about us or our customers, including the potential loss or disclosure of such information or data as a result of fraud, trickery, or other forms of deception, could expose us, our customers, or the individuals affected to a risk of loss or misuse of this information, which could ultimately result in litigation and potential legal and financial liability. These events could also damage our reputation or otherwise harm our business.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Interruption in ordinary sources of raw material or energy supply or an inability to recover increases in energy and raw material costs from customers could result in lost sales or reduced profitability.</u>

Hydrocarbons, including natural gas, are the primary feedstock for the production of hydrogen, carbon monoxide, and syngas. Energy, including electricity, natural gas, and diesel fuel for delivery trucks, is the largest cost component of our business. Because our industrial gas facilities use substantial amounts of electricity, inflation and energy price fluctuations have impacted our revenues and earnings and may continue to do so in the future. A disruption in raw material sources or the supply of energy or components, whether due to market conditions, legislative or regulatory actions, natural disasters, public health crises and pandemics, or other disruption, could prevent us from meeting our contractual commitments and harm our business and financial results.

Our supply of crude helium for purification and resale is largely dependent upon natural gas production by crude helium suppliers. Lower or higher natural gas production resulting from natural gas pricing dynamics, supplier operating or transportation issues, or other changes to the global supply of crude helium can affect pricing for helium for our customers, which can adversely affect our results of operations.

We typically contract to pass-through cost increases in energy and raw materials to customers, but such cost pass-through results in declining margins, and cost variability can negatively impact our other operating results. For example, we may be unable to raise prices as quickly as costs rise, or competitive pressures may prevent full recovery of such costs. In addition, increases in energy or raw material costs that cannot be passed on to customers for competitive or other reasons may negatively impact our revenues and earnings. Even where costs are passed through, price increases can cause lower sales volume.

<u>New technologies create performance risks that could impact our financial results or reputation, and failure to develop new technologies may harm our competitive position.</u>

We are continually developing and implementing new technologies and product offerings. Existing technologies, including those procured exclusively from third-party suppliers, are being implemented in products and designs or at scales beyond our experience base. These technological expansions can create nontraditional performance risks to our operations. Failure of the technologies to work as predicted, or unintended consequences of new designs or uses, could lead to cost overruns, project delays, financial penalties, or damage to our reputation. We may face difficulties marketing products produced using new technologies including, but not limited to, green hydrogen, which may adversely impact our sales and financial results. In addition, certain large-scale projects may contain processes or technologies that we have not operated at the same scale or in the same combination, and although such projects generally include technologies and processes that have been demonstrated previously by others, such technologies or processes may be new to us and may introduce new risks to our operations. Further, if we are unsuccessful in developing new technologies, including development and application of artificial intelligence, our development activities do not keep pace with those of our competitors, or if we do not create new technologies that benefit customers, our competitive position and operating results may be negatively affected. Additionally, there is also a risk that our new technologies may become obsolete and be replaced by other market alternatives, or that new technologies may not become commercially accepted. Performance difficulties on these larger projects may have a material adverse effect on our operations and financial results. In addition, performance challenges may adversely affect our reputation and our ability to obtain future contracts.

<u>Protecting our intellectual property is critical to our technological development, and we may suffer competitive harm from infringement on such rights.</u> 

As we develop new technologies, it is critical that we protect our intellectual property assets against third-party infringement. We own a number of patents and other forms of intellectual property related to our products and services. As we develop new technologies there is a risk that our patent applications may not be granted, or we may not receive sufficient protection of our proprietary interests. We may also expend considerable resources in defending our patents against third-party infringement. It is critical that we protect our proprietary interests to prevent competitive harm.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Risks related to pension benefit plans may adversely impact our results of operations and cash flows.</u>

Pension benefits represent significant financial obligations that will be ultimately settled in the future with employees who meet eligibility requirements. Because of the uncertainties involved in estimating the timing and amount of future payments and asset returns, significant estimates are required to calculate pension expense and liabilities related to our plans. We utilize the services of third-party actuaries, whose models support these calculations.

In addition to complying with local regulatory requirements for recognizing pension expense, liabilities, and cash flows, several key assumptions are used in the actuarial models to calculate pension expense and liability amounts recorded in the consolidated financial statements as well as the amounts that we contribute to such plans. These assumptions include, but are not limited to, discount rates, expected long-term rates of return on plan assets, and demographic factors. Changes in actuarial assumptions, interest and inflation rates, and volatility in capital markets may adversely impact the valuation of pension liabilities and the performance of asset portfolios.

Additionally, significant changes in actual investment returns on pension assets, discount rates, or regulatory developments could impact future results of operations and required pension contributions.

**Legal and Regulatory Risks**

<u>Legislative, regulatory, societal, and market efforts to address global climate change may impact our business and create financial risk.</u>

We are the world's leading supplier of hydrogen, the primary use of which is the production of ultra-low sulfur transportation fuels that have significantly reduced transportation emissions and helped improve human health. To make the high volumes of hydrogen needed by our customers, we have historically used steam methane reforming to produce hydrogen without carbon capture (i.e., "gray hydrogen"), which results in the emission of CO2. In addition, gasification enables the conversion of lower value feedstocks into cleaner energy and value-added products; however, our gasification projects also produce CO2. Some of our operations are within jurisdictions that have or are developing regulatory regimes governing disclosure of GHG emissions, including CO2, which may lead to direct and indirect costs on our operations. We could also face scrutiny from stakeholders regarding our reporting under various frameworks for disclosing GHG emissions-related data, including those we use currently in our sustainability reporting. If our GHG emissions-related data, processes, and reporting are incomplete or inaccurate, or if we fail to comply with relevant reporting frameworks from newly emerging regulations, we may incur monetary penalties and reputational harm, and we could become subject to litigation or government investigations, which may also adversely affect our reputation and business.

Increased public concern and governmental action may result in more international, U.S. federal and/or regional requirements to reduce or mitigate the effects of GHG emissions or increased demand for technologies and projects to limit the impact of global climate change. Although uncertain, these developments could increase our costs related to consumption of electric power, hydrogen (including clean hydrogen) production, and application of our gasification technology. We believe we will be able to mitigate some of the increased costs through contractual terms, but the lack of definitive legislation or regulatory requirements prevents an accurate estimate of the long-term impact these measures will have on our operations. Any legislation or governmental action that limits or taxes GHG emissions could negatively impact our growth, increase our operating costs, or reduce demand for certain of our products, particularly for our core industrial gases business.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Our operations may present a safety risk to our employees and others.</u>

Notwithstanding our emphasis on the safety of our employees and contractors and the precautions we take related to health and safety, we may be unable to avoid safety incidents relating to our operations that result in injuries or deaths. Certain safety incidents may result in legal or regulatory action that could result in increased expenses or reputational damage. We maintain workers' compensation insurance to address the risk of incurring material liabilities for injuries or deaths, but there can be no assurance that the insurance coverage will be adequate or will continue to be available on terms acceptable to us, or at all, which could result in material liabilities to us for any injuries or deaths. Changes to federal, state, and local employee health and safety regulations, and legislative, regulatory, or societal responses to safety incidents may result in heightened regulations or public scrutiny that may increase our compliance costs or result in reputational damage.

The manufacturing and sale of our products, as well as the construction and sale of plants and facilities, may give rise to risks associated with the production, filling, storage, handling, and transport of raw materials, goods, or waste. Our products and services, if defective or not handled or performed appropriately, have in the past and may in the future lead to personal injuries, business interruptions, environmental damages, or other significant damages, which may result, among other consequences, in liability, losses, monetary penalties, or compensation payments, environmental clean-up costs, or other costs and expenses, exclusion from certain market sectors deemed important for future development of the business, and/or loss of reputation, all of which could have a material adverse effect on our business and results of operations.

<u>Our business depends on our ability to attract, develop, engage, and retain qualified employees.</u>

Our success depends on our ability to attract, develop, engage, and retain employees with the skills necessary to our business. Competitive labor market conditions have resulted in increased demand for qualified personnel, which makes it difficult to attract, hire, and retain employees with specialized technical experience. In addition, the increasing number of experienced employees becoming retirement-eligible amplifies this challenge. The number of our employees has grown both internationally and in the United States, with our total headcount increasing from approximately 16,300 at the end of fiscal 2018 to as high as approximately 23,000 in fiscal 2024. However, we have been taking actions since that time to reduce the size of our workforce and currently expect headcount to stabilize at approximately 20,000 at the end of fiscal 2026 as we complete certain projects and complete actions to right-size the organization. Our results of operations have been and in the future could be adversely affected by increased costs due to increased competition for skilled talent in the market as well as by actions we have taken to manage the size of our workforce. In addition, increased turnover and decreased tenure of employees may impact productivity, costs, and organizational culture. We undertake significant efforts to hire, engage, and retain our employees and to effectively manage workforce costs, even with rapid political, social, and economic shifts in our markets. If these efforts are unsuccessful, our growth may be limited and we may suffer financial or reputational harm that could have a material adverse effect on our business, financial condition, or results of operations.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Our financial results may be affected by various legal and regulatory proceedings, including antitrust, tax, environmental, or other matters.</u>

We are subject to litigation and regulatory investigations and proceedings in the normal course of business and could become subject to additional claims in the future, some of which could be material. While we seek to limit our liability in our commercial contractual arrangements, there are no guarantees that each contract will contain suitable limitations of liability or that limitations of liability will be enforceable. Also, the outcome of existing legal proceedings may differ from our expectations because the outcomes of litigation, including regulatory matters, are often difficult to predict reliably. Various factors or developments can lead us to change current estimates of liabilities and related insurance receivables, where applicable, or make such estimates for matters previously not susceptible to reasonable estimates, such as a significant judicial ruling or judgment, a significant settlement, significant regulatory developments, or changes in applicable law. A future adverse ruling, settlement, or unfavorable development could result in charges that could have a material adverse effect on our financial condition, results of operations, and cash flows in any particular period.

<u>Costs and expenses resulting from compliance with environmental regulations may negatively impact our operations and financial results.</u>

We are subject to extensive federal, state, local, and foreign environmental and safety laws and regulations concerning, among other things, emissions in the air; discharges to land and water; and the generation, handling, treatment, and disposal of hazardous waste and other materials. We take our environmental responsibilities very seriously, but there is a risk of adverse environmental impact inherent in our manufacturing operations and in the transportation of our products. Future developments and more stringent environmental regulations may require us to make additional unforeseen environmental expenditures. In addition, laws and regulations may require significant expenditures for environmental protection equipment, compliance, and remediation. These additional costs may adversely affect our financial results. For a more detailed description of these matters, see Item 1, *Business–Environmental Regulation*, above.

<u>A change of tax law in key jurisdictions could result in a material increase in our tax expense.</u>

The multinational nature of our business subjects us to taxation in the United States and numerous foreign jurisdictions. Due to economic and political conditions, tax rates in various jurisdictions may be subject to significant change. Our future effective tax rates could be affected by changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, global minimum taxes related to the new tax framework established by the Organization for Economic Co-operation and Development, or changes in tax laws or their interpretation.

Changes to income tax laws and regulations in any of the jurisdictions in which we operate, or in the interpretation of such laws, could significantly increase our effective tax rate and adversely impact our financial condition, results of operations, or cash flows. Various levels of government, including the U.S. federal government, are increasingly focused on tax reform and other legislative action to increase tax revenue. Further changes in tax laws in the U.S. or foreign jurisdictions where we operate could have a material adverse effect on our business, results of operations, or financial condition.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**General Risk Factors** 

<u>Catastrophic events could disrupt our operations or the operations of our suppliers or customers, having a negative impact on our business, financial results, and cash flows.</u>

Our operations could be impacted by catastrophic events outside our control, including severe weather conditions such as hurricanes, floods, earthquakes, storms, epidemics, pandemics, acts of war, and terrorism. Any such event could cause a serious business disruption that could affect our ability to produce and distribute products and possibly expose us to third-party liability claims. Additionally, such events could impact our suppliers, customers, and partners, which could cause energy and raw materials to be unavailable to us, or our customers to be unable to purchase or accept our products and services. Any such occurrence could have a negative impact on our operations and financial results.

<u>Inability to compete effectively in a segment could adversely impact sales and financial performance.</u>

We face strong competition from large global competitors and many smaller regional competitors in many of our business segments. Introduction by competitors of new technologies, competing products, or additional capacity could weaken demand for, or impact pricing of our products, negatively impacting financial results. In addition, competitors' pricing policies could affect our profitability or market share.

**Item 1B. Unresolved Staff Comments**

We have not received any written comments from the Commission staff that remain unresolved.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Item 1C. Cybersecurity**

Cybersecurity risk management and oversight are of utmost importance to Air Products and are necessary to maintain the trust and confidence of our customers, employees, and other stakeholders. The Company has implemented a thorough cybersecurity program for assessing, identifying, and managing material risks from cybersecurity threats as a fully integrated component of the Company's overall Enterprise Risk Management ("ERM") process.

In fiscal year 2025, we achieved our primary cybersecurity risk management objective of having no material cybersecurity incidents. Over the past three years, we have not experienced any material information security breaches and have not incurred material expenses from cybersecurity incidents, including those arising at third parties.

**Cybersecurity Risk Management and Strategy**

Our cybersecurity risk management program is designed as a holistic program focused on predicting, preventing, detecting, and responding to cybersecurity threats across enterprise systems as well as the operational technology systems for our plants and pipelines. This program involves relevant employees as well as third-party subject matter experts who collaborate to identify and proactively address risks.

The Company regularly assesses industry best practices, frameworks, and standards, and leverages them to advance its cybersecurity risk management maturity. These frameworks include the International Society of Automation and the International Electrotechnical Commission standards for industrial automation (ISA 62443) and information security (ISO 27001), as well as the National Institute of Standards and Technology Cybersecurity Framework (NIST CSF).

Our cybersecurity program includes risk-based procedures for the detection, analysis, and mitigation of cybersecurity incidents. Our cybersecurity incident response includes criteria for prioritization and escalation based on severity under an established incident prioritization framework. Incidents are reported internally to senior management, the Board or the Board's Audit and Finance Committee, as appropriate based on this framework. Incidents that are elevated based on their potential severity, including any event that is potentially material, are promptly escalated and analyzed for potential external reporting requirements.

As part of the Company's information security training program, all employees participate in various cybersecurity awareness activities, including an annual Information Security Awareness training module and monthly simulated email phishing events.

In addition to our internal resources, we leverage third-party service partners to expand the capabilities of our cybersecurity program. This may include testing the program's protection measures as well as services for incident detection, investigation, and recovery. We also leverage third-party service providers to conduct tabletop exercises and perform assessments against cybersecurity frameworks. In fiscal year 2025, Air Products conducted a comprehensive internal audit of its cybersecurity program to evaluate the effectiveness of controls across enterprise information technology, operational technology, and pipeline environments.

Our suppliers and third-party service providers are subject to cybersecurity obligations. Prior to engagement, we assess the cybersecurity posture of third-party service providers who store, process, or transmit Air Products' information. In many cases, our agreements include requirements for suppliers and other service providers to notify us if they suffer a cybersecurity incident that may affect us.

The Company maintains policies and procedures for preventive controls for enterprise applications including, but not limited to, access controls and change management. In addition, we maintain relevant business continuity and disaster recovery plans as part of our overall cybersecurity risk management strategy.

For a discussion of risks related to potential cybersecurity incidents, please refer to Item 1A, *Risk Factors - Risks Related to Our Business - Risks related to the approval, execution, and operation of our projects, particularly with respect to our largest projects, may adversely affect our operations or results of operations*, of this Annual Report on Form 10-K.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Cybersecurity Governance**

Our Board of Directors recognizes the importance of cybersecurity and has oversight responsibility for cybersecurity risks. The Board of Directors receives updates on our cybersecurity program at least quarterly from our Chief Information Officer ("CIO") and Chief Information Security Officer ("CISO"). In addition, the Board's Audit and Finance Committee, which is composed entirely of independent directors, receives quarterly reports regarding our ERM program and top risks, including those relating to cybersecurity.

Our CIO is a member of the Company's senior executive leadership team and is responsible for the administration of the cybersecurity risk management program. Prior to joining the company in 2020, our CIO spent 24 years in the aerospace and defense industry and held multiple senior leadership roles within digital technology, leading large global organizations in all aspects of digital technology, including cybersecurity risk management.

Under the direction of our CIO, our CISO oversees the development and implementation of our enterprise-wide cybersecurity risk management program, ensuring the protection of both enterprise and operational technology systems. Our CISO joined the Company in 2025 with an extensive background in cybersecurity strategy, governance, risk, compliance, and data protection. Prior to joining Air Products, our CISO spent over 25 years in executive security and operations management across the industrial manufacturing, software, and financial services industries. Our CISO maintains professional certifications in cybersecurity and information management, including as a Certified Chief Information Security Officer, Certified Information Systems Security Professional, and Certified Information Systems Manager.

The Information Security leadership team that reports to the CISO is composed of four security leaders with over 80 years of combined experience and multiple professional certifications.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Item 2. Properties**

Air Products and Chemicals, Inc. owns its principal administrative offices located at the Company's global headquarters and co-located research and development facility in Allentown, Pennsylvania, as well as regional offices in Medellin, Colombia; and Santiago, Chile. We lease the principal administrative offices in Shanghai, China; Pune, India; Vadodara, India; and Dhahran, Saudi Arabia. We lease administrative offices in the United States, Canada, England, Spain, Malaysia, and China, primarily for our Finance and Business Services organization.

Descriptions of the properties used by our five business segments are provided below. We believe that our facilities are suitable and adequate for our current and anticipated future levels of operation.

**Americas**

Our Americas segment operates from approximately 445 production and distribution facilities in North and South America. Of these facilities, approximately 20% are located on owned property. We have sufficient property rights and permits for the ongoing operation of our pipeline systems in the Gulf Coast, California, and Arizona in the United States and Alberta and Ontario in Canada. Management and sales support is based in our Allentown, Medellin, and Santiago offices referred to above, and at approximately 30 leased properties located throughout North and South America.

**Asia**

Our Asia segment operates from approximately 300 production and distribution facilities within the region, of which approximately 35% are on owned property or long-duration term grants. We have sufficient property rights and permits for the ongoing operation of our pipeline systems in China, South Korea, Taiwan, Malaysia, and Indonesia. Management and sales support for this business segment is based in Shanghai, China, and Kuala Lumpur, Malaysia, and in approximately 30 leased office locations throughout the region.

**Europe**

Our Europe segment operates from approximately 245 production and distribution facilities in Europe, of which approximately 35% are on owned property. We have sufficient property rights and permits for the ongoing operation of our pipeline systems in the Netherlands, the United Kingdom, Belgium, and France. Management and sales support for this business segment is based in Chertsey, England; and Barcelona, Spain; and at approximately 20 leased regional office sites and 15 leased local office sites throughout the region.

**Middle East and India**

Our Middle East and India segment operates from approximately 20 production and distribution facilities throughout the region, all of which are leasehold properties. Management and sales support for this business segment are based in Dharan, Saudi Arabia; Dubai, United Arab Emirates; and Pune, India; as well as approximately 10 leased local office sites throughout the region.

**Corporate and other**

This business segment includes our sale of equipment businesses for which equipment is manufactured in Missouri in the United States; Shanghai, China; and Johor, Malaysia. The Gardner Cryogenic business operates at facilities in Pennsylvania and Kansas in the United States. The Rotoflow business operates manufacturing and service facilities in Texas and Pennsylvania in the United States with management, engineering, and sales support based in the Allentown offices referred to above and a nearby leased office.

Research and development activities are primarily conducted at owned locations in the United States, the United Kingdom, and Saudi Arabia.

Helium is processed at multiple sites in the United States, Algeria, and Qatar, and distributed globally through a network of transfill sites.

Our Corporate and other segment also has management, sales, engineering support, and corporate administrative functions that are based in our administrative offices referred to above.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Item 3. Legal Proceedings**

In the normal course of business, we and our subsidiaries are involved in various legal proceedings, including commercial, competition, environmental, intellectual property, regulatory, product liability, and insurance matters. Although litigation with respect to these matters is routine and incidental to the conduct of our business, such litigation could result in large monetary awards, especially if compensatory and/or punitive damages are awarded. However, we believe that litigation currently pending to which we are a party will be resolved without any material adverse effect on our financial position, earnings, or cash flows.

From time to time, we are also involved in proceedings, investigations, and audits involving governmental authorities in connection with environmental, health, safety, competition, and tax matters.

We are a party to proceedings under CERCLA, RCRA, and similar state and foreign environmental laws relating to the designation of certain sites for investigation or remediation. Presently there are 26 sites on which a final settlement or remediation has not been achieved where we, usually along with others, have been designated as a potentially responsible party by environmental authorities or are otherwise engaged in investigation or remediation, including cleanup activity at certain of our former and current manufacturing sites. We do not expect that any sums we may have to pay in connection with these environmental matters would have a material adverse impact on our consolidated financial position. Additional information on our environmental exposure is included under Item 1, *Business*–*Environmental Regulation*, and Note 19, *Commitments and Contingencies*, to the consolidated financial statements.

In September 2010, the Brazilian Administrative Council for Economic Defense ("CADE") issued a decision against our Brazilian subsidiary, Air Products Brasil Ltda., and several other Brazilian industrial gas companies for alleged anticompetitive activities. CADE imposed a civil fine of R$179.2 million (approximately $34 as of 30 September 2025) on Air Products Brasil Ltda., which was based on a percentage of our total revenue in Brazil in 2003. In May 2014, our appeal was granted and the fine was dismissed. CADE appealed that ruling and in October 2025 the Supreme Court of Brazil rendered a judgment confirming the appellate ruling, which annulled the administrative proceeding and the fine imposed by CADE. Under applicable law, no further remedies are available and the judgment is final.

We do not currently believe there are any legal proceedings, individually or in the aggregate, that are reasonably possible to have a material impact on our financial condition, results of operations, or cash flows. However, a future charge for regulatory fines or damage awards could have a significant impact on our net income in the period in which it is recorded.

**Item 4. Mine Safety Disclosures**

Not applicable.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**PART II**

**Item 5. Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities**

Our common stock is listed on the New York Stock Exchange under the symbol "APD". As of 31 October 2025, there were 4,036 record holders of our common stock.

The Board of Directors determines whether to declare cash dividends on our common stock and the timing and amount based on financial condition and other factors it deems relevant. Dividends are paid quarterly, usually during the sixth week after the close of the fiscal quarter. We have increased our quarterly dividend for 43 consecutive years. Dividend information for each quarter of fiscal years 2025 and 2024 is summarized below:

---

| | | |
|:---|:---|:---|
| | **2025** | 2024 |
| Fourth quarter | **$1.79** | $1.77 |
| Third quarter | **1.79** | 1.77 |
| Second quarter | **1.79** | 1.77 |
| First quarter | **1.77** | 1.75 |
| Total | **$7.14** | $7.06 |

---

**Purchases of Equity Securities by the Issuer**

On 15 September 2011, the Board of Directors authorized the repurchase of up to $1.0 billion of our outstanding common stock. This program does not have a stated expiration date. If we repurchase shares pursuant to this authorization, we may do so under Rules 10b5-1 and 10b-18 under the Exchange Act through repurchase agreements established with one or more brokers. We have not purchased any of our outstanding shares under this program since fiscal year 2013. As of 30 September 2025, $485.3 million in share repurchase authorization remained available. Any future purchases will be completed at our discretion while maintaining sufficient funds for investing in our business and pursuing growth opportunities.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Performance Graph**

The performance graph below compares the five-year cumulative returns of our common stock with those of the Standard & Poor's 500 Index ("S&P 500 Index") and the Standard & Poor's 500 Materials Index ("S&P 500 Materials Index"). The figures assume an initial investment of $100 and the reinvestment of all dividends.

![1769](apd-20250930_g2.jpg)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Sept 2020 | Sept 2021 | Sept 2022 | Sept 2023 | Sept 2024 | Sept 2025 |
| Air Products & Chemicals, Inc. | 100 | 120 | 112 | 140 | 150 | 141 |
| S&P 500 Index | 100 | 150 | 126 | 154 | 210 | 247 |
| S&P 500 Materials Index | 100 | 142 | 125 | 147 | 184 | 176 |

---

**Item 6. [Reserved]**

Not applicable.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations**

---

| | |
|:---|:---|
| <u>[Business Overview](#i6c5d80e205be49368cbb0bd080310540_49)</u> | [29](#i6c5d80e205be49368cbb0bd080310540_49) |
| <u>[2025 in Summary](#i6c5d80e205be49368cbb0bd080310540_52)</u> | [30](#i6c5d80e205be49368cbb0bd080310540_52) |
| <u>[Outlook](#i6c5d80e205be49368cbb0bd080310540_55)</u> | [32](#i6c5d80e205be49368cbb0bd080310540_55) |
| <u>[Results of Operations](#i6c5d80e205be49368cbb0bd080310540_58)</u> | [33](#i6c5d80e205be49368cbb0bd080310540_58) |
| <u>[Reconciliations of Non-GAAP Financial Measures](#i6c5d80e205be49368cbb0bd080310540_61)</u> | [42](#i6c5d80e205be49368cbb0bd080310540_61) |
| <u>[Liquidity and Capital Resources](#i6c5d80e205be49368cbb0bd080310540_76)</u> | [49](#i6c5d80e205be49368cbb0bd080310540_76) |
| <u>[Pension Benefits](#i6c5d80e205be49368cbb0bd080310540_79)</u> | [54](#i6c5d80e205be49368cbb0bd080310540_79) |
| <u>[Critical Accounting Policies and Estimates](#i6c5d80e205be49368cbb0bd080310540_82)</u> | [56](#i6c5d80e205be49368cbb0bd080310540_82) |

---

This Management's Discussion and Analysis contains "forward-looking statements" within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements about business outlook. These forward-looking statements are based on management's expectations and assumptions as of the date of this Annual Report on Form 10-K and are not guarantees of future performance. Actual performance and financial results may differ materially from projections and estimates expressed in the forward-looking statements because of many factors not anticipated by management, including, without limitation, those described in "*Forward-Looking Statements"* and Item 1A, *Risk Factors*, of this Annual Report on Form 10-K.

This discussion should be read in conjunction with the consolidated financial statements and the accompanying notes contained in this Annual Report on Form 10-K. Financial information is presented on a continuing operations basis. Unless otherwise stated, amounts discussed are in millions of U.S. Dollars, except for per share data, which is calculated and presented on a diluted basis in U.S. Dollars per weighted average common share.

The financial measures discussed below are presented in accordance with U.S. generally accepted accounting principles ("GAAP"), except as noted. We present certain financial measures on an "adjusted", or "non-GAAP", basis because we believe such measures, when viewed together with financial results computed in accordance with GAAP, provide a more complete understanding of the factors and trends affecting our historical financial performance. For each non-GAAP financial measure, including adjusted operating income, adjusted operating margin, adjusted earnings per share ("EPS"), adjusted EBITDA, adjusted effective tax rate, and capital expenditures, we present a reconciliation to the most directly comparable financial measure calculated in accordance with GAAP. These reconciliations and explanations regarding the use of non-GAAP financial measures are presented under the "*Reconciliations of Non-GAAP Financial Measures*" section beginning on page <u>[42](#i6c5d80e205be49368cbb0bd080310540_61)</u>.

Comparisons included in the discussion that follows are for fiscal year 2025 versus ("vs.") fiscal year 2024. A discussion of changes from fiscal year 2023 to fiscal year 2024 and other financial information related to fiscal year 2023 is available in <u>[Part II, Item 7,](https://www.sec.gov/Archives/edgar/data/2969/000000296924000056/apd-20240930.htm#i81a6c7b1aa154edda95d8bb8e734184e_49)[Management's Discussion and Analysis of Financial Condition and Results of Operations](https://www.sec.gov/Archives/edgar/data/2969/000000296924000056/apd-20240930.htm#i81a6c7b1aa154edda95d8bb8e734184e_49)</u>, of our Annual Report on Form 10-K for the fiscal year ended 30 September 2024, which was filed with the SEC on 21 November 2024.

For information concerning activity with our related parties, refer to Note 25, *Supplemental Information*, to the consolidated financial statements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**BUSINESS OVERVIEW**

Air Products and Chemicals, Inc., a Delaware corporation founded in 1940, is a world-leading industrial gases company that has built a reputation for its innovation, operational excellence, and commitment to safety and environmental stewardship. Focused on serving energy, environmental, and emerging markets and generating a cleaner future, we offer products and services that improve our customers' operations and sustainability.

We serve a broad range of industries, including refining, chemicals, metals, electronics, manufacturing, medical, and food, providing essential industrial gases, related equipment, and applications expertise. We also develop, engineer, build, own, and operate some of the world's largest clean hydrogen projects supporting the transition to low- and zero-carbon energy, particularly in industrial applications and the heavy-duty transportation sector. Additionally, our sale of equipment businesses provide specialized products such as turbomachinery, membrane systems, and cryogenic containers to customers worldwide. For additional information on our product and service offerings, including production, distribution, and end use, refer to Item 1, *Business*, of this Annual Report on Form 10-K.

We conduct business in approximately 50 countries and regions throughout the world. Our industrial gases business is organized and operated regionally in the Americas, Asia, Europe, and Middle East and India segments and generates the majority of our sales via our on-site and merchant supply modes. Approximately half our total revenue is generated through the on-site supply mode, which is governed by contracts that are generally long-term in nature with provisions that allow us to pass through changes in energy costs to our customers.

Our Corporate and other segment includes the results of our sale of equipment businesses, costs for corporate support functions and global management activities, and other income and expenses not directly associated with the regional segments, such as foreign exchange gains and losses. In fiscal year 2024, this segment also included the results of our former liquefied natural gas ("LNG") process technology and equipment business, which we sold to Honeywell International Inc. on 30 September 2024.

For additional information regarding our supply modes and business segments, refer to Note 7, *Revenue Recognition*, and Note 26, *Business Segment and Geographic Information*, to the consolidated financial statements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**2025 IN SUMMARY**

Fiscal year 2025 was a transitional year for Air Products, marked by a renewed focus on our core industrial gas business under the leadership of our new Chief Executive Officer, who joined the Company in February 2025. We took decisive actions to reshape our portfolio, including the cancellation and descoping of several large energy transition projects, and enhance operations through targeted productivity initiatives. We also sharpened our approach to capital deployment, emphasizing strict return thresholds, appropriate risk-sharing, and alignment with long-term customer relationships. These efforts are helping to improve execution and support reductions in capital expenditures and debt over time.

Key results versus the prior year include:

&nbsp;&nbsp;&nbsp;&nbsp;• Sales of $12.0 billion decreased 1%, or $63.3, as 4% lower volumes were partially offset by 2% higher energy cost pass-through to customers and 1% higher pricing driven by non-helium merchant products across all regions. Lower volumes primarily reflect the September 2024 LNG sale, lower global helium demand, and previously announced project exits, partially offset by higher on-sites and favorable non-helium merchant.

&nbsp;&nbsp;&nbsp;&nbsp;• Operating loss was $877.0 compared to operating income of $4.5 billion in fiscal year 2024. The operating loss in fiscal year 2025 included approximately $3.7 billion in pre-tax charges related to business and asset actions ($3.0 billion after tax, or $13.68 per share). Operating income in fiscal year 2024 included a $1.6 billion pre-tax gain on the September 2024 sale of the LNG business ($1.2 billion after tax, or $5.38 per share).

&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted operating income of $2.9 billion decreased 3%, or $89.8, due to lower volumes and higher costs, partially offset by higher non-helium pricing. The higher costs were driven by fixed-cost inflation and depreciation, partially offset by productivity improvements across all segments.

&nbsp;&nbsp;&nbsp;&nbsp;• Equity affiliates' income of $647.7 was flat. Increased contributions from affiliates in the Europe and Asia segments were offset by lower income from affiliates in the Corporate and other, Middle East and India, and Americas segments.

&nbsp;&nbsp;&nbsp;&nbsp;• Net loss was $354.4 compared to net income of $3.9 billion in fiscal year 2024. The decrease was primarily due to higher charges for business and asset actions in fiscal year 2025 and the prior year gain from the sale of the LNG business.

&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA of $5.1 billion increased 1%, or $30.1.

&nbsp;&nbsp;&nbsp;&nbsp;• Loss per share of $1.74 was driven by an after-tax charge attributable to Air Products of $3.0 billion for business and asset actions recorded during fiscal year 2025. On a non-GAAP basis, adjusted earnings per share ("EPS") was $12.03. In the prior year, EPS was $17.24 and adjusted EPS was $12.43. A summary table of changes in EPS is presented on page <u>[31](#i6c43be20e397408780b888b1263c1007_3757)</u>.

&nbsp;&nbsp;&nbsp;&nbsp;• We believe providing a consistent dividend plays a critical part in the creation of shareholder value. During fiscal year 2025, we marked our 43<sup>rd</sup> consecutive year of increasing our dividends and returned approximately $1.6 billion to our shareholders through dividend payments.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Changes in Diluted EPS Attributable to Air Products**

The per share impacts for the items presented in the table below were calculated independently and may not sum to the total change in diluted EPS due to rounding.

---

| | | | |
|:---|:---|:---|:---|
| Fiscal Year Ended 30 September | **2025** | 2024 | Change vs.<br>Prior Year |
| **Earnings (Loss) per share** | **($1.77)** | $17.18 | ($18.95) |
| Less: Loss per share from discontinued operations | **(0.04)** | (0.06) | 0.02 |
| **Earnings (Loss) per share from continuing operations** | **($1.74)** | $17.24 | ($18.98) |
| **% Change from prior year** |  |  | \*\* |
| **Operating Items** |  |  |  |
| Underlying business: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Volume |  |  | ($0.45) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Price, net of variable costs |  |  | 0.20 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other costs |  |  | (0.11) |
| Currency |  |  | 0.03 |
| Business and asset actions<sup>(A)</sup> |  |  | (13.46) |
| Shareholder activism-related costs |  |  | (0.32) |
| Gain on sale of business |  |  | (5.15) |
| Gain on sale of other assets<sup>(B)</sup> |  |  | 0.11 |
| **Total Operating Items** |  |  | ($19.15) |
| **Other Impacts** |  |  |  |
| Equity affiliates' income |  |  | $0.03 |
| Equity method investment impairment associated with business and asset actions<sup>(A)</sup> |  |  | (0.02) |
| Interest expense |  |  | 0.02 |
| Other non-operating income/expense, net: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on de-designation of cash flow hedges<sup>(C)</sup> |  |  | 0.05 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-service pension cost, net |  |  | 0.19 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other |  |  | (0.09) |
| Change in effective tax rate, excluding discrete items below |  |  | (0.07) |
| Tax reform adjustment related to deemed foreign dividends |  |  | 0.16 |
| Tax on repatriation of foreign earnings |  |  | (0.14) |
| Noncontrolling interests <sup>(A)(C)</sup> |  |  | 0.05 |
| Weighted average diluted shares |  |  | (0.01) |
| **Total Other Items** |  |  | $0.17 |
| **Total Change** |  |  | ($18.98) |
| **% Change from prior year** |  |  | \*\* |

---

\*\*Change versus prior period is not meaningful due to materially higher charges for business and asset actions in fiscal year 2025. The per share impact of these charges is primarily reflected in the "Operating Items" section in the table above.

<sup>(A)</sup>The per share impacts associated with charges for business and asset actions were calculated based on a total after-tax charge attributable to Air Products of approximately $3.0 billion ($13.68 per share). The amount of the charges attributable to our noncontrolling partners was $10.7.

<sup>(B)</sup>Gain on the sale of a regional office in Hersham, England, is reflected on the consolidated income statements within "Other income (expense), net."

<sup>(C)</sup>The per share impact reflected within "Gain on de-designation of cash flow hedges" was calculated based on an after-tax gain attributable to Air Products of $7.2 ($0.03 per share) compared to a loss of $4.3 ($0.02 per share) in the prior year. Amounts attributable to our noncontrolling partners were a gain of $17.6 and a loss of $10.6, respectively.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

The table below summarizes the diluted per share impact of our non-GAAP adjustments in fiscal years 2025 and 2024. These impacts were calculated independently and may not sum to totals due to rounding.

---

| | | | |
|:---|:---|:---|:---|
| Fiscal Year Ended 30 September | **2025** | 2024 | Change vs.<br>Prior Year |
| **Earnings (Loss) per Share** | **($1.74)** | $17.24 | ($18.98) |
| Business and asset actions | **13.68** | 0.20 | 13.48 |
| Shareholder activism-related costs | **0.32** |  | 0.32 |
| Gain on sale of business | **(0.23)** | (5.38) | 5.15 |
| Gain on sale of other assets | **(0.11)** |  | (0.11) |
| (Gain) Loss on de-designation of cash flow hedges | **(0.03)** | 0.02 | (0.05) |
| Non-service pension cost, net | **0.15** | 0.34 | (0.19) |
| Tax reform adjustment related to deemed foreign dividends | **(0.16)** |  | (0.16) |
| Tax on repatriation of foreign earnings | **0.14** |  | 0.14 |
| **Adjusted Earnings per Share** | **$12.03** | $12.43 | ($0.40) |
| **% Change from prior year** |  |  | (3%) |

---

**OUTLOOK**

Statements regarding business outlook should be read in conjunction with the Forward-Looking Statements of this Annual Report on Form 10-K.

As we look ahead, we believe Air Products is well-positioned to deliver sustainable growth through a renewed focus on our core industrial gas business. Decisive actions taken in fiscal year 2025, including the cancellation and descoping of several large energy transition projects and other targeted productivity initiatives, reflect our commitment to disciplined capital allocation and operational excellence. These actions allow us to concentrate resources on opportunities that will deliver the greatest value to our shareholders.

While clean energy markets have not developed as previously anticipated, we remain confident in the long-term demand fundamentals for industrial gases and clean energy solutions. We continue to pursue opportunities in both traditional industrial gas and energy transition projects that meet our projected return requirements. Additionally, we have made significant progress on the construction of several energy transition projects, including the NEOM Green Hydrogen Project, which we expect to come onstream and deliver green ammonia in 2027.

In fiscal year 2026, we expect to achieve earnings growth from new plant onstreams, continued pricing discipline, and productivity improvements. We remain committed to cost control, a reduction in capital expenditures, and other measures aimed at unlocking value and generating cash. Cost discipline remains a top priority as we seek to mitigate the impact of ongoing inflationary pressures and continued helium headwinds, while continuing to reward shareholders through increased dividends, as we have done for the past 43 consecutive years.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**RESULTS OF OPERATIONS**

**DISCUSSION OF CONSOLIDATED RESULTS**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | | Change vs. Prior Year | Change vs. Prior Year |
| Fiscal Year Ended 30 September | 2025 | 2024 | $%/bp | %/bp |
| **GAAP Measures** |  |  |  |  |
| &nbsp;&nbsp;Sales | $12037.3 | $12100.6 | (1 | %) |
| &nbsp;&nbsp;Operating income (loss) | (877.0) | 4466.1 | \*\* | \*\* |
| &nbsp;&nbsp;Operating margin | (7.3%) | 36.9% | \*\* | \*\* |
| &nbsp;&nbsp;Equity affiliates' income | $647.7 | $647.7 |  | % |
| &nbsp;&nbsp;Net income (loss) | (354.4) | 3862.4 | \*\* | \*\* |
| **Non-GAAP Measures** |  |  |  |  |
| &nbsp;&nbsp;Adjusted operating income | $2857.7 | $2947.5 | (3 | %) |
| &nbsp;&nbsp;Adjusted operating margin | 23.7% | 24.4% | (70 | bp) |
| &nbsp;&nbsp;Adjusted EBITDA | $5076.4 | $5046.3 | 1 | % |

---

\*\* Change versus prior period is not meaningful due to charges for business and asset actions recorded in fiscal year 2025.

<u>Sales</u>

The table below summarizes the major factors that impacted consolidated sales for the periods presented:

---

| | |
|:---|:---|
| Volume | (4%) |
| Price | 1% |
| Energy cost pass-through to customers | 2% |
| Currency | —% |
| **Total Consolidated Sales Change** | **(1** **%)** |

---

Sales of $12.0 billion decreased 1%, or $63.3, as lower volumes of 4% were partially offset by higher energy cost pass-through to customers of 2% and favorable pricing of 1%. Lower volumes primarily reflect the September 2024 LNG sale, lower global helium demand, and the previously announced project exits, partially offset by higher on-sites and favorable non-helium merchant. The overall pricing improvement reflects a 2% increase in our merchant business, which was driven by non-helium product lines in our Europe and Americas segments. Currency was flat versus the prior year.

<u>Cost of Sales and Gross Margin</u>

Cost of sales of $8.3 billion increased 1%, or $87.3, due to higher energy cost pass-through to customers of $278, higher costs of $73, higher power and fuel costs in our merchant business of $49, and an unfavorable currency impact of $12. The higher costs of $73 were driven by fixed-cost inflation and depreciation, partially offset by productivity improvements. These impacts were partially offset by lower costs of $325 attributable to lower sales volumes. Gross margin of 31.4% decreased 110 bp from 32.5% in the prior year primarily due to higher costs and increased energy cost pass-through to customers.

<u>Selling and Administrative Expense</u>

Selling and administrative expense of $906.1 decreased 4%, or $36.3, as our productivity actions were partially offset by labor inflation. Selling and administrative expense as a percentage of sales decreased to 7.5% from 7.8% in the prior year.

<u>Research and Development Expense</u>

Research and development expense of $96.3 decreased 4%, or $3.9. Research and development expense as a percentage of sales of 0.8% was flat versus the prior year.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Business and Asset Actions</u>

The charges we record for business and asset actions are not recorded in segment results. Additional information regarding these actions can be found in Note 5, *Business and Asset Actions*, to the consolidated financial statements.

In fiscal year 2025, total pre-tax charges related to business and asset actions were approximately $3.7 billion ($3.0 billion attributable to Air Products after tax, or $13.68 per share) compared to $57.0 ($43.8 after tax, or $0.20 per share) in fiscal year 2024.

During the second quarter of fiscal year 2025, our Board of Directors and Chief Executive Officer initiated a project review to focus resources on projects we believe will deliver the greatest value to our shareholders. As a result of this review, we made the decision to exit various projects, primarily related to clean energy generation and distribution. The review remains ongoing and may result in additional costs in future periods. In connection with this review, we recognized project exit costs totaling approximately $3.6 billion, primarily consisting of noncash asset write-downs and estimated costs to terminate contractual commitments. Costs attributable to our noncontrolling partners totaled $10.7.

The remaining charge of $123.7 in fiscal year 2025 related to severance and other employee benefits under a global cost reduction program initiated in June 2023. Fiscal year 2024 costs under the plan totaled $57.0. Once all actions under the plan are fully executed, we expect to realize annual pre-tax savings of approximately $240 to $260, primarily through selling and administrative expense.

Our estimates related to the actions discussed above reflect our best judgment based on information available as of 30 September 2025. Final settlement of these items may differ materially from our current estimates, which could impact our consolidated financial statements in future periods.

<u>Shareholder Activism-Related Costs</u>

Shareholder activism-related costs totaling $86.3 ($71.7 after tax, or $0.32 per share) were reflected in our consolidated income statements during the first three quarters of fiscal year 2025. These costs were recorded in connection with a proxy contest that concluded in January 2025 following certification of the election of directors at the 2025 Annual Meeting of Shareholders. These costs were not allocated to our reportable segments. No shareholder activism-related charges were recorded during the fourth quarter.

Of the total $86.3 reflected on our fiscal year 2025 income statement, $31.9 related to legal and professional service fees and proxy solicitation expenses incurred directly by Air Products, primarily during the first quarter. In the second quarter, $29.7 was recorded for executive separation costs following the Board of Directors' appointment of a new Chief Executive Officer in February 2025, which included a noncash expense of $22.4 to accelerate vesting of share-based awards and $7.3 in severance and other cash benefits. The remaining $24.7 was authorized and paid during the third quarter as a reimbursement to Mantle Ridge LP and its affiliated entities (collectively, "Mantle Ridge") for expenses incurred in connection with the proxy contest. The reimbursement was unanimously approved by our Board of Directors, with one director abstaining from the vote due to his role as founder and Chief Executive Officer of Mantle Ridge.

Refer to Note 25, *Supplemental Information*, for additional information.

<u>Gain on Sale of Business</u>

In April 2025, we completed the sale of our 100% ownership interest in a consolidated subsidiary in Singapore for cash proceeds of $104.3. We recognized a gain of $67.3 ($51.9 after tax, or $0.23 per share) in connection with the transaction during the third quarter of fiscal year 2025. Prior to the divestiture, the subsidiary contributed annual sales of approximately $50 to our Asia segment.

On 30 September 2024, we completed the sale of our LNG business to Honeywell International Inc. As a result of the transaction, we recorded a gain of $1.6 billion ($1.2 billion after tax, or $5.38 per share) during the fourth quarter of fiscal year 2024. Prior to the divestiture, the results of the LNG business were reflected within the Corporate and other segment.

The gains from the sale of the businesses discussed above were not recorded in segment results. Refer to Note 4, *Gain on Sale of Business*, to the consolidated financial statements for additional information.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Other Income (Expense), Net</u>

Other income of $110.1 increased 89%, or $51.9. The increase was primarily driven by a $31.3 gain ($23.8 after tax, or $0.11 per share) on the sale of a regional office in Hersham, England, during the third quarter of fiscal year 2025. This gain is not reflected in the results of the Europe segment.

<u>Operating Income (Loss) and Operating Margin</u>

Operating loss was $877.0 in fiscal year 2025 compared to income of $4.5 billion in the prior year. The loss in fiscal year 2025 was primarily attributable to higher pre-tax charges for business and asset actions, which totaled $3.7 billion in fiscal year 2025 compared to $57 in fiscal year 2024. Additionally, the prior year included a $1.6 billion pre-tax gain on the sale of the LNG business. Unfavorable volumes lowered operating income by $122, primarily due to the divestiture of the LNG business in September 2024. Operating income contributed by the LNG business in the prior year was approximately $135. Fiscal year 2025 also included shareholder activism-related costs of $86. In addition, other costs were unfavorable by $31, primarily reflecting fixed-cost inflation and higher depreciation, partially offset by productivity improvements. We also recorded pre-tax gains totaling approximately $99 in connection with the sale of a consolidated subsidiary and the sale of a regional office during the third quarter of fiscal year 2025. Furthermore, higher pricing primarily from non-helium merchant products favorably impacted operating results by $55, net of power and fuel costs.

Due to these factors, operating margin was negative 7.3% compared to 36.9% in the prior year.

<u>Adjusted Operating Income and Adjusted Operating Margin</u>

Adjusted operating income of $2.9 billion decreased 3%, or $89.8, due to lower volumes and higher costs, partially offset by higher non-helium pricing. The higher costs were driven by fixed-cost inflation and depreciation, partially offset by productivity improvements. Adjusted operating margin of 23.7% decreased 70bp from 24.4% in the prior year. Approximately 50bp of the decline was attributable to increased energy cost pass-through to customers.

<u>Equity Affiliates' Income</u>

Equity affiliates' income of $647.7 was flat compared to the prior year. Increased contributions from affiliates in the Europe and Asia segments were offset by lower income from affiliates in the Corporate and other, Middle East and India, and Americas segments.

<u>Interest Expense</u>

---

| | | |
|:---|:---|:---|
| Fiscal Year Ended 30 September | **2025** | 2024 |
| Interest incurred | **$615.8** | $507.9 |
| Less: Capitalized interest | **401.8** | 289.1 |
| **Interest expense** | **$214.0** | $218.8 |

---

Interest expense decreased 2%, or $4.8, driven by a higher carrying value of ongoing projects under construction despite our decision to exit various projects in fiscal year 2025. This decrease was partially offset by higher interest incurred on principal borrowings from Euro- and U.S. Dollar-denominated senior fixed-rate notes issued in February and June 2025.

<u>Other Non-Operating Income (Expense), Net</u>

Other non-operating income of $2.6 increased $76.4 from an expense of $73.8 in the prior year. The increase was primarily driven by lower non-service pension costs, which totaled $45.0 ($33.7 after tax, or $0.15 per share) in fiscal year 2025, compared to $102.0 ($76.8 after tax, or $0.34 per share) in the prior year. Additionally, de-designated interest rate swaps related to financing for the NEOM Green Hydrogen Project resulted in an unrealized gain of $27.0 ($7.2 attributable to Air Products after tax, or $0.03 per share), compared to an unrealized loss of $16.3 ($4.3 after tax, or $0.02 per share) in the prior year. Refer to Note 3, *Variable Interest Entities*, and Note 15, *Financial Instruments*, to the consolidated financial statements for additional information. These benefits were partially offset by lower interest income on short-term investments.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Discontinued Operations</u>

We recorded net losses from discontinued operations of $8.0 and $13.9 in fiscal years 2025 and 2024, respectively.

In fiscal year 2025, a pre-tax loss from discontinued operations of $10.6 ($8.0 after tax, or $0.04 per share) was recorded in the third quarter primarily to increase our existing liability for retained environmental remediation obligations related to production facilities in the atmospheric emulsions and global pressure-sensitive adhesives businesses, which were sold in 2008. Refer to the "Piedmont" discussion under Note 19, *Commitments and Contingencies*, for additional information.

In fiscal year 2024, a pre-tax loss from discontinued operations of $19.4 ($13.9 after tax, or $0.06 per share) was recorded in the fourth quarter to increase our existing liability for retained environmental remediation obligations related to the 2006 sale of the Amines business. Refer to the "Pace" discussion under Note 19, *Commitments and Contingencies*, for additional information.

<u>Net Income (Loss)</u>

Net loss was $354.4 for fiscal year 2025 compared to net income of $3.9 billion in the prior year. The loss in fiscal year 2025 was primarily attributable to after-tax charges for business and asset actions, which totaled $3.0 billion in fiscal year 2025 compared to $44 in the prior year. Additionally, fiscal year 2024 included a $1.2 billion after-tax gain recognized from the sale of the LNG business in September 2024.

<u>Adjusted EBITDA</u>

Adjusted EBITDA of $5.1 billion increased 1%, or $30.1, as higher pricing and productivity improvements were partially offset by lower volumes and fixed-cost inflation.

<u>Effective Tax Rate</u>

The effective tax rate equals the income tax expense (benefit) divided by income or loss before taxes. Equity affiliates' income is primarily included net of income taxes within income before taxes on our consolidated income statements.

For the fiscal year ended 30 September 2025, our consolidated income statements include an income tax benefit of $94.3 compared to an income tax expense of $944.9 for the comparative prior-year period. The tax benefit in fiscal year 2025 represents an effective tax rate of 21.4% on the pre-tax loss reported for the fiscal year ended 30 September 2025 compared to an effective rate of 19.6% for tax expense on the pre-tax income reported for the fiscal year ended 30 September 2024.

The current year rate was primarily impacted by charges for business and asset actions and other items as further discussed below. Our estimates related to these items reflect our best judgment based on information available as of 30 September 2025. The amount and timing of final settlement of these items may differ from our current estimates, which could impact our tax provision in future periods.

Our prior year effective tax rate included impacts from the $1.6 billion gain on the sale of the LNG business during the fourth quarter of fiscal year 2024. This gain increased our income from continuing operations before taxes, which diluted the impact of recurring effective tax rate reconciling items for fiscal year 2024.

For additional information, refer to Note 24, *Income Taxes*, to the consolidated financial statements.

*Business and Asset Actions*

In fiscal year 2025, we recorded charges for project exits and other cost reduction measures as described in Note 5, *Business and Asset Actions*, to the consolidated financial statements. These actions resulted in a pre-tax charge of approximately $3.7 billion. The related net tax benefit of these actions totaled $695.2, which includes an $11.3 cost for reserves established for uncertain tax positions related to the deductibility of the amount of the charges incurred in foreign subsidiaries. We also recorded a net tax cost of $197.4 resulting from a $364.9 increase in our valuation allowance net of $167.5 of deferred tax assets related to the future disposal of certain foreign subsidiaries.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

*Tax Reform Adjustment Related to Deemed Foreign Dividends*

During the second quarter of fiscal year 2025, we recorded a net income tax benefit of $34.9 related to our intent to file a refund claim after a review of several U.S. Tax Court cases regarding the U.S. taxation of deemed foreign dividends in the transition year of the U.S. Tax Cuts and Jobs Act (our fiscal year 2018).

*Tax on Repatriation of Foreign Earnings*

During the second quarter of fiscal year 2025, we recorded an income tax expense of $31.4 related to estimated withholding taxes on foreign earnings that we no longer intend to indefinitely reinvest. There were no other significant changes to our assumptions regarding the reinvestment of foreign earnings during fiscal year 2025.

*Shareholder Activism-Related Costs*

During fiscal year 2025, we recorded costs of $86.3 related to a proxy contest as further discussed in Note 25, *Supplemental Information*, to the consolidated financial statements. We recognized an income tax benefit of $14.6 primarily related to costs for legal and other professional service fees as well as incremental proxy solicitation costs related to the 2025 Annual Meeting of Shareholders.

*Other*

In addition to the items discussed above, our effective tax rate was higher in fiscal year 2025 due to lower tax benefits on U.S. export income in fiscal year 2025, higher net costs on foreign-related income taxed in the U.S, and an income tax benefit for a tax election related to a non-U.S. subsidiary that occurred in our prior fiscal year but did not recur in fiscal year 2025. These increases were partially offset by larger benefits in fiscal year 2025 for the release of unrecognized tax benefits upon expiration of the applicable statute of limitations.

<u>Adjusted Effective Tax Rate</u>

Our adjusted effective tax rate, which excludes the impact of the business and asset actions described above as well as other adjustments in the "Reconciliations of Non-GAAP Financial Measures" section beginning on page <u>[42](#i6c5d80e205be49368cbb0bd080310540_61)</u>, was 18.2% and 17.8% for the fiscal years ended 30 September 2025 and 2024, respectively.

<u>H.R.1</u>

On 4 July 2025, H.R.1, commonly referred to as the One Big Beautiful Bill Act ("OBBBA"), was enacted in the United States. OBBBA includes a broad range of tax reform provisions, including extending and modifying certain key U.S. Tax Cuts and Jobs Act provisions (both domestic and international), expanding certain Inflation Reduction Act incentives, and accelerating the phase-out of others. OBBBA did not have a material impact on our fiscal year 2025 results and is expected to primarily affect future fiscal years.

While OBBBA revised certain Inflation Reduction Act incentives, we continue to anticipate future benefits from tax credits related to certain clean hydrogen production projects, where construction has begun or is expected to begin prior to the applicable phase-out dates.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**DISCUSSION OF RESULTS BY BUSINESS SEGMENT**

<u>Americas</u>

---

| | | | |
|:---|:---|:---|:---|
| | | | <u>Change vs. Prior Year</u> |
| Fiscal Year Ended 30 September | **2025** | 2024 | $%/bp |
| **GAAP Measures** |  |  |  |
| &nbsp;&nbsp;Sales | **$5125.9** | $5040.1 | 2% |
| &nbsp;&nbsp;Operating income | **1519.6** | 1565.1 | (3%) |
| &nbsp;&nbsp;Operating margin | **29.6%** | 31.1% | (150 bp) |
| &nbsp;&nbsp;Equity affiliates' income | **$157.0** | $158.8 | (1%) |
| **Non-GAAP Measure** |  |  |  |
| &nbsp;&nbsp;Adjusted EBITDA | **2408.7** | 2423.2 | (1%) |

---

The table below summarizes the major factors that impacted sales in the Americas segment for the periods presented:

---

| | |
|:---|:---|
| Volume | (3%) |
| Price | 2% |
| Energy cost pass-through to customers | 4% |
| Currency | (1%) |
| **Total Americas Sales Change** | **2%** |

---

Sales of $5.1 billion increased 2%, or $85.8, as higher energy cost pass-through to customers of 4% and higher pricing of 2% were partially offset by lower volumes of 3% and an unfavorable currency impact of 1%. Higher energy cost pass-through to customers was primarily attributable to higher natural gas prices. The overall pricing improvement reflects a 3% increase in our merchant business, which was driven by non-helium product lines. Volumes were unfavorable primarily due to lower on-sites, driven by previously announced project exits and the impact of a one-time asset sale in the prior year related to a customer-initiated early contract termination. Lower helium demand also contributed to the volume decline, despite a significant, non-recurring helium sale to an existing merchant customer in the first quarter. These headwinds were partially offset by a favorable one-time customer contract amendment in the second quarter of fiscal year 2025.

Operating income of $1.5 billion decreased 3%, or $45.5, due to higher costs of $92 and unfavorable currency of $10, partially offset by positive pricing, net of power and fuel costs, of $41 and favorable business mix of $15. The increase in costs was mainly driven by higher depreciation, maintenance, and fixed-cost inflation, partially offset by productivity improvements. Additionally, income recognized from the sale of an equity method investment in the first quarter of fiscal year 2025 was largely offset by a favorable legal settlement recorded in the prior year. Operating margin of 29.6% decreased 150 bp from 31.1% in the prior year as the margin impacts of higher costs and higher energy cost pass-through to customers were partially offset by favorable business mix. Approximately 100 bp of the decline was attributable to higher energy cost pass-through.

Equity affiliates' income of $157.0 decreased 1%, or $1.8, driven by our share of income from an asset sale in the prior year, partially offset by higher income from an affiliate in Mexico.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Asia</u>

---

| | | | |
|:---|:---|:---|:---|
| | | | <u>Change vs. Prior Year</u> |
| Fiscal Year Ended 30 September | **2025** | 2024 | $%/bp |
| **GAAP Measures** |  |  |  |
| &nbsp;&nbsp;Sales | **$3271.0** | $3224.3 | 1% |
| &nbsp;&nbsp;Operating income | **851.1** | 859.2 | (1%) |
| &nbsp;&nbsp;Operating margin | **26.0%** | 26.6% | (60 bp) |
| &nbsp;&nbsp;Equity affiliates' income | **$42.3** | $32.9 | 29% |
| **Non-GAAP Measure** |  |  |  |
| &nbsp;&nbsp;Adjusted EBITDA | **1412.3** | 1363.1 | 4% |

---

The table below summarizes the major factors that impacted sales in the Asia segment for the periods presented:

---

| | |
|:---|:---|
| Volume | —% |
| Price | (1%) |
| Energy cost pass-through to customers | 2% |
| Currency | —% |
| **Total Asia Sales Change** | **1%** |

---

Sales of $3.3 billion increased 1%, or $46.7, as higher energy cost pass-through to customers of 2% was partially offset by lower pricing of 1%. The overall pricing decrease reflects a 2% decline in our merchant business, primarily driven by lower helium pricing. Volumes were flat, with growth in on-sites offset by lower demand for helium.

Operating income of $851.1 decreased 1%, or $8.1, primarily due to lower pricing, net of power and fuel costs, of $30 and unfavorable business mix of $23, partially offset by lower costs of $48. The cost improvement was primarily attributable to productivity and lower maintenance costs, which was partially offset by higher costs related to incentive compensation and fixed-cost inflation. Due to these factors, operating margin of 26.0% decreased 60 bp from 26.6% in the prior year.

Equity affiliates' income of $42.3 increased 29%, or $9.4, driven by prior year maintenance expense at an affiliate in China as well as higher income from affiliates in Thailand in fiscal year 2025.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Europe</u>

---

| | | | |
|:---|:---|:---|:---|
| | | | <u>Change vs. Prior Year</u> |
| Fiscal Year Ended 30 September | **2025** | 2024 | $%/bp |
| **GAAP Measures** |  |  |  |
| &nbsp;&nbsp;Sales | **$2984.5** | $2823.4 | 6% |
| &nbsp;&nbsp;Operating income | **844.7** | 810.0 | 4% |
| &nbsp;&nbsp;Operating margin | **28.3%** | 28.7% | (40 bp) |
| &nbsp;&nbsp;Equity affiliates' income | **$101.9** | $88.1 | 16% |
| **Non-GAAP Measure** |  |  |  |
| &nbsp;&nbsp;Adjusted EBITDA | **1194.0** | 1105.2 | 8% |

---

The table below summarizes the major factors that impacted sales in the Europe segment for the periods presented:

---

| | |
|:---|:---|
| Volume | 1% |
| Price | 2% |
| Energy cost pass-through to customers | 1% |
| Currency | 2% |
| **Total Europe Sales Change** | **6%** |

---

Sales of $3.0 billion increased 6%, or $161.1, due to higher pricing of 2%, a favorable currency impact of 2%, higher volumes of 1%, and higher energy cost pass-through to customers of 1%. The overall pricing improvement reflects a 3% increase in our merchant business, which was driven by non-helium product lines. The 1% volume growth was supported by higher on-site activity, partially offset by lower helium demand.

Operating income of $844.7 increased 4%, or $34.7, due to favorable pricing, net of power and fuel costs, of $42 and favorable currency of $14, partially offset by an unfavorable business mix of $13 and higher costs of $8. Higher costs for depreciation and fixed-cost inflation were partially offset by productivity improvements. Due to these factors, operating margin of 28.3% decreased 40 bp from 28.7% in the prior year.

Equity affiliates' income of $101.9 increased 16%, or $13.8, driven by higher income from affiliates in Italy and South Africa.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Middle East and India</u>

---

| | | | |
|:---|:---|:---|:---|
| | | | <u>Change vs. Prior Year</u> |
| Fiscal Year Ended 30 September | **2025** | 2024 | $% |
| **GAAP Measures** |  |  |  |
| &nbsp;&nbsp;Sales | **$135.9** | $134.4 | 1% |
| &nbsp;&nbsp;Operating income | **9.6** | 5.9 | 63% |
| &nbsp;&nbsp;Equity affiliates' income | **340.9** | 347.5 | (2%) |
| **Non-GAAP Measure** |  |  |  |
| &nbsp;&nbsp;Adjusted EBITDA | **376.4** | 380.0 | (1%) |

---

Sales of $135.9 increased 1%, or $1.5, primarily due to higher volumes. Operating income of $9.6 increased 63%, or $3.7, primarily due to lower costs following the deconsolidation of Blue Hydrogen Industrial Gases Company ("BHIG") in the second quarter of fiscal year 2025, as well as productivity improvements.

Equity affiliates' income of $340.9 decreased 2%, or $6.6, driven by JIGPC.

<u>Corporate and other</u>

---

| | | | |
|:---|:---|:---|:---|
| | | | <u>Change vs. Prior Year</u> |
| Fiscal Year Ended 30 September | **2025** | 2024 | $% |
| **GAAP Measures** |  |  |  |
| &nbsp;&nbsp;Sales | **$520.0** | $878.4 | (41%) |
| &nbsp;&nbsp;Operating loss | **(367.3)** | (292.7) | (25%) |
| &nbsp;&nbsp;Equity affiliates' income | **12.4** | 20.4 | (39%) |
| **Non-GAAP Measure** |  |  |  |
| &nbsp;&nbsp;Adjusted EBITDA | **(315.0)** | (225.2) | (40%) |

---

Sales of $520.0 decreased 41%, or $358.4, and operating loss of $367.3 increased 25%, or $74.6, primarily due to the divestiture of the LNG business in September 2024. Operating income generated by the LNG business in the prior year was approximately $135. This headwind was partially offset by lower changes to sale of equipment project estimates and productivity improvements, net of fixed-cost inflation.

Equity affiliates' income of $12.4 decreased 39%, or $8.0, driven by lower contributions from an affiliate in Algeria.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**RECONCILIATIONS OF NON-GAAP FINANCIAL MEASURES**

*(Millions of U.S. Dollars unless otherwise indicated, except for per share data)*

We present certain financial measures, other than in accordance with U.S. generally accepted accounting principles ("GAAP"), on an "adjusted" or "non-GAAP" basis. On a consolidated basis, these measures include adjusted operating income, adjusted operating margin, adjusted earnings per share ("EPS"), adjusted EBITDA, the adjusted effective tax rate, and capital expenditures. On a segment basis, we present adjusted EBITDA. In addition to these measures, we also present certain supplemental non-GAAP financial measures to help the reader understand the impact that certain disclosed items, or "non-GAAP adjustments," have on the calculation of our adjusted EPS. For each non-GAAP financial measure, we present a reconciliation to the most directly comparable financial measure calculated in accordance with GAAP.

We provide these non-GAAP financial measures to allow investors, potential investors, securities analysts, and others to evaluate the performance of our business in the same manner as our management. We believe these measures, when viewed together with financial results computed in accordance with GAAP, provide a more complete understanding of the factors and trends affecting our historical financial performance and projected future results. However, we caution readers not to consider these measures in isolation or as a substitute for the most directly comparable measures calculated in accordance with GAAP. Readers should also consider the limitations associated with these non-GAAP financial measures, including the potential lack of comparability of these measures from one company to another.

In many cases, non-GAAP financial measures are determined by adjusting the most directly comparable GAAP measure to exclude non-GAAP adjustments that we believe are not representative of our underlying business performance. For example, we exclude the impact of the non-service components of net periodic benefit/cost for our defined benefit pension plans. Non-service related components are recurring, non-operating items that include interest cost, expected returns on plan assets, prior service cost amortization, actuarial loss amortization, as well as special termination benefits, curtailments, and settlements. The net impact of non-service related components is reflected within "Other non-operating income (expense), net" on our consolidated income statements. Adjusting for the impact of non-service pension components provides management and users of our financial statements with a more accurate representation of our underlying business performance because these components are driven by factors that are unrelated to our operations, such as volatility in equity and debt markets. Further, non-service related components are not indicative of our defined benefit plans' future contribution needs due to the funded status of the plans. We may also exclude certain expenses associated with cost reduction actions and impairment charges as well as gains on disclosed transactions, such as the sale of the LNG business. The reader should be aware that we may recognize similar losses or gains in the future.

When applicable, the tax impact of our pre-tax non-GAAP adjustments reflects the expected current and deferred income tax impact of our non-GAAP adjustments. These tax impacts are primarily driven by the statutory tax rate of the various relevant jurisdictions and the taxability of the adjustments in those jurisdictions.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**ADJUSTED OPERATING INCOME AND ADJUSTED EPS**

In addition to adjusted EPS, adjusted operating income is an important measure to evaluate our business performance following the appointment of our new Chief Executive Officer in February 2025. The table below presents a reconciliation of adjusted operating income to the most directly comparable GAAP measure, along with reconciliations for each major component used in the calculation of adjusted EPS.

In periods that we have non-GAAP adjustments, we believe it is important for readers to understand the impact of each adjustment as management excludes these items when assessing the Company's underlying performance.

Per share amounts are calculated and presented on a diluted basis from continuing operations attributable to Air Products. These amounts are computed independently and may not sum to totals due to rounding. Because we reported a loss from operations for fiscal year 2025, GAAP loss per share is calculated using the basic weighted average share count of 222.7 million, which does not consider outstanding share-based awards due to their anti-dilutive effect. Both adjusted earnings per share and the individual adjustments used in its calculation are based on a diluted weighted average share count of 222.9 million.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **FY2025 vs. FY2024** | Operating<br>Income/<br>Loss | Equity<br> Affiliates'<br> Income | Other Non-<br>Operating<br>Inc/Exp, Net | Income Tax<br>Benefit/<br>Expense | Net Income/Loss Attributable to Air Products | Earnings/<br>Loss per Share |
| FY2025 GAAP | ($877.0) | $647.7 | $2.6 | ($94.3) | ($386.5) | ($1.74) |
| FY2024 GAAP  | 4466.1 | 647.7 | (73.8) | 944.9 | 3842.1 | 17.24 |
| $ GAAP Change | ($5343.1) |  |  |  |  | ($18.98) |
| % GAAP Change | \*\* |  |  |  |  | \*\* |
| **FY2025 GAAP Measures** | **($877.0)** | **$647.7** | **$2.6** | **($94.3)** | **($386.5)** | **($1.74)** |
| Business and asset actions<sup>(A)</sup> | 3747.0 | 6.8 |  | 695.2 | 3047.9 | 13.68 |
| Shareholder activism-related costs | 86.3 |  |  | 14.6 | 71.7 | 0.32 |
| Gain on sale of business | (67.3) |  |  | (15.4) | (51.9) | (0.23) |
| Gain on sale of other assets<sup>(B)</sup> | (31.3) |  |  | (7.5) | (23.8) | (0.11) |
| Gain on de-designation of cash flow hedges<sup>(c)</sup> |  |  | (27.0) | (2.2) | (7.2) | (0.03) |
| Non-service pension cost, net |  |  | 45.0 | 11.3 | 33.7 | 0.15 |
| Tax reform adjustment related to deemed foreign dividends |  |  |  | 34.9 | (34.9) | (0.16) |
| Tax on repatriation of foreign earnings |  |  |  | (31.4) | 31.4 | 0.14 |
| **FY2025 Adjusted Measures** | **$2857.7** | **$654.5** | **$20.6** | **$605.2** | **$2680.4** | **$12.03** |
| **FY2024 GAAP Measures** | **$4466.1** | **$647.7** | **($73.8)** | **$944.9** | **$3842.1** | **$17.24** |
| Gain on sale of business | (1575.6) |  |  | (377.2) | (1198.4) | (5.38) |
| Business and asset actions | 57.0 |  |  | 13.2 | 43.8 | 0.20 |
| Loss on de-designation of cash flow hedges<sup>(C)</sup> |  |  | 16.3 | 1.4 | 4.3 | 0.02 |
| Non-service pension cost, net |  |  | 102.0 | 25.2 | 76.8 | 0.34 |
| **FY2024 Adjusted Measures** | **$2947.5** | **$647.7** | **$44.5** | **$607.5** | **$2768.6** | **$12.43** |
| $ Adjusted Change | ($89.8) |  |  |  |  | ($0.40) |
| % Adjusted Change | (3%) |  |  |  |  | (3%) |

---

<sup>(A)</sup>Charge attributable to noncontrolling interests was $10.7.

<sup>(B)</sup>Reflected on the fiscal year 2025 consolidated income statement in "Other income (expense), net."

<sup>(C)</sup>Gain attributable to noncontrolling interests was $17.6 in fiscal year 2025. Loss attributable to noncontrolling interests was $10.6 in fiscal year 2024.

\*\* Change versus prior period is not meaningful due to charges for business and asset actions recorded in fiscal year 2025.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**ADJUSTED OPERATING MARGIN**

The table below reconciles GAAP operating margin to adjusted operating margin, illustrating the impact of non-GAAP adjustments on our reported margins. Margins are calculated independently for each period by dividing each line item by consolidated sales for the respective period. As a result, individual components may not sum to totals due to rounding.

---

| | | | |
|:---|:---|:---|:---|
| **FY2025 vs. FY2024** | Operating Income/Loss | Operating Margin | Operating Margin |
| FY2025 GAAP | ($877.0) | (7.3 | %) |
| FY2024 GAAP  | 4466.1 | 36.9 | % |
| $ GAAP Change | ($5343.1) |  |  |
| %/bp GAAP Change | \*\* | \*\* | \*\* |
| **FY2025 GAAP Measures** | **($877.0)** | **(7.3** | **%)** |
| Business and asset actions | 3747.0 | 31.1 | % |
| Shareholder activism-related costs | 86.3 | 0.7 | % |
| Gain on sale of business | (67.3) | (0.6 | %) |
| Gain on sale of other assets | (31.3) | (0.3 | %) |
| **FY2025 Adjusted Measures** | **$2857.7** | **23.7** | **%** |
| **FY2024 GAAP Measures** | **$4466.1** | **36.9** | **%** |
| Gain on sale of business | (1575.6) | (13.0 | %) |
| Business and asset actions | 57.0 | 0.5 | % |
| **FY2024 Adjusted Measures** | **$2947.5** | **24.4** | **%** |
| $ Adjusted Change | ($89.8) |  |  |
| %/bp Adjusted Change | (3%) | (70 | bp) |

---

\*\* Change versus prior period is not meaningful due to charges for business and asset actions recorded in fiscal year 2025.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**ADJUSTED EBITDA**

We define adjusted EBITDA as net income or loss less income or loss from discontinued operations, net of tax, and excluding non-GAAP adjustments, which we do not believe to be indicative of underlying business trends, before interest expense, other non-operating income (expense), net, income tax expense (benefit), and depreciation and amortization expense. Adjusted EBITDA provides a useful metric for management to assess operating performance on both a consolidated and a segment basis.

The tables below present a reconciliation of consolidated net income on a GAAP basis to consolidated adjusted EBITDA:

---

| | | |
|:---|:---|:---|
| | **2025** | 2024 |
| **Net income (loss)** | **($354.4)** | $3862.4 |
| Less: Loss from discontinued operations, net of tax | **(8.0)** | (13.9) |
| Add: Interest expense | **214.0** | 218.8 |
| Less: Other non-operating income (expense), net | **2.6** | (73.8) |
| Add: Income tax expense (benefit) | **(94.3)** | 944.9 |
| Add: Depreciation and amortization | **1564.2** | 1451.1 |
| Add: Business and asset actions | **3747.0** | 57.0 |
| Add: Shareholder activism-related costs | **86.3** |  |
| Less: Gain on sale of business | **67.3** | 1575.6 |
| Less: Gain on sale of other assets | **31.3** |  |
| Add: Equity method investment impairment associated with business and asset actions | **6.8** |  |
| **Adjusted EBITDA** | **$5076.4** | $5046.3 |
|  | **2025**<br>**vs. 2024** |  |
| **Change GAAP** |  |  |
| &nbsp;&nbsp;&nbsp;Net income $ change | **($4216.8)** |  |
| &nbsp;&nbsp;&nbsp;Net income % change | **\*\*** |  |
| **Change Non-GAAP** |  |  |
| &nbsp;&nbsp;&nbsp;Adjusted EBITDA $ change | **$30.1** |  |
| &nbsp;&nbsp;&nbsp;Adjusted EBITDA % change | **1%** |  |

---

<sup>\*\*</sup> Change versus prior period is not meaningful due to charges for business and asset actions recorded in fiscal year 2025.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

The tables below present a reconciliation of operating income (loss) by segment to adjusted EBITDA by segment for the fiscal years ended 30 September 2025 and 2024:

<u>Americas</u>

---

| | | | |
|:---|:---|:---|:---|
| | | | <u>Change vs. Prior Year</u> |
| Fiscal Year Ended 30 September | **2025** | 2024 | $%/bp |
| Operating income | **$1519.6** | $1565.1 | (3%) |
| Add: Depreciation and amortization | **732.1** | 699.3 |  |
| Add: Equity affiliates' income | **157.0** | 158.8 |  |
| Adjusted EBITDA | **$2408.7** | $2423.2 | (1%) |

---

<u>Asia</u>

---

| | | | |
|:---|:---|:---|:---|
| | | | <u>Change vs. Prior Year</u> |
| Fiscal Year Ended 30 September | **2025** | 2024 | $%/bp |
| Operating income | **$851.1** | $859.2 | (1%) |
| Add: Depreciation and amortization | **518.9** | 471.0 |  |
| Add: Equity affiliates' income | **42.3** | 32.9 |  |
| Adjusted EBITDA | **$1412.3** | $1363.1 | 4% |

---

<u>Europe</u>

---

| | | | |
|:---|:---|:---|:---|
| | | | <u>Change vs. Prior Year</u> |
| Fiscal Year Ended 30 September | **2025** | 2024 | $%/bp |
| Operating income | **$844.7** | $810.0 | 4% |
| Add: Depreciation and amortization | **247.4** | 207.1 |  |
| Add: Equity affiliates' income | **101.9** | 88.1 |  |
| Adjusted EBITDA | **$1194.0** | $1105.2 | 8% |

---

<u>Middle East and India</u>

---

| | | | |
|:---|:---|:---|:---|
| | | | <u>Change vs. Prior Year</u> |
| Fiscal Year Ended 30 September | **2025** | 2024 | $%/bp |
| Operating income | **$9.6** | $5.9 | 63% |
| Add: Depreciation and amortization | **25.9** | 26.6 |  |
| Add: Equity affiliates' income | **340.9** | 347.5 |  |
| Adjusted EBITDA | **$376.4** | $380.0 | (1%) |

---

<u>Corporate and other</u>

---

| | | | |
|:---|:---|:---|:---|
| | | | <u>Change vs. Prior Year</u> |
| Fiscal Year Ended 30 September | **2025** | 2024 | $%/bp |
| Operating loss | **($367.3)** | ($292.7) | (25%) |
| Add: Depreciation and amortization | **39.9** | 47.1 |  |
| Add: Equity affiliates' income | **12.4** | 20.4 |  |
| Adjusted EBITDA | **($315.0)** | ($225.2) | (40%) |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**ADJUSTED EFFECTIVE TAX RATE**

The effective tax rate equals the income tax expense (benefit) divided by income or loss from continuing operations before taxes. We calculate our adjusted effective tax rate by adjusting the numerator and denominator to exclude the tax and before tax impacts of our non-GAAP adjustments, respectively. The table below presents a reconciliation of the GAAP effective tax rate to our adjusted effective tax rate:

---

| | | |
|:---|:---|:---|
| Fiscal Year Ended 30 September | **2025** | 2024 |
| Income tax expense (benefit) | **($94.3)** | $944.9 |
| Income (loss) from continuing operations before taxes | **(440.7)** | 4821.2 |
| Effective tax rate | **21.4%** | 19.6% |
| **<u>Reconciliation of GAAP to Non-GAAP:</u>** |  |  |
| &nbsp;&nbsp;Income tax expense (benefit) | **($94.3)** | $944.9 |
| &nbsp;&nbsp;Business and asset actions tax impact | **695.2** | 13.2 |
| &nbsp;&nbsp;Shareholder activism-related costs tax impact | **14.6** |  |
| &nbsp;&nbsp;Gain on sale of business tax impact | **(15.4)** | (377.2) |
| &nbsp;&nbsp;Gain on sale of other assets tax impact | **(7.5)** |  |
| &nbsp;&nbsp;(Gain) Loss on de-designation of cash flow hedges tax impact | **(2.2)** | 1.4 |
| &nbsp;&nbsp;Non-service pension cost, net tax impact | **11.3** | 25.2 |
| &nbsp;&nbsp;Tax reform adjustment related to deemed foreign dividends | **34.9** |  |
| &nbsp;&nbsp;Tax on repatriation of foreign earnings | **(31.4)** |  |
| **Adjusted income tax expense** | **$605.2** | $607.5 |
| &nbsp;&nbsp;Income (loss) from continuing operations before taxes | **($440.7)** | $4821.2 |
| &nbsp;&nbsp;Business and asset actions | **3747.0** | 57.0 |
| &nbsp;&nbsp;Shareholder activism-related costs | **86.3** |  |
| &nbsp;&nbsp;Gain on sale of business | **(67.3)** | (1575.6) |
| &nbsp;&nbsp;Gain on sale of other assets | **(31.3)** |  |
| &nbsp;&nbsp;(Gain) Loss on de-designation of cash flow hedges | **(27.0)** | 16.3 |
| &nbsp;&nbsp;Non-service pension cost, net | **45.0** | 102.0 |
| &nbsp;&nbsp;Business and asset actions-equity method investment | **6.8** |  |
| **Adjusted income from continuing operations before taxes** | **$3318.8** | $3420.9 |
| **Adjusted effective tax rate** | **18.2%** | 17.8% |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**CAPITAL EXPENDITURES**

Capital expenditures is a non-GAAP financial measure that we define as the sum of cash flows for additions to plant and equipment, including long-term deposits, acquisitions (less cash acquired), investment in and advances to unconsolidated affiliates, and investment in financing receivables on our consolidated statements of cash flows. Additionally, we adjust additions to plant and equipment to exclude NEOM Green Hydrogen Company ("NGHC") expenditures funded by the joint venture's project financing, which is non-recourse to Air Products, as well as our partners' equity contributions to arrive at a measure that we believe is more representative of our investment activities. Substantially all the funding we provide to NGHC is limited for use by the venture for its capital expenditures.

A reconciliation of cash used for investing activities to our reported capital expenditures is provided below:

---

| | | |
|:---|:---|:---|
| Fiscal Year Ended 30 September | **2025** | 2024 |
| **Cash used for investing activities** | **$7168.7** | $4919.2 |
| Proceeds from sale of assets and investments | **245.8** | 1878.8 |
| Purchases of short-term investments | **(117.6)** | (141.4) |
| Proceeds from short-term investments | **122.5** | 470.7 |
| Proceeds from other investing activities | **115.4** | 72.4 |
| NGHC expenditures not funded by Air Products' equity<sup>(A)</sup> | **(2470.7)** | (2047.7) |
| **Capital expenditures** | **$5064.1** | $5152.0 |

---

<sup>(A)</sup>Reflects the portion of "Additions to plant and equipment, including long-term deposits" that is associated with NGHC, less our approximate cash investment in the joint venture.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**LIQUIDITY AND CAPITAL RESOURCES**

We believe we have sufficient cash, cash flows from operations, and access to funding sources to meet our liquidity needs. As further discussed in the "Cash Flows From Financing Activities" section on page <u>[52](#i7a6098d7ff6c4942a0427dc07b43285a_146422)</u>, we are able to raise capital through a variety of financing activities, including accessing capital or commercial paper markets or drawing upon our credit facilities.

As of 30 September 2025, we had $1.4 billion of foreign cash and cash items, compared to total cash and cash items of $1.9 billion. We do not expect a significant portion of the earnings from our foreign subsidiaries and affiliates to be subject to U.S. income tax upon repatriation. Depending on the country in which these entities operate, repatriation of earnings may be subject to foreign withholding and other taxes. However, we intend to indefinitely reinvest the majority of our foreign cash and cash items that would be subject to additional taxes outside the U.S.

**Cash Flows From Operations**

---

| | | |
|:---|:---|:---|
| Fiscal Year Ended 30 September | **2025** | 2024 |
| Net income (loss) from continuing operations attributable to Air Products | **($386.5)** | $3842.1 |
| Adjustments to reconcile net income (loss) to cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **1564.2** | 1451.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **(554.8)** | (69.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax reform repatriation | **(34.9)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Business and asset actions | **3747.0** | 57.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of business | **(67.3)** | (1575.6) |
| &nbsp;&nbsp;&nbsp;&nbsp;Undistributed earnings of equity method investments | **(269.8)** | (206.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of assets and investments | **(66.4)** | (31.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | **76.4** | 61.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncurrent lease receivables | **52.5** | 116.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other adjustments | **48.0** | 183.8 |
| Changes in working capital accounts | **(851.6)** | (183.0) |
| **Cash Provided by Operating Activities** | **$3256.8** | $3646.7 |

---

In fiscal year 2025, cash provided by operating activities was $3.3 billion. Charges for business and asset actions totaled $3.7 billion, primarily driven by project exit costs as described in Note 5, *Business and Asset Actions*, to the consolidated financial statements. The adjustment for deferred income taxes of $554.8 was largely attributable to tax impacts associated with these costs.

Working capital accounts in fiscal year 2025 resulted in a net use of cash of $851.6, including $562.6 of other working capital driven by accrued income taxes. In fiscal year 2025, we made approximately $395 in tax payments related to the prior year sale of the LNG business. Payables and accrued liabilities were a use of cash of $224.0, primarily due to payments for contract terminations associated with our business and asset actions and previously accrued severance actions under our global cost reduction plan.

In fiscal year 2024, cash provided by operating activities totaled $3.6 billion. This included a $1.6 billion gain related to the sale of the LNG business as discussed in Note 4, *Gain on Sale of Business*, to the consolidated financial statements. Business and asset actions of $57.0 reflected expenses recognized for severance and other benefits associated with our global cost reduction plan. Refer to Note 5, *Business and Asset Actions*, to the consolidated financial statements for additional information. Other operating adjustments of $183.8 primarily included pension expense, net of contributions, totaling $89.1.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

Working capital changes in fiscal year 2024 resulted in a net use of cash of $183.0. A use of cash of $338.7 within payables and accrued liabilities primarily resulted from a reduction in customer advances for sale of equipment projects as revenue was recognized, along with payments related to previously accrued severance actions and incentive compensation under the fiscal year 2023 plan. An inventory-related cash use of $137.8 was largely attributable to helium purchases. A use of cash of $111.0 from trade receivables was primarily due to the timing of collections. Offsetting these uses, other working capital provided a source of cash of $370.1, largely driven by the timing of income tax payments related to the LNG business sale. As noted above, tax payments associated with the LNG sale were remitted in fiscal year 2025.

**Cash Flows From Investing Activities**

---

| | | |
|:---|:---|:---|
| Fiscal Year Ended 30 September | **2025** | 2024 |
| Additions to plant and equipment, including long-term deposits | **($7022.6)** | ($6796.7) |
| Acquisitions, less cash acquired | **(59.9)** |  |
| Investment in and advances to unconsolidated affiliates | **(390.4)** |  |
| Investment in financing receivables | **(61.9)** | (403.0) |
| Proceeds from sale of assets and investments | **245.8** | 1878.8 |
| Purchases of short-term investments | **(117.6)** | (141.4) |
| Proceeds from short-term investments | **122.5** | 470.7 |
| Proceeds from other investing activities | **115.4** | 72.4 |
| **Cash Used for Investing Activities** | **($7168.7)** | ($4919.2) |

---

In fiscal year 2025, cash used for investing activities was $7.2 billion. The primary use of cash was $7.0 billion for additions to plant and equipment, including long-term deposits, of which approximately $3 billion related to the NEOM Green Hydrogen Project. Additional uses included investments in and advances to unconsolidated affiliates of $390.4, investments in financing receivables of $61.9, and cash paid for acquisitions, net of cash acquired, of $59.9. These activities are further detailed in the "Capital Expenditures" section on page <u>[51](#i7a6098d7ff6c4942a0427dc07b43285a_111841)</u>.

Cash proceeds of $245.8 from sales of assets and investments primarily included $104.3 from the sale of a subsidiary in Singapore and $37.7 for the sale of a regional office in Hersham, England, as further described in Note 6, *Acquisitions and Divestitures*, to the consolidated financial statements. Maturities of short-term investments provided cash of $122.5, which exceeded purchases of $117.6.

In fiscal year 2024, cash used for investing activities was $4.9 billion. The primary use of cash was $6.8 billion for additions to plant and equipment, including long-term deposits, and investments in financing receivables of $403.0. Additional information regarding the investments in financing receivables is provided in the "Capital Expenditures" section on page <u>[51](#i7a6098d7ff6c4942a0427dc07b43285a_111841)</u>. Proceeds from the sale of assets and investments totaled $1.9 billion and primarily related to the sale of the LNG business in September 2024. Refer to Note 4, *Gain on Sale of Business*, to the consolidated financial statements for additional information. Maturities of short-term investments provided cash of $470.7, which exceeded purchases of $141.4.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Capital Expenditures</u> *(Non-GAAP Financial Measure)*

The components of our capital expenditures are detailed in the table below. Refer to page <u>[48](#i6c5d80e205be49368cbb0bd080310540_73)</u> for a definition of this non-GAAP financial measure as well as a reconciliation to cash used for investing activities.

---

| | | |
|:---|:---|:---|
| Fiscal Year Ended 30 September | **2025** | 2024 |
| Additions to plant and equipment, including long-term deposits | **$7022.6** | $6796.7 |
| Acquisitions, less cash acquired | **59.9** |  |
| Investment in and advances to unconsolidated affiliates | **390.4** |  |
| Investment in financing receivables | **61.9** | 403.0 |
| NGHC expenditures not funded by Air Products' equity<sup>(A)</sup> | **(2470.7)** | (2047.7) |
| **Capital Expenditures** | **$5064.1** | $5152.0 |

---

<sup>(A)</sup>Reflects the portion of "Additions to plant and equipment, including long-term deposits" that is associated with NGHC, less our approximate cash investment in the joint venture.

Capital expenditures totaled $5.1 billion in fiscal year 2025, a 2% decrease from capital expenditures of $5.2 billion in fiscal year 2024. Spending in fiscal year 2025 was driven by $7.0 billion in additions to plant and equipment, primarily supporting our clean energy initiatives, including the NEOM Green Hydrogen Project in NEOM City, Saudi Arabia, and clean energy complexes in Louisiana, United States, and Alberta, Canada. We also continued to invest in our core industrial gases business, funding the development of new plants and the maintenance and replacement of existing facilities.

The $390.4 investment in and advances to unconsolidated affiliates in fiscal year 2025 included approximately $238 related to BHIG and approximately $115 for our final investment in the JIGPC joint venture. Additional information regarding these affiliates is provided in Note 6, *Acquisitions and Divestitures*, and Note 10, *Equity Affiliates*, to the consolidated financial statements. The $61.9 investment in financing receivables related to the financing arrangement for the natural gas-to-syngas processing facility in Uzbekistan. Additional details regarding this arrangement are provided in Note 6, *Acquisitions and Divestitures*, to the consolidated financial statements. In the prior year, the $403.0 investment in financing receivables included approximately $120 associated with the Uzbekistan arrangement, with the remaining amount related to the purchase of renewable fuel assets from World Energy. As discussed in Note 3, *Variable Interest Entities*, to the consolidated financial statements, we exited the World Energy sustainable aviation fuel project in fiscal year 2025. Cash paid for acquisitions, net of cash acquired, totaled $59.9 in fiscal year 2025 and was paid at the closing of our acquisition of an independent industrial gases company in Belgium.

<u>Outlook for Investing Activities</u>

It is not possible, without unreasonable efforts, to reconcile our forecasted capital expenditures to future cash used for investing activities because management is unable to identify the timing or occurrence of our future investment activity, which is driven by our assessment of competing opportunities at the time we enter into transactions. These decisions, either individually or in the aggregate, could have a significant effect on our cash used for investing activities. Accordingly, management is unable to fully reconcile, without unreasonable efforts, our forecasted capital expenditures to future cash used for investing activities.

We expect capital expenditures for fiscal year 2026 to be approximately $4 billion, reflecting continued investment in our energy transition projects, traditional industrial gas projects, and maintenance within our core business. Approximately $1 billion is expected to be dedicated to traditional industrial gas projects. We anticipate funding these expenditures through our existing cash balance and cash generated from continuing operations. We also have access to capital and money market financing as well as other sources of funding as discussed in the "Financing and Capital Structure" section on page <u>[52](#i7a6098d7ff6c4942a0427dc07b43285a_145675)</u>.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Cash Flows From Financing Activities**

---

| | | |
|:---|:---|:---|
| Fiscal Year Ended 30 September | **2025** | 2024 |
| Long-term debt proceeds | **$4386.7** | $4678.3 |
| Payments on long-term debt | **(429.9)** | (486.2) |
| Net decrease in commercial paper and short-term borrowings | **(74.7)** | (289.9) |
| Dividends paid to shareholders | **(1584.1)** | (1564.9) |
| Proceeds from stock option exercises | **1.1** | 7.9 |
| Investments by noncontrolling interests | **594.6** | 428.5 |
| Distributions to noncontrolling interests | **(7.2)** | (25.8) |
| Other financing activities | **(91.3)** | (132.5) |
| **Cash Provided by Financing Activities** | **$2795.2** | $2615.4 |

---

In fiscal year 2025, cash provided by financing activities was $2.8 billion. The primary source of cash was long-term debt proceeds of $4.4 billion, which included $2.7 billion from Euro- and U.S. Dollar-denominated senior fixed-rate notes issued in February and June 2025. Net proceeds from the notes were used to repay commercial paper obligations, including those incurred prior to the closing of the February 2025 Offering that were used to repay €300 million (approximately $311) aggregate principal amount outstanding of our 1.000% Euro-denominated senior fixed-rate notes at maturity, plus accrued interest, and for general corporate purposes. An additional $1.6 billion in long-term debt proceeds was provided through project financing available to the NGHC joint venture, as further discussed on page <u>[53](#i7a6098d7ff6c4942a0427dc07b43285a_145636)</u>. Separately, we received $594.6 in contributions from noncontrolling interests, primarily related to NGHC. These sources of cash were partially offset by dividend payments to shareholders of $1.6 billion.

In fiscal year 2024, cash provided by financing activities was $2.6 billion. The primary source of cash was long-term debt proceeds of $4.7 billion, which included $2.5 billion from green senior notes issued during the second quarter of fiscal year 2024 through U.S. Dollar-denominated fixed-rate offerings. In line with our Green Finance Framework, we allocated the net proceeds to finance or refinance, in whole or in part, projects expected to deliver environmental benefits, such as pollution prevention and control, renewable energy generation and procurement, and sustainable aviation fuel. Additionally, the NGHC joint venture borrowed approximately $2.0 billion from project financing in fiscal year 2024. These proceeds were partially offset by financing fees of approximately $112.0, which were reflected within "Other financing activities." We also received $428.5 in contributions from noncontrolling interests.

Cash proceeds from financing activities in fiscal year 2024 were partially offset by dividend payments to shareholders of $1.6 billion, payments on long-term debt of $486.2, and net decreases in commercial paper and short-term borrowings of $289.9.

<u>Financing and Capital Structure</u>

*Debt*

Total debt increased to $17.7 billion as of 30 September 2025 from $14.2 billion as of 30 September 2024. We issued Euro- and U.S. Dollar-denominated senior fixed-rate notes in February and June 2025, which together had a combined carrying value of $2.9 billion as of 30 September 2025. Total debt also increased due to approximately $1.6 billion in incremental borrowings under the project financing arrangement related to the NEOM Green Hydrogen Project, which is nonrecourse to Air Products, as further discussed on page <u>[53](#i7a6098d7ff6c4942a0427dc07b43285a_145636)</u>. Total debt included related party debt of $236.5 and $304.4 as of 30 September 2025 and 2024, respectively.

Subsequent to the balance sheet date, we repaid at maturity $550.0 aggregate principal amount of our 1.50% senior notes due October 2025, plus accumulated and unpaid interest through the maturity date.

Various debt agreements to which we are a party include financial covenants and other restrictions, including restrictions pertaining to the ability to create property liens and enter into certain sale and leaseback transactions. As of 30 September 2025, we were in compliance with all the financial and other covenants under our debt agreements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

*Committed Credit Facilities*

During the second quarter of fiscal year 2025, we refinanced our existing 364-day $500 revolving credit agreement to extend its maturity date from 27 March 2025 to 26 March 2026 (the "364-Day Credit Agreement"). All other terms remain consistent with the original 364-Day Credit Agreement, including our ability to convert the facility into a term loan maturing 26 March 2027. Fees incurred in connection with the refinancing were not material.

We also maintain a five-year $3.0 billion revolving credit agreement that matures on 31 March 2029 (the "Five-Year Credit Agreement"). Both the 364-Day Credit Agreement and the Five-Year Credit Agreement are syndicated committed facilities that provide a source of liquidity and support our commercial paper program through the availability of senior unsecured debt to us and certain of our subsidiaries. No borrowings were outstanding under either of the 364-Day Credit Agreement or the Five-Year Credit Agreement as of 30 September 2025 or 30 September 2024.

Separately, certain of our foreign subsidiaries maintain access to committed credit facilities with a combined maximum borrowing capacity of $394.0, all of which was borrowed and outstanding as of 30 September 2025. The amount borrowed from available facilities as of 30 September 2024 was $1.1 billion, which included long-term borrowings of approximately $675 that were derecognized upon deconsolidation of BHIG during the second quarter of fiscal year 2025. Refer to Note 6, *Acquisitions and Divestitures*, to the consolidated financial statements for additional information.

*NEOM Green Hydrogen Project Financing*

To support the NEOM Green Hydrogen Project, NGHC has access to project financing of approximately $6.1 billion, which is expected to fund about 73% of the project and is being drawn over the construction period, as well as additional credit facilities totaling approximately $500 primarily for NGHC's working capital needs. Creditors of NGHC do not have recourse to the general credit of Air Products. As of 30 September 2025, the joint venture had borrowed short- and long-term principal amounts totaling $4.9 billion compared to $3.3 billion as of 30 September 2024. Refer to Note 3, *Variable Interest Entities*, to the consolidated financial statements for additional information.

<u>Dividends</u>

We believe that providing a consistent dividend plays a critical role in creating shareholder value. The Board of Directors determines whether to declare cash dividends on our common stock, as well as the timing and amount, based on our financial condition and other factors it deems relevant. We returned approximately $1.6 billion to shareholders in fiscal year 2025, an increase of 1% compared to the prior year, and we remain committed to continuing our history of dividend growth as part of our long-term capital allocation strategy.

Dividends are paid quarterly, usually during the sixth week after the close of the fiscal quarter. On 18 July 2025, the Board of Directors declared a quarterly dividend of $1.79 per share that was payable on 10 November 2025 to shareholders of record at the close of business on 1 October 2025. Additionally, on 19 November 2025, the Board of Directors declared a quarterly dividend of $1.79 per share that is payable on 9 February 2026 to shareholders of record at the close of business on 2 January 2026.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**PENSION BENEFITS**

We and certain of our subsidiaries sponsor defined benefit pension plans and defined contribution plans that cover a substantial portion of our worldwide employees. The principal defined benefit pension plans are the U.S. salaried pension plan and the U.K. pension plan. These plans were closed to new participants in 2005, after which defined contribution plans were offered to new employees. The shift to defined contribution plans is expected to continue to reduce volatility of both plan expense and contributions. For additional information, refer to Note 18, *Retirement Benefits*, to the consolidated financial statements.

**Net Periodic Cost**

The table below summarizes the components of net periodic cost for our U.S. and international defined benefit pension plans for the fiscal years ended 30 September:

---

| | | |
|:---|:---|:---|
| | **2025** | 2024 |
| Service cost | **$20.7** | $20.9 |
| Non-service related costs | **45.0** | 102.0 |
| Other | **0.3** | 0.9 |
| **Net Periodic Cost** | **$66.0** | $123.8 |

---

Net periodic cost was $66.0 and $123.8 in fiscal years 2025 and 2024, respectively. The decrease in costs versus the prior year was primarily attributable to non-service costs, which were driven by a higher expected return on plan assets due to a higher beginning balance of plan assets, lower interest cost, and a decrease in actuarial loss amortization. The net impact of non-service related items are reflected within "Other non-operating income (expense), net" on our consolidated income statements.

Service costs result from benefits earned by active employees and are reflected as operating expenses primarily within "Cost of sales" and "Selling and administrative expense" on our consolidated income statements. The amount of service costs capitalized in fiscal years 2025 and 2024 was not material.

The table below summarizes the assumptions used in the calculation of net periodic cost for the fiscal years ended 30 September:

---

| | | |
|:---|:---|:---|
| | **2025** | 2024 |
| Weighted average discount rate – Service cost | **4.9%** | 5.6% |
| Weighted average discount rate – Interest cost | **4.6%** | 5.7% |
| Weighted average expected rate of return on plan assets | **5.4%** | 5.3% |
| Weighted average expected rate of compensation increase | **3.5%** | 3.5% |

---

<u>2026 Outlook</u>

In fiscal year 2026, we expect to recognize pension expense of approximately $30 to $40, which includes approximately $10 to $20 of non-service related costs. The lower non-service related costs are the result of higher expected return on plan assets from increases in the return assumption and a decrease in actuarial loss amortization.

In fiscal year 2025, we recognized net actuarial losses of $39.4 in other comprehensive income. Actuarial gains and losses are amortized into pension expense over prospective periods to the extent they are not offset by future gains or losses. Future changes in the discount rate and actual returns on plan assets could impact the actuarial gain or loss and resulting amortization in years beyond fiscal year 2026.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Pension Funding**

<u>Funded Status</u>

The projected benefit obligation represents the actuarial present value of benefits attributable to employee service rendered to date, including the effects of estimated future salary increases. The plan funded status is calculated as the difference between the projected benefit obligation and the fair value of plan assets at the end of the period.

The table below summarizes the projected benefit obligation, the fair value of plan assets, and the funded status for our U.S. and international plans as of 30 September:

---

| | | |
|:---|:---|:---|
| | **2025** | 2024 |
| Projected benefit obligation | **$3795.3** | $3951.8 |
| Fair value of plan assets at end of year | **3727.6** | 3907.5 |
| Plan Funded Status | **($67.7)** | ($44.3) |

---

The net unfunded liability of $67.7 as of 30 September 2025 increased $23.4 from $44.3 as of 30 September 2024, as the interest cost component of the net periodic pension cost was greater than decreases to the projected benefit obligation from actuarial gains due to higher discount rates.

<u>Company Contributions</u>

Pension funding includes both contributions to funded plans and benefit payments for unfunded plans, which are primarily non-qualified plans. With respect to funded plans, our funding policy is that contributions, combined with appreciation and earnings, will be sufficient to pay benefits without creating unnecessary surpluses.

In addition, we make contributions to satisfy all legal funding requirements while managing our capacity to benefit from tax deductions attributable to plan contributions. With the assistance of third-party actuaries, we analyze the liabilities and demographics of each plan, which help guide the level of contributions. During fiscal years 2025 and 2024, our cash contributions to funded pension plans and benefit payments for unfunded pension plans were $29.9 and $34.7, respectively.

For fiscal year 2026, cash contributions to defined benefit plans are estimated to be $25 to $35. The estimate is based on expected contributions to certain international plans and anticipated benefit payments for unfunded plans, which are dependent upon the timing of retirements. Actual future contributions will depend on future funding legislation, discount rates, investment performance, plan design, and various other factors.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**CRITICAL ACCOUNTING POLICIES AND ESTIMATES**

Refer to Note 1, *Basis of Presentation and Major Accounting Policies*, and Note 2, *New Accounting Guidance*, to the consolidated financial statements for a description of our major accounting policies and information concerning implementation and impact of new accounting guidance.

The accounting policies discussed below are those policies that we consider to be the most critical to understanding our financial statements because they require management's most difficult, subjective, or complex judgments, often as the result of the need to make estimates about the effects of matters that are inherently uncertain. These estimates reflect our best judgment about current and/or future economic and market conditions and their effect based on information available as of the date of our consolidated financial statements. If conditions change, actual results may differ materially from these estimates. Our management has reviewed these critical accounting policies and estimates and related disclosures with the Audit and Finance Committee of our Board of Directors.

**Depreciable Lives of Plant and Equipment**

Plant and equipment, net as of 30 September 2025 totaled approximately $25.3 billion, and depreciation expense totaled approximately $1.5 billion during fiscal year 2025. Disclosures related to plant and equipment are included in Note 11, *Plant and Equipment, net*, to the consolidated financial statements.

Plant and equipment is recorded at cost and depreciated using the straight-line method, which deducts equal amounts of the cost of each asset from earnings every year over its estimated economic useful life. Economic useful life is the duration of time an asset is expected to be productively employed by us, which may be less than its physical life. Assumptions on the following factors, among others, affect the determination of estimated economic useful life: wear and tear, obsolescence, technical standards, contract life, market demand, competitive position, raw material availability, and geographic location.

The estimated economic useful life of an asset is monitored to determine its appropriateness, especially when business circumstances change. For example, changes in technology, changes in the estimated future demand for products, excessive wear and tear, or unanticipated government actions may result in a shorter estimated useful life than originally anticipated. In these cases, we would depreciate the remaining net book value over the new estimated remaining life, thereby increasing depreciation expense per year on a prospective basis. Likewise, if the estimated useful life is increased, the adjustment to the useful life decreases depreciation expense per year on a prospective basis.

Our regional industrial gas segments have numerous long-term customer supply contracts for which we construct an on-site plant on or near the customer's facility. These contracts typically have initial contract terms of 10 to 20 years. Depreciable lives of the production assets related to long-term supply contracts are generally matched to the contract lives. Extensions to the contract term of supply frequently occur prior to the expiration of the initial term. As contract terms are extended, the depreciable life of the associated production assets is adjusted to match the new contract term, as long as it does not exceed the remaining physical life of the asset.

Our regional industrial gas segments also have contracts for liquid or gaseous bulk supply and, for smaller customers, packaged gases. The depreciable lives of production facilities associated with these contracts are generally 15 years. These depreciable lives have been determined based on historical experience combined with judgment on future assumptions such as technological advances, potential obsolescence, and competitors' actions.

In addition, we may purchase assets through transactions accounted for as either an asset acquisition or a business combination. Depreciable lives are assigned to acquired assets based on the age and condition of the assets, the remaining duration of long-term supply contracts served by the assets, and our historical experience with similar assets. Management monitors its assumptions and may potentially need to adjust depreciable life as circumstances change.

We continue to depreciate assets that are temporarily idle. Depreciation is discontinued when assets meet the criteria for classification as held for sale.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Impairment of Assets**

As part of a project review initiated by our Board of Directors and Chief Executive Officer in fiscal year 2025, we made the decision to exit various projects, primarily related to clean energy generation and distribution. As a result, we assessed the carrying values of the affected project assets against their estimated fair values. Where carrying values exceeded fair values, we recorded impairment charges as described under "*Impairment of Assets: Plant and Equipment*". The review also led to the recognition of an other-than-temporary impairment in one of our joint ventures, as discussed under "*Impairment of Assets: Equity Method Investments*".

No triggering events were identified in fiscal year 2025 that would require impairment testing for any of our reporting units containing goodwill or indefinite-lived intangible assets. We completed our annual impairment tests for these assets and concluded there were no indications of impairment. Refer to "*Impairment of Assets: Goodwill*" and "*Impairment of Assets: Intangible Assets*" for additional detail.

<u>Impairment of Assets: Plant and Equipment</u>

Plant and equipment meeting the held for sale criteria are reported at the lower of carrying amount or fair value less cost to sell. Plant and equipment to be disposed of other than by sale may be reviewed for impairment upon the occurrence of certain triggering events, such as decisions to discontinue or exit projects, unexpected contract terminations, or unforeseen foreign government-imposed restrictions or expropriations. Plant and equipment held for use is grouped for impairment testing at the lowest level for which there is identifiable cash flows. Impairment testing of the asset group occurs whenever events or changes in circumstances indicate that the carrying amount of the assets may not be recoverable. Such circumstances may include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a significant decrease in the market value of a long-lived asset grouping;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a significant adverse change in the manner in which the asset grouping is being used or in its physical condition;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• an accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of the long-lived asset;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a reduction in revenues that is other than temporary;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a history of operating or cash flow losses associated with the use of the asset grouping; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in the expected useful life of the long-lived assets.

If such circumstances are determined to exist, an estimate of undiscounted future cash flows produced by the asset group is compared to the carrying value to determine whether impairment exists. If an asset group is determined to be impaired, the loss is measured based on the difference between the asset group's fair value and its carrying value. An estimate of the asset group's fair value is based on the discounted value of its estimated cash flows.

The assumptions underlying the undiscounted future cash flow projections require significant management judgment. Factors that management must estimate include but are not limited to industry and market conditions, sales volume and prices, costs to produce, and inflation. The assumptions underlying the cash flow projections represent management's best estimates at the time of the impairment review and could include probability weighting of cash flow projections associated with multiple potential future scenarios. Changes in key assumptions or actual conditions that differ from estimates could result in an impairment charge. We use reasonable and supportable assumptions when performing impairment reviews and cannot predict the occurrence of future events and circumstances that could result in impairment charges.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

As part of a project review initiated by our Board of Directors and Chief Executive Officer in fiscal year 2025, we made the decision to exit various projects, primarily related to clean energy generation and distribution. Accordingly, we assessed the recoverability of project assets and recorded a total impairment charge of approximately $2.5 billion in fiscal year 2025 to write down long-lived assets to their estimated value, depending on the intended manner of disposal. For assets that met the held-for-sale criteria and are actively being marketed, observable market prices were not available. As a result, fair value less cost to sell was estimated using various data points, including an offer to purchase the facility, amounts due from the customer if the customer was contractually required to repurchase the asset, and an internally-developed discounted cash flow analysis. An impairment loss of $350.6 was recognized to reduce the long-lived assets held for sale to their estimated fair value, net of estimated selling costs, of $418.3 as of 30 September 2025. We expect the sale of these assets to be completed during fiscal year 2026. For plant and equipment that did not meet the held-for-sale criteria but is capable of being sold through secondary equipment markets, recoverability was evaluated using an orderly liquidation valuation approach. An impairment loss of approximately $2.1 billion was recognized as the difference between the estimated liquidation value of $22.5 and the net book value of the assets as of 31 March 2025. There have been no significant changes in the estimated net realizable value for the remaining assets as of 30 September 2025.

These estimates are considered critical because they involve significant assumptions regarding future cash flows, asset disposition strategies, and market conditions, all of which are subject to change and could materially affect the amount and timing of impairment charges. Additionally, because the project review is ongoing, we may make further project-related decisions that could impact the intended use or recoverability of certain assets, potentially resulting in the recognition of additional impairment charges in future periods.

Other than the impairment charges recorded as discussed above, no additional asset groupings required impairment testing, as no other events or changes in circumstances indicated that their carrying amounts may not be recoverable.

<u>Impairment of Assets: Goodwill</u>

The acquisition method of accounting for business combinations requires us to make use of estimates and judgments to allocate the purchase price paid for acquisitions to the fair value of the net tangible and identifiable intangible assets. Goodwill represents the excess of the aggregate purchase price, plus the fair value of any noncontrolling interest and previously held equity interest in the acquiree, over the fair value of identifiable net assets of an acquired entity. Goodwill, net was $963.9 as of 30 September 2025. Disclosures related to goodwill are included in Note 12, *Goodwill*, to the consolidated financial statements.

We review goodwill for impairment annually in the fourth quarter of the fiscal year and whenever events or changes in circumstances indicate that the carrying value of goodwill might not be recoverable. The tests are done at the reporting unit level, which is defined as being equal to or one level below the operating segment for which discrete financial information is available and whose operating results are reviewed by segment managers regularly. At the time of our fiscal year 2025 testing, we had five reportable business segments, six operating segments and 10 reporting units, eight of which included a goodwill balance. Reporting units are primarily based on products and subregions within each reportable segment. The majority of our goodwill is assigned to reporting units within our regional industrial gases segments. Refer to Note 26, *Business Segment and Geographic Information*, for additional information.

As part of annual goodwill impairment testing, we have the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Our evaluation of qualitative factors includes an assessment of relevant facts, events, and circumstances of a reporting unit including but not limited to: business performance, strategy, and outlook; macroeconomic conditions; local market dynamics; cost management; and significant changes in key personnel, customers, operating assets, or product mix. We perform a quantitative test when qualitative factors alone are not sufficient to conclude whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If we perform a quantitative test, an impairment loss will only be recognized for the amount by which the carrying value of the reporting unit exceeds its fair value, not to exceed the total amount of goodwill allocated to that reporting unit.

In the fourth quarter of fiscal year 2025, we conducted our annual assessment and concluded that it was more likely than not that the fair value of each reporting unit was greater than its carrying value.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Impairment of Assets: Intangible Assets</u>

Disclosures related to intangible assets other than goodwill are included in Note 13, *Intangible Assets*, to the consolidated financial statements.

Intangible assets, net with determinable lives as of 30 September 2025 totaled $258.4 and consisted primarily of customer relationships. Finite-lived intangible assets are tested for impairment as part of the long-lived asset grouping impairment tests. Impairment testing of the asset group occurs whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. See the impairment discussion above under "*Impairment of Assets – Plant and Equipment*" for a description of how impairment losses are determined.

Indefinite-lived intangible assets as of 30 September 2025 totaled $35.1 and consisted of trade names and trademarks. Indefinite-lived intangibles are subject to impairment testing at least annually or more frequently if events or changes in circumstances indicate that potential impairment exists. As part of annual indefinite-lived intangible asset impairment testing, we have the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of the intangible asset is less than its carrying value. Our evaluation of qualitative factors includes an assessment of relevant facts, events, and circumstances including but not limited to: business performance, strategy and outlook; macroeconomic conditions; local market dynamics; cost management; and significant changes in key personnel, customers, operating assets, or product mix. We perform a quantitative test when qualitative factors alone are not sufficient to conclude whether it is more likely than not that the fair value of the intangible asset is less than its carrying value. If we perform a quantitative test, an impairment loss will only be recognized for the amount by which the carrying value of the indefinite-lived intangible asset exceeds its fair value, not to exceed the total carrying value of the asset.

In the fourth quarter of fiscal year 2025, we conducted our annual assessment and concluded that it was more likely than not that the fair value of each asset was greater than its carrying value.

<u>Impairment of Assets: Equity Method Investments</u>

Investments in and advances to equity affiliates totaled approximately $5.4 billion as of 30 September 2025. The majority of our equity method investments are ventures with other industrial gas companies. Summarized financial information of our equity affiliates is included in Note 10, *Equity Affiliates*, to the consolidated financial statements.

We review our equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment may not be recoverable. An impairment loss is recognized in the event that an other-than-temporary decline in fair value below the carrying value of an investment occurs. We estimate the fair value of our investments under the income approach, which considers the estimated discounted future cash flows expected to be generated by the investee, and/or the market approach, which considers market multiples of revenue and earnings derived from comparable publicly-traded industrial gas companies. Changes in key assumptions about the financial condition of an investee or actual conditions that differ from estimates could result in an impairment charge.

In fiscal year 2025, we determined there was an other-than-temporary impairment of a joint venture in China that had been established to develop clean hydrogen infrastructure in the region. As a result, we recorded a charge of $6.8 to write down the full carrying value of the investment. There were no other events or changes in circumstances that indicated the carrying amount of our equity method investments may not be recoverable, and therefore, no further impairment testing was required.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Revenue Recognition: Cost Incurred Input Method**

Revenue from sale of equipment contracts is generally recognized over time as we have an enforceable right to payment for performance completed to date and our performance under the contract terms does not create an asset with alternative use. We use a cost incurred input method to recognize revenue by which costs incurred to date relative to total estimated costs at completion are used to measure progress toward satisfying performance obligations. Costs incurred include material, labor, and overhead costs and represent work contributing and proportionate to the transfer of control to the customer.

Accounting for contracts using the cost incurred input method requires management judgment relative to assessing risks and their impact on the estimates of revenues and costs. Our estimates are impacted by factors such as the potential for incentives or penalties on performance, schedule delays, technical issues, cost inflation, labor productivity, the complexity of work performed, the availability of materials, and performance of subcontractors. When adjustments in estimated total contract revenues or estimated total costs are required, any changes in the estimated profit from prior estimates are recognized in the current period for the inception-to-date effect of such change. When estimates of total costs to be incurred on a contract exceed estimates of total revenues to be earned, a provision for the entire estimated loss on the contract is recorded in the period in which the loss is determined.

In addition to the typical risks associated with underlying performance of engineering, project procurement, and construction activities, our sale of equipment projects within our Corporate and other segment require monitoring of risks associated with schedule, geography, and other aspects of the contract and their effects on our estimates of total revenues and total costs to complete the contract.

We assess the performance of our sale of equipment projects as they progress. Our earnings could be positively or negatively impacted by changes to our contractual revenues and cost forecasts on these projects. Changes to project revenue and cost estimates unfavorably impacted operating results by approximately $85 in fiscal year 2025.

**Revenue Recognition: On-site Customer Contracts**

For customers who require large volumes of gases on a long-term basis, we produce and supply gases under long-term contracts from large facilities that we build, own, and operate on or near the customer's facilities. Certain of these on-site contracts contain complex terms and provisions regarding tolling arrangements, minimum payment requirements, variable components, pricing provisions, and amendments, which require significant judgment to determine the amount and timing of revenue recognition.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Income Taxes**

We account for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the tax effects of temporary differences between the financial reporting and tax basis of assets and liabilities measured using enacted tax rates in effect for the year in which the differences are expected to be recovered or settled. As of 30 September 2025, accrued income taxes were $179.4, and our net deferred income tax liability was $451.7. Tax liabilities related to uncertain tax positions as of 30 September 2025 were $194.8, excluding interest and penalties. Income tax benefit for the fiscal year ended 30 September 2025 was $94.3.

Management judgment is required concerning the ultimate outcome of tax contingencies and the realization of deferred tax assets.

Actual income taxes paid may vary from estimates, depending upon changes in income tax laws, actual results of operations, and the final audit of tax returns by taxing authorities. Tax assessments may arise several years after tax returns have been filed. We believe that our recorded tax liabilities adequately provide for these assessments.

Deferred tax assets are recorded for operating losses and tax credit carryforwards. However, when we do not expect sufficient sources of future taxable income to realize the benefit of the operating losses or tax credit carryforwards, these deferred tax assets are reduced by a valuation allowance. A valuation allowance is recognized if, based on the weight of available evidence, it is considered more likely than not that some portion or all of the deferred tax asset will not be realized. The factors used to assess the likelihood of realization include forecasted future taxable income and available tax planning strategies that could be implemented to realize or renew net deferred tax assets in order to avoid the potential loss of future tax benefits. The effect of a change in the valuation allowance is reported in income tax expense.

A 1% increase or decrease in our effective tax rate may result in a decrease or increase to net income, respectively, of approximately $4.

Disclosures related to income taxes are included in Note 24, *Income Taxes*, to the consolidated financial statements.

**Pension and Other Postretirement Benefits**

The amounts recognized in the consolidated financial statements for pension and other postretirement benefits are determined on an actuarial basis utilizing numerous assumptions. The discussion that follows provides information on the significant assumptions, expense, and obligations associated with the defined benefit plans.

Actuarial models are used in calculating the expense and liability related to the various defined benefit plans. These models have an underlying assumption that the employees render service over their service lives on a relatively consistent basis; therefore, the expense of benefits earned should follow a similar pattern.

Several assumptions and statistical variables are used in the models to calculate the expense and liability related to the plans. We determine assumptions about the discount rate, the expected rate of return on plan assets, and the rate of compensation increase. Note 18, *Retirement Benefits*, to the consolidated financial statements includes disclosure of these rates on a weighted-average basis for both the U.S. and international plans. The actuarial models also use assumptions about demographic factors such as retirement age, mortality, and turnover rates. Mortality rates are based on the most recent U.S. and international mortality tables. We believe the actuarial assumptions are reasonable. However, actual results could vary materially from these actuarial assumptions due to economic events and differences in rates of retirement, mortality, and turnover.

One of the assumptions used in the actuarial models is the discount rate used to measure benefit obligations. This rate reflects the prevailing market rate for high-quality, fixed-income debt instruments with maturities corresponding to the expected timing of benefit payments as of the annual measurement date for each of the various plans. We measure the service cost and interest cost components of pension expense by applying spot rates along the yield curve to the relevant projected cash flows. The rates along the yield curve are used to discount the future cash flows of benefit obligations back to the measurement date. These rates change from year to year based on market conditions that affect corporate bond yields. A higher discount rate decreases the present value of the benefit obligations and results in lower pension expense. With respect to impacts on pension benefit obligations, a 50 bp increase or decrease in the discount rate may result in a decrease or increase, respectively, to pension expense of approximately $14 per year.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

The expected rate of return on plan assets represents an estimate of the long-term average rate of return to be earned by plan assets reflecting current asset allocations. In determining estimated asset class returns, we take into account historical and future expected long-term returns and the value of active management, as well as the interest rate environment. Asset allocation is determined based on long-term return, volatility and correlation characteristics of the asset classes, the profiles of the plans' liabilities, and acceptable levels of risk. Lower returns on the plan assets result in higher pension expense. A 50 bp increase or decrease in the estimated rate of return on plan assets may result in a decrease or increase, respectively, to pension expense of approximately $18 per year.

We use a market-related valuation method for recognizing certain investment gains or losses for our significant pension plans. Investment gains or losses are the difference between the expected return and actual return on plan assets. The expected return on plan assets is determined based on a market-related value of plan assets. This is a calculated value that recognizes investment gains and losses on equities over a five-year period from the year in which they occur and reduces year-to-year volatility. The market-related value for non-equity investments equals the actual fair value. Expense in future periods will be impacted as gains or losses are recognized in the market-related value of assets.

The expected rate of compensation increase is another key assumption. We determine this rate based on review of the underlying long-term salary increase trend characteristic of labor markets and historical experience, as well as comparison to peer companies. A 50 bp increase or decrease in the expected rate of compensation may result in an increase or decrease to pension expense, respectively, of approximately $4 per year.

**Loss Contingencies**

In the normal course of business, we encounter contingencies, or situations involving varying degrees of uncertainty as to the outcome and effect on our company. We accrue a liability for loss contingencies when it is considered probable that a liability has been incurred and the amount of loss can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued.

Contingencies include those associated with litigation and environmental matters, for which our accounting policy is discussed in Note 1, *Basis of Presentation and Major Accounting Policies*, to the consolidated financial statements, and details are provided in Note 19, *Commitments and Contingencies*, to the consolidated financial statements. Significant judgment is required to determine both the probability and whether the amount of loss associated with a contingency can be reasonably estimated. These determinations are made based on the best available information at the time. As additional information becomes available, we reassess probability and estimates of loss contingencies. Revisions to the estimates associated with loss contingencies could have a significant impact on our results of operations in the period in which an accrual for loss contingencies is recorded or adjusted. For example, due to the inherent uncertainties related to environmental exposures, a significant increase to environmental liabilities could occur if a new site is designated, the scope of remediation is increased, a different remediation alternative is identified, or our proportionate share of the liability increases. Similarly, a future charge for regulatory fines or damage awards associated with litigation could have a significant impact on our net income in the period in which it is recorded.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Item 7A. Quantitative and Qualitative Disclosures About Market Risk**

Our earnings, cash flows, and financial position are exposed to market risks arising from fluctuations in interest rates and foreign currency exchange rates. It is our policy to minimize our cash flow exposure to adverse changes in currency exchange rates and to manage the financial risks inherent in funding with debt capital.

We address these financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. We have established counterparty credit guidelines and generally enter into transactions with financial institutions of investment grade or better, thereby minimizing the risk of credit loss. All instruments are entered into for other than trading purposes. For details on the types and use of these derivative instruments and related major accounting policies, refer to Note 1, *Basis of Presentation and Major Accounting Policies*, and Note 15, *Financial Instruments*, to the consolidated financial statements. Additionally, we mitigate adverse energy price impacts through our cost pass-through contracts with customers and price increases.

Our derivative and other financial instruments consist of long-term debt, including the current portion and amounts owed to related parties; interest rate swaps; cross currency interest rate swaps; and foreign exchange-forward contracts. The net market value of these financial instruments combined is referred to below as the "net financial instrument position" and is disclosed in Note 16, *Fair Value Measurements*, to the consolidated financial statements. Our net financial instrument position increased from a liability of approximately $13.9 billion at 30 September 2024 to a liability of approximately $17.2 billion at 30 September 2025. The increase was primarily due to the issuance of Euro- and U.S. Dollar-denominated senior fixed-rate notes during the second and third quarters of fiscal year 2025, as well as additional borrowings under the project financing associated with the NEOM Green Hydrogen Project as discussed in Note 3, *Variable Interest Entities*, to the consolidated financial statements. Aggregate principal amounts of Euro- and U.S. Dollar-denominated senior fixed-rate notes issued were €1.5 billion (approximately $1.6 billion) and $1.1 billion, respectively. These increases were partially offset by the derecognition of long-term debt associated with the deconsolidation of BHIG and the repayment of €300 million (approximately $311) aggregate principal amount outstanding of our 1.000% Euro-denominated senior fixed-rate notes at maturity in February 2025. For additional information regarding deconsolidation of BHIG, refer to Note 6, *Acquisitions and Divestitures*, to the consolidated financial statements.

The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market rates and prices. Market values are the present values of projected future cash flows based on the market rates and prices chosen. The market values for interest rate risk and foreign currency risk are calculated by us using a third-party software model that utilizes standard pricing models to determine the present value of the instruments based on market conditions as of the valuation date, such as interest rates, spot and forward exchange rates, and implied volatility.

**Interest Rate Risk**

Our debt portfolio as of 30 September 2025, including the effect of currency and interest rate swap agreements, was composed of 91% fixed-rate debt and 9% variable-rate debt. Our debt portfolio as of 30 September 2024, including the effect of currency and interest rate swap agreements, was composed of 87% fixed-rate debt and 13% variable-rate debt.

The sensitivity analysis related to the interest rate risk on the fixed portion of our debt portfolio assumes an instantaneous 100 bp parallel move in interest rates from the level at 30 September 2025, with all other variables held constant. A 100 bp increase in market interest rates would result in a decrease of $1,128 and $1,035 in the net liability position of financial instruments at 30 September 2025 and 2024, respectively. A 100 bp decrease in market interest rates would result in an increase of $1,290 and $1,197 in the net liability position of financial instruments at 30 September 2025 and 2024, respectively.

Based on the variable-rate debt included in our debt portfolio, including the interest rate swap agreements, a 100 bp increase in interest rates would result in an additional $16 and $19 of interest incurred per year at 30 September 2025 and 2024, respectively. A 100 bp decline in interest rates would lower interest incurred by $16 and $19 per year at 30 September 2025 and 2024, respectively.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Foreign Currency Exchange Rate Risk**

The sensitivity analysis related to foreign currency exchange rates assumes an instantaneous 10% change in the foreign currency exchange rates from their levels at 30 September 2025 and 2024, with all other variables held constant. A 10% strengthening or weakening of the functional currency of an entity versus all other currencies would result in a decrease or increase, respectively, of $565 and $408 in the net liability position of financial instruments at 30 September 2025 and 2024, respectively. The increase in sensitivity is primarily due to the issuance of the Euro-denominated senior fixed-rate notes noted above.

The primary currency pairs for which we have exchange rate exposure are the Chinese Renminbi and U.S. Dollar and Euro and U.S. Dollar. Foreign currency debt, cross currency interest rate swaps, and foreign exchange-forward contracts are used in countries where we do business, thereby reducing our net asset exposure. Foreign exchange-forward contracts and cross currency interest rate swaps are also used to hedge our firm and highly anticipated foreign currency cash flows. Thus, there is either an asset or liability or cash flow exposure related to all of the financial instruments in the above sensitivity analysis for which the impact of a movement in exchange rates would be in the opposite direction and materially equal to the impact on the instruments in the analysis.

The majority of our sales are denominated in foreign currencies as they are derived outside the United States. Therefore, financial results will be affected by changes in foreign currency rates. The Chinese Renminbi and the Euro represent the largest exposures in terms of our foreign earnings. We estimate that a 10% reduction in either the Chinese Renminbi or the Euro versus the U.S. Dollar would lower our annual operating income by approximately $50 and $34, respectively.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Item 8. Financial Statements and Supplementary Data**

**INDEX TO CONSOLIDATED FINANCIAL STATEMENTS**

---

| | |
|:---|:---|
| <u>[Management's Report on Internal Control Over Financial Reporting](#i6c5d80e205be49368cbb0bd080310540_91)</u> | [66](#i6c5d80e205be49368cbb0bd080310540_91) |
| <u>[Report of Deloitte & Touche LLP, Independent Registered Public Accounting Firm](#i6c5d80e205be49368cbb0bd080310540_94)</u> (PCAOB ID No. 34) | [67](#i6c5d80e205be49368cbb0bd080310540_94) |
| <u>[Consolidated Income Statements – Fiscal Years Ended 30 September 2025, 2024, and 2023](#i6c5d80e205be49368cbb0bd080310540_97)</u> | [69](#i6c5d80e205be49368cbb0bd080310540_97) |
| <u>[Consolidated Comprehensive Income Statements – Fiscal Years Ended 30 September 2025, 2024, and 2023](#i6c5d80e205be49368cbb0bd080310540_100)</u> | [70](#i6c5d80e205be49368cbb0bd080310540_100) |
| <u>[Consolidated Balance Sheets – 30 September 2025 and 2024](#i6c5d80e205be49368cbb0bd080310540_103)</u> | [71](#i6c5d80e205be49368cbb0bd080310540_103) |
| <u>[Consolidated Statements of Cash Flows – Fiscal Years Ended 30 September 2025, 2024, and 2023](#i6c5d80e205be49368cbb0bd080310540_106)</u> | [72](#i6c5d80e205be49368cbb0bd080310540_106) |
| <u>[Consolidated Statements of Equity – Fiscal Years Ended 30 September 2025, 2024, and 2023](#i6c5d80e205be49368cbb0bd080310540_109)</u> | [73](#i6c5d80e205be49368cbb0bd080310540_109) |
| <u>[Notes to Consolidated Financial Statements](#i6c5d80e205be49368cbb0bd080310540_112)</u> | [74](#i6c5d80e205be49368cbb0bd080310540_112) |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING**

Air Products' management is responsible for establishing and maintaining adequate internal control over financial reporting. Our internal control over financial reporting, which is defined in the following sentences, is a process designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles and includes those policies and procedures that:

&nbsp;&nbsp;&nbsp;&nbsp;(i)pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;(ii)provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

&nbsp;&nbsp;&nbsp;&nbsp;(iii)provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements.

Because of inherent limitations, internal control over financial reporting can only provide reasonable assurance and may not prevent or detect misstatements. Further, because of changes in conditions, the effectiveness of our internal control over financial reporting may vary over time. Our processes contain self-monitoring mechanisms, and actions are taken to correct deficiencies as they are identified.

Management has evaluated the effectiveness of its internal control over financial reporting based on criteria established in *Internal Control—Integrated Framework (2013)* issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this evaluation, management concluded that, as of 30 September 2025, the Company's internal control over financial reporting was effective.

Deloitte & Touche LLP, an independent registered public accounting firm, has issued its opinion on the Company's internal control over financial reporting as of 30 September 2025 as stated in its report which appears herein.

---

| | |
|:---|:---|
| /s/ Eduardo F. Menezes | /s/ Melissa N. Schaeffer |
| Eduardo F. Menezes | Melissa N. Schaeffer |
| Chief Executive Officer and Director | Executive Vice President and |
| (Principal Executive Officer) | Chief Financial Officer |
| 20 November 2025 | 20 November 2025 |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

To the shareholders and the Board of Directors of Air Products and Chemicals, Inc.

**Opinions on the Financial Statements and Internal Control over Financial Reporting**

We have audited the accompanying consolidated balance sheets of Air Products and Chemicals, Inc. and subsidiaries (the "Company") as of September 30, 2025 and 2024, the related consolidated income statements, comprehensive income statements, statements of equity, and statements of cash flows, for each of the three years in the period ended September 30, 2025, and the related notes (collectively referred to as the "financial statements"). We also have audited the Company's internal control over financial reporting as of September 30, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of the Company as of September 30, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended September 30, 2025, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of September 30, 2025, based on criteria established in Internal Control — Integrated Framework (2013) issued by COSO.

**Basis for Opinions**

The Company's management is responsible for these financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on these financial statements and an opinion on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.

Our audits of the financial statements included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures to respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

**Definition and Limitations of Internal Control over Financial Reporting**

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

**Critical Audit Matter**

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

**Revenue Recognition – On-site Customer Contracts – Refer to Notes 1 and 7 to the Financial Statements**

<u>Critical Audit Matter Description</u>

On-site industrial gas customer contracts involve large capital investments to serve customers who require large volumes of gases and have relatively constant demand. The Company builds, owns and operates facilities on or near the customer's facilities to produce and supply the customer with gases under a long-term arrangement. Typically, these contracts have 15- to 20-year terms and contain fixed monthly charges and/or minimum purchase requirements. Revenue associated with these contracts is generally recognized over time during the period in which the Company delivers or makes available the agreed upon quantity of gases. In addition, certain on-site industrial gas contracts contain complex terms and provisions such as tolling arrangements, minimum payment requirements, and pricing provisions that are specific to a customer arrangement. These arrangements may require greater judgment in determining when contractual requirements have been met, impacting the amount of revenue to be recorded.

We identified revenue recognition for certain on-site industrial gas customer contracts with complex terms and provisions as a critical audit matter because of the judgments necessary for management to evaluate these contract terms, including amendments, in order to determine the amount of revenue to be recognized. This required a high degree of auditor judgment when performing procedures to audit management's determination of the amount and timing of revenue recognition and evaluating the results of those procedures.

<u>How the Critical Audit Matter Was Addressed in the Audit</u>

Our audit procedures related to revenue recognition for certain on-site industrial gas customer contracts with complex terms and provisions included the following procedures, among others:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We tested the effectiveness of the Company's controls related to the amount of revenue recognition, including controls over the evaluation of complex terms and provisions in certain on-site industrial gas customer contracts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We evaluated the terms included within original customer contracts and related amendments to assess the accounting for provisions such as minimum payment requirements, pricing provisions, and settlement terms that require management to apply judgment in determining revenue recognition associated with the contract.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We evaluated customer transactions and agreed the amount of revenue recognized to underlying contracts, customer invoices, and cash receipts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• We inquired of personnel who oversee operations and revenue recognition as to the presence of contract amendments, and interpretation of contract terms.

/s/ Deloitte & Touche LLP

Philadelphia, Pennsylvania

November 20, 2025

We have served as the Company's auditor since 2018.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Air Products and Chemicals, Inc. and Subsidiaries**

**CONSOLIDATED INCOME STATEMENTS**

For the Fiscal Years Ended 30 September

---

| | | | |
|:---|:---|:---|:---|
| *(Millions of U.S. Dollars, except for share and per share data)* | **2025** | 2024 | 2023 |
| **Sales** | **$12037.3** | $12100.6 | $12600.0 |
| Cost of sales | **8256.0** | 8168.7 | 8833.0 |
| Selling and administrative expense | **906.1** | 942.4 | 957.0 |
| Research and development expense | **96.3** | 100.2 | 105.6 |
| Business and asset actions | **3747.0** | 57.0 | 244.6 |
| Shareholder activism-related costs | **86.3** |  |  |
| Gain on sale of business | **67.3** | 1575.6 |  |
| Other income (expense), net | **110.1** | 58.2 | 34.8 |
| **Operating Income (Loss)** | **(877.0)** | 4466.1 | 2494.6 |
| Equity affiliates' income | **647.7** | 647.7 | 604.3 |
| Interest expense | **214.0** | 218.8 | 177.5 |
| Other non-operating income (expense), net | **2.6** | (73.8) | (39.0) |
| **Income (Loss) From Continuing Operations Before Taxes** | **(440.7)** | 4821.2 | 2882.4 |
| Income tax expense (benefit) | **(94.3)** | 944.9 | 551.2 |
| **Income (Loss) From Continuing Operations** | **(346.4)** | 3876.3 | 2331.2 |
| Income (Loss) from discontinued operations, net of tax | **(8.0)** | (13.9) | 7.4 |
| **Net Income (Loss)** | **(354.4)** | 3862.4 | 2338.6 |
| Net income attributable to noncontrolling interests | **40.1** | 34.2 | 38.4 |
| **Net Income (Loss) Attributable to Air Products** | **($394.5)** | $3828.2 | $2300.2 |
| **Net Income (Loss) Attributable to Air Products** |  |  |  |
| Net income (loss) from continuing operations | **($386.5)** | $3842.1 | $2292.8 |
| Net income (loss) from discontinued operations | **(8.0)** | (13.9) | 7.4 |
| **Net Income (Loss) Attributable to Air Products** | **($394.5)** | $3828.2 | $2300.2 |
| **Per Share Data**<sup>(A)</sup> *(U.S. Dollars per share)* |  |  |  |
| Basic earnings (loss) per share from continuing operations | **($1.74)** | $17.27 | $10.31 |
| Basic earnings (loss) per share from discontinued operations | **(0.04)** | (0.06) | 0.03 |
| **Basic Earnings (Loss) Per Share Attributable to Air Products** | **($1.77)** | $17.21 | $10.35 |
| Diluted earnings (loss) per share from continuing operations | **($1.74)** | $17.24 | $10.30 |
| Diluted earnings (loss) per share from discontinued operations | **(0.04)** | (0.06) | 0.03 |
| **Diluted Earnings (Loss) Per Share Attributable to Air Products** | **($1.77)** | $17.18 | $10.33 |
| **Weighted Average Common Shares** *(in millions)* |  |  |  |
| Basic | **222.7** | 222.5 | 222.3 |
| Diluted | **222.7** | 222.8 | 222.7 |

---

<sup>(A)</sup>Earnings (loss) per share is calculated independently for each component and may not sum to total earnings (loss) per share due to rounding.

The accompanying notes are an integral part of these statements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Air Products and Chemicals, Inc. and Subsidiaries**

**CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS**

For the Fiscal Years Ended 30 September

---

| | | | |
|:---|:---|:---|:---|
| *(Millions of U.S. Dollars)* | **2025** | 2024 | 2023 |
| **Net Income (Loss)** | **($354.4)** | $3862.4 | $2338.6 |
| **Other Comprehensive Income, net of tax:** |  |  |  |
| Translation adjustments, net of tax of ($61.4), ($33.0), and ($32.8) | **(95.6)** | 381.5 | 151.1 |
| Net gain (loss) on derivatives, net of tax of ($1.8), $10.7, and $48.6 | **40.0** | (159.5) | 369.2 |
| Pension and postretirement benefits, net of tax of ($10.2), $9.6, and ($2.9) | **(32.3)** | 32.0 | (8.9) |
| Reclassification adjustments: |  |  |  |
| &nbsp;&nbsp;&nbsp; Currency translation adjustment | **5.7** | (1.5) | (0.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivatives, net of tax of $12.0, ($9.7), and ($13.6) | **41.2** | (33.7) | (43.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and postretirement benefits, net of tax of $14.7, $18.1, and $17.5 | **46.0** | 55.9 | 53.8 |
| **Total Other Comprehensive Income** | **5.0** | 274.7 | 521.0 |
| **Comprehensive Income (Loss)** | **(349.4)** | 4137.1 | 2859.6 |
| **Net Income Attributable to Noncontrolling Interests** | **40.1** | 34.2 | 38.4 |
| **Other Comprehensive Income (Loss) Attributable to Noncontrolling Interests** | **65.1** | (147.0) | 184.3 |
| **Comprehensive Income (Loss) Attributable to Air Products** | **($454.6)** | $4249.9 | $2636.9 |

---

The accompanying notes are an integral part of these statements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Air Products and Chemicals, Inc. and Subsidiaries**

**CONSOLIDATED BALANCE SHEETS**

As of the Fiscal Years Ended 30 September

---

| | | |
|:---|:---|:---|
| *(Millions of U.S. Dollars, except for share and per share data)* | **2025** | 2024 |
| **Assets** |  |  |
| **Current Assets** |  |  |
| Cash and cash items | **$1856.0** | $2979.7 |
| Short-term investments | **—** | 5.0 |
| Trade receivables, net | **1901.2** | 1821.6 |
| Inventories | **776.5** | 766.0 |
| Prepaid expenses | **174.9** | 179.9 |
| Assets held for sale | **427.7** |  |
| Other receivables and current assets | **689.5** | 610.8 |
| **Total Current Assets** | **$5825.8** | $6363.0 |
| Investment in net assets of and advances to equity affiliates | **5366.1** | 4792.5 |
| Plant and equipment, net | **25337.8** | 23370.9 |
| Goodwill, net | **963.9** | 905.1 |
| Intangible assets, net | **293.5** | 311.6 |
| Operating lease right-of-use assets, net | **944.0** | 1047.7 |
| Noncurrent lease receivables | **307.1** | 392.1 |
| Financing receivables | **1000.0** | 1220.2 |
| Other noncurrent assets | **1021.3** | 1171.5 |
| **Total Noncurrent Assets** | **$35233.7** | $33211.6 |
| **Total Assets**<sup>(A)</sup> | **$41059.5** | $39574.6 |
| **Liabilities and Equity** |  |  |
| **Current Liabilities** |  |  |
| Payables and accrued liabilities | **$3237.7** | $2926.2 |
| Accrued income taxes | **179.4** | 558.5 |
| Short-term borrowings | **34.7** | 83.5 |
| Current portion of long-term debt | **716.3** | 611.4 |
| Liabilities held for sale | **50.5** |  |
| **Total Current Liabilities** | **$4218.6** | $4179.6 |
| Long-term debt | **16769.9** | 13428.6 |
| Long-term debt – related party | **177.5** | 104.4 |
| Noncurrent operating lease liabilities | **616.0** | 677.9 |
| Other noncurrent liabilities | **1348.1** | 1350.5 |
| Deferred income taxes | **579.6** | 1159.9 |
| **Total Noncurrent Liabilities** | **$19491.1** | $16721.3 |
| **Total Liabilities**<sup>(A)</sup> | **$23709.7** | $20900.9 |
| **Commitments and Contingencies - See Note 19** |  |  |
| **Air Products Shareholders' Equity** |  |  |
| Common stock (par value $1 per share; issued 2025 and 2024 - 249,455,584 shares) | **$249.4** | $249.4 |
| Capital in excess of par value | **1306.5** | 1253.2 |
| Retained earnings | **17558.6** | 19545.7 |
| Accumulated other comprehensive loss | **(2087.8)** | (2027.7) |
| Treasury stock, at cost (2025 - 26,867,328 shares; 2024 - 27,083,166 shares) | **(2001.8)** | (1984.1) |
| **Total Air Products Shareholders' Equity** | **$15024.9** | $17036.5 |
| **Noncontrolling Interests**<sup>(A)</sup> | **2324.9** | 1637.2 |
| **Total Equity** | **$17349.8** | $18673.7 |
| **Total Liabilities and Equity** | **$41059.5** | $39574.6 |

---

<sup>(A)</sup>Includes balances associated with a consolidated variable interest entity ("VIE"), including amounts reflected in "Total Assets" that can only be used to settle obligations of the VIE of $7,134.7 and $4,393.9 as of 30 September 2025 and 2024, respectively, as well as liabilities of the VIE reflected within "Total Liabilities" for which creditors do not have recourse to the general credit of Air Products of $4,937.7 and $3,473.4 as of 30 September 2025 and 2024, respectively. Refer to Note 3, *Variable Interest Entities*, for additional information regarding the NEOM Green Hydrogen Company joint venture.

The accompanying notes are an integral part of these statements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Air Products and Chemicals, Inc. and Subsidiaries**

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

For the Fiscal Years Ended 30 September

---

| | | | |
|:---|:---|:---|:---|
| *(Millions of U.S. Dollars)* | **2025** | 2024 | 2023 |
| **Operating Activities** |  |  |  |
| Net income (loss) | **($354.4)** | $3862.4 | $2338.6 |
| Less: Net income attributable to noncontrolling interests of continuing operations | **40.1** | 34.2 | 38.4 |
| Net income (loss) attributable to Air Products | **(394.5)** | 3828.2 | 2300.2 |
| Net (income) loss from discontinued operations | **8.0** | 13.9 | (7.4) |
| Net income (loss) from continuing operations attributable to Air Products | **(386.5)** | 3842.1 | 2292.8 |
| Adjustments to reconcile net income (loss) to cash provided by operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | **1564.2** | 1451.1 | 1358.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | **(554.8)** | (69.3) | (24.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax reform repatriation | **(34.9)** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Business and asset actions | **3747.0** | 57.0 | 244.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of business | **(67.3)** | (1575.6) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Undistributed earnings of equity method investments | **(269.8)** | (206.0) | (261.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of assets and investments | **(66.4)** | (31.4) | (15.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Share-based compensation | **76.4** | 61.8 | 59.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Noncurrent lease receivables | **52.5** | 116.2 | 79.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other adjustments | **48.0** | 183.8 | (103.0) |
| Working capital changes that provided (used) cash, excluding effects of acquisitions: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Trade receivables | **(36.3)** | (111.0) | 130.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | **(35.8)** | (137.8) | (129.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other receivables | **7.1** | 34.4 | (93.8) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payables and accrued liabilities | **(224.0)** | (338.7) | (213.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other working capital | **(562.6)** | 370.1 | (119.0) |
| **Cash Provided by Operating Activities** | **3256.8** | 3646.7 | 3205.7 |
| **Investing Activities** |  |  |  |
| Additions to plant and equipment, including long-term deposits | **(7022.6)** | (6796.7) | (4626.4) |
| Acquisitions, less cash acquired | **(59.9)** |  |  |
| Investment in and advances to unconsolidated affiliates | **(390.4)** |  | (912.0) |
| Investment in financing receivables | **(61.9)** | (403.0) | (665.1) |
| Proceeds from sale of assets and investments | **245.8** | 1878.8 | 25.4 |
| Purchases of short-term investments | **(117.6)** | (141.4) | (640.1) |
| Proceeds from short-term investments | **122.5** | 470.7 | 897.0 |
| Proceeds from other investing activities | **115.4** | 72.4 | 4.8 |
| **Cash Used for Investing Activities** | **(7168.7)** | (4919.2) | (5916.4) |
| **Financing Activities** |  |  |  |
| Long-term debt proceeds | **4386.7** | 4678.3 | 3516.2 |
| Payments on long-term debt | **(429.9)** | (486.2) | (615.4) |
| Net (decrease) increase in commercial paper and short-term borrowings | **(74.7)** | (289.9) | 268.2 |
| Dividends paid to shareholders | **(1584.1)** | (1564.9) | (1496.6) |
| Proceeds from stock option exercises | **1.1** | 7.9 | 24.0 |
| Investments by noncontrolling interests | **594.6** | 428.5 | 234.9 |
| Distributions to noncontrolling interests | **(7.2)** | (25.8) | (115.9) |
| Other financing activities | **(91.3)** | (132.5) | (205.8) |
| **Cash Provided by Financing Activities** | **2795.2** | 2615.4 | 1609.6 |
| **Discontinued Operations** |  |  |  |
| Cash provided by operating activities | **—** |  | 0.6 |
| Cash provided by investing activities | **—** |  |  |
| Cash provided by financing activities | **—** |  |  |
| **Cash Provided by Discontinued Operations** | **—** |  | 0.6 |
| **Effect of Exchange Rate Changes on Cash** | **(7.0)** | 19.8 | 6.5 |
| (Decrease) Increase in cash and cash items | **(1123.7)** | 1362.7 | (1094.0) |
| Cash and cash items – Beginning of year | **2979.7** | 1617.0 | 2711.0 |
| **Cash and Cash Items – End of Period** | **$1856.0** | $2979.7 | $1617.0 |

---

The accompanying notes are an integral part of these statements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Air Products and Chemicals, Inc. and Subsidiaries**

**CONSOLIDATED STATEMENTS OF EQUITY**

For the Fiscal Years Ended 30 September

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| *(Millions of U.S. Dollars, except for per share data)* | Common<br>Stock | Capital<br>in Excess<br>of Par<br>Value | Retained<br>Earnings | Accumulated<br>Other<br>Comprehensive<br>Income (Loss) | Treasury<br>Stock | Air Products<br>Shareholders'<br>Equity | Non-<br>controlling<br>Interests | Total<br>Equity |
| **Balance as of 30 September 2022** | **$249.4** | **$1141.4** | **$16520.3** | **($2786.1)** | **($1981.0)** | **$13144.0** | **$558.4** | **$13702.4** |
| Net income |  |  | 2300.2 |  |  | 2300.2 | 38.4 | 2338.6 |
| Other comprehensive income |  |  |  | 336.7 |  | 336.7 | 184.3 | 521.0 |
| Dividends on common stock ($6.87 per share) |  |  | (1526.2) |  |  | (1526.2) |  | (1526.2) |
| Distributions to noncontrolling interests |  |  |  |  |  |  | (115.9) | (115.9) |
| Share-based compensation |  | 54.6 |  |  |  | 54.6 |  | 54.6 |
| Issuance of treasury shares for stock option and award plans |  | (6.1) |  |  | 13.7 | 7.6 |  | 7.6 |
| Investments by noncontrolling interests <sup>(A)</sup> |  |  |  |  |  |  | 682.2 | 682.2 |
| Other equity transactions |  | 0.6 | (4.6) |  |  | (4.0) |  | (4.0) |
| **Balance as of 30 September 2023** | **$249.4** | **$1190.5** | **$17289.7** | **($2449.4)** | **($1967.3)** | **$14312.9** | **$1347.4** | **$15660.3** |
| Net income |  |  | 3828.2 |  |  | 3828.2 | 34.2 | 3862.4 |
| Other comprehensive income (loss) |  |  |  | 421.7 |  | 421.7 | (147.0) | 274.7 |
| Dividends on common stock ($7.06 per share) |  |  | (1569.7) |  |  | (1569.7) |  | (1569.7) |
| Distributions to noncontrolling interests |  |  |  |  |  |  | (25.4) | (25.4) |
| Share-based compensation |  | 58.3 |  |  |  | 58.3 |  | 58.3 |
| Issuance of treasury shares for stock option and award plans |  | 3.9 |  |  | (16.8) | (12.9) |  | (12.9) |
| Investments by noncontrolling interests |  |  |  |  |  |  | 428.5 | 428.5 |
| Other equity transactions |  | 0.5 | (2.5) |  |  | (2.0) | (0.5) | (2.5) |
| **Balance as of 30 September 2024** | **$249.4** | **$1253.2** | **$19545.7** | **($2027.7)** | **($1984.1)** | **$17036.5** | **$1637.2** | **$18673.7** |
| Net income (loss) |  |  | (394.5) |  |  | (394.5) | 40.1 | (354.4) |
| Other comprehensive income (loss) |  |  |  | (60.1) |  | (60.1) | 65.1 | 5.0 |
| Dividends on common stock ($7.14 per share) |  |  | (1588.9) |  |  | (1588.9) |  | (1588.9) |
| Distributions to noncontrolling interests |  |  |  |  |  |  | (7.2) | (7.2) |
| Share-based compensation |  | 72.0 |  |  |  | 72.0 |  | 72.0 |
| Issuance of treasury shares for stock option and award plans |  | (18.9) |  |  | (17.7) | (36.6) |  | (36.6) |
| Investments by noncontrolling interests |  |  |  |  |  |  | 595.6 | 595.6 |
| Purchase of noncontrolling interests |  |  |  |  |  |  | (5.9) | (5.9) |
| Other equity transactions |  | 0.2 | (3.7) |  |  | (3.5) |  | (3.5) |
| **Balance as of 30 September 2025** | **$249.4** | **$1306.5** | **$17558.6** | **($2087.8)** | **($2001.8)** | **$15024.9** | **$2324.9** | **$17349.8** |

---

<sup>(A)</sup>Includes noncash activity related to the NEOM Green Hydrogen Company joint venture.

The accompanying notes are an integral part of these statements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Air Products and Chemicals, Inc. and Subsidiaries**

**NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS**

*(Millions of U.S. Dollars unless otherwise indicated, except for share and per share data)*

1. <u>[Basis of Presentation and Major Accounting Policies](#i6c5d80e205be49368cbb0bd080310540_115)</u> [75](#i6c5d80e205be49368cbb0bd080310540_115)

2. <u>[New Accounting Guidance](#i6c5d80e205be49368cbb0bd080310540_121)</u> [86](#i6c5d80e205be49368cbb0bd080310540_121)

3. <u>[Variable Interest Entities](#i6c5d80e205be49368cbb0bd080310540_124)</u> [87](#i6c5d80e205be49368cbb0bd080310540_124)

4. <u>[Gain on Sale of Business](#i6c5d80e205be49368cbb0bd080310540_130)</u> [91](#i6c5d80e205be49368cbb0bd080310540_130)

5. <u>[Business and Asset Actions](#i6c5d80e205be49368cbb0bd080310540_133)</u> [92](#i6c5d80e205be49368cbb0bd080310540_133)

6. <u>[Acquisitions and Divestitures](#i6c5d80e205be49368cbb0bd080310540_136)</u> [94](#i6c5d80e205be49368cbb0bd080310540_136)

7. <u>[Revenue Recognition](#i6c5d80e205be49368cbb0bd080310540_139)</u> [96](#i6c5d80e205be49368cbb0bd080310540_139)

8. <u>[Discontinued Operations](#i6c5d80e205be49368cbb0bd080310540_145)</u> [100](#i6c5d80e205be49368cbb0bd080310540_145)

9. <u>[Inventories](#i6c5d80e205be49368cbb0bd080310540_148)</u> [100](#i6c5d80e205be49368cbb0bd080310540_148)

10. <u>[Equity Affiliates](#i6c5d80e205be49368cbb0bd080310540_151)</u> [101](#i6c5d80e205be49368cbb0bd080310540_151)

11. <u>[Plant and Equipment, net](#i6c5d80e205be49368cbb0bd080310540_154)</u> [102](#i6c5d80e205be49368cbb0bd080310540_154)

12. <u>[Goodwill](#i6c5d80e205be49368cbb0bd080310540_157)</u> [103](#i6c5d80e205be49368cbb0bd080310540_157)

13. <u>[Intangible Assets](#i6c5d80e205be49368cbb0bd080310540_160)</u> [104](#i6c5d80e205be49368cbb0bd080310540_160)

14. <u>[Leases](#i6c5d80e205be49368cbb0bd080310540_163)</u> [105](#i6c5d80e205be49368cbb0bd080310540_163)

15. <u>[Financial Instruments](#i6c5d80e205be49368cbb0bd080310540_166)</u> [107](#i6c5d80e205be49368cbb0bd080310540_166)

16. <u>[Fair Value Measurements](#i6c5d80e205be49368cbb0bd080310540_169)</u> [113](#i6c5d80e205be49368cbb0bd080310540_169)

17. <u>[Debt](#i6c5d80e205be49368cbb0bd080310540_172)</u> [116](#i6c5d80e205be49368cbb0bd080310540_172)

18. <u>[Retirement Benefits](#i6c5d80e205be49368cbb0bd080310540_175)</u> [119](#i6c5d80e205be49368cbb0bd080310540_175)

19. <u>[Commitments and Contingencies](#i6c5d80e205be49368cbb0bd080310540_178)</u> [126](#i6c5d80e205be49368cbb0bd080310540_178)

20. <u>[Capital Stock](#i6c5d80e205be49368cbb0bd080310540_181)</u> [130](#i6c5d80e205be49368cbb0bd080310540_181)

21. <u>[Share-Based Compensation](#i6c5d80e205be49368cbb0bd080310540_184)</u> [131](#i6c5d80e205be49368cbb0bd080310540_184)

22. <u>[Accumulated Other Comprehensive Loss](#i6c5d80e205be49368cbb0bd080310540_187)</u> [133](#i6c5d80e205be49368cbb0bd080310540_187)

23. <u>[Earnings (Loss) Per Share](#i6c5d80e205be49368cbb0bd080310540_190)</u> [134](#i6c5d80e205be49368cbb0bd080310540_190)

24. <u>[Income Taxes](#i6c5d80e205be49368cbb0bd080310540_193)</u> [135](#i6c5d80e205be49368cbb0bd080310540_193)

25. <u>[Supplemental Information](#i6c5d80e205be49368cbb0bd080310540_196)</u> [141](#i6c5d80e205be49368cbb0bd080310540_196)

26. <u>[Business Segment and Geographic Information](#i6c5d80e205be49368cbb0bd080310540_202)</u> [144](#i6c5d80e205be49368cbb0bd080310540_202)

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**1. BASIS OF PRESENTATION AND MAJOR ACCOUNTING POLICIES**

As used in this report, unless the context indicates otherwise, the terms "we," "our," "us," the "Company," "Air Products," or "registrant" include our controlled subsidiaries and affiliates.

**About Air Products**

Air Products and Chemicals, Inc., a Delaware corporation founded in 1940, is a world-leading industrial gases company that has built a reputation for its innovation, operational excellence, and commitment to safety and environmental stewardship. Focused on serving energy, environmental, and emerging markets and generating a cleaner future, we offer products and services that improve our customers' operations and sustainability.

We serve a broad range of industries, including refining, chemicals, metals, electronics, manufacturing, medical, and food, providing essential industrial gases, related equipment, and applications expertise. We also develop, engineer, build, own, and operate some of the world's largest clean hydrogen projects supporting the transition to low- and zero-carbon energy, particularly in industrial applications and the heavy-duty transportation sector. Additionally, our sale of equipment businesses provide specialized products such as turbomachinery, membrane systems, and cryogenic containers to customers worldwide.

We manage our operations, assess performance, and report earnings under five reportable segments: Americas, Asia, Europe, Middle East and India, and Corporate and other. Refer to Note 26, *Business Segment and Geographic Information*, for additional information.

**Basis of Presentation**

The accompanying consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") and include the accounts of Air Products and Chemicals, Inc. and those of its controlled subsidiaries. The notes that follow are an integral part of our consolidated financial statements. These notes, unless otherwise indicated, are presented on a continuing operations basis. Intercompany transactions and balances are eliminated in consolidation. Certain prior period information has been reclassified to conform to the current year presentation.

As further described in Note 2, *New Accounting Guidance*, we adopted Accounting Standards Update ("ASU") No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures" in fiscal year 2025. Accordingly, additional segment disclosure information has been included for fiscal years 2023 and 2024.

**Discontinued Operations**

The results of operations and cash flows for our discontinued operations have been segregated from the results of continuing operations and segment results. The comprehensive income related to discontinued operations has not been segregated and is included in the consolidated comprehensive income statements. There were no assets and liabilities presented as discontinued operations on our consolidated balance sheets. Refer to Note 8, *Discontinued Operations*, for additional information.

**Estimates and Assumptions**

Preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect amounts reported in the consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Consolidation Principles**

We consolidate all entities we control under either the voting interest model, which generally applies when we hold a majority of the voting interest of an entity, or the variable interest model, which applies to arrangements for which we are the primary beneficiary of a variable interest entity ("VIE"). For consolidated subsidiaries in which our ownership is less than 100%, the outside shareholders' interests are reflected as non-controlling interests on our consolidated financial statements.

We are considered the primary beneficiary of a VIE when we have both the power to direct the activities that most significantly impact the economic performance of the VIE and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE. We are the primary beneficiary of the NEOM Green Hydrogen Company and consolidate the joint venture within our Middle East and India segment. For additional information, refer to Note 3, *Variable Interest Entities*. We are not the primary beneficiary of any other material VIEs.

We account for a VIE for which we have an equity interest and exercise significant influence but are not the primary beneficiary, such as the Jazan Integrated Gasification and Power Company joint venture, as an equity method investment. For additional information on this joint venture, refer to Note 10, *Equity Affiliates*.

**Revenue Recognition**

We recognize revenue when or as performance obligations are satisfied, which occurs when control is transferred to the customer. We determine the transaction price of our contracts based on the amount of consideration to which we expect to be entitled to receive in exchange for the goods or services provided. Our contracts within the scope of revenue guidance do not contain payment terms that include a significant financing component. Consistent with industry business practice, we generally do not accept sales returns or provide return allowances.

Our sale of gas contracts are either accounted for over time during the period in which we deliver or make available the agreed upon quantity of goods or at a point in time when the customer receives and obtains control of the product, which generally occurs upon delivery. We generally recognize revenue from our sale of gas contracts based on the right to invoice practical expedient.

Our sale of equipment contracts are generally comprised of a single performance obligation as the individual promised goods or services contained within the contracts are integrated with or dependent upon other goods or services in the contract for a single output to the customer. Revenue from our sale of equipment contracts is generally recognized over time as we have an enforceable right to payment for performance completed to date and our performance under the contract terms does not create an asset with alternative use. We recognize these contracts using a cost incurred input method by which costs incurred to date relative to total estimated costs at completion are used to measure progress toward satisfying performance obligations.

Amounts billed for shipping and handling fees are classified as sales in the consolidated income statements. Shipping and handling activities for our sale of equipment contracts may be performed after the customer obtains control of the promised goods. In these cases, we have elected to apply the practical expedient to account for shipping and handling as activities to fulfill the promise to transfer the goods.

Amounts billed for sales and use taxes, value-added taxes, and certain excise and other specific transactional taxes imposed on revenue-producing transactions are presented on a net basis and excluded from sales in the consolidated income statements.

For additional information, refer to Note 7, *Revenue Recognition*.

**Cost of Sales**

Cost of sales predominantly represents the cost of tangible products sold. These costs include labor, raw materials, plant engineering, power, depreciation, production supplies and materials packaging costs, and maintenance costs. Costs incurred for shipping and handling are also included in cost of sales.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Depreciation**

Depreciation is recorded using the straight-line method, which deducts equal amounts of the cost of each asset from earnings every year over its estimated economic useful life. The principal lives for major classes of plant and equipment are summarized in Note 11, *Plant and Equipment, net*.

We continue to depreciate assets that are temporarily idle. Depreciation is discontinued when assets meet the criteria for classification as held for sale.

**Selling and Administrative Expense**

The principal components of selling and administrative expense are costs related to compensation, administrative functions, and professional fees.

**Postemployment Benefits**

We provide ongoing benefit arrangements that provide nonretirement postemployment benefits such as severance and outplacement services to involuntarily terminated employees. We record a liability for these benefits when we determine it is probable that the benefits will be paid in an amount that can be reasonably estimated. These criteria are met when management, with the appropriate level of authority, approves and commits to a termination plan that identifies impacted employees and their related benefits and is expected to be substantially completed within one year. We do not provide material one-time benefit arrangements.

**Fair Value Measurements**

We are required to measure certain assets and liabilities at fair value, either upon initial measurement or for subsequent accounting or reporting. For example, fair value is used in the initial measurement of assets and liabilities acquired in a business combination; on a recurring basis in the measurement of derivative financial instruments; and on a nonrecurring basis when long-lived assets are written down to fair value when held for sale or determined to be impaired. Refer to Note 16, *Fair Value Measurements*, and Note 18, *Retirement Benefits*, for information on the methods and assumptions used in our fair value measurements.

**Financial Instruments**

We address certain financial exposures through a controlled program of risk management that includes the use of derivative financial instruments. The types of derivative financial instruments permitted for such risk management programs are specified in policies set by management. Refer to Note 15, *Financial Instruments*, for further detail on the types and use of derivative instruments into which we enter.

Major financial institutions are counterparties to all of these derivative contracts. We have established counterparty credit guidelines and generally enter into transactions with financial institutions of investment grade or better. Management believes the risk of incurring losses related to credit risk is remote, and any losses would be immaterial to the consolidated financial results, financial condition, or liquidity.

We recognize derivatives on the balance sheet at fair value. On the date the derivative instrument is entered into, we generally designate the derivative as either (1) a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge), (2) a hedge of a net investment in a foreign operation (net investment hedge), or (3) a hedge of the fair value of a recognized asset or liability (fair value hedge).

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

The following details the accounting treatment of our cash flow, fair value, net investment, and non-designated hedges:

&nbsp;&nbsp;&nbsp;&nbsp;• Changes in the fair value of a derivative that is designated as and meets the cash flow hedge criteria are recorded in accumulated other comprehensive loss ("AOCL") to the extent effective and then recognized in earnings when the hedged items affect earnings.

&nbsp;&nbsp;&nbsp;&nbsp;• Changes in the fair value of a derivative that is designated as and meets all the required criteria for a fair value hedge, along with the gain or loss on the hedged asset or liability that is attributable to the hedged risk, are recorded in current period earnings.

&nbsp;&nbsp;&nbsp;&nbsp;• Changes in the fair value of a derivative and foreign currency debt that are designated as and meet all the required criteria for a hedge of a net investment are recorded as translation adjustments in AOCL.

&nbsp;&nbsp;&nbsp;&nbsp;• Changes in the fair value of a derivative that is not designated as a hedge are recorded immediately in earnings.

We formally document the relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. This process includes relating derivatives that are designated as fair value or cash flow hedges to specific assets and liabilities on the balance sheet or to specific firm commitments or forecasted transactions. We also formally assess, at the inception of the hedge and on an ongoing basis, whether derivatives are highly effective in offsetting changes in fair values or cash flows of the hedged item. If it is determined that a derivative is not highly effective as a hedge, or if a derivative ceases to be a highly effective hedge, we will discontinue hedge accounting with respect to that derivative prospectively.

**Foreign Currency**

Since we do business in many foreign countries, fluctuations in currency exchange rates affect our financial position and results of operations.

In most of our foreign operations, the local currency is considered the functional currency. Foreign subsidiaries translate their assets and liabilities into U.S. dollars at current exchange rates in effect as of the balance sheet date. The gains or losses that result from this process are shown as translation adjustments in AOCL in the equity section of the balance sheet.

The revenue and expense accounts of foreign subsidiaries are translated into U.S. dollars at the average exchange rates that prevail during the period. Therefore, the U.S. dollar value of these items on the consolidated income statements fluctuates from period to period, depending on the value of the U.S. dollar against foreign currencies. Some transactions are made in currencies different from an entity's functional currency. Gains and losses from these foreign currency transactions, and the impact of related hedges, are generally reflected in "Other income (expense), net" on our consolidated income statements as they occur and were not material for the periods presented in this report.

Foreign exchange gains and losses from the foreign currency remeasurement of balances associated with income tax assets and liabilities, intercompany and third-party financing transactions, and the impact of related hedges are reflected within "Other non-operating income (expense), net" and were not material for the periods presented in this report.

In addition, foreign currency forward points and currency swap basis differences that are excluded from the assessment of hedge effectiveness of our cash flow hedges of intercompany loans ("excluded components") are recorded within "Other non-operating income (expense), net" on a straight-line basis. Excluded components were expenses of $20.4, $31.4, and $25.1 in fiscal years 2025, 2024, and 2023, respectively.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Government Assistance**

We receive various types of government assistance, primarily in the form of grants or refundable tax credits. Government assistance is recognized when there is reasonable assurance that we have complied with relevant conditions and the assistance will be received. Government assistance is recognized in the consolidated income statements on a systematic basis over the periods in which we recognize the related costs for which the government assistance is intended to compensate. Government assistance related to assets is included in the balance sheet as a reduction of the cost of the asset and results in reduced depreciation expense over the useful life of the asset. Government assistance that relates to expenses is recognized in the income statement as a reduction of the related expense or as a component of other income (expense), net. Government assistance did not have a material impact on our consolidated financial statements for the periods presented in this report.

**Environmental Expenditures**

Accruals for environmental loss contingencies are recorded when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. Remediation costs are capitalized if the costs improve our property as compared with the condition of the property when originally constructed or acquired, or if the costs prevent environmental contamination from future operations. We expense environmental costs related to existing conditions resulting from past or current operations and from which no current or future benefit is discernible. The amounts charged to income from continuing operations related to environmental matters totaled $37.7, $27.0, and $24.9 in fiscal years 2025, 2024, and 2023, respectively.

Additionally, in fiscal years 2025 and 2024, we recorded pre-tax losses from discontinued operations of $10.6 and $19.4, respectively, primarily to increase our existing liabilities for retained environmental remediation obligations associated with previously divested businesses. Refer to the "Piedmont" and "Pace" discussions under Note 19, *Commitments and Contingencies*, for additional information.

The measurement of environmental liabilities is based on an evaluation of currently available information with respect to each individual site and considers factors such as existing technology, presently enacted laws and regulations, and prior experience in remediation of contaminated sites. An environmental liability related to cleanup of a contaminated site might include, for example, a provision for one or more of the following types of costs: site investigation and testing costs, remediation costs, post-remediation monitoring costs, natural resource damages, and outside legal fees. These liabilities include costs related to other potentially responsible parties to the extent that we have reason to believe such parties will not fully pay their proportionate share. They do not consider any claims for recoveries from insurance or other parties and are not discounted.

As assessments and remediation progress at individual sites, the amount of projected cost is reviewed, and the liability is adjusted to reflect additional technical and legal information that becomes available. Management has an established process in place to identify and monitor our environmental exposures. An environmental accrual analysis is prepared and maintained that lists all environmental loss contingencies, even where an accrual has not been established. This analysis assists in monitoring our overall environmental exposure and serves as a tool to facilitate ongoing communication among our technical experts, environmental managers, environmental lawyers, and financial management to ensure that required accruals are recorded and potential exposures disclosed.

Due to inherent uncertainties involved in evaluating environmental exposures, actual costs to be incurred at identified sites in future periods may vary from the estimates. Refer to Note 19, *Commitments and Contingencies*, for additional information on our environmental loss contingencies.

The accruals for environmental liabilities are reflected in the consolidated balance sheets, primarily as part of other noncurrent liabilities.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Litigation**

In the normal course of business, we are involved in legal proceedings. We accrue a liability for such matters when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. When only a range of possible loss can be established, the most probable amount in the range is accrued. If no amount within this range is a better estimate than any other amount within the range, the minimum amount in the range is accrued. The accrual for a litigation loss contingency includes estimates of potential damages and other directly related costs expected to be incurred. Refer to Note 19, *Commitments and Contingencies*, for additional information on our current legal proceedings.

**Share-Based Compensation**

We expense the grant-date fair value of our share-based awards over the vesting period during which employees perform related services. Expense recognition is accelerated for retirement-eligible individuals who would meet the requirements for vesting of awards upon their retirement. Refer to Note 21, *Share-Based Compensation*, for additional information regarding our awards, including the models and assumptions used to determine their grant-date fair value.

**Income Taxes**

We account for income taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the tax effects of temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to be recovered or settled. A principal temporary difference results from the excess of tax depreciation over book depreciation because accelerated methods of depreciation and shorter useful lives are used for income tax purposes. The cumulative impact of a change in tax rates or regulations is included in income tax expense in the period that includes the enactment date. We recognize deferred tax assets net of existing valuation allowances to the extent we believe that these assets are more likely than not to be realized considering all available evidence.

A tax benefit for an uncertain tax position is recognized when it is more likely than not that the position will be sustained upon examination based on its technical merits. This position is measured as the largest amount of tax benefit that is greater than 50% likely of being realized. Interest and penalties related to unrecognized tax benefits are recognized as a component of income tax expense.

We have elected as an accounting policy to account for Global Intangible Low Tax Income ("GILTI") as a period cost when incurred.

For additional information regarding our income taxes, refer to Note 24, *Income Taxes*.

**Other Non-Operating Income (Expense), net**

"Other non-operating income (expense), net" includes interest income associated with our cash and cash items and short-term investments, certain foreign currency remeasurements and impacts from the related hedging activities discussed in the *Foreign Currency* section above, and non-service cost components of net periodic pension and postretirement benefit cost. Our non-service costs primarily include interest cost, expected return on plan assets, amortization of actuarial gains and losses, and settlements.

Additionally, during the third quarter of fiscal year 2024, we discontinued cash flow hedge accounting for certain interest rate swaps associated with financing for the NEOM Green Hydrogen Project. As a result of the de-designation, unrealized gains and losses are recorded to "Other non-operating income (expense), net" until the instruments re-qualify for cash flow hedge accounting. Refer to Note 3, *Variable Interest Entities*, and Note 15, *Financial Instruments*, for additional information.

**Cash and Cash Items**

"Cash and cash items" include cash, time deposits, and treasury securities acquired with an original maturity of three months or less.

**Short-term Investments**

"Short-term investments" include time deposits and treasury securities with original maturities greater than three months and less than one year.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Credit Losses**

We are exposed to credit losses primarily through sales of products and services. When extending credit, we evaluate customer creditworthiness based on a combination of qualitative and quantitative factors that include, but are not limited to, the customer's credit score from external providers, financial condition, and past payment experience.

We assess allowances for credit losses on our trade receivable, lease receivable, and financing receivable portfolios. Allowances are evaluated by portfolio on a collective basis where similar characteristics exist. A provision for customer defaults is made on a general formula basis as the risk of some default is expected but cannot yet be associated with specific customers. The assessment of the likelihood of default is based on various factors, including the length of time the receivables are past due, historical experience, existing economic conditions, and forward-looking information. When we identify specific customers with known collectability issues, the assessment for credit losses is performed on an individual basis, considering current and forward-looking information about the customer. We also consider variables that may mitigate the inherent credit risk of a particular transaction, such as the estimated fair value of the collateral, whether by use or sale.

The use of forward-looking information considers economic conditions that may affect the customers' ability to pay. Although we historically have not experienced significant credit losses, our exposure to credit losses may increase if our customers are adversely affected by economic pressures or uncertainty associated with local or global economic recessions, or other customer-specific factors. We review our reserves for credit losses on a quarterly basis.

Trade receivables comprise amounts owed to us through our operating activities and are presented net of allowances for credit losses. Changes to the carrying amount of the allowance for credit losses on trade receivables are summarized below:

---

| | |
|:---|:---|
| Balance at 30 September 2022 | $24.1 |
| Provision for credit losses | 8.2 |
| Write-offs charged against the allowance | (7.9) |
| Currency translation and other | (1.5) |
| Balance at 30 September 2023 | $22.9 |
| Provision for credit losses | 10.7 |
| Write-offs charged against the allowance | (8.5) |
| Currency translation and other | 1.2 |
| Balance at 30 September 2024 | $26.3 |
| Provision for credit losses | 10.3 |
| Write-offs charged against the allowance | (7.5) |
| Currency translation and other | 1.1 |
| **Balance at 30 September 2025** | **$30.2** |

---

Additionally, lease and financing receivables are presented net of allowances for credit losses. As of 30 September 2025 and 2024, the allowance on lease receivables was not material. In fiscal year 2025, we recorded a $300 allowance for credit loss related to a financing receivable in connection with our exit from the sustainable aviation fuel expansion project with World Energy. Refer to Note 3, *Variable Interest Entities*, and Note 5, *Business and Asset Actions*, for additional information. The allowance on financing receivables was not material as of 30 September 2024.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Inventories**

We carry inventories consisting of finished goods, work-in-process, raw materials, and supplies.

Inventories are stated at the lower of cost or net realizable value and are presented net of applicable reserves on our consolidated balance sheets. Cost is determined using the first-in, first-out ("FIFO") method. We write down our inventories for estimated obsolescence or when inventories become unmarketable based on assumptions about future demand and market conditions. Refer to Note 9, *Inventories*, for further detail.

**Equity Method Investments**

We apply the equity method of accounting when we have the ability to exercise significant influence but do not control the operating and financial decisions of an investee, which generally applies when our ownership interest in common stock or in-substance common stock of the investee is between 20% and 50%. Under the equity method, we initially record our investment at cost and subsequently adjust the investment to recognize our share of net earnings or losses, distributions received, and other-than-temporary impairments. The carrying value of our equity method investments is reflected as "Investment in net assets of and advances to equity affiliates" on our consolidated balance sheets. We use the cumulative earnings approach for determining cash flow presentation of cash distributions received from equity method investees. Equity investments are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment may not be recoverable.

Our share of the investee's net earnings is primarily presented net of income taxes within "Equity affiliates' income" on our consolidated income statements. Profits or losses related to intra-entity sales with our equity method investees are eliminated consistent with our ownership percentage in the entity until realized by the investee through a transaction with a third party. In addition, "Equity affiliates' income" includes interest income from shareholder loans viewed as in-substance common stock.

**Plant and Equipment, net**

Plant and equipment, net is stated at cost less accumulated depreciation. Construction costs, labor, and applicable overhead related to installations are capitalized. Expenditures for additions and improvements that extend the lives or increase the capacity of plant assets are capitalized. The costs of maintenance and repairs of plant and equipment are expensed as incurred.

Fully depreciated assets are retained in the gross plant and equipment and accumulated depreciation accounts until they are removed from service. In the case of disposals, assets and related accumulated depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in income. Refer to Note 11, *Plant and Equipment, net*, for further detail.

**Computer Software**

We capitalize costs incurred to purchase or develop software for internal use. Capitalized costs include purchased computer software packages, payments to vendors/consultants for development and implementation or modification to a purchased package to meet our requirements, payroll and related costs for employees directly involved in development, and interest incurred while software is being developed. Capitalized costs are reflected in "Plant and equipment, net" on the consolidated balance sheets and are depreciated over the estimated useful life of the software, generally a period of three to five years.

We capitalize costs incurred with the implementation of a cloud computing arrangement that is a service contract, consistent with our policy for software developed or obtained for internal use. However, the capitalized costs are reflected in "Other noncurrent assets" on our consolidated balance sheets and expensed over the term of the related hosting arrangement.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Leases as Lessee**

As lessee, we recognize a right-of-use ("ROU") asset and lease liability on the balance sheet for all leases with terms in excess of 12 months. We evaluate whether an arrangement contains a lease at inception by determining whether there is an identifiable asset, we obtain substantially all the economic benefits from that asset, and we direct how and for what purpose the asset is used during the term of the arrangement. We apply a practical expedient to exclude arrangements with initial terms of 12 months or less from our balance sheet.

ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. Since our leases generally do not provide an implicit discount rate, we use our incremental borrowing rates based on the information available at the commencement date in determining the present value of lease payments. To determine the incremental borrowing rate, we consider our unsecured borrowings and published market rates, and then adjust those rates to assume full collateralization and to factor in the individual lease term, geography, and payment structure.

Our lease term includes periods covered by options to extend or terminate the lease when it is reasonably certain that we will exercise an option to extend or not exercise an option to terminate. Lease payments consider our practical expedient to combine amounts for lease and related non-lease components for all classes of underlying assets in which we are lessee. Fixed payments and payments associated with escalation clauses based on an index are included in the ROU asset and lease liability at commencement. Variable lease payments are excluded from the ROU assets and lease liabilities and are recognized in the period in which the obligation for those payments is incurred. Our variable lease payments primarily include the impact from escalation clauses that are not fixed or based on an index. Prepaid lease payments are included in the recognition of ROU assets. Our lease agreements do not contain any material lease incentives, residual value guarantees or restrictions or covenants.

**Leases as Lessor**

Certain contracts associated with facilities that are built to provide product to a specific customer are accounted for as containing embedded leases. Our lease receivables are primarily long-term in nature and relate to sales-type leases on certain on-site assets for which payments are collected over the contract term. Revenue representing interest income from the financing component of the lease receivable is reflected as sales over the life of the contract.

In cases for which operating lease treatment is appropriate, there is no difference in revenue recognition over the life of the contract as compared to accounting for the contract under a sale of gas agreement. These contracts qualify for a practical expedient available to lessors to combine the lease and non-lease components and account for the combined component in accordance with the accounting treatment for the predominant component. We elected to apply this practical expedient and have accounted for the combined component as product sales under the revenue standard as we control the operations and maintenance of the assets that provide the supply of gas to our customers.

There have been no new arrangements that qualified as a lease for which we are the lessor in fiscal year 2025.

**Financing Receivables**

Some of our acquisitions include terms that provide the seller with both the right to receive all output from the acquired asset for an agreed upon term as well as the right to reacquire the asset at a future date. In these instances, we evaluate the contract terms to determine whether we have obtained control of the underlying asset, or the transaction qualifies as a financing arrangement. For transactions that qualify as financing arrangements, we record our investment as a financing receivable, net of any allowances for credit losses, on our consolidated balance sheets. We then recognize a portion of the payments received as a reduction to the financing receivable. Related interest income is presented within "Sales" on our consolidated income statements with revenue received to operate the plant. Accrued interest is presented within trade receivables, net and was not material as of 30 September 2025 and 2024.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Impairment of Long-Lived Assets**

Long-lived assets are grouped for impairment testing at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. We assess recoverability by comparing the carrying amount of the asset or asset group to estimated undiscounted future cash flows expected to be generated by the asset group. If an asset group is determined to be impaired, the impairment loss to be recognized is measured as the amount by which the asset group's carrying amount exceeds its estimated fair value. An estimate of the asset group's fair value is based on the discounted value of its estimated cash flows.

Long-lived assets that meet the criteria to be classified as held for sale are reported at the lower of their carrying amount or fair value less cost to sell. The fair value of the disposal group is estimated utilizing a discounted cash flow analysis. Long-lived assets intended for disposal through means other than sale are evaluated for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or disposal group may not be recoverable.

In fiscal year 2025, we recorded impairment charges to reduce the carrying value of long-lived assets associated with exited projects. A portion of the related plant and equipment is capable of being marketed through secondary equipment channels but did not meet the criteria for classification as held for sale. The estimated net realizable value of these assets was $22.5, which remains classified within "Plant and equipment, net" on our consolidated balance sheet as of 30 September 2025. Separately, two coal gasification plants in China met the criteria to be classified as held for sale. Accordingly, the estimated fair value less cost to sell for long-lived assets of $418.3 is included in "Assets held for sale" on our consolidated balance sheet as of 30 September 2025. Refer to Note 5, *Business and Asset Actions*, and Note 16, *Fair Value Measurements*, for additional information.

**Asset Retirement Obligations**

The fair value of a liability for an asset retirement obligation is recognized in the period in which it is incurred. The fair value of the liability is measured using discounted estimated cash flows and is adjusted to its present value in subsequent periods as accretion expense is recorded. The corresponding asset retirement costs are capitalized as part of the carrying amount of the related long-lived asset and depreciated over the asset's useful life. Our asset retirement obligations are primarily associated with on-site long-term supply contracts under which we have built a facility on land owned by the customer and are obligated to remove the facility at the end of the contract term. Refer to Note 19, *Commitments and Contingencies*, for further detail.

**Goodwill**

Business combinations are accounted for using the acquisition method. The purchase price is allocated to the assets acquired and liabilities assumed based on their estimated fair values. Any excess purchase price (plus the fair value of any noncontrolling interest and previously held equity interest in the acquiree) over the fair market value of the net assets acquired, including identified intangibles, is recorded as goodwill. Preliminary purchase price allocations are made at the date of acquisition and finalized when information about facts and circumstances that existed as of the acquisition date needed to finalize underlying estimates is obtained or when we determine that such information is not obtainable, within a maximum measurement period of one year.

Goodwill is tested for impairment at least annually, and more frequently if events or changes in circumstances indicate that goodwill may be impaired. During fiscal year 2025, no triggering events were identified that would require impairment testing for any of our reporting units containing goodwill. We completed our annual goodwill impairment test and concluded there were no indications of impairment.

Refer to Note 12, *Goodwill*, for further detail.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Intangible Assets**

Intangible assets with determinable lives primarily consist of customer relationships. The cost of intangible assets with determinable lives is amortized on a straight-line basis over the estimated period of economic benefit. No residual value is estimated for these intangible assets. Indefinite-lived intangible assets consist of trade names and trademarks. Indefinite-lived intangibles are tested for impairment at least annually, and more frequently if events or changes in circumstances indicate that the assets may be impaired. During fiscal year 2025, no triggering events were identified that would require impairment testing for any of our indefinite-lived intangible assets. We completed our annual impairment test for these assets and concluded there were no indications of impairment.

Customer relationships are generally amortized over periods of five to 25 years. Purchased patents and technology and other finite-lived intangibles are generally amortized over periods of five to 15 years. Other intangibles includes certain land use rights, which are generally amortized over a period of 50 years. Amortizable lives are adjusted whenever there is a change in the estimated period of economic benefit. Refer to Note 13, *Intangible Assets*, for further detail.

**Retirement Benefits**

Our retirement benefit plans are discussed in Note 18, *Retirement Benefits*. The cost of benefits we contribute to defined contribution plans is recognized in the year earned. The cost of benefits under our defined benefit and other post-retirement plans is generally recognized over the employees' service period. We use actuarial methods and assumptions in the valuation of defined benefit obligations and the determination of expense. Differences between actual and expected results or changes in the value of obligations and plan assets are recognized systematically over subsequent periods.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**2. NEW ACCOUNTING GUIDANCE**

**Accounting Guidance Implemented in Fiscal Year 2025**

<u>Reportable Segment Disclosures</u>

In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures". We adopted the update upon its effective date in fiscal year 2025 and implemented the expanded disclosure requirements in Note 26, *Business Segment and Geographic Information*, of this Annual Report on Form 10-K.

Pursuant to the update, we expanded our disclosures to include significant expense categories that are regularly provided to our Chief Operating Decision Maker, as well as other segment items included in the reported measure of segment profit or loss. Prior period segment disclosures presented in this report have been updated to reflect the additional information now required under the new guidance.

These updates will also be reflected in our Quarterly Reports on Form 10-Q beginning with the first quarter of fiscal year 2026.

**New Accounting Guidance to be Implemented**

<u>Climate-Related Disclosures</u>

In March 2024, the SEC issued Release No. 33-11275, "The Enhancement and Standardization of Climate-Related Disclosures for Investors", which includes final rules for providing annual qualitative and quantitative disclosures regarding certain climate-related topics. As a result of legal challenges, the SEC issued an order in April 2024 to stay the effectiveness of the rules pending the completion of judicial review of the consolidated challenges before the United States Court of Appeals for the Eighth Circuit.

The SEC subsequently announced its withdrawal of its legal defense to such challenges in March 2025; however, the rules have not been formally rescinded by the SEC. In April 2025, the appellate court suspended its proceedings indefinitely and directed the SEC to file a status report outlining its next steps. In response, the SEC stated in July 2025 that it does not intend to revisit the rules and requested the court to rule on the pending petitions.

In September 2025, the appellate court declined the SEC's request and placed the litigation in abeyance, which will remain in effect until the SEC reconsiders the rules by notice-and-comment rulemaking or renews its defense. We continue to monitor these developments.

<u>Income Tax Disclosures</u>

In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740)—Improvements to Income Tax Disclosures", to expand income tax disclosures, primarily through disaggregation requirements for the rate reconciliation and income taxes paid. The update will be effective in our Annual Report on Form 10-K for the fiscal year ending 30 September 2026, although early adoption is permitted. The amendments should be applied on a prospective basis with a retrospective option. We are evaluating the impact this update will have on our disclosures.

<u>Disaggregation of Income Statement Expenses</u>

In November 2024, the FASB issued ASU 2024-03, "Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses", which requires additional disclosures of certain costs and expenses, including purchases of inventory, employee compensation, depreciation, intangible asset amortization, as well as selling expenses in the notes to the financial statements. In January 2025, the FASB clarified that the update will be effective in our Annual Report on Form 10-K for the fiscal year ending 30 September 2028 as well as interim periods thereafter, although early adoption is permitted. The amendments should be applied either prospectively after the effective date or retrospectively to any or all periods presented. We are evaluating the impact this update will have on our disclosures.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Measurement of Credit Losses for Accounts Receivable and Contract Assets</u>

In July 2025, the FASB issued ASU 2025-09, "Measurement of Credit Losses for Accounts Receivable and Contract Assets", which allows an entity to elect a practical expedient to assume that current conditions as of the balance sheet date do not change when estimating expected credit losses. This update will be effective at the beginning of fiscal year 2027, although early adoption is permitted. The amendments should be applied on a prospective basis. We are evaluating the implications of this update. At this time, we do not expect it will have a material impact on our financial statements.

<u>Accounting for Internal-Use Software</u> 

In September 2025, the FASB issued ASU 2025-06, "Targeted Improvements to the Accounting for Internal-Use Software", which establishes criteria for commencing cost capitalization for software projects. This update will be effective at the beginning of fiscal year 2029, although early adoption is permitted. The amendments can be applied prospectively, retrospectively, or via a modified prospective transition method. We are evaluating the impact this update will have on our financial statements.

**3. VARIABLE INTEREST ENTITIES**

We are the primary beneficiary of the NEOM Green Hydrogen Company joint venture ("NGHC"), a variable interest entity ("VIE") that is consolidated in our Middle East and India segment. We are not the primary beneficiary of any other material VIEs.

Our other material VIEs are those in which we hold variable interests but are not the primary beneficiary. We have an equity interest and exercise significant influence in the Jazan Integrated Gasification and Power Company joint venture ("JIGPC"), which we account for as an equity method investment in our Middle East and India segment. We have no equity interest in World Energy, LLC ("World Energy"), but hold a variable interest through a financing receivable that was fully reserved in fiscal year 2025 in connection with our exit from the SAF expansion project.

Our variable interests in NGHC, JIGPC, and World Energy are further discussed below.

**<u>NGHC Joint Venture</u>**

Air Products is an equal owner in NGHC with our joint venture partners, ACWA Power and NEOM Company. While we only hold one-third of the voting interests in the joint venture, substantially all the activities of the joint venture involve or are conducted on behalf of Air Products. Since we have disproportionately few voting rights relative to our economic interests in the joint venture, we determined that NGHC is a VIE. In addition, we determined that we are the primary beneficiary of NGHC since we have the power to unilaterally direct certain significant activities, including key design and construction decisions, and we share power with our joint venture partners related to other activities that are significant to the economic performance of NGHC. Therefore, we consolidate NGHC within the Middle East and India segment.

Under the project financing discussed below, the assets of NGHC can only be used to settle obligations of the joint venture, and creditors of NGHC do not have recourse to the general credit of Air Products. A table summarizing balances associated with NGHC as reflected on our consolidated balance sheets is provided on page <u>[89](#i78b2e0314d464c1e9bfe4a6bfd469437_10595)</u>.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Project Financing</u>

In May 2023, NGHC finalized the $6.7 billion engineering, procurement, and construction agreement, naming Air Products as the main contractor and system integrator for the facility. To support the project, NGHC secured project financing that is non-recourse to Air Products of approximately $6.1 billion, which is expected to fund about 73% of the project and will be drawn over the construction period. At the same time, NGHC secured additional credit facilities totaling approximately $500, primarily for NGHC's working capital needs. These facilities are also non-recourse to Air Products.

Total principal borrowings were $4.9 billion and $3.3 billion as of 30 September 2025 and 2024, respectively. These balances include short-term borrowings of $24.0 and $51.6, respectively, under a variable-rate Saudi Riyal facility, which carried an interest rate of 6.30% as of 30 September 2025. The remaining borrowings are from long-term facilities, which are reflected net of unamortized discounts and debt issuance costs within "Long-term debt" on our consolidated balance sheets. A summary of NGHC's long-term borrowings is provided in the table below:

---

| | | | |
|:---|:---|:---|:---|
| **30 September** | Fiscal Year Maturities | **2025** | 2024 |
| **Payable in U.S. Dollars** |  |  |  |
| &nbsp;&nbsp;U.S. Dollar variable-rate facilities 5.49%<sup>(A)</sup> | 2027 to 2053 | **$2911.0** | $1945.2 |
| &nbsp;&nbsp;U.S. Dollar variable-rate facility 5.14%<sup>(A)</sup> | 2027 to 2041 | **630.6** | 345.5 |
| &nbsp;&nbsp;U.S. Dollar stated-rate facility 5.00% | 2027 to 2053 | **368.0** | 245.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total Payable in U.S. Dollars** |  | **$3909.6** | $2536.6 |
| **Payable in Other Currencies** |  |  |  |
| Saudi Riyal stated-rate facility 2.00% | 2028 to 2041 | **1000.1** | 735.2 |
| **Total Principal Amount** |  | **$4909.7** | $3271.8 |
| Less: Unamortized discount and debt issuance costs<sup>(B)</sup> |  | **232.1** | 218.5 |
| **Total NGHC Long-term Debt** |  | **$4677.6** | $3053.3 |

---

<sup>(A)</sup>Reflects a daily compounded SOFR as of 30 September 2025 plus an annual margin of 1.31% and 0.96%, respectively. These rates do not include the impact of our floating-to-fixed interest rate swaps, which result in an overall lower interest rate for the borrowings. Additional information regarding these instruments is provided below.

<sup>(B)</sup>Our consolidated balance sheets as of 30 September 2025 and 2024 also included $3.8 and $4.6, respectively, for remaining project financing fees that were eligible for deferral as a noncurrent asset. As additional borrowings are drawn, the unamortized balance is reclassified as an offset to the outstanding debt.

<u>Interest Rate Swaps</u>

In May 2023, NGHC entered into floating-to-fixed interest rate swaps designed to hedge the long-term variable rate debt facilities available under the project financing during the construction period of the project. We discontinued cash flow hedge accounting for certain swaps during the third quarter of fiscal year 2024 due to changes in the anticipated drawdown timeline for the hedged borrowings. As a result of the de-designation, unrealized gains and losses are recorded to "Other non-operating income (expense), net" on our consolidated income statements as summarized in the table below:

---

| | | | |
|:---|:---|:---|:---|
| Fiscal Year Ended 30 September | **2025** | 2024 | 2023 |
| Gain (loss) on de-designation of cash flow hedges | **$27.0** | ($16.3) | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Amount attributable to noncontrolling partners in NGHC | **17.6** | (10.6) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Amount attributable to Air Products after tax | **7.2** | (4.3) |  |

---

We re-designated certain affected swaps as outstanding borrowings under the available project financing became commensurate with the swaps' notional values. The remaining de-designated swaps will continue to be excluded from hedge accounting until additional borrowings align with their notional amounts, at which point they may re-qualify for cash flow hedge accounting.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Land Lease</u>

The green hydrogen-based ammonia production facility is being constructed on land owned by our joint venture partner, NEOM Company. NGHC signed a 50-year lease agreement for the site, which commenced during the third quarter of fiscal year 2023. As a result, we recognized an operating lease with a right-of-use asset and corresponding liability of $223, of which $209 was paid as a lump-sum in August 2023. Additional lease payments are due after the first 30 years of the lease term.

<u>NGHC Balance Sheet</u>

The table below summarizes balances associated with NGHC as reflected on our consolidated balance sheets:

---

| | | |
|:---|:---|:---|
| | **30 September**<br>**2025** | 30 September<br>2024 |
| **Assets** |  |  |
| Cash and cash items | **$40.3** | $34.5 |
| Trade receivables, net | **1.1** | 6.7 |
| Prepaid expenses | **20.7** | 31.2 |
| Other receivables and current assets | **107.2** | 120.6 |
| **Total Current Assets** | **$169.3** | $193.0 |
| Plant and equipment, net | **6593.9** | 3929.9 |
| Operating lease right-of-use assets, net | **218.0** | 233.9 |
| Other noncurrent assets | **153.5** | 37.1 |
| **Total Noncurrent Assets** | **$6965.4** | $4200.9 |
| **Total Assets** | **$7134.7** | $4393.9 |
| **Liabilities** |  |  |
| Payables and accrued liabilities | **$201.7** | $308.4 |
| Accrued income taxes | **1.2** | 2.0 |
| Short-term borrowings | **24.0** | 51.6 |
| **Total Current Liabilities** | **$226.9** | $362.0 |
| Long-term debt | **4677.6** | 3053.3 |
| Noncurrent operating lease liabilities | **17.8** | 24.5 |
| Other noncurrent liabilities | **1.6** | 30.4 |
| Deferred income taxes | **13.8** | 3.2 |
| **Total Noncurrent Liabilities** | **$4710.8** | $3111.4 |
| **Total Liabilities** | **$4937.7** | $3473.4 |
| **Equity** |  |  |
| Accumulated other comprehensive income | **$38.3** | $13.8 |
| Noncontrolling interests | **1493.6** | 937.6 |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**<u>JIGPC Joint Venture</u>**

JIGPC is a joint venture with Saudi Aramco Power Company (a subsidiary of Aramco), ACWA Power, and Air Products Qudra ("APQ"). JIGPC entered into project financing to purchase power blocks, gasifiers, air separation units, syngas cleanup assets, and utilities to supply electricity, steam, hydrogen, and utilities to Aramco's refinery and terminal complex under a 25-year agreement, which commenced in the first quarter of fiscal year 2022. JIGPC recorded financing receivables upon acquisition of the assets and recognizes financing income over the supply term.

We determined JIGPC is a VIE for which we exercise significant influence but are not the primary beneficiary as we do not have the power to direct the activities that are most significant to its economic performance. Instead, these activities, including plant dispatch, operating and maintenance decisions, budgeting, capital expenditures, and financing, require unanimous approval of the owners or are controlled by the customer. Accordingly, we account for our 55% investment, which includes 4% that is attributable to the noncontrolling partner of APQ, under the equity method within the Middle East and India segment.

Our loss exposure is limited to our investment in the joint venture. The carrying value of our investment, including amounts attributable to noncontrolling interests, totaled $3.1 billion and $2.9 billion as of 30 September 2025 and 2024, respectively. The balance as of 30 September 2025 reflects a final investment of approximately $115 that we completed during the second quarter of fiscal year 2025. This investment was made in the form of a shareholder loan, which the joint venture used to purchase the remaining project assets.

Our total investment in JIGPC primarily consists of shareholder loans that qualify as in-substance common stock in the joint venture. Certain shareholders receive a preferred cash distribution pursuant to the joint venture agreement, which specifies each shareholder's share of income after considering the amount of cash available for distribution. As such, the earnings attributable to Air Products may not be proportionate to our ownership interest in the venture.

**<u>World Energy</u>**

In November 2023, we purchased a sustainable aviation fuel ("SAF") facility in Paramount, California, from World Energy and accounted for the transaction as a financing arrangement because the agreement contained an embedded sales-type lease. As of 30 September 2024, the related financing receivable had a carrying value of approximately $300. Additionally, we entered into a Master Project Agreement ("MPA") that included terms for operation of the acquired facility as well as amended terms for the construction and operation of an SAF expansion project subject to construction at the same location. The MPA also included a tolling arrangement whereby we would receive feedstock from and produce renewable fuels for World Energy over a term to conclude 15 years after onstream of the expansion project with the option to renew for two five-year terms. Subsequently, the expansion project was put on hold pending receipt of permits.

We determined that World Energy is a VIE, and our financing receivable represented a variable interest in World Energy. We are not the primary beneficiary as we do not have control over their key operating decisions, including feedstock supply, production of renewable fuels, and negotiating and executing supply agreements with customers.

During the second quarter of fiscal year 2025, we terminated the MPA and announced our decision to exit the project. In connection with this decision, we recorded project exit charges totaling approximately $1.9 billion, the majority of which were recognized at the time of the announcement. The charges included approximately $1.6 billion to write down assets that had primarily been reflected within "Plant and equipment, net" and $300 to establish an allowance for credit loss equal to the value of the financing receivable, which had previously been placed on non-accrual status. The remaining charge primarily reflects estimated costs to terminate contractual commitments and satisfy other obligations associated with exiting the site. We have no further loss exposure related to our variable interest in World Energy as of 30 September 2025; however, there could be future impacts to earnings as we finalize our exit from the project.

The charges discussed above were recorded in aggregate with those related to other actions as described in Note 5, *Business and Asset Actions*. Estimates used to calculate the charges reflect our best judgment based on information available as of 30 September 2025.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**4. GAIN ON SALE OF BUSINESS**

**Fiscal Year 2025 Sale of Singapore Business**

In April 2025, we completed the sale of our 100% ownership interest in a consolidated subsidiary located in Singapore. The transaction resulted in cash proceeds of $104.3, which was received in full upon closing. As a result of the divestiture, we recognized a gain of $67.3 ($51.9 after tax) that is presented as "Gain on sale of business" on our consolidated income statement for fiscal year 2025. The gain was not recorded in the results of the Asia segment.

Prior to the divestiture, the subsidiary contributed annual sales of approximately $50 to our Asia segment, primarily through the merchant gas supply mode. Assets divested in the transaction primarily included regionally located on-site production facilities and associated infrastructure.

**Fiscal Year 2024 Sale of LNG Business**

On 30 September 2024, we completed the sale of our liquefied natural gas ("LNG") process technology and equipment business to Honeywell International Inc. for approximately $1.8 billion in an all-cash transaction. As a result of the transaction, we recorded a gain of approximately $1.6 billion during the fourth quarter of fiscal year 2024 that is reflected within "Gain on sale of business" on our consolidated income statements (approximately $1.2 billion after tax). This gain was not recorded in the results of the Corporate and other segment.

The LNG business did not qualify for presentation as a discontinued operation because the disposal did not represent a strategic shift that had or will have a major effect on our operations and financial results. The LNG business generated operating income for our Corporate and other segment of approximately $135 in fiscal year 2024 and $120 in fiscal year 2023.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**5. BUSINESS AND ASSET ACTIONS**

The table below summarizes charges related to business and asset actions as reflected on our consolidated income statements. These charges are not included in segment results.

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | 2024 | 2023 |
| Project exit costs | **$3623.3** | $— | $217.6 |
| Global cost reduction plan | **123.7** | 57.0 | 27.0 |
| Business and asset actions recorded through operating results | **$3747.0** | $57.0 | $244.6 |
| Project exit-related impairment of equity method investment<sup>(A)</sup> | **6.8** |  |  |
| Subtotal | **$3753.8** | $57.0 | $244.6 |
| Income tax benefit | **695.2** | 13.2 | 34.7 |
| Amount attributable to noncontrolling interests | **10.7** |  | 5.0 |
| Business and asset actions attributable to Air Products after-tax | **$3047.9** | $43.8 | $204.9 |

---

<sup>(A)</sup>Amount recorded through "Equity affiliates' income" reflects an other-than-temporary impairment of a joint venture in China that had been formed to develop clean hydrogen infrastructure in the region.

**Project Exit Costs**

<u>Fiscal Year 2025</u>

During the second quarter of fiscal year 2025, our Board of Directors and Chief Executive Officer initiated a project review to focus resources on projects we believe will deliver the greatest value to our shareholders. As a result of this review, we made the decision to exit various projects, primarily related to clean energy generation and distribution. The review remains ongoing and may result in additional costs in future periods.

In connection with this review, we recognized project exit costs totaling approximately $3.6 billion in fiscal year 2025. These costs primarily consisted of noncash write-downs of project assets to their estimated net realizable value or fair value less cost to sell, as well as estimated costs to terminate contractual commitments. Of the total charge, approximately $2.4 billion related to our decision to exit three U.S.-based projects within our Americas segment in the second quarter and approximately $755 related to several smaller-scale projects across our global portfolio, primarily supporting the energy transition. These exits were driven by challenging commercial conditions, unfavorable regulatory actions, project-specific economic factors, and slower-than-expected development in certain markets. The remaining $425 charge related to the impairment of two coal gasification plants in China that we decided to market for sale in the fourth quarter of fiscal year 2025 due to customer-related challenges. These actions did not result in the impairment of goodwill or intangible assets.

The table below reconciles project exit charges recognized in operating results for fiscal year 2025 to the related accrual reflected in "Payables and Accrued Liabilities" on our consolidated balance sheet as of 30 September 2025:

---

| | |
|:---|:---|
| Project exit costs | $3623.3 |
| Noncash expenses<sup>(A)</sup> | (3282.7) |
| Cash payments<sup>(B)</sup> | (174.4) |
| Currency translation adjustment | 12.1 |
| Amount accrued as of 30 September 2025 | $178.3 |

---

<sup>(A)</sup>Noncash expenses included approximately $2.5 billion to write down plant and equipment. The remaining amount primarily relates to other assets associated with our exit from the sustainable aviation fuel expansion project with World Energy as discussed in Note 3, *Variable Interest Entities*.

<sup>(B)</sup>Cash expenditures associated with these actions primarily reflect costs to terminate contractual commitments and settle asset retirement obligations. Total cash outflows are projected to be approximately $355 once the exit strategy is fully implemented.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

We determined that assets and liabilities associated with two coal gasification plants in our Asia segment met the criteria for held-for-sale classification. As discussed above, we recorded an impairment charge of approximately $425 to write down the assets to their estimated fair value less costs to sell. Of the charge, $350.6 related to plant and equipment. As of 30 September 2025, our consolidated balance sheet included assets held for sale of $427.7, which primarily consisted of plant and equipment with an estimated value of $418.3, and liabilities held for sale of $50.5.

We expect to complete the sales of these plants in fiscal year 2026. Any gain or loss from the sales will be recognized at the time of the transaction based on the carrying amounts classified as held for sale. Interim adjustments to these amounts may be recorded prior to closing, depending on changes in market participant assumptions or updated indications of fair value, including developments in the expected selling price and transaction timing.

In addition, we identified plant and equipment with a net realizable value of $22.5 that did not meet the held-for-sale criteria but is capable of being marketed through a secondary equipment market. These assets remain classified within "Plant and equipment, net" on our consolidated balance sheet as of 30 September 2025.

Both the held-for-sale assets and the marketable plant and equipment were subject to Level 3 fair value measurements due to the use of significant unobservable inputs. Refer to Note 16, *Fair Value Measurements,* for additional information.

Estimates related to the actions described above reflect our best judgment based on information available as of 30 September 2025. Final settlement of these items may differ materially from our current estimates, which could impact our consolidated financial statements in future periods. While we expect to complete exit activities within the next twelve months, we cannot predict the occurrence of future events and circumstances that could extend this process beyond one year in certain cases.

<u>Fiscal Year 2023</u>

In fiscal year 2023, we recorded a noncash charge of $217.6 to write off assets associated with exited projects that were previously under construction in our Asia and Europe segments. The assets written off included those related to our withdrawal from coal gasification in Indonesia as well as a project in Ukraine that was permanently suspended due to Russia's invasion of the country.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Global Cost Reduction Plan**

In June 2023, we initiated a global cost reduction plan that provides severance and other postemployment benefits to employees designated for involuntary separation. In accordance with our accounting policy, we recognize related costs in the period management formally commits to a defined set of actions under the plan. Benefits are determined based on the terms of our established ongoing benefit arrangements. Since the plan was initiated in 2023, we incurred costs totaling $207.7 for approximately 3,600 employees globally.

The table below reconciles costs related to our global cost reduction plan to payables and accrued liability balances as reflected on our consolidated balance sheets:

---

| | |
|:---|:---|
| 2023 Charge | $27.0 |
| Cash payments | (6.8) |
| Currency translation adjustment | (0.4) |
| Amount accrued as of 30 September 2023 | $19.8 |
| 2024 Charge | $57.0 |
| Cash payments | (43.6) |
| Currency translation adjustment | 0.8 |
| Amount accrued as of 30 September 2024 | $34.0 |
| 2025 Charge | $123.7 |
| Cash payments | (57.5) |
| Currency translation adjustment | 1.4 |
| Amount accrued as of 30 September 2025 | **$101.6** |

---

The remaining liability as of 30 September 2025 primarily relates to employees identified during fiscal year 2025. We expect implementation of these actions to be substantially complete by the end of fiscal year 2026. However, position eliminations are subject to legal requirements that vary by jurisdiction, which may extend this process beyond one year in certain cases.

**6. ACQUISITIONS AND DIVESTITURES** 

**Acquisition of Ijsfabriek Strombeek**

On 30 April 2025, we acquired a 100% interest in Ijsfabriek Strombeek, an independent industrial gases company located in Belgium. Total consideration, net of cash acquired, was $74.2, which included $59.9 paid in cash at closing. Ijsfabriek Strombeek produces and distributes a portfolio of merchant gases, including medical gases, dry ice, and carbon dioxide.

We accounted for the acquisition as a business combination within our Europe segment. Assets recognized primarily consisted of plant and equipment of $32.2; goodwill of $31.3; and intangible assets of $15.8. The goodwill is not expected to be deductible for income tax purposes. Intangible assets acquired primarily include customer relationships with a weighted-average amortization period of approximately 10 years. The acquired assets were recorded at their estimated fair values based primarily on a preliminary purchase price allocation. We may record adjustments to these assets during the preliminary purchase price allocation period, which could be up to one year from the acquisition date.

**Financing Arrangement: Uzbekistan Facility**

On 25 May 2023, we entered into an investment agreement with the Government of the Republic of Uzbekistan and Uzbekneftegaz JSC ("UNG") to purchase a natural gas-to-syngas processing facility in Qashqadaryo Province, Uzbekistan, for $1 billion. Under the agreement, Air Products owns and operates the acquired facility and is supplying all offtake products to UNG under a 15-year on-site contract, with UNG supplying the feedstock natural gas and utilities. Throughout this term, we receive a fixed monthly fee (regardless of whether UNG requires the output) comprised of two components: a plant capacity fee and an operating and maintenance fee.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

We are accounting for the transaction as a financing arrangement as we did not obtain accounting control of the facility due to UNG having the unilateral right to reacquire the facility at the end of the contract term. The repurchase price on a discounted basis, which consists of the total monthly plant capacity fees received over the term of the arrangement plus the repurchase option price, exceeds our purchase price. Accordingly, our payments related to the facility are reflected within "Financing receivables" on our consolidated balance sheets. Financing receivables associated with the Uzbekistan transaction were $1 billion as of 30 September 2025 and $920 as of 30 September 2024. Amounts paid in connection with the facility are reflected on our consolidated statements of cash flows within "Investment in financing receivables" and were approximately $62, $120, and $600 in fiscal years 2025, 2024, and 2023, respectively.

**Divestitures**

Refer to Note 4, *Gain on Sale of Business*, for details regarding gains recognized from the sale of a Singapore subsidiary in fiscal year 2025 and the LNG business in fiscal year 2024.

<u>Sale of Other Assets</u>

In June 2025, we sold a regional office in Hersham, England, for cash proceeds of $37.7. We recognized a gain on sale of $31.3 ($23.8 after tax) that is presented within "Other income (expense), net" on our consolidated income statements for the fiscal year ended 30 September 2025. The gain was not recorded in the results of the Europe segment.

<u>Deconsolidation of Blue Hydrogen Industrial Gases Company</u>

In January 2025, our 51%-owned consolidated subsidiary, Air Products Qudra ("APQ"), issued equity in its wholly-owned subsidiary, Blue Hydrogen Industrial Gases Company ("BHIG"), resulting in a 50/50 joint venture with Saudi Aramco Development Company (a subsidiary of Aramco). BHIG is currently constructing plants and pipelines to distribute hydrogen, nitrogen and oxygen in Saudi Arabia's Jubail Industrial City.

As a result of the transaction, we determined that APQ no longer holds a controlling financial interest in BHIG. Accordingly, the assets and liabilities associated with the entity were derecognized from our consolidated balance sheet during the second quarter of fiscal year 2025. Amounts derecognized primarily included plant and equipment of approximately $600 and long-term debt, net of deferred financing costs, of approximately $655.

While we no longer control BHIG, we maintain the ability to exercise significant influence regarding key decisions. Accordingly, we recorded an equity method investment for APQ's 50% interest in the entity. This investment is reflected within "Investment in net assets of and advances to equity affiliates" on our consolidated balance sheet and totaled $164.6 as of 30 September 2025.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**7. REVENUE RECOGNITION**

**Nature of Goods and Services**

The principal activities from which we generate revenue under our contracts with customers are described below, along with the related revenue recognition policies. For a comprehensive overview of these policies, including payment terms and presentation, refer to Note 1, *Basis of Presentation and Major Accounting Policies*.

<u>Regional Industrial Gases</u>

Our industrial gases business, which is organized and operated regionally in the Americas, Asia, Europe, and Middle East and India segments, produces and sells atmospheric gases such as oxygen, nitrogen, and argon (primarily recovered by the cryogenic distillation of air); process gases such as hydrogen, helium, carbon dioxide, carbon monoxide, and syngas (a mixture of hydrogen and carbon monoxide); and specialty gases. The majority of our revenue is generated from our sale of gas customers within these regional industrial gases segments.

We distribute product to our industrial gas customers through either our on-site or merchant supply mode depending on various factors, including the customer's volume requirements and location. Each sale of gas supply mode is described below:

*On-site Gases*—This supply mode serves customers who require large volumes of gases and have relatively constant demand. Gases are produced and supplied through large facilities constructed or acquired on or near customer facilities, or by pipeline systems from centralized production locations. These sale of gas arrangements are generally governed by long-term contracts ranging from 15- to 20-years. We also deliver smaller quantities of product through small on-site plants (cryogenic or non-cryogenic generators), generally under 10- to 15-year contracts. Contracts in this supply mode commonly include fixed monthly charges and/or minimum purchase requirements with price escalation provisions that are typically based on external indices. Revenue associated with this supply mode is generally recognized over time during the period in which we deliver or make available the agreed upon quantity of goods.

*Merchant Gases*—This supply mode includes liquid bulk and packaged gas products. Liquid bulk gases are delivered in either liquid or gaseous form via tanker or tube trailer and stored, usually in its liquid state, in equipment that we typically design and install at the customer's site for vaporizing into a gaseous state as needed. Packaged gases customers receive small quantities of product delivered in either cylinders or dewars. Sales of both liquid bulk and packaged gases do not include minimum purchase requirements, as they are governed by contracts and/or purchase orders that reflect the customer's specific needs. These contracts contain stated terms that are generally five years or less. Performance obligations associated with this supply mode are satisfied at a point in time when the customer receives and obtains control of the product, which generally occurs upon delivery.

The timing of revenue recognition for our regional industrial gases business is generally consistent with our right to invoice the customer. Variable components of consideration that may not be resolved within the month, such as the ability to earn an annual bonus or incur a penalty, are more relevant to on-site contracts and are considered constrained as they can be impacted by a single significant event such as a plant outage, which could occur at the end of a contract period. We consider contract modifications on an individual basis to determine appropriate accounting treatment. However, contract modifications are generally accounted for prospectively as they relate to distinct goods or services associated with future periods of performance.

We mitigate energy and natural gas price risk contractually through pricing formulas, surcharges, and cost pass-through arrangements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Equipment</u>

We design and manufacture equipment for air separation, hydrocarbon recovery and purification, and liquid helium and liquid hydrogen transport and storage. The Corporate and other segment includes activity related to the sale of cryogenic and gas processing equipment for air separation. The Corporate and other segment also includes the results of our Rotoflow business, which manufactures turboexpanders and other precision rotating equipment, and our Gardner Cryogenics business, which fabricates helium and hydrogen transport and storage containers.

Our sale of equipment contracts are generally comprised of a single performance obligation as the individual promised goods or services contained within the contracts are integrated with or dependent upon other goods or services in the contract for a single output to the customer. Revenue from our sale of equipment contracts is generally recognized over time as we have an enforceable right to payment for performance completed to date and our performance under the contract terms does not create an asset with alternative use. Otherwise, sale of equipment contracts are satisfied at the point in time the customer obtains control of the equipment, which is generally determined based on the shipping terms of the contract. For contracts recognized over time, we primarily recognize revenue using a cost incurred input method by which costs incurred to date relative to total estimated costs at completion are used to measure progress toward satisfying performance obligations. Costs incurred include those for materials, labor, and overhead and represent work contributing and proportionate to the transfer of control to the customer.

Since our contracts are generally comprised of a single performance obligation, contract modifications are typically accounted for as part of the existing contract and are recognized as a cumulative adjustment for the inception-to-date effect of such change. In addition, changes in estimates on sale of equipment projects accounted for under the cost incurred input method are recognized as a cumulative adjustment for the inception-to-date effect of such changes. Changes to project revenue and cost estimates unfavorably impacted operating results by approximately $85 in fiscal year 2025, $175 in fiscal year 2024, and $115 in fiscal year 2023.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Disaggregation of Revenue**

The tables below present our consolidated sales disaggregated by supply mode for each of our reportable segments. We believe this presentation best depicts the nature, timing, type of customer, and contract terms for our sales.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | Americas | Asia | Europe | Middle East and India | Corporate and other | Total | % |
| **2025** |  |  |  |  |  |  |  |
| On-site | $2918.2 | $2190.9 | $992.7 | $78.6 | $— | $6180.4 | 52% |
| Merchant | 2207.7 | 1080.1 | 1991.8 | 57.3 |  | 5336.9 | 44% |
| Sale of equipment |  |  |  |  | 520.0 | 520.0 | 4% |
| **Total** | **$5125.9** | **$3271.0** | **$2984.5** | **$135.9** | **$520.0** | **$12037.3** | **100%** |
| **2024** |  |  |  |  |  |  |  |
| On-site | $2844.4 | $2066.4 | $910.5 | $71.4 | $— | $5892.7 | 49% |
| Merchant | 2195.7 | 1157.9 | 1912.9 | 63.0 |  | 5329.5 | 44% |
| Sale of equipment<sup>(A)</sup> |  |  |  |  | 878.4 | 878.4 | 7% |
| **Total** | **$5040.1** | **$3224.3** | **$2823.4** | **$134.4** | **$878.4** | **$12100.6** | **100%** |
| **2023** |  |  |  |  |  |  |  |
| On-site | $3143.9 | $1923.0 | $1036.6 | $75.7 | $— | $6179.2 | 49% |
| Merchant | 2225.4 | 1293.1 | 1926.5 | 86.8 |  | 5531.8 | 44% |
| Sale of equipment<sup>(A)</sup> |  |  |  |  | 889.0 | 889.0 | 7% |
| **Total** | **$5369.3** | **$3216.1** | **$2963.1** | **$162.5** | **$889.0** | **$12600.0** | **100%** |

---

<sup>(A)</sup>Through the end of fiscal year 2024, our Corporate and other segment included the liquefied natural gas ("LNG") process technology and equipment business, which was sold to Honeywell International Inc. on 30 September 2024. Refer to Note 4, *Gain on Sale of Business*, for additional information regarding the sale.

Interest income from financing and lease arrangements represented approximately 1% of our total consolidated sales in fiscal years 2025 and 2024, and less than 1% in fiscal year 2023.

**Remaining Performance Obligations**

As of 30 September 2025, the transaction price allocated to remaining performance obligations is estimated to be approximately $26 billion. This amount includes fixed-charge contract provisions associated with our on-site and sale of equipment supply modes. We estimate that approximately half of this revenue will be recognized over the next five years and the balance thereafter.

Our remaining performance obligations do not include (1) expected revenue associated with new on-site plants that are not yet on-stream; (2) consideration associated with contracts that have an expected duration of less than one year; and (3) variable consideration for which we recognize revenue at the amount to which we have the right to invoice, including energy cost pass-through to customers.

In the future, actual amounts will differ due to events outside of our control, including, but not limited to, inflationary price escalations; currency exchange rates; and amended, terminated, or renewed contracts.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Contract Balances** 

The table below details balances arising from contracts with customers:

---

| | | | |
|:---|:---|:---|:---|
| 30 September | Balance Sheet Location | **2025** | 2024 |
| **Assets** |  |  |  |
| &nbsp;&nbsp;&nbsp;Contract assets – current | Other receivables and current assets | **$152.6** | $76.2 |
| &nbsp;&nbsp;&nbsp;Contract fulfillment costs – current | Other receivables and current assets | **85.4** | 103.7 |
| &nbsp;&nbsp;Contract assets – noncurrent | Other noncurrent assets | **82.3** |  |
| &nbsp;&nbsp;&nbsp;Contract fulfillment costs – noncurrent | Other noncurrent assets | **33.8** |  |
| **Liabilities** |  |  |  |
| &nbsp;&nbsp;&nbsp;Contract liabilities – current | Payables and accrued liabilities | **$253.4** | $240.0 |
| &nbsp;&nbsp;&nbsp;Contract liabilities – noncurrent | Other noncurrent liabilities | **283.6** | 290.0 |

---

Contract assets and liabilities result from differences in timing of revenue recognition and customer invoicing. These balances are reported on the consolidated balance sheets on a contract-by-contract basis at the end of each reporting period.

Contract assets primarily relate to our sale of equipment contracts for which revenue is recognized over time. These balances represent unbilled revenue, which occurs when revenue recognized under the measure of progress exceeds the amount invoiced to our customers. Our ability to invoice the customer for contract asset balances is not only based on the passage of time, but also the achievement of certain contractual milestones.

We defer contract fulfillment costs for sale of equipment projects that cannot be inventoried due to their custom nature and alignment with specific customer specifications. These costs are expected to be recovered when revenue is recognized, which generally occurs upon transfer of control at project completion. We also defer contract fulfillment costs incurred to enhance on-site supply assets, which are expected to be recovered as performance obligations are satisfied under the corresponding customer agreement.

Costs to obtain a contract, or "contract acquisition costs," are capitalized at the time we establish a contract with the customer. We elected to apply the practical expedient to expense these costs as they are incurred if the amortization period of the asset that would have otherwise been recognized is one year or less. Our contract acquisition costs capitalized as of 30 September 2025 and 2024 were not material.

Contract liabilities include advanced payments or right to consideration prior to performance under the contract and are recognized as revenue when or as we perform. Increases to our contract liabilities primarily relate to new sale of equipment projects as balances associated with our sale of gas contracts are generally related to fixed charges and are relatively consistent period over period. During the fiscal year ended 30 September 2025, we recognized sales of approximately $110 associated with sale of equipment contracts that were included within our contract liabilities balance as of 30 September 2024. Advanced payments from our customers do not represent a significant financing component as these payments are intended for purposes other than financing, such as to meet working capital demands or to protect us from our customer failing to meet its obligations under the terms of the contract.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**8. DISCONTINUED OPERATIONS**

We recorded net losses from discontinued operations of $8.0 and $13.9 in fiscal years 2025 and 2024, respectively, compared to net income from discontinued operations of $7.4 in fiscal year 2023.

In fiscal year 2025, a pre-tax loss from discontinued operations of $10.6 was recorded in the third quarter primarily to increase our existing liability for retained environmental remediation obligations related to production facilities in the atmospheric emulsions and global pressure-sensitive adhesives businesses, which were sold in 2008. Refer to the "Piedmont" discussion under Note 19, *Commitments and Contingencies*, for additional information. The loss did not impact the statement of cash flows for the fiscal year ended 30 September 2025.

In fiscal year 2024, a pre-tax loss from discontinued operations of $19.4 was recorded in the fourth quarter to increase our existing liability for retained environmental remediation obligations related to the 2006 sale of the Amines business. Refer to the "Pace" discussion under Note 19, *Commitments and Contingencies*, for additional information. The loss did not impact the statement of cash flows for the fiscal year ended 30 September 2024.

In fiscal year 2023, net income from discontinued operations of $7.4 was driven by a net tax benefit recognized during the fourth quarter upon the release of tax liabilities for uncertain tax positions associated with the 2017 sale of the Performance Materials Division. The consolidated statement of cash flows for the fiscal year ended 30 September 2023 included $0.6 of cash provided by operating activities of discontinued operations, resulting from income tax refunds associated with the sale.

**9. INVENTORIES** 

The components of inventories are as follows:

---

| | | |
|:---|:---|:---|
| **30 September** | **2025** | 2024 |
| Finished goods | **$191.9** | $210.2 |
| Work in process | **42.4** | 42.2 |
| Raw materials, supplies, and other | **542.2** | 513.6 |
| Inventories | **$776.5** | $766.0 |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**10. EQUITY AFFILIATES** 

"Investment in net assets of and advances to equity affiliates" on our consolidated balance sheets were $5,366.1 and $4,792.5 as of 30 September 2025 and 2024, respectively.

As of 30 September 2025, all of our equity method investments are foreign affiliates. These affiliates and related ownership percentages were as follows:

---

| | |
|:---|:---|
| Abdullah Hashim Industrial Gases & Equipment Co., Ltd. (25%); | INFRA Group (40%); |
| Air Products South Africa (Proprietary) Limited (50%); | INOX Air Products Private Limited (50%); |
| Bangkok Cogeneration Company Limited (49%); | Jazan Integrated Gasification and Power Company (51%); |
| Bangkok Industrial Gases Co., Ltd. (49%); | Kulim Industrial Gases Sdn. Bhd. (50%); |
| Blue Hydrogen Industrial Gases Company (26%)<sup>(A)</sup>; | Sapio Produzione Idrogeno Ossigeno S.r.l. (49%); |
| Chengdu Air & Gas Products Ltd. (50%); | and principally, other industrial gas producers. |
| Helios S.p.A. (49%); |  |

---

<sup>(A)</sup>We recorded an equity method investment for a 51%-owned consolidated subsidiary's interest in the Blue Hydrogen Industrial Gases Company joint venture following a deconsolidation event in the second quarter of fiscal year 2025. Refer to Note 6, *Acquisitions and Divestitures*, for additional information.

Dividends and other distributions received from equity affiliates were $385.5, $441.7, and $344.3 in fiscal years 2025, 2024, and 2023, respectively.

As of 30 September 2025 and 2024, the amount of investment in companies accounted for by the equity method included equity method goodwill of $34.5 and $38.7, respectively.

**Summarized Financial Information**

The summarized financial information presented below is on a combined 100% basis and has been compiled based on the financial statements of our equity affiliates.

---

| | | | |
|:---|:---|:---|:---|
| **30 September** |  | **2025** | 2024 |
| Current assets |  | **$3968.5** | $3197.2 |
| Noncurrent assets |  | **16490.1** | 14719.8 |
| Current liabilities |  | **1441.4** | 1138.3 |
| Noncurrent liabilities |  | **12626.3** | 11690.4 |
| **Fiscal Year Ended 30 September** | **2025** | 2024 | 2023 |
| Net sales<sup>(A)</sup> | **$5831.7** | $5666.4 | $5192.9 |
| Gross profit | **2849.0** | 2722.0 | 2465.5 |
| Operating income | **2206.6** | 2149.3 | 1847.4 |
| Net income | **1263.6** | 1209.5 | 1062.9 |

---

<sup>(A)</sup>Includes financing revenue of $1,137.3, $1,128.6, and $1,011.3 in fiscal years 2025, 2024, and 2023, respectively. Financing revenue primarily relates to the JIGPC joint venture discussed below.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Investment in JIGPC**

We hold a 55% ownership interest in the JIGPC joint venture, of which a 4% interest is attributable to the noncontrolling partner of APQ. We determined JIGPC is a VIE for which we have an equity interest and exercise significant influence but are not the primary beneficiary. Refer to Note 3, *Variable Interest Entities*, for additional information.

Our investment in JIGPC was completed in stages to align with the joint venture's acquisition of project assets, beginning with an initial investment of $1.6 billion in fiscal year 2022 followed by a $908 investment in fiscal year 2023. The second investment is reflected within "Investment in and advances to unconsolidated affiliates" on the consolidated statement of cash flows for the fiscal year ended 30 September 2023. These amounts included approximately $130 and $73 received from the noncontrolling partner of APQ for the first and second installments, respectively.

As of 30 September 2024, the carrying value of our investment totaled approximately $2.9 billion. In the second quarter of fiscal year 2025, we made a final investment of approximately $115 in the form of a shareholder loan, which the joint venture used to purchase the remaining project assets. The carrying value of our investment totaled approximately $3.1 billion as of 30 September 2025.

The carrying value of our investment includes amounts attributable to the noncontrolling partner.

**Project Exit-Related Impairment of Equity Method Investment**

In fiscal year 2025, we determined there was an other-than-temporary impairment of a joint venture in China that had been established to develop clean hydrogen infrastructure in the region. As a result, we recorded a charge of $6.8 to write down the full carrying value of the investment. There were no other events or changes in circumstances that indicated the carrying amount of our equity method investments may not be recoverable, and therefore, no further impairment testing was required.

Additional information regarding project exit decisions is provided in Note 5, *Business and Asset Actions*.

**11. PLANT AND EQUIPMENT, NET** 

The major classes of plant and equipment are as follows:

---

| | | | |
|:---|:---|:---|:---|
| **30 September** | Useful life | **2025** | 2024 |
| Land |  | **$343.0** | $312.1 |
| Buildings | 30 years | **1766.1** | 1730.7 |
| Production facilities<sup>(A)</sup> | 10-20 years | **21412.9** | 21245.2 |
| Distribution and other machinery and equipment<sup>(B)</sup> | 5-25 years | **5776.0** | 5472.7 |
| Construction in progress |  | **13456.8** | 11190.2 |
| **Plant and equipment, at cost** |  | **$42754.8** | $39950.9 |
| Less: Accumulated depreciation |  | **17417.0** | 16580.0 |
| **Plant and equipment, net** |  | **$25337.8** | $23370.9 |

---

<sup>(A)</sup>Depreciable lives of production facilities related to long-term customer supply contracts are generally matched to the contract lives.

<sup>(B)</sup>The depreciable lives for various types of distribution equipment are: 10 to 25 years for cylinders, depending on the nature and properties of the product; 20 years for tanks; generally 7.5 years for customer stations; and 5 to 15 years for tractors and trailers.

Depreciation expense was $1,526.9, $1,419.6, and $1,325.8 in fiscal years 2025, 2024, and 2023, respectively.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**12. GOODWILL** 

Changes to the carrying amount of consolidated goodwill by segment are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Americas | Asia | Europe | Middle East and India | Corporate and other | Total |
| Goodwill, net as of 30 September 2023 | $146.6 | $171.9 | $493.5 | $15.8 | $33.9 | $861.7 |
| Currency translation and other | (0.3) | 2.8 | 40.8 |  | 0.1 | 43.4 |
| Goodwill, net as of 30 September 2024 | $146.3 | $174.7 | $534.3 | $15.8 | $34.0 | $905.1 |
| Acquisition |  |  | 31.3 |  |  | 31.3 |
| Currency translation and other | (2.8) | (2.2) | 32.3 |  | 0.2 | 27.5 |
| **Goodwill, net as of 30 September 2025** | **$143.5** | **$172.5** | **$597.9** | **$15.8** | **$34.2** | **$963.9** |

---

---

| | | | |
|:---|:---|:---|:---|
| **30 September** | **2025** | 2024 | 2023 |
| Goodwill, gross | **$1238.6** | $1199.8 | $1158.4 |
| Accumulated impairment losses<sup>(A)</sup> | **(274.7)** | (294.7) | (296.7) |
| **Goodwill, net** | **$963.9** | $905.1 | $861.7 |

---

<sup>(A)</sup>Accumulated impairment losses are attributable to our Latin America reporting unit ("LASA") within the Americas segment and include the impact of currency translation.

We review goodwill for impairment annually in the fourth quarter of the fiscal year and whenever events or changes in circumstances indicate that the carrying value of goodwill might not be recoverable. The impairment test for goodwill involves an optional assessment of qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If qualitative factors alone are not sufficient to support this conclusion, we perform quantitative testing that involves calculating the fair value of each reporting unit. If the fair value of the reporting unit is less than its carrying value, the difference is recorded as a goodwill impairment charge, not to exceed the total amount of goodwill allocated to that reporting unit.

During the fourth quarter of fiscal year 2025, we conducted our annual goodwill impairment test and concluded that it was more likely than not that the fair value of each reporting unit was greater than its carrying value.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**13. INTANGIBLE ASSETS**

The table below summarizes the major classes of our intangible assets:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | 2024 | 2024 | 2024 |
| **30 September** | **Gross** | **Accumulated<br>Amortization/<br>Impairment** | **Net** | Gross | Accumulated<br>Amortization/<br>Impairment | Net |
| Finite-lived: |  |  |  |  |  |  |
| &nbsp;&nbsp;Customer relationships | **$532.3** | **($318.5)** | **$213.8** | $524.9 | ($298.2) | $226.7 |
| &nbsp;&nbsp;Patents and technology | **31.1** | **(21.0)** | **10.1** | 32.9 | (20.7) | 12.2 |
| &nbsp;&nbsp;Other | **64.4** | **(29.9)** | **34.5** | 69.3 | (32.9) | 36.4 |
| Total finite-lived intangible assets | **$627.8** | **($369.4)** | **$258.4** | $627.1 | ($351.8) | $275.3 |
| Indefinite-lived: |  |  |  |  |  |  |
| &nbsp;&nbsp;Trade names and trademarks | **44.6** | **(9.5)** | **35.1** | 46.2 | (9.9) | 36.3 |
| Total intangible assets | **$672.4** | **($378.9)** | **$293.5** | $673.3 | ($361.7) | $311.6 |

---

Amortization expense for intangible assets was $37.3, $31.5, and $32.5 in fiscal years 2025, 2024, and 2023, respectively. For details on the amortization periods applicable to each major class of intangible assets, refer to Note 1, *Basis of Presentation and Major Accounting Policies*.

The table below details the amount of amortization expense expected to be recorded for our finite-lived intangible assets in each of the next five years and thereafter:

---

| | |
|:---|:---|
| 2026 | $31.5 |
| 2027 | 30.7 |
| 2028 | 27.1 |
| 2029 | 24.1 |
| 2030 | 23.5 |
| Thereafter | 121.5 |
| Total | $258.4 |

---

Indefinite-lived intangible assets are subject to impairment testing at least annually or more frequently if events or changes in circumstances indicate that potential impairment exists. The impairment test for indefinite-lived intangible assets involves an optional assessment of qualitative factors to determine whether it is more likely than not that the fair value of the asset is less than its carrying value. If qualitative factors alone are not sufficient to support this conclusion, we perform quantitative testing that involves calculating the fair value of the indefinite-lived intangible asset. If the fair value of the asset is less than its carrying value, the difference is recorded as an impairment loss, not to exceed the total carrying value of the asset. During the fourth quarter of fiscal year 2025, we conducted our annual impairment test and concluded that it was more likely than not that the fair value of each indefinite-lived intangible asset was greater than its carrying value.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**14. LEASES** 

**Lessee Accounting**

We are the lessee under various agreements for real estate, vehicles, aircraft, and other equipment that are accounted for as operating leases. Our finance leases principally relate to the right to use machinery and equipment and are not material.

Amounts associated with operating leases and their presentation on our consolidated balance sheets are as follows:

---

| | | |
|:---|:---|:---|
| **30 September** | **2025** | 2024 |
| **Operating lease right-of-use assets, net** | **$944.0** | $1047.7 |
| **Operating lease liabilities** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Payables and accrued liabilities | **91.8** | 100.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Noncurrent operating lease liabilities | **616.0** | 677.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total operating lease liabilities** | **$707.8** | $778.2 |

---

---

| | | |
|:---|:---|:---|
| **30 September** | **2025** | 2024 |
| Weighted-average remaining lease term in years<sup>(A)</sup> | **20.7** | 20.0 |
| Weighted-average discount rate<sup>(B)</sup> | **2.9%** | 2.9% |

---

<sup>(A)</sup>Calculated on the basis of the remaining lease term and the lease liability balance for each lease as of the reporting date.

<sup>(B)</sup>Calculated on the basis of the discount rate used to calculate the lease liability for each lease and the remaining balance of the lease payments for each lease as of the reporting date.

The following maturity analysis of our operating lease liabilities as of 30 September 2025 presents the undiscounted cash flows for each of the next five years and thereafter with a reconciliation to the lease liability recognized on our balance sheet:

---

| | |
|:---|:---|
| | Operating<br>Leases |
| 2026 | $109.0 |
| 2027 | 72.6 |
| 2028 | 62.0 |
| 2029 | 49.9 |
| 2030 | 48.5 |
| Thereafter | 647.9 |
| Total undiscounted lease payments | 989.9 |
| Imputed interest | (282.1) |
| **Present value of lease liability recognized on balance sheet** | **$707.8** |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

Operating lease expense was $124.0, $122.4, and $109.9 for fiscal years 2025, 2024, and 2023, respectively. These amounts do not include short-term and variable lease expenses, which were not material. The impacts associated with our operating leases on the consolidated statements of cash flows are reflected within "Other adjustments" within operating activities. This includes the noncash operating lease expense as well as a use of cash of $125.2, $154.6, and $337.8 for payments on amounts included in the measurement of the lease liability for fiscal years 2025, 2024, and 2023, respectively. Payments in fiscal year 2023 included a lump-sum payment of $209 for a land lease associated with the NGHC joint venture. Refer to Note 3, *Variable Interest Entities*, for additional information.

We recorded noncash right-of-use asset additions of approximately $65, $159, and $150 in fiscal years 2025, 2024, and 2023, respectively.

**Lessor Accounting**

Certain contracts associated with facilities that are built to provide product to a specific customer have been accounted for as containing embedded leases. Refer to Note 1, *Basis of Presentation and Major Accounting Policies*, for a description of our accounting policy for arrangements in which we are the lessor.

"Lease receivables, net" relate to sales-type leases on certain on-site assets for which payments are collected over the contract term. The table below details balances associated with our lease receivables:

---

| | | |
|:---|:---|:---|
| **30 September** | **2025** | 2024 |
| Current lease receivables, net<sup>(A)</sup> | **$49.4** | $74.5 |
| Noncurrent lease receivables, net | **307.1** | 392.1 |
| **Total lease receivables, net** | **$356.5** | $466.6 |

---

<sup>(A)</sup>Presented within "Other receivables and current assets" on our consolidated balance sheets.

The majority of our leases are of high credit quality and were originated prior to fiscal year 2017. As of 30 September 2025 and 2024, the credit quality of lease receivables did not require a material allowance for credit losses.

The table below summarizes lease payments collected in fiscal years 2025, 2024, and 2023:

---

| | | | |
|:---|:---|:---|:---|
| **Fiscal Year Ended 30 September** | **2025** | 2024 | 2023 |
| Payments that reduced the lease receivable balance | **$56.2** | $122.1 | $79.6 |
| Payments recognized as interest income | **32.6** | 42.6 | 49.6 |
| **Total lease payments collected** | **$88.8** | $164.7 | $129.2 |

---

As of 30 September 2025, minimum lease payments expected to be collected were as follows:

---

| | |
|:---|:---|
| 2026 | $78.0 |
| 2027 | 72.6 |
| 2028 | 69.6 |
| 2029 | 66.5 |
| 2030 | 63.6 |
| Thereafter | 137.6 |
| Total | 487.9 |
| Unearned interest income | (131.4) |
| **Lease receivables, net** | **$356.5** |

---

Our contracts generally do not have the option to extend or terminate the lease or provide the customer the right to purchase the asset at the end of the contract term. Instead, renewal of such contracts requires negotiation of mutually agreed terms by both parties. Unless the customer terminates within the required notice period, the contract will go into evergreen. Given the long-term duration of our contracts, there is no assumed residual value for the assets at the end of the lease term.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**15. FINANCIAL INSTRUMENTS** 

**Currency Price Risk Management**

Our earnings, cash flows, and financial position are exposed to foreign currency risk from foreign currency-denominated transactions and net investments in foreign operations. It is our policy to seek to minimize our cash flow volatility from changes in currency exchange rates. This is accomplished by identifying and evaluating the risk that our cash flows will change in value due to changes in exchange rates and by executing strategies necessary to manage such exposures. Our objective is to maintain economically balanced currency risk management strategies that provide adequate downside protection.

**Forward Exchange Contracts**

We enter into forward exchange contracts to reduce the cash flow exposure to foreign currency fluctuations associated with highly anticipated cash flows and certain firm commitments, such as the purchase of plant and equipment. We also enter into forward exchange contracts to hedge the cash flow exposure on intercompany loans and third-party debt. This portfolio of forward exchange contracts consists primarily of the U.S. Dollar and each of the South Korean Won, Canadian Dollar, Chinese Renminbi, and Euro. The maximum remaining term of any forward exchange contract currently outstanding and designated as a cash flow hedge at 30 September 2025 is 2.5 years.

Forward exchange contracts are also used to hedge the value of investments in certain foreign subsidiaries and affiliates by creating a liability in a currency in which we have a net equity position. The primary currency pair in this portfolio of forward exchange contracts is the U.S. Dollar and Chilean Peso.

We also utilize forward exchange contracts that are not designated as hedges. These contracts are used to economically hedge foreign currency-denominated monetary assets and liabilities, primarily working capital. The primary objective of these forward exchange contracts is to protect the value of foreign currency-denominated monetary assets and liabilities from the effects of volatility in foreign exchange rates that might occur prior to their receipt or settlement. This portfolio of forward exchange contracts consists of multiple foreign currency pairs, with a profile that changes from time to time depending on our business activity and sourcing decisions.

The table below summarizes our outstanding currency price risk management instruments:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | 2024 | 2024 |
| **30 September** | **US$Notional** | **Years<br>Average<br>Maturity** | US$Notional | Years<br>Average<br>Maturity |
| **Forward Exchange Contracts** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Cash flow hedges | **$3625.5** | **0.6** | $4003.2 | 0.6 |
| &nbsp;&nbsp;&nbsp;Net investment hedges | **73.9** | **0.8** | 911.4 | 2.5 |
| &nbsp;&nbsp;&nbsp;Not designated | **2968.6** | **1.2** | 1880.0 | 0.3 |
| **Total Forward Exchange Contracts** | **$6668.0** | **0.9** | $6794.6 | 0.8 |

---

The increase in the notional value of forward exchange contracts that are not designated is primarily due to the origination of forward exchange contracts that offset other forward exchange contracts previously designated as net investment hedges that were de-designated during fiscal year 2025.

We also use foreign currency-denominated debt to hedge the foreign currency exposures of our net investment in certain foreign subsidiaries. The designated foreign currency-denominated debt and related accrued interest was €3,188.1 million ($3,741.5) at 30 September 2025 and €1,905.7 million ($2,121.9) at 30 September 2024. The designated foreign currency-denominated debt is presented on our consolidated balance sheets within "Long-term debt" as of 30 September 2025 and "Long-term debt" and "Current portion of long-term debt" as of 30 September 2024.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Debt Portfolio Management**

It is our policy to identify, on a continuing basis, the need for debt capital and to evaluate the financial risks inherent in funding the Company with debt capital. Reflecting the result of this ongoing review, we manage our debt portfolio and hedging program with the intent to (1) reduce funding risk with respect to borrowings made by us to preserve our access to debt capital and provide debt capital as required for funding and liquidity purposes, and (2) manage the aggregate interest rate risk and the debt portfolio in accordance with certain debt management parameters.

**Interest Rate Management Contracts**

We enter into interest rate swaps to change the fixed/variable interest rate mix of our debt portfolio in order to maintain the percentage of fixed- and variable-rate debt within the parameters set by management. In accordance with these parameters, the agreements are used to manage interest rate risks and costs inherent in our debt portfolio. Our interest rate management portfolio generally consists of fixed-to-floating interest rate swaps (which are designated as fair value hedges), pre-issuance interest rate swaps and treasury locks (which hedge the interest rate risk associated with anticipated fixed-rate debt issuances and are designated as cash flow hedges), and floating-to-fixed interest rate swaps (which are designated as cash flow hedges). As of 30 September 2025, the outstanding interest rate swaps were denominated in U.S. Dollars. The notional amount of the interest rate swap agreements is equal to or less than the designated debt being hedged. When interest rate swaps are used to hedge variable-rate debt, the indices of the swaps and the debt to which they are designated are the same. It is our policy not to enter into any interest rate management contracts which lever a move in interest rates on a greater than one-to-one basis.

**Cross Currency Interest Rate Swap Contracts**

We enter into cross currency interest rate swap contracts when our risk management function deems necessary. These contracts may entail both the exchange of fixed- and floating-rate interest payments periodically over the life of the agreement and the exchange of one currency for another currency at inception and at a specified future date. The contracts are used to hedge either certain net investments in foreign operations or non-functional currency cash flows related to intercompany loans. The current cross currency interest rate swap portfolio consists of fixed-to-fixed swaps primarily between the U.S. Dollar and each of the Chinese Renminbi, Chilean Peso, and Indian Rupee.

The table below summarizes our outstanding interest rate management contracts and cross currency interest rate swaps:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2025** | 2024 | 2024 | 2024 | 2024 |
| **30 September** | **US$Notional** | **Average Pay %** | **Average<br>Receive%** | **Years<br>Average<br>Maturity** | US$Notional | Average Pay % | Average<br>Receive% | Years<br>Average<br>Maturity |
| Interest rate swaps (fair value hedge) | **$800.0** | **SOFR** | **1.64%** | **2.0** | $800.0 | SOFR | 1.64% | 3.0 |
| Interest rate swaps (cash flow hedge)<sup>(A)</sup> | **$3106.0** | **2.78%** | **SOFR** | **20.1** | $2159.3 | 2.72% | SOFR | 21.2 |
| Interest rate swaps (not designated)<sup>(A)</sup> | **$269.1** | **3.28%** | **SOFR** | **20.2** | $461.4 | 3.27% | SOFR | 20.5 |
| Cross currency interest rate swaps (net investment hedge) | **$70.3** | **4.86%** | **4.53%** | **0.5** | $16.7 | 5.39% | 3.64% | 0.2 |
| Cross currency interest rate swaps (cash flow hedge) | **$247.7** | **5.21%** | **3.12%** | **1.6** | $410.6 | 4.96% | 2.80% | 1.9 |
| Cross currency interest rate swaps (not designated) | **$—** | **—%** | **—%** | **0.0** | $34.7 | 5.39% | 3.64% | 0.2 |

---

<sup>(A)</sup>In May 2023, NGHC entered into floating-to-fixed interest rate swaps designed to hedge long-term variable rate debt facilities available under non-recourse project financing during the construction period of the NEOM Green Hydrogen Project. During the third quarter of fiscal year 2024, we discontinued cash flow hedge accounting for certain instruments that will remain de-designated until outstanding borrowings from the available financing are commensurate with the notional value of the instruments.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

The table below provides the amounts recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Carrying amounts of hedged item | Carrying amounts of hedged item | Cumulative hedging adjustment, included in carrying amount | Cumulative hedging adjustment, included in carrying amount |
| **30 September** | **2025** | 2024 | **2025** | 2024 |
| Current portion of long-term debt | **$549.7** | $— | **($0.3)** | $— |
| Long-term debt | **$1522.5** | $2057.1 | **($23.1)** | ($36.6) |

---

The tables below summarize the fair value and balance sheet location of our outstanding derivatives.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **30 September** | Balance Sheet Location | **2025** | 2024 | Balance Sheet Location | **2025** | 2024 |
| **Derivatives Designated as Hedging Instruments:** |  |  |  |  |  |  |
| Forward exchange contracts | Other receivables and current assets | **$50.7** | $74.5 | Payables and accrued liabilities | **$21.4** | $21.6 |
| Interest rate management contracts | Other receivables and current assets | **13.1** | 1.2 | Payables and accrued liabilities | **0.3** | 1.2 |
| Forward exchange contracts | Other noncurrent assets | **10.1** | 9.6 | Other noncurrent liabilities | **3.4** | 15.6 |
| Interest rate management contracts | Other noncurrent assets | **138.2** | 34.3 | Other noncurrent liabilities | **23.8** | 40.2 |
| **Total Derivatives Designated as Hedging Instruments** |  | **$212.1** | $119.6 |  | **$48.9** | $78.6 |
| **Derivatives Not Designated as Hedging Instruments:** |  |  |  |  |  |  |
| Forward exchange contracts | Other receivables and current assets | **$17.8** | $16.5 | Payables and accrued liabilities | **$14.2** | $21.8 |
| Interest rate management contracts | Other receivables and current assets | **—** | 1.7 | Payables and accrued liabilities | **—** |  |
| Forward exchange contracts | Other noncurrent assets | **2.7** | 0.2 | Other noncurrent liabilities | **30.5** | 0.2 |
| Interest rate management contracts | Other noncurrent assets | **11.8** | 4.6 | Other noncurrent liabilities | **—** |  |
| **Total Derivatives Not Designated as Hedging Instruments** |  | **$32.3** | $23.0 |  | **$44.7** | $22.0 |
| **Total Derivatives** |  | **$244.4** | $142.6 |  | **$93.6** | $100.6 |

---

Refer to Note 16, *Fair Value Measurements*, which defines fair value, describes the method for measuring fair value, and provides additional disclosures regarding fair value measurements.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

The tables below summarize gains (losses) recognized in other comprehensive income during the period related to our net investment and cash flow hedging relationships:

---

| | | |
|:---|:---|:---|
| | **2025** | 2024 |
| **Net Investment Hedging Relationships** |  |  |
| &nbsp;&nbsp;Forward exchange contracts | **$2.8** | ($23.7) |
| &nbsp;&nbsp;Foreign currency debt | **(232.8)** | (107.4) |
| &nbsp;&nbsp;Cross currency interest rate swaps | **1.2** | (0.8) |
| &nbsp;&nbsp;**Total Amount Recognized in OCI** | **(228.8)** | (131.9) |
| &nbsp;&nbsp;Tax effects | **54.8** | 32.2 |
| &nbsp;&nbsp;**Net Amount Recognized in OCI** | **($174.0)** | ($99.7) |
| **Derivatives in Cash Flow Hedging Relationships** |  |  |
| &nbsp;&nbsp;Forward exchange contracts | **($56.4)** | $142.8 |
| &nbsp;&nbsp;Forward exchange contracts, excluded components | **(9.6)** | (31.2) |
| &nbsp;&nbsp;Other<sup>(A)</sup> | **104.2** | (260.4) |
| &nbsp;&nbsp;**Total Amount Recognized in OCI** | **38.2** | (148.8) |
| &nbsp;&nbsp;Tax effects | **1.8** | (10.7) |
| &nbsp;&nbsp;**Net Amount Recognized in OCI** | **$40.0** | ($159.5) |

---

<sup>(A)</sup>Other primarily includes interest rate and cross currency interest rate swaps for which excluded components are recognized in "Payables and accrued liabilities" and "Other receivables and current assets" as a component of accrued interest payable and accrued interest receivable, respectively. These excluded components are recorded in "Other non-operating income (expense), net" over the life of the cross currency interest rate swap. Other also includes the recognition of our share of gains and losses, net of tax, related to interest rate swaps held by our equity affiliates.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

The tables below summarize the location and amounts recognized in income related to our cash flow and fair value hedging relationships by contract type:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Sales | Sales | Cost of Sales | Cost of Sales | Interest Expense | Interest Expense | Other Non-Operating Income (Expense), Net | Other Non-Operating Income (Expense), Net |
| | **2025** | 2024 | **2025** | 2024 | **2025** | 2024 | **2025** | 2024 |
| Total presented in consolidated income statements that includes effects of hedging below | **$12037.3** | $12100.6 | **$8256.0** | $8168.7 | **$214.0** | $218.8 | **$2.6** | ($73.8) |
| **(Gain) Loss Effects of Cash Flow Hedging:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;<u>Forward Exchange Contracts:</u> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amount reclassified from OCI into income | **($0.2)** | $— | **$7.5** | $2.4 | **$—** | $— | **$39.7** | ($86.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amount excluded from effectiveness testing recognized in earnings based on amortization approach | **—** |  | **—** |  | **—** |  | **15.1** | 23.5 |
| &nbsp;&nbsp;&nbsp;<u>Other:</u> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amount reclassified from OCI into income | **—** |  | **—** |  | **—** | 3.9 | **(8.9)** | 16.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amount reclassified from OCI into income due to de-designation | **—** |  | **—** |  | **—** |  | **—** | (3.1) |
| **Total (Gain) Loss Reclassified from OCI to Income** | **(0.2)** |  | **7.5** | 2.4 | **—** | 3.9 | **45.9** | (49.7) |
| Tax effects | **—** |  | **(1.5)** | (0.5) | **(0.1)** | (1.6) | **(10.4)** | 11.8 |
| **Net (Gain) Loss Reclassified from OCI to Income** | **($0.2)** | $— | **$6.0** | $1.9 | **($0.1)** | $2.3 | **$35.5** | ($37.9) |
| **(Gain) Loss Effects of Fair Value Hedging:** |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;<u>Other:</u> |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hedged items | **$—** | $— | **$—** | $— | **$13.2** | $43.9 | **$—** | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Derivatives designated as hedging instruments | **—** |  | **—** |  | **(13.2)** | (43.9) | **—** |  |
| **Total (Gain) Loss Recognized in Income** | **$—** | $— | **$—** | $— | **$—** | $— | **$—** | $— |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

The table below summarizes the location and amounts recognized in income related to our derivatives not designated as hedging instruments by contract type:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Other Income (Expense), Net | Other Income (Expense), Net | Other Non-Operating Income (Expense), Net | Other Non-Operating Income (Expense), Net |
| | **2025** | 2024 | **2025** | 2024 |
| **The Effects of Derivatives Not Designated as Hedging Instruments:** | **The Effects of Derivatives Not Designated as Hedging Instruments:** | **The Effects of Derivatives Not Designated as Hedging Instruments:** |  |  |
| Forward exchange contracts | **($3.0)** | $0.7 | **($2.2)** | $— |
| De-designated interest rate swaps | **—** |  | **(27.0)** | 19.4 |
| Other | **—** |  | **(1.7)** | 1.5 |
| **Total (Gain) Loss Recognized in Income** | **($3.0)** | $0.7 | **($30.9)** | $20.9 |

---

The amount of unrealized gains and losses related to cash flow hedges as of 30 September 2025 that are expected to be reclassified to earnings in the next twelve months is not material.

The cash flows related to derivative contracts are generally reported in the operating activities section of the consolidated statements of cash flows.

**Credit Risk-Related Contingent Features**

Certain derivative instruments are executed under agreements that require us to maintain a minimum credit rating with both Standard & Poor's and Moody's. If our credit rating falls below this threshold, the counterparty to the derivative instruments has the right to request full collateralization on the derivatives' net liability position. The net liability position of derivatives with credit risk-related contingent features was $43.3 and $47.3 as of 30 September 2025 and 2024, respectively. Because our current credit rating is above the various pre-established thresholds, no collateral has been posted on these liability positions.

**Counterparty Credit Risk Management**

We execute financial derivative transactions with counterparties that are highly rated financial institutions, all of which are investment grade at this time. Some of our underlying derivative agreements give us the right to require the institution to post collateral if its credit rating falls below the pre-established thresholds with Standard & Poor's, Moody's, or Fitch. The collateral that the counterparties would be required to post was $174.0 and $57.2 as of 30 September 2025 and 2024, respectively. No financial institution is required to post collateral at this time, as all have credit ratings at or above threshold.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**16. FAIR VALUE MEASUREMENTS** 

Fair value is defined as an exit price, or the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.

The fair value hierarchy prioritizes the inputs to valuation techniques used to measure fair value into three broad levels as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Level 1*—Quoted prices (unadjusted) in active markets for identical assets or liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Level 2*—Inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the asset or liability.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• *Level 3*—Inputs that are unobservable for the asset or liability based on our own assumptions about the assumptions market participants would use in pricing the asset or liability.

The methods and assumptions used to measure the fair value of financial instruments are as follows:

**Short-term Investments**

Short-term investments primarily include time deposits with original maturities greater than three months and less than one year. We estimated the fair value of our short-term investments, which approximates carrying value as of the balance sheet date, using Level 2 inputs within the fair value hierarchy. Level 2 measurements were based on current interest rates for similar investments with comparable credit risk and time to maturity.

**Derivatives**

The fair value of our interest rate management contracts and forward exchange contracts are quantified using the income approach and are based on estimates using standard pricing models. These models consider the value of future cash flows as of the balance sheet date, discounted to a present value using discount factors that match both the time to maturity and currency of the underlying instruments. These standard pricing models utilize inputs that are derived from or corroborated by observable market data such as interest rate yield curves as well as currency spot and forward rates; therefore, the fair value of our derivatives is classified as a Level 2 measurement. On an ongoing basis, we randomly test a subset of our valuations against valuations received from the transaction's counterparty to validate the accuracy of our standard pricing models. Counterparties to these derivative contracts are highly rated financial institutions.

Refer to Note 15, *Financial Instruments*, for a description of derivative instruments, including details related to the balance sheet line classifications.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Long-term Debt, Including Related Party**

The fair value of our debt is based on estimates using standard pricing models that consider the value of future cash flows as of the balance sheet date, discounted to a present value using discount factors that match both the time to maturity and currency of the underlying instruments. These standard valuation models utilize observable market data such as interest rate yield curves and currency spot rates; therefore, the fair value of our debt is classified as a Level 2 measurement.

The carrying values and fair values of financial instruments were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | 2024 | 2024 |
| **30 September** | **Carrying Value** | **Fair Value** | Carrying Value | Fair Value |
| **Assets** |  |  |  |  |
| Derivatives |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Forward exchange contracts | **$81.3** | **$81.3** | $100.8 | $100.8 |
| &nbsp;&nbsp;&nbsp;Interest rate management contracts | **163.1** | **163.1** | 41.8 | 41.8 |
| **Liabilities** |  |  |  |  |
| Derivatives |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Forward exchange contracts | **$69.5** | **$69.5** | $59.2 | $59.2 |
| &nbsp;&nbsp;&nbsp;Interest rate management contracts | **24.1** | **24.1** | 41.4 | 41.4 |
| Long-term debt, including current portion and related party | **17663.7** | **17348.7** | 14144.4 | 13897.3 |

---

The carrying amounts reported on the consolidated balance sheets for cash and cash items, short-term investments, trade receivables, payables and accrued liabilities, accrued income taxes, and short-term borrowings approximate fair value due to the short-term nature of these instruments. Accordingly, these items have been excluded from the above table.

The table below summarizes assets and liabilities on the consolidated balance sheets that are measured at fair value on a recurring basis:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2025** | 2024 | 2024 | 2024 | 2024 |
| **30 September** | **Total** | **Level 1** | **Level 2** | **Level 3** | Total | Level 1 | Level 2 | Level 3 |
| **Assets at Fair Value** |  |  |  |  |  |  |  |  |
| Derivatives |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Forward exchange contracts | **$81.3** | **$—** | **$81.3** | **$—** | $100.8 | $— | $100.8 | $— |
| &nbsp;&nbsp;&nbsp;Interest rate management contracts | **163.1** | **—** | **163.1** | **—** | 41.8 |  | 41.8 |  |
| **Total Assets at Fair Value** | **$244.4** | **$—** | **$244.4** | **$—** | $142.6 | $— | $142.6 | $— |
| **Liabilities at Fair Value** |  |  |  |  |  |  |  |  |
| Derivatives |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Forward exchange contracts | **$69.5** | **$—** | **$69.5** | **$—** | $59.2 | $— | $59.2 | $— |
| &nbsp;&nbsp;&nbsp;Interest rate management contracts | **24.1** | **—** | **24.1** | **—** | 41.4 |  | 41.4 |  |
| **Total Liabilities at Fair Value** | **$93.6** | **$—** | **$93.6** | **$—** | $100.6 | $— | $100.6 | $— |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Nonrecurring Fair Value Measurements – Project Exit Activities**

We estimate the value of certain long-lived assets associated with exited projects using Level 3 inputs under the fair value hierarchy due to the absence of observable market prices and significant reliance on management judgment and estimation techniques. These assets include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Assets meeting the held for sale criteria that are actively being marketed for sale. We utilized an internally- developed discounted cash flow analysis to estimate the fair value, including costs to sell, as there were no observable market prices available. We expect to complete the sale of these assets in fiscal year 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Plant and equipment that do not meet the held for sale criteria but are capable of being sold through secondary equipment markets. These assets were evaluated for recoverability and the impairment loss was measured using an orderly liquidation valuation approach. The impairment loss was recognized as the difference between the estimated liquidation value and the net book value of the assets as of 31 March 2025. There have been no significant changes in the estimated net realizable value for the remaining assets as of 30 September 2025.

The table below presents the nonrecurring fair value measurements of these long-lived assets, categorized within the fair value hierarchy:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| Balance Sheet Location | Total Estimated Value | Level 1 | Level 2 | Level 3 | FY25<br>Impairment Charges<sup>(A)</sup> |
| Assets held for sale | $418.3 | $— | $— | $418.3 | $350.6 |
| Plant and equipment, net | 22.5 |  |  | 22.5 | 2116.2 |

---

<sup>(A)</sup>Impairment charges were recorded in aggregate with other project exit-related costs as described in Note 5, *Business and Asset Actions*.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**17. DEBT** 

The table below summarizes our total outstanding debt as reflected on our consolidated balance sheets:

---

| | | |
|:---|:---|:---|
| **30 September** | **2025** | 2024 |
| Short-term borrowings<sup>(A)</sup> | **$34.7** | $83.5 |
| Current portion of long-term debt<sup>(B)</sup> | **716.3** | 611.4 |
| Long-term debt | **16769.9** | 13428.6 |
| Long-term debt – related party | **177.5** | 104.4 |
| **Total Debt** | **$17698.4** | $14227.9 |

---

<sup>(A)</sup>Short-term borrowings include bank obligations with weighted average interest rates of 5.0% and 4.0% as of 30 September 2025 and 2024, respectively.

<sup>(B)</sup>Current portion of long-term debt includes amounts of $59.0 and $200.0 owed to related parties as of 30 September 2025 and 2024, respectively.

**Related Party Debt**

As of 30 September 2025, total debt owed to related parties was $236.5, consisting of shareholder loans with our joint venture partner, Lu'An Clean Energy Company. As of 30 September 2024, total debt owed to related parties was $304.4.

**Fiscal Year 2025 Registered Public Offerings**

In February 2025, we issued Euro-denominated senior fixed-rate notes with an aggregate principal amount of €1.0 billion (approximately $1.0 billion) in a registered public offering (the "February 2025 Offering"). The related proceeds were reduced by deferred financing charges and discounts of approximately $8. In June 2025, we issued U.S. Dollar- and Euro-denominated senior fixed-rate notes with aggregate principal amounts of $1.1 billion and €500 million (approximately $570), respectively, in registered public offerings (the "June 2025 Offerings"). The related proceeds were reduced by deferred financing charges and discounts of approximately $12. Deferred financing charges and discounts are amortized through interest expense over the life of the underlying bonds.

We used the net proceeds from the February 2025 Offering to repay commercial paper obligations, including those incurred prior to the closing of the February 2025 Offering that were used to repay €300 million (approximately $311) aggregate principal amount outstanding of our 1.000% Euro-denominated senior fixed-rate notes at maturity, plus accrued interest, and for general corporate purposes. We used the net proceeds from the June 2025 Offerings to repay commercial paper obligations and for general corporate purposes.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Summary of Long-Term Debt Instruments**

The table below summarizes the coupon interest rates, fiscal year maturities, and carrying amounts of our long-term debt, including current portion and amounts owed to related parties. Variable rates are determined as of 30 September 2025.

---

| | | | |
|:---|:---|:---|:---|
| **30 September** | Maturities | **2025** | 2024 |
| **Payable in U.S. Dollars** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;7.6% Medium-term Series E Notes (weighted average rate) | 2026 | **$17.2** | $17.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;1.500% Senior Notes<sup>(A)</sup> | 2026 | **550.0** | 550.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;1.850% Senior Notes | 2027 | **650.0** | 650.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;4.300% Senior Notes | 2028 | **600.0** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;4.600% Senior Notes<sup>(B)</sup> | 2029 | **750.0** | 750.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;2.050% Senior Notes | 2030 | **900.0** | 900.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;4.750% Senior Notes<sup>(B)</sup> | 2031 | **600.0** | 600.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;4.800% Senior Notes | 2033 | **600.0** | 600.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;4.900% Senior Notes | 2033 | **500.0** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;4.850% Senior Notes<sup>(B)</sup> | 2034 | **1150.0** | 1150.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;2.700% Senior Notes | 2040 | **750.0** | 750.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;2.800% Senior Notes | 2050 | **950.0** | 950.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;2.802% Industrial Revenue Bonds (weighted average variable-rate) | 2035 to 2050 | **618.9** | 618.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;7.11% Other (variable-rate) | 2025 | **—** | 38.8 |
| **Payable in Other Currencies** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;1.000% Euro-denominated Notes | 2025 | **—** | 334.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;0.500% Euro-denominated Notes | 2028 | **586.8** | 556.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;2.950% Euro-denominated Notes | 2031 | **586.8** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;0.800% Euro-denominated Notes | 2032 | **586.8** | 556.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;3.250% Euro-denominated Notes | 2032 | **586.8** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;4.000% Euro-denominated Notes | 2035 | **821.5** | 779.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;3.450% Euro-denominated Notes | 2037 | **586.8** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;7.35% Saudi Riyal Loan Facility (variable-rate)<sup>(C)</sup> | 2027 | **—** | 451.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;2.00% Saudi Riyal Loan Facility<sup>(C)</sup>  | 2026 to 2034 | **—** | 222.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;1.86% New Taiwan Dollar Loan Facility | 2026 to 2028 | **98.5** | 131.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;2.66% New Taiwan Dollar Loan Facility | 2026 to 2029 | **197.0** | 190.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;2.75% New Taiwan Dollar Loan Facility (variable-rate) | 2026 to 2030 | **98.5** | 94.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;4.07% Other (weighted average rate) | 2030 to 2034 | **10.0** | 9.4 |
| **Related Party Debt** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;5.5% Chinese Renminbi | 2026 to 2030 | **236.5** | 279.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;5.7% Chinese Renminbi | 2033 | **—** | 24.6 |
| **Non-Recourse Debt Associated With NGHC**<sup>(D)</sup> | 2027 to 2053 | **4909.7** | 3271.8 |
| **Finance Lease Obligations** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign 11.5% (weighted average rate) | 2026 to 2052 | **54.2** | 8.0 |
| **Total Principal Amount** |  | **$17996.0** | $14485.5 |
| Less: Unamortized discount and debt issuance costs |  | **308.9** | 304.5 |
| Less: Fair value hedge accounting adjustments<sup>(E)</sup> |  | **23.4** | 36.6 |
| **Total Long-term Debt** |  | **$17663.7** | $14144.4 |
| Less: Current portion of long-term debt |  | **716.3** | 611.4 |
| Less: Long-term debt – related party |  | **177.5** | 104.4 |
| **Long-term Debt** |  | **$16769.9** | $13428.6 |

---

<sup>(A)</sup>Subsequent to the balance sheet date, we repaid at maturity $550.0 aggregate principal amount of our 1.50% senior notes due October 2025, plus accumulated and unpaid interest through the maturity date.

<sup>(B)</sup>In February 2024, we issued green senior notes with an aggregate principal amount of $2.5 billion in a registered public offering. All proceeds have been disbursed or allocated to eligible projects that are expected to have environmental benefits as defined under our Green Finance Framework.

<sup>(C)</sup>Borrowings derecognized during the second quarter of fiscal year 2025 following the deconsolidation of BHIG. For additional information, refer to the Credit Facilities discussion on page <u>[118](#idb74d0db9b8d44369290116dd34ae9d2_33153)</u>.

<sup>(D)</sup>Refer to Note 3, *Variable Interest Entities*, for additional information.

<sup>(E)</sup>Refer to Note 15, *Financial Instruments*, for additional information.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

Principal maturities of long-term debt, including current portion and amounts owed to related parties, in each of the next five years and thereafter are as follows:

---

| | |
|:---|:---|
| 2026 | $716.6 |
| 2027 | 906.5 |
| 2028 | 1405.3 |
| 2029 | 1114.0 |
| 2030 | 1141.2 |
| Thereafter | 12712.4 |
| **Total** | **$17996.0** |

---

**Interest**

The table below reconciles interest incurred to interest expense as presented on our consolidated income statements. Capitalized interest represents the portion of interest incurred that we include in the cost of new plant and equipment that we build during the year.

---

| | | | |
|:---|:---|:---|:---|
| **Fiscal Year Ended 30 September** | **2025** | 2024 | 2023 |
| Interest incurred | **$615.8** | $507.9 | $292.9 |
| Less: Capitalized interest | **401.8** | 289.1 | 115.4 |
| **Interest expense** | **$214.0** | $218.8 | $177.5 |

---

Cash paid for interest, net of amounts capitalized, was $192.2, $198.2, and $131.5 in fiscal years 2025, 2024, and 2023, respectively.

**Debt Covenants**

Various debt agreements to which we are a party include financial covenants and other restrictions, including restrictions pertaining to the ability to create property liens and enter into certain sale and leaseback transactions. As of 30 September 2025, we were in compliance with all the financial and other covenants under our debt agreements.

**Committed Credit Facilities**

During the second quarter of fiscal year 2025, we refinanced our existing 364-day $500 revolving credit agreement to extend its maturity date from 27 March 2025 to 26 March 2026 (the "364-Day Credit Agreement"). All other terms remain consistent with the original 364-Day Credit Agreement. Fees incurred in connection with the refinancing were not material.

We also maintain a five-year $3.0 billion revolving credit agreement that matures on 31 March 2029 (the "Five-Year Credit Agreement"). Both the 364-Day Credit Agreement and the Five-Year Credit Agreement are syndicated committed facilities that provide a source of liquidity and support our commercial paper program through the availability of senior unsecured debt to us and certain of our subsidiaries. No borrowings were outstanding under either of the 364-Day Credit Agreement or the Five-Year Credit Agreement as of 30 September 2025 or 30 September 2024.

Separately, certain of our foreign subsidiaries maintain access to committed credit facilities. As of 30 September 2025, the amount available under foreign committed credit facilities totaled $394.0, all of which was borrowed and outstanding.

As of 30 September 2024, these facilities had a combined maximum borrowing capacity of $1.2 billion, of which $1.1 billion was borrowed and outstanding. During the second quarter of fiscal year 2025, we derecognized long-term borrowings from two Saudi Riyal-denominated facilities upon deconsolidation of BHIG. These borrowings had been drawn from a 7.35% variable-rate facility and a 2.00% fixed-rate facility, which had carrying values of $451.1 and $222.2 as of 30 September 2024, respectively. As further discussed in Note 6, *Acquisitions and Divestitures*, we continue to have exposure to BHIG's borrowings through our equity method investment in the entity.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**18. RETIREMENT BENEFITS** 

We and certain of our subsidiaries sponsor defined benefit pension plans and defined contribution plans that cover a substantial portion of our worldwide employees. The principal defined benefit pension plans are the U.S. salaried pension plan and the U.K. pension plan. These plans were closed to new participants in 2005, after which defined contribution plans were offered to new employees. The principal defined contribution plan is the Retirement Savings Plan, in which a substantial portion of the U.S. employees participate. A similar plan is offered to U.K. employees. We also provide other postretirement benefits consisting primarily of healthcare benefits to U.S. retirees who meet age and service requirements.

**Defined Benefit Pension Plans**

Pension benefits earned are generally based on years of service and compensation during active employment. The components of net periodic cost for our defined benefit pension plans for fiscal years 2025, 2024, and 2023 were as follows:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Fiscal Year Ended 30 September** | **Fiscal Year Ended 30 September** | **Fiscal Year Ended 30 September** | **Fiscal Year Ended 30 September** | **Fiscal Year Ended 30 September** | **Fiscal Year Ended 30 September** | **Fiscal Year Ended 30 September** | **Fiscal Year Ended 30 September** | **Fiscal Year Ended 30 September** |
| | **2025** | **2025** | **2025** | 2024 | 2024 | 2024 | 2023 | 2023 | 2023 |
| | **U.S.** | **Inter-<br>national** | **Total** | U.S. | Inter-<br>national | Total | U.S. | Inter-<br>national | Total |
| Service cost | **$9.1** | **$11.6** | **$20.7** | $9.6 | $11.3 | $20.9 | $10.9 | $12.3 | $23.2 |
| Non-service cost (benefit): |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;Interest cost | **119.5** | **57.0** | **176.5** | 134.9 | 60.0 | 194.9 | 129.9 | 59.9 | 189.8 |
| &nbsp;&nbsp;Expected return on plan assets | **(132.6)** | **(60.0)** | **(192.6)** | (120.1) | (47.3) | (167.4) | (127.1) | (49.2) | (176.3) |
| &nbsp;&nbsp;Prior service cost amortization | **1.1** | **1.0** | **2.1** | 1.1 | 0.9 | 2.0 | 1.2 | 0.7 | 1.9 |
| &nbsp;&nbsp;Actuarial loss amortization | **46.8** | **9.7** | **56.5** | 57.3 | 12.9 | 70.2 | 59.7 | 11.6 | 71.3 |
| &nbsp;&nbsp;Settlements | **0.8** | **0.5** | **1.3** | 1.1 | 1.2 | 2.3 | 1.4 | 0.6 | 2.0 |
| &nbsp;&nbsp;Curtailments | **1.2** | **—** | **1.2** |  |  |  |  | (1.9) | (1.9) |
| Other | **—** | **0.3** | **0.3** |  | 0.9 | 0.9 |  | 0.9 | 0.9 |
| **Net Periodic Cost** | **$45.9** | **$20.1** | **$66.0** | $83.9 | $39.9 | $123.8 | $76.0 | $34.9 | $110.9 |

---

Our service costs are primarily included within "Cost of sales" and "Selling and administrative expense" on our consolidated income statements. The amount of service costs capitalized in fiscal years 2025, 2024 and 2023 were not material. The non-service related impacts are presented outside operating income within "Other non-operating income (expense), net."

Certain of our pension plans provide for a lump sum benefit payment option at the time of retirement, or for corporate officers, six months after their retirement date. A participant's vested benefit is considered settled upon cash payment of the lump sum. We recognize pension settlement losses when cash payments exceed the sum of the service and interest cost components of net periodic cost of the plan for the fiscal year. We recognized pension settlement losses of $0.8, $1.1 and $1.4 in fiscal years 2025, 2024 and 2023, respectively, to accelerate recognition of a portion of actuarial losses deferred in accumulated other comprehensive loss associated with the U.S. supplementary pension plan.

We calculate net periodic cost for a given fiscal year based on assumptions developed at the end of the previous fiscal year. The following table sets forth the weighted average assumptions used in the calculation of net periodic cost:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | 2024 | 2024 | 2023 | 2023 |
| | **U.S.** | **International** | U.S. | International | U.S. | International |
| Discount rate – Service cost | **5.1%** | **4.6%** | 6.1% | 5.3% | 5.7% | 4.6% |
| Discount rate – Interest cost | **4.7%** | **4.5%** | 6.0% | 5.1% | 5.5% | 5.0% |
| Expected return on plan assets | **5.8%** | **4.8%** | 5.8% | 4.3% | 5.8% | 4.2% |
| Rate of compensation increase | **3.5%** | **3.4%** | 3.5% | 3.4% | 3.5% | 3.4% |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

The projected benefit obligation ("PBO") is the actuarial present value of benefits attributable to employee service rendered to date, including the effects of estimated future salary increases. The following table sets forth the weighted average assumptions used in the calculation of the PBO:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | 2024 | 2024 |
| | **U.S.** | **International** | U.S. | International |
| Discount rate | **5.2%** | **5.2%** | 5.0% | 4.6% |
| Rate of compensation increase | **3.5%** | **3.4%** | 3.5% | 3.4% |

---

The following tables reflect the change in the PBO and the change in the fair value of plan assets based on the plan year measurement date, as well as the amounts recognized in the consolidated balance sheets:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | 2024 | 2024 |
| | **U.S.** | **International** | U.S. | International |
| **Change in Projected Benefit Obligation** |  |  |  |  |
| Obligation at beginning of year | **$2613.1** | **$1338.7** | $2348.8 | $1162.4 |
| Service cost | **9.1** | **11.6** | 9.6 | 11.3 |
| Interest cost | **119.5** | **57.0** | 134.9 | 60.0 |
| Amendments | **0.3** | **—** | 1.3 |  |
| Actuarial (gain) loss | **(44.7)** | **(88.7)** | 296.2 | 50.7 |
| Curtailments | **1.2** | **—** |  |  |
| Settlements | **(3.0)** | **(6.0)** | (3.6) | (8.6) |
| Participant contributions | **—** | **0.7** |  | 0.7 |
| Benefits paid | **(179.8)** | **(59.7)** | (174.1) | (55.8) |
| Currency translation and other | **—** | **26.0** |  | 118.0 |
| **Obligation at End of Year** | **$2515.7** | **$1279.6** | $2613.1 | $1338.7 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | 2024 | 2024 |
| | **U.S.** | **International** | U.S. | International |
| **Change in Plan Assets** |  |  |  |  |
| Fair value at beginning of year | **$2533.0** | **$1374.5** | $2299.0 | $1134.0 |
| Actual return on plan assets | **52.1** | **(31.1)** | 404.4 | 154.5 |
| Settlements | **(3.0)** | **(6.0)** | (3.6) | (8.6) |
| Company contributions | **6.7** | **23.2** | 7.3 | 27.4 |
| Participant contributions | **—** | **0.7** |  | 0.7 |
| Benefits paid | **(179.8)** | **(59.7)** | (174.1) | (55.8) |
| Currency translation and other | **—** | **17.0** |  | 122.3 |
| **Fair Value at End of Year** | **$2409.0** | **$1318.6** | $2533.0 | $1374.5 |
| **Funded Status at End of Year** | **($106.7)** | **$39.0** | ($80.1) | $35.8 |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | 2024 | 2024 |
| | **U.S.** | **International** | U.S. | International |
| **Amounts Recognized** |  |  |  |  |
| Noncurrent assets | **$44.9** | **$166.0** | $45.3 | $154.7 |
| Accrued liabilities | **9.8** | **2.7** | 7.3 | 0.9 |
| Noncurrent liabilities | **141.8** | **124.3** | 118.1 | 118.0 |
| **Net (Liability) Asset Recognized** | **($106.7)** | **$39.0** | ($80.1) | $35.8 |

---

The changes in plan assets and benefit obligation that have been recognized in other comprehensive income on a pretax basis during fiscal years 2025 and 2024 consist of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | 2024 | 2024 |
| | **U.S.** | **International** | U.S. | International |
| Net actuarial loss (gain) arising during the period | **$37.0** | **$2.4** | $11.9 | ($56.5) |
| Amortization of net actuarial loss | **(48.8)** | **(10.2)** | (58.4) | (14.1) |
| Prior service cost arising during the period | **0.3** | **—** | 1.3 |  |
| Amortization of prior service cost | **(1.1)** | **(1.0)** | (1.1) | (0.9) |
| **Total** | **($12.6)** | **($8.8)** | ($46.3) | ($71.5) |

---

The net actuarial gains and losses represent the actual changes in the estimated obligation and plan assets that have not yet been recognized in the consolidated income statements and are included in accumulated other comprehensive loss. Actuarial losses arising during fiscal year 2025 are primarily attributable to lower than expected returns on plan assets that were partially offset by higher discount rates. Accumulated actuarial gains and losses that exceed a corridor are amortized over the average remaining service period of active U.S. participants, which was approximately six years as of 30 September 2025. For U.K. participants, accumulated actuarial gains and losses that exceed a corridor are amortized over the average remaining life expectancy, which was approximately 22 years as of 30 September 2025.

The components recognized in accumulated other comprehensive loss on a pretax basis at 30 September consisted of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | 2024 | 2024 |
| | **U.S.** | **International** | U.S. | International |
| Net actuarial loss | **$403.5** | **$428.0** | $415.3 | $435.8 |
| Prior service cost | **5.0** | **10.0** | 5.8 | 11.0 |
| Net transition liability | **—** | **0.4** |  | 0.4 |
| **Total** | **$408.5** | **$438.4** | $421.1 | $447.2 |

---

The accumulated benefit obligation ("ABO") is the actuarial present value of benefits attributed to employee service rendered to a particular date, based on current salaries. The ABO for all defined benefit pension plans was $3,715.6 and $3,860.4 as of 30 September 2025 and 2024, respectively.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

The following table provides information on pension plans where the benefit liability exceeds the value of plan assets:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | 2024 | 2024 |
| **30 September** | **U.S.** | **International** | U.S. | International |
| **Pension Plans with PBO in Excess of Plan Assets:** |  |  |  |  |
| PBO | **$2356.3** | **$315.3** | $2446.5 | $326.1 |
| Fair value of plan assets | **2204.7** | **188.3** | 2321.1 | 207.2 |
| **PBO in excess of plan assets** | **$151.6** | **$127.0** | $125.4 | $118.9 |
| **Pension Plans with ABO in Excess of Plan Assets:** |  |  |  |  |
| ABO | **$2313.9** | **$152.0** | $2394.5 | $139.8 |
| Fair value of plan assets | **2204.7** | **45.9** | 2321.1 | 42.0 |
| **ABO in excess of plan assets** | **$109.2** | **$106.1** | $73.4 | $97.8 |

---

The tables above include several pension arrangements that are not funded because of jurisdictional practice. The ABO and PBO related to these plans as of 30 September 2025 were $59.7 and $66.5, respectively.

<u>Pension Plan Assets</u>

Our pension plan investment strategy is to invest in diversified portfolios to earn a long-term return consistent with acceptable risk in order to pay retirement benefits and meet regulatory funding requirements while minimizing company cash contributions over time. De-risking strategies are also employed for closed plans as funding improves, generally resulting in higher allocations to long duration bonds. The plans invest primarily in actively and passively managed equity, debt, and real estate securities and funds. Equity investments are diversified geographically and by investment style and market capitalization. Fixed income portfolios may include investment grade and high yield investments in sovereign, corporate, emerging market debt, asset-backed securities, distressed and convertible debt, loans, and private credit instruments generally denominated in the currency of the plan. The U.S. and U.K. plans' investment managers are authorized to utilize derivatives to manage interest and inflation exposure.

Asset allocation targets are established based on the long-term return, volatility and correlation characteristics of the asset classes, the profiles of the plans' liabilities, and acceptable levels of risk. As of 30 September 2025, the U.S. and international pension plans were within the allowable target allocation ranges. We continue to monitor the investment portfolios and various investment markets and will take action accordingly. Assets are routinely rebalanced through contributions, benefit payments, and otherwise as deemed appropriate. The actual and target allocations at the measurement date are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025 Target Allocation** | **2025 Target Allocation** | **2025 Actual Allocation** | **2025 Actual Allocation** | 2024 Actual Allocation | 2024 Actual Allocation |
| | **U.S.** | **International** | **U.S.** | **International** | U.S. | International |
| **Asset Category** |  |  |  |  |  |  |
| Equity securities | **15 - 25%** | **5 - 22%** | **16%** | **14%** | 20% | 14% |
| Fixed income securities | **60 - 74%** | **70 - 87%** | **72%** | **77%** | 73% | 78% |
| Real estate | **5 - 8%** | **—%** | **5%** | **—%** | 6% | —% |
| Alternative credit | **5 - 8%**  | **4 - 12%** | **6%** | **9%** | —% | 8% |
| Cash | **—%** | **—%** | **1%** | **—%** | 1% | —% |
| **Total** |  |  | **100%** | **100%** | 100% | 100% |

---

In fiscal year 2025, the 5.8% expected return for U.S. plan assets was based on a weighted average of estimated long-term returns of major asset classes. In determining the estimated long-term asset class returns, we take into account historical long-term returns of asset classes and the value of active management, as well as other economic and market expectations, and input from our actuaries and investment advisors.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

In fiscal year 2025, the 4.8% expected rate of return for international plan assets was based on a weighted average return for plans outside the U.S., which vary significantly in size, asset structure and expected returns. The expected asset return for the U.K. plan, which represents approximately 80% of the assets of our International plans, was 5.0% and was derived from expected equity and debt security returns.

The table below summarizes pension plan assets measured at fair value by asset class (see Note 16, *Fair Value Measurements*, for definition of the levels):

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2025** | 2024 | 2024 | 2024 | 2024 |
| **30 September** | **Total** | **Level 1** | **Level 2** | **Level 3** | Total | Level 1 | Level 2 | Level 3 |
| **U.S. Qualified Pension Plans** |  |  |  |  |  |  |  |  |
| Cash and cash equivalents | **$15.4** | **$15.4** | **$—** | **$—** | $14.7 | $14.7 | $— | $— |
| Equity securities | **271.5** | **271.5** | **—** | **—** | 320.0 | 320.0 |  |  |
| Equity pooled funds | **109.3** | **—** | **109.3** | **—** | 204.7 |  | 204.7 |  |
| Fixed income securities | **1747.7** | **—** | **1747.7** | **—** | 1844.7 |  | 1844.7 |  |
| **Total U.S. Qualified Pension Plans at Fair Value** | **$2143.9** | **$286.9** | **$1857.0** | **$—** | $2384.1 | $334.7 | $2049.4 | $— |
| Real estate pooled funds<sup>(A)</sup> | **129.5** |  |  |  | 148.9 |  |  |  |
| Alternative credit pooled funds<sup>(B)</sup> | **135.6** |  |  |  |  |  |  |  |
| **Total U.S. Qualified Pension Plans** | **$2409.0** |  |  |  | $2533.0 |  |  |  |
| **International Pension Plans** |  |  |  |  |  |  |  |  |
| Cash and cash equivalents | **$5.4** | **$5.4** | **$—** | **$—** | $3.6 | $3.6 | $— | $— |
| Equity pooled funds | **180.4** | **—** | **180.4** | **—** | 192.1 |  | 192.1 |  |
| Fixed income pooled funds | **810.2** | **—** | **810.2** | **—** | 858.0 |  | 858.0 |  |
| Alternative credit pooled funds | **115.4** | **—** | **—** | **115.4** | 113.6 |  |  | 113.6 |
| Other pooled funds | **18.9** | **—** | **18.9** | **—** | 19.4 |  | 19.4 |  |
| Insurance contracts | **188.3** | **—** | **—** | **188.3** | 187.8 |  |  | 187.8 |
| **Total International Pension Plans** | **$1318.6** | **$5.4** | **$1009.5** | **$303.7** | $1374.5 | $3.6 | $1069.5 | $301.4 |

---

<sup>(A)</sup>Real estate pooled funds consist of funds that invest in properties. These funds generally allow for quarterly redemption with 30 days' notice. Timing for redemption could be delayed based on the priority of our request and the availability of funds. Interests in these funds are valued using the net asset value ("NAV") per share practical expedient and are not classified in the fair value hierarchy.

<sup>(B)</sup>Alternative credit pooled funds in our U.S. plans generally allow for monthly redemption with approximately 30 days' notice. Timing for redemption could be delayed based on the priority of our request and the availability of funds. Interests in these funds are valued using the net asset value ("NAV") per share practical expedient and are not classified in the fair value hierarchy. For additional information related to these funds, refer to the *Alternative Credit Pooled Funds* description below.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

The table below summarizes changes in fair value of the pension plan assets classified as Level 3:

---

| | | | |
|:---|:---|:---|:---|
| | Insurance Contracts | Alternative Credit <br>Pooled Funds | Total Level 3 |
| Balance at 30 September 2023 | $165.8 | $94.2 | $260.0 |
| Purchases, sales, and settlements, net | (4.9) | (7.5) | (12.4) |
| Actual return on plan assets held at end of year | 26.9 | 26.9 | 53.8 |
| Balance at 30 September 2024 | $187.8 | $113.6 | $301.4 |
| Purchases, sales, and settlements, net | (4.2) | (7.5) | (11.7) |
| Actual return on plan assets held at end of year | 4.7 | 9.3 | 14.0 |
| **Balance at 30 September 2025** | **$188.3** | **$115.4** | **$303.7** |

---

The descriptions and fair value methodologies for the U.S. and International pension plan assets are as follows:

*Cash and Cash Equivalents*

The carrying amounts of cash and cash equivalents approximate fair value due to the short-term maturity.

*Equity Securities*

Equity securities are valued at the closing market price reported on a U.S. or international exchange where the security is actively traded and are therefore classified as Level 1 assets.

*Equity Pooled Funds*

Units of pooled funds are valued at the per unit NAV determined by the fund manager based on the value of the underlying traded holdings and are classified as Level 2 assets.

*Fixed Income Securities*

Corporate and government bonds, and related fixed income securities, are classified as Level 2 assets, as they are either valued at quoted market prices from observable pricing sources at the reporting date or valued based upon comparable securities with similar yields and credit ratings. U.S. plan fixed income investments primarily include U.S. corporate bonds, U.S. treasury investments, interest rate swaps, total return swaps, and U.S. treasury future contracts.

*Fixed Income Pooled Funds* 

Fixed income pooled funds may hold government bonds, index linked bonds, corporate bonds, cash, and derivative instruments. The fixed income pooled funds are classified as Level 2 assets since the NAV of these assets is based on quoted market pricing from observable pricing sources or valued based upon comparable securities with similar yields, credit ratings, or factors as of the reporting date.

*Alternative Credit Pooled Funds*

Alternative credit pooled funds may hold high yield bonds, emerging market debt, loans, structured credit, distressed and convertible debt, private credit, and other instruments. Due to the limited market activity of the underlying securities, the NAV of these assets is based on the fund manager's estimate of the fair value of the shares held as of the reporting date. Alternative credit pooled funds are classified as either Level 3 assets or measured using the NAV per share practical expedient, based on how frequently the NAV is determined and how much advance notice is required for redemption.

*Other Pooled Funds*

Other pooled funds are classified as Level 2 assets, as they are valued at the NAV of the shares held at year end, which is based on the fair value of the underlying investments.

*Insurance Contracts*

Insurance contracts are classified as Level 3 assets, as they are carried at contract value, which approximates the estimated fair value. The estimated fair value is based on the fair value of the underlying investment of the insurance company and discount rates that require inputs with limited observability.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Contributions and Projected Benefit Payments**

Pension contributions to funded plans and benefit payments for unfunded plans for fiscal year 2025 were $29.9. Contributions for funded plans resulted primarily from contractual and regulatory requirements. Benefit payments to unfunded plans were due primarily to the timing of retirements. We anticipate contributing $25 to $35 to the defined benefit pension plans in fiscal year 2026. These contributions are anticipated to be driven primarily by contractual and regulatory requirements for funded plans and benefit payments for unfunded plans, which are dependent upon timing of retirements.

Projected benefit payments, which reflect expected future service, are as follows:

---

| | | |
|:---|:---|:---|
| | U.S. | International |
| 2026 | $189.2 | $69.5 |
| 2027 | 185.6 | 74.4 |
| 2028 | 188.2 | 74.7 |
| 2029 | 190.4 | 76.7 |
| 2030 | 191.8 | 80.3 |
| 2031-2035 | 950.6 | 433.8 |

---

These estimated benefit payments are based on assumptions about future events. Actual benefit payments may vary significantly from these estimates.

**Defined Contribution Plans**

We maintain a non-leveraged employee stock ownership plan ("ESOP") which forms part of the Air Products and Chemicals, Inc. Retirement Savings Plan ("RSP"). The ESOP was established in May of 2002. The balance of the RSP is a qualified defined contribution plan including a 401(k) elective deferral component. A substantial portion of U.S. employees are eligible and participate.

We treat dividends paid on ESOP shares as ordinary dividends. Under existing tax law, we may deduct dividends which are paid with respect to shares held by the plan. Shares of our common stock in the ESOP totaled 1,501,888 as of 30 September 2025.

Our contributions to the RSP include a Company core contribution for certain eligible employees who do not receive their primary retirement benefit from the defined benefit pension plans, with the core contribution based on a percentage of pay that is dependent on years of service. For the RSP, we also make matching contributions on overall employee contributions as a percentage of the employee contribution and include an enhanced contribution for certain eligible employees that do not participate in the defined benefit pension plans. Worldwide contributions expensed to income in fiscal years 2025, 2024, and 2023 were $81.0, $82.6, and $71.5, respectively.

**Other Postretirement Benefits**

We provide other postretirement benefits consisting primarily of healthcare benefits to certain U.S. retirees who meet age and service requirements. The healthcare benefit is a continued medical benefit until the retiree reaches age 65. Healthcare benefits are contributory, with contributions adjusted periodically. The retiree medical costs are capped at a specified dollar amount, with the retiree contributing the remainder. The cost of these benefits was not material in fiscal years 2025, 2024, and 2023. Accumulated postretirement benefit obligations as of the end of fiscal years 2025 and 2024 were $8.3 and $12.0, respectively, of which $3.3 and $3.1 were current obligations, respectively.

We recognize changes in other postretirement benefit plan obligations in other comprehensive income on a pretax basis. During fiscal years 2025 and 2024 we recognized a loss of $2.8 and $1.7, respectively, that arose during the period, and $0.4 and $0.5 of net actuarial gain amortization, respectively.

The net actuarial (gain) loss recognized in accumulated other comprehensive loss on a pre-tax basis was $3.0 and ($0.2) as of 30 September 2025 and 2024, respectively.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**19. COMMITMENTS AND CONTINGENCIES** 

**Litigation**

We are involved in various legal proceedings, including commercial, competition, environmental, intellectual property, regulatory, product liability, and insurance matters. We do not currently believe there are any legal proceedings for which it is reasonably possible, individually or in the aggregate, to have a material impact on our financial condition, results of operations, or cash flows.

In September 2010, the Brazilian Administrative Council for Economic Defense ("CADE") issued a decision against our Brazilian subsidiary, Air Products Brasil Ltda., and several other Brazilian industrial gas companies for alleged anticompetitive activities. CADE imposed a civil fine of R$179.2 million (approximately $34 as of 30 September 2025) on Air Products Brasil Ltda., which was based on a percentage of our total revenue in Brazil in 2003. In May 2014, our appeal was granted and the fine was dismissed. CADE appealed that ruling and in October 2025 the Supreme Court of Brazil rendered a judgment confirming the appellate ruling, which annulled the administrative proceeding and the fine imposed by CADE. Under applicable law, no further remedies are available and the judgment is final.

**Environmental**

In the normal course of business, we are involved in legal proceedings under the Comprehensive Environmental Response, Compensation, and Liability Act ("CERCLA," the federal Superfund law), the Resource Conservation and Recovery Act ("RCRA"), and similar state and foreign environmental laws relating to the designation of certain sites for investigation or remediation. Presently, there are 26 sites on which a final settlement or remediation has not been achieved where we, usually along with others, have been designated as a potentially responsible party by environmental authorities or are otherwise engaged in investigation or remediation, including cleanup activity at certain of our former and current manufacturing sites. We continually monitor these sites for which we have environmental exposure.

Accruals for environmental loss contingencies are recorded when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. As of 30 September 2025 and 2024, the consolidated balance sheets included accruals of $85.6 and $79.1, respectively, primarily as part of other noncurrent liabilities. These environmental liabilities will be paid over a period of up to 30 years. We estimate the exposure for environmental loss contingencies to range from $85 to a reasonably possible upper exposure of $98 as of 30 September 2025.

Actual costs to be incurred at identified sites in future periods may vary from the estimates, given inherent uncertainties in evaluating environmental exposures. Using reasonably possible alternative assumptions of the exposure level could result in an increase to the environmental accrual. Due to these inherent uncertainties, a significant increase to the reasonably possible upper exposure level could occur if a new site is designated, the scope of remediation is increased, a different remediation alternative is identified, or a significant increase in our proportionate share occurs. We do not expect that any sum we may have to pay in connection with environmental matters in excess of the amounts recorded or disclosed above would have a material adverse impact on our financial position or results of operations in any one year.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Pace</u>

As of 30 September 2025, $53.8 of the environmental accrual was related to our facility in Pace, Florida.

In 2006, we sold our Amines business, which included operations at the Pace facility and recognized a liability for retained environmental obligations associated with remediation activities at the facility. We are required by the Florida Department of Environmental Protection ("FDEP") and the United States Environmental Protection Agency ("USEPA") to continue our remediation efforts. We recognized a before-tax expense of $42 in fiscal year 2006 in results from discontinued operations and recorded an environmental accrual of $42 in continuing operations on the consolidated balance sheets.

In the first quarter of 2015, we entered into a consent order with the FDEP requiring us to continue our remediation efforts at the Pace facility and complete a cost review every five years. In fiscal year 2020, we completed an updated cost review of the environmental remediation status at the Pace facility and increased our environmental accrual for this site by $19 in continuing operations on the consolidated balance sheet and recognized a before-tax expense of $19 in results from discontinued operations. In fiscal year 2024, we completed our most recent cost review of the environmental remediation status at the Pace facility. Based on our review, we expect ongoing activities to continue for 30 years. Additionally, we increased our estimate of near-term spending for an optimized groundwater recovery system and future annual costs due to higher inflation. As a result of these changes, we increased our environmental accrual for this site by $19 in continuing operations on the consolidated balance sheets and recognized a before-tax expense of $19 in results from discontinued operations in fiscal year 2024. There have been no significant changes to the estimated exposure.

We have implemented many of the remedial corrective measures at the Pace facility required under the 1995 consent orders issued by the FDEP and the USEPA. Contaminated soils have been bioremediated, and the treated soils have been secured in a lined on-site corrective action management unit. Several groundwater recovery systems have been installed to contain and remove contamination from groundwater. We completed an extensive assessment of the site to determine the efficacy of existing measures, what additional corrective measures may be needed, and whether newer remediation technologies that were not available in the 1990s might be better suited for groundwater remediation. Based on assessment results, we completed a focused feasibility study that identified alternative approaches that may more effectively remove contaminants. We continue to review alternative remedial approaches with the FDEP, and we completed additional field work during 2021 to support the design of an improved groundwater recovery network. This network targets areas of higher contaminant concentration and avoids areas of high groundwater iron which has proven to be a significant operability issue for the project. The design of the optimized recovery system was completed in fiscal year 2024, with construction expected to begin in fiscal year 2026. In the fourth quarter of fiscal year 2024, we completed an updated cost review which resulted in a change in assumptions regarding future operating costs as discussed above.

<u>Piedmont</u> 

As of 30 September 2025, $9.8 of the environmental accrual was related to a production facility site in Piedmont, South Carolina.

On 30 June 2008, we sold our Elkton, Maryland, and Piedmont, South Carolina, production facilities and the related North American atmospheric emulsions and global pressure sensitive adhesives businesses. In connection with the sale, we recognized a liability for retained environmental obligations associated with remediation activities at the Piedmont site. This site is under active remediation for contamination caused by an insolvent prior owner.

We are required by the South Carolina Department of Health and Environmental Control ("SCDHEC") to address both contaminated soil and groundwater. Numerous areas of soil contamination have been addressed, and contaminated groundwater is being recovered and treated. The SCDHEC issued its final approval to the site-wide feasibility study on 13 June 2017 and the Record of Decision for the site on 27 June 2018, after which we signed a Consent Agreement Amendment memorializing our obligations to complete the cleanup of the site.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

Remediation has started in accordance with the design, which includes in-situ chemical oxidation treatment, as well as soil vapor extraction to remove volatile organic compounds from the unsaturated soils beneath the impacted areas of the plant. We estimate that source area remediation and groundwater recovery and treatment will continue through 2033. Thereafter, we currently expect this site to go into a state of monitored natural attenuation through 2038. We recognized a before-tax expense of $24 in 2008 as a component of income from discontinued operations and recorded an environmental liability of $24 in continuing operations on the consolidated balance sheets.

In the third quarter of fiscal year 2025, we completed an updated cost review of the environmental remediation status at Piedmont. Based on our review, we increased our estimate of remaining costs due to the extended period of time that will be required to complete the remediation along with higher annual costs due to inflation. As a result of these changes, we increased the environmental accrual for this site by $9 in continuing operations on the consolidated balance sheets and recognized a before-tax expense of $9 in results from discontinued operations.

<u>Pasadena</u>

As of 30 September 2025, $9.9 of the environmental accrual was related to a production facility site in Pasadena, Texas.

During fiscal year 2012, management committed to permanently shutting down our polyurethane intermediates ("PUI") production facility in Pasadena, Texas. In shutting down and dismantling the facility, we have undertaken certain obligations related to soil and groundwater contaminants. We have been pumping and treating groundwater to control off-site contaminant migration in compliance with regulatory requirements and under the approval of the Texas Commission on Environmental Quality ("TCEQ"). We estimate that the pump and treat system will continue to operate until 2042.

We continue to perform additional work to address other environmental obligations at the site. This additional work includes remediating impacted soils as required, investigating groundwater west of the former PUI facility, cleaning production wells, continuing post closure care for two closed RCRA surface impoundment units, and maintaining engineering controls. Additionally, we have conducted an interim corrective action to treat impacted soils as recommended in the TCEQ 2019 Annual Report. We are currently in the process of renewing the site's RCRA permit. In 2012, we estimated the total exposure at this site to be $13. There have been no significant changes to the estimated exposure.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Asset Retirement Obligations**

Our asset retirement obligations are primarily associated with long-term on-site supply contracts under which we have built a facility on land owned by the customer and are obligated to remove the facility at the end of the contract term. The retirement of assets includes the contractually required removal of a long-lived asset from service and encompasses the sale, removal, abandonment, recycling, or disposal of the assets as required at the end of the contract term. These obligations are primarily reflected within "Other noncurrent liabilities" on the consolidated balance sheets. The timing and/or method of settlement of these obligations are conditional on a future event that may or may not be within our control.

Changes to the carrying amount of our asset retirement obligations were as follows:

---

| | |
|:---|:---|
| 30 September 2023 | $297.3 |
| Additional accruals | 33.3 |
| Liabilities settled | (13.7) |
| Accretion expense | 12.0 |
| Currency translation adjustment | 5.8 |
| 30 September 2024 | $334.7 |
| Additional accruals<sup>(A)</sup> | 87.5 |
| Liabilities settled | (11.7) |
| Accretion expense | 13.0 |
| Currency translation adjustment | (1.6) |
| Reclass to liabilities held for sale | (15.7) |
| **30 September 2025** | **$406.2** |

---

<sup>(A)</sup>Primarily relates to project exits discussed in Note 5, *Business and Asset Actions*.

**Warranties and Guarantees**

We do not expect that any sum we may have to pay in connection with warranties and guarantees will have a material adverse effect on our consolidated financial condition, liquidity, or results of operations.

<u>Warranties</u>

We, in the normal course of business operations, have issued product warranties related to equipment sales. Also, contracts often contain standard terms and conditions which typically include a warranty and indemnification to the buyer that the goods and services purchased do not infringe on third-party intellectual property rights. The provision for estimated future costs relating to warranties is not material to the consolidated financial statements.

<u>Guarantees</u>

To date, no payments have been made under the guarantees discussed below.

We issued performance guarantees as a condition of project financing associated with the NEOM Green Hydrogen Project that would require us to pay up to approximately $0.8 billion in the event of nonperformance in our role as EPC contractor. Our exposure will decline over time before expiring in November 2028. Refer to Note 3, *Variable Interest Entities,* for additional information regarding the project.

We also have a long-term sale of equipment contract with the JIGPC joint venture to engineer, procure, and construct the industrial gas facilities that will supply gases to Aramco. We provided bank guarantees to the joint venture to support our performance under the contract. As of 30 September 2025, our maximum potential payments were $244.5.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Unconditional Purchase Obligations**

We are obligated to make future payments under unconditional purchase obligations as summarized below:

---

| | |
|:---|:---|
| 2026 | $4446 |
| 2027 | 779 |
| 2028 | 608 |
| 2029 | 634 |
| 2030 | 621 |
| Thereafter | 3380 |
| **Total** | **$10468** |

---

Approximately $4.0 billion of our unconditional purchase obligations relate to open purchase orders for plant and equipment, of which approximately $1 billion relates to the NEOM Green Hydrogen Project. Although open purchase orders are considered enforceable and legally binding, the terms generally allow us the option to reschedule, cancel, or otherwise modify based on our business needs. We have estimated the timing of these payments in the table above; however, timing of actual satisfaction of the obligations may vary.

Approximately $5.0 billion of our unconditional purchase obligations relate to helium. The majority of these obligations occur after fiscal year 2030. Helium purchases include crude feedstock supply to helium refining plants in North America as well as refined helium purchases from sources around the world. As a rare byproduct of natural gas production in the energy sector, these helium sourcing agreements are medium- to long-term and contain take-if-tendered provisions. The refined helium is distributed globally and sold as a merchant gas, primarily under medium-term requirements contracts. While contract terms in our helium sourcing contracts are generally longer than our customer sales contracts, helium is a rare gas used in applications with few or no substitutions because of its unique physical and chemical properties.

Our unconditional purchase obligations also include commitments for power and natural gas supply as well as feedstock supply for numerous HyCO (hydrogen, carbon monoxide, and syngas) facilities. Our long-term sales contracts to customers are generally matched to the term of these obligations and provide recovery of price increases. As a result, we do not believe these purchase obligations would have a material effect on our financial condition or results of operations.

**20. CAPITAL STOCK** 

**Common Stock**

Authorized common stock consists of 300 million shares with a par value of $1 per share. As of 30 September 2025, 249 million shares were issued, with 223 million issued and outstanding.

On 15 September 2011, the Board of Directors authorized the repurchase of up to $1.0 billion of our outstanding common stock. This program does not have a stated expiration date. If we repurchase shares pursuant to this authorization, we may do so under Rules 10b5-1 and 10b-18 under the Securities Exchange Act through repurchase agreements established with one or more brokers. We have not purchased any of our outstanding shares under this program since fiscal year 2013. As of 30 September 2025, $485.3 in share repurchase authorization remained available.

A summary of the changes in common shares issued and outstanding in fiscal year 2025 is presented below:

---

| | | | |
|:---|:---|:---|:---|
| **Fiscal Year Ended 30 September** | **2025** | 2024 | 2023 |
| Number of common shares, beginning of year | **222372418** | 222199845 | 221838696 |
| Issuance of treasury shares for stock option and award plans | **215838** | 172573 | 361149 |
| Number of common shares, end of year | **222588256** | 222372418 | 222199845 |

---

**Preferred Stock**

Authorized preferred stock consisted of 25 million shares with a par value of $1 per share. There were no preferred shares issued or outstanding as of 30 September 2025 and 2024.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**21. SHARE-BASED COMPENSATION** 

Our outstanding share-based compensation program includes market-based and time-based deferred stock units. We issue shares from treasury stock upon the payout of deferred stock units and the exercise of stock options. As of 30 September 2025, there were 0.9 million shares available for future grant under our Long-Term Incentive Plan ("LTIP"), which is shareholder approved.

Share-based compensation cost recognized on the consolidated income statements is summarized below:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | 2024 | 2023 |
| Before-tax share-based compensation cost<sup>(A)</sup> | **$76.6** | $61.7 | $60.7 |
| Income tax benefit | **(18.3)** | (14.9) | (14.6) |
| After-tax share-based compensation cost | **$58.3** | $46.8 | $46.1 |

---

<sup>(A)</sup>Fiscal year 2025 includes noncash executive separation costs of $22.4 to accelerate vesting of share-based awards. Refer to the "Shareholder Activism-Related Costs" disclosure in Note 25, *Supplemental Information*, for additional information.

Before-tax share-based compensation cost is primarily included in "Selling and administrative expense" on our consolidated income statements. The amount of share-based compensation cost capitalized in fiscal years 2025, 2024, and 2023 was not material.

**Deferred Stock Units**

We have granted deferred stock units to executives, selected employees, and outside directors. These deferred stock units entitle the recipient to one share of common stock upon vesting, which is conditioned, for employee recipients, on continued employment during the deferral period and may be conditioned on achieving certain performance targets. We grant deferred stock unit awards with a two- to five-year deferral period that are subject to payout upon death, disability, or retirement. Deferred stock units issued to outside directors are paid after their service on the Board of Directors ends at the time elected by the director (not to exceed ten years after service ends). We generally expense the grant-date fair value of awards on a straight-line basis over the vesting period; however, expense recognition is accelerated for retirement eligible individuals who meet the requirements for vesting upon retirement. We have elected to account for forfeitures as they occur, rather than to estimate them. Forfeitures have not been significant historically.

Market-based deferred stock units vest as long as the employee continues to be employed by the Company and upon the achievement of the performance target. The performance target, which is approved by the Compensation Committee, is our share price appreciation and dividends paid, or "total shareholder return," in relation to the S&P 500 Index over a three-year performance period beginning 1 October of the fiscal year of grant. We granted 95,490, 102,120, and 85,612 market-based deferred stock units in fiscal years 2025, 2024, and 2023, respectively.

The fair value of market-based deferred stock units was estimated using a Monte Carlo simulation model as these equity awards are tied to a market condition. The model utilizes multiple input variables that determine the probability of satisfying the market condition stipulated in the grant and calculates the fair value of the awards. We generally expense the grant-date fair value of these awards on a straight-line basis over the vesting period. The estimated grant-date fair value of market-based deferred stock units was $470.13, $302.10, and $502.03 per unit in fiscal years 2025, 2024, and 2023, respectively. The calculation of the fair value of market-based deferred stock units used the following assumptions:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | 2024 | 2023 |
| Expected volatility | **30.3%** | 25.0% | 32.5% |
| Risk-free interest rate | **4.1%** | 4.3% | 4.0% |
| Expected dividend yield | **2.1%** | 2.6% | 2.4% |

---

In addition, in fiscal year 2025, we granted 143,059 time-based deferred stock units at a weighted average grant-date fair value of $328.54. In fiscal years 2024 and 2023, we granted 146,947 and 119,954 time-based deferred stock units at a weighted average grant-date fair value of $270.86 and $308.91, respectively.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

A summary of deferred stock unit activity in fiscal year 2025 is presented below:

---

| | | |
|:---|:---|:---|
| | Shares (000) | Weighted Average<br>Grant-Date Fair Value |
| Deferred stock units outstanding at 30 September 2024 | 758 | $293.99 |
| Granted | 239 | 385.22 |
| Paid out | (314) | 288.02 |
| Forfeited | (50) | 321.37 |
| **Deferred stock units outstanding at 30 September 2025** | **633** | **$329.23** |

---

Cash payments made for deferred stock units totaled $4.6, $2.7, and $3.6 in fiscal years 2025, 2024, and 2023, respectively. As of 30 September 2025, there was $68.5 of unrecognized compensation cost related to deferred stock units. This cost is expected to be recognized over a weighted average period of 1.7 years. The total fair value of deferred stock units paid out during fiscal years 2025, 2024, and 2023, including shares vested in prior periods, was $94.5, $24.1, and $45.3, respectively.

**Stock Options**

We have not issued stock option awards since fiscal year 2015. These awards generally vested incrementally over three years and remained exercisable for ten years from the date of grant. All stock options have now been exercised, and no intrinsic value remains as of 30 September 2025.

A summary of stock option activity in fiscal year 2025 is presented below:

---

| | | |
|:---|:---|:---|
| | Shares (000) | Weighted Average<br>Exercise Price |
| Stock options outstanding and exercisable at 30 September 2024 | 54 | $134.54 |
| Exercised | (54) | 134.54 |
| **Stock options outstanding and exercisable at 30 September 2025** | **—** | **$—** |

---

The intrinsic value of stock options exercised during fiscal years 2025, 2024, and 2023 was $10.5, $35.1, and $53.5, respectively.

Cash received from option exercises during fiscal year 2025 was $1.1. The total tax benefit realized from stock option exercises in fiscal year 2025 was $2.5, of which $1.9 was the excess tax benefit.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**22. ACCUMULATED OTHER COMPREHENSIVE LOSS** 

The table below summarizes changes in accumulated other comprehensive loss ("AOCL"), net of tax, attributable to Air Products:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Derivatives<br>qualifying<br>as hedges | Foreign<br>currency<br>translation<br>adjustments | Pension and<br>postretirement<br>benefits | Total |
| **Balance at 30 September 2022** | **($71.9)** | **($2072.4)** | **($641.8)** | **($2786.1)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 369.2 | 151.1 | (8.9) | 511.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCL | (43.9) | (0.3) | 53.8 | 9.6 |
| Net current period other comprehensive income | $325.3 | $150.8 | $44.9 | $521.0 |
| Amount attributable to noncontrolling interests | 192.3 | (8.3) | 0.3 | 184.3 |
| **Balance at 30 September 2023** | **$61.1** | **($1913.3)** | **($597.2)** | **($2449.4)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive (loss) income before reclassifications | (159.5) | 381.5 | 32.0 | 254.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCL | (33.7) | (1.5) | 55.9 | 20.7 |
| Net current period other comprehensive (loss) income | ($193.2) | $380.0 | $87.9 | $274.7 |
| Amount attributable to noncontrolling interests | (159.3) | 12.0 | 0.3 | (147.0) |
| **Balance at 30 September 2024** | **$27.2** | **($1545.3)** | **($509.6)** | **($2027.7)** |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassifications | 40.0 | (95.6) | (32.3) | (87.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amounts reclassified from AOCL | 41.2 | 5.7 | 46.0 | 92.9 |
| Net current period other comprehensive income (loss) | $81.2 | ($89.9) | $13.7 | $5.0 |
| Amount attributable to noncontrolling interests | 59.1 | 5.5 | 0.5 | 65.1 |
| **Balance at 30 September 2025** | **$49.3** | **($1640.7)** | **($496.4)** | **($2087.8)** |

---

The table below summarizes the reclassifications out of AOCL and the affected line item on the consolidated income statements:

---

| | | | |
|:---|:---|:---|:---|
| **Fiscal Year Ended 30 September** | **2025** | 2024 | 2023 |
| Loss (Gain) on Cash Flow Hedges, net of tax |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Sales | **($0.2)** | $— | ($0.5) |
| &nbsp;&nbsp;&nbsp;&nbsp;Cost of sales | **6.0** | 1.9 | 3.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense | **(0.1)** | 2.3 | 3.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other non-operating income (expense), net | **35.5** | (37.9) | (50.6) |
| Total Loss (Gain) on Cash Flow Hedges, net of tax | **$41.2** | ($33.7) | ($43.9) |
| Currency Translation Adjustment |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of business | **$0.1** | ($1.5) | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Business and asset actions | **1.0** |  | (0.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other income (expense), net | **4.6** |  |  |
| Currency Translation Adjustment | **$5.7** | ($1.5) | ($0.3) |
| Pension and Postretirement Benefits, net of tax<sup>(A)</sup> | **$46.0** | $55.9 | $53.8 |

---

<sup>(A)</sup>The components of net periodic benefit cost reclassified out of AOCL include items such as prior service cost amortization, actuarial loss amortization, settlements, and curtailments and are included in "Other non-operating income (expense), net" on the consolidated income statements. Refer to Note 18, *Retirement Benefits*, for additional information.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**23. EARNINGS (LOSS) PER SHARE** 

The table below details the computation of basic and diluted earnings (loss) per share:

---

| | | | |
|:---|:---|:---|:---|
| **Fiscal Year Ended 30 September** | **2025** | 2024 | 2023 |
| **Numerator** |  |  |  |
| Net income (loss) from continuing operations | **($386.5)** | $3842.1 | $2292.8 |
| Net income (loss) from discontinued operations | **(8.0)** | (13.9) | 7.4 |
| **Net Income (Loss) attributable to Air Products** | **($394.5)** | $3828.2 | $2300.2 |
| **Denominator** (*in millions*) |  |  |  |
| Weighted average common shares — Basic | **222.7** | 222.5 | 222.3 |
| Effect of dilutive securities |  |  |  |
| &nbsp;&nbsp;&nbsp;Employee stock option and other award plans | **—** | 0.3 | 0.4 |
| **Weighted average common shares — Diluted** | **222.7** | **222.8** | **222.7** |
| **Per Share Data**<sup>(A)</sup> *(U.S. Dollars per share)* |  |  |  |
| Basic earnings (loss) per share from continuing operations | **($1.74)** | $17.27 | $10.31 |
| Basic earnings (loss) per share from discontinued operations | **(0.04)** | (0.06) | 0.03 |
| **Basic earnings (loss) per share attributable to Air Products** | **($1.77)** | $17.21 | $10.35 |
| Diluted earnings (loss) per share from continuing operations | **($1.74)** | $17.24 | $10.30 |
| Diluted earnings (loss) per share from discontinued operations | **(0.04)** | (0.06) | 0.03 |
| **Diluted earnings (loss) per share attributable to Air Products** | **($1.77)** | $17.18 | $10.33 |

---

<sup>(A)</sup>Earnings (loss) per share is calculated independently for each component and may not sum to total EPS due to rounding.

Diluted earnings (loss) per share attributable to Air Products reflects the potential dilution that could occur if share-based awards were exercised or converted into common stock. The dilutive effect is computed using the treasury stock method, which assumes all share-based awards are exercised, and the hypothetical proceeds from exercise are used by the Company to purchase common stock at the average market price during the period. To the extent they would have been dilutive, the incremental shares, or the difference between shares assumed to be issued versus purchased, are included in the denominator of the diluted EPS calculation.

The table below summarizes antidilutive outstanding share-based awards that were excluded from the computation of diluted earnings (loss) per share:

---

| | | | |
|:---|:---|:---|:---|
| | Twelve Months Ended | Twelve Months Ended | Twelve Months Ended |
| | 30 September | 30 September | 30 September |
| | 2025 | 2024 | 2023 |
| Antidilutive outstanding share-based awards<sup>(A)</sup> | 0.2 |  |  |

---

<sup>(A)</sup>Due to the net loss reported for the twelve months ended 30 September 2025, outstanding share-based awards were excluded from the computation of diluted loss per share. These shares would have had an antidilutive impact, thus diluting the loss per share

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**24. INCOME TAXES** 

The table below summarizes income from U.S. and foreign operations before taxes:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | 2024 | 2023 |
| United States income (Loss) | **($1911.8)** | $2602.5 | $1050.5 |
| Foreign income | **823.4** | 1571.0 | 1227.6 |
| Equity affiliates' income | **647.7** | 647.7 | 604.3 |
| **Income (Loss) From Continuing Operations Before Taxes** | **($440.7)** | $4821.2 | $2882.4 |

---

The table below details the components of our income tax provision:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | 2024 | 2023 |
| **Current Tax Provision** |  |  |  |
| Federal | **$38.0** | $550.3 | $167.6 |
| State | **5.6** | 109.2 | 41.0 |
| Foreign | **416.9** | 354.7 | 367.3 |
| **Total Current Tax Provision** | **$460.5** | $1014.2 | $575.9 |
| **Deferred Tax (Benefit) Provision** |  |  |  |
| Federal | **(497.4)** | (97.8) | (12.5) |
| State | **(95.0)** | (15.0) | (5.8) |
| Foreign | **37.6** | 43.5 | (6.4) |
| **Total Deferred Tax (Benefit) Provision** | **(554.8)** | (69.3) | (24.7) |
| **Total Income Tax (Benefit) Provision** | **($94.3)** | $944.9 | $551.2 |

---

**Cash Paid for Taxes (Net of Cash Refunds)**

Income tax payments, net of refunds, were $940.7, $615.9, and $645.2 in fiscal years 2025, 2024, and 2023, respectively. Our income tax payments increased in fiscal year 2025 primarily due to tax payments of approximately $395 related to the gain on the sale of the LNG business in fiscal year 2024. Income tax payments for fiscal year 2024 include cash paid to purchase $50.0 of transferable tax credits that were used to offset estimated tax payments in 2024.

**U.S. Tax Cuts and Jobs Act**

On 22 December 2017, the United States enacted the U.S. Tax Cuts and Jobs Act (the "Tax Act" or "Tax Reform"), which significantly changed existing U.S. tax laws, including a reduction in the federal corporate income tax rate to 21%, a deemed repatriation tax on unremitted foreign earnings, as well as other changes. As of 30 September 2025, our outstanding liability for the deemed repatriation tax was $60.8 which will be paid in our second quarter of fiscal year 2026.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Effective Tax Rate**

The effective tax rate equals the income tax provision divided by income from continuing operations before taxes. A reconciliation of the differences between the United States federal statutory tax rate and the effective tax rate is provided below:

---

| | | | |
|:---|:---|:---|:---|
| (Percent of income before taxes) | **2025** | 2024 | 2023 |
| U.S. federal statutory tax rate | **21.0%** | 21.0% | 21.0% |
| State taxes, net of federal benefit | **16.1** | 1.5 | 1.0 |
| Income from equity affiliates | **26.6** | (2.4) | (3.8) |
| Foreign tax differentials | **5.6** | 0.3 | 0.7 |
| Tax on foreign repatriated earnings | **—** |  | 0.5 |
| Business and asset actions | **(49.0)** |  | 0.7 |
| Other | **1.1** | (0.8) | (1.0) |
| **Effective Tax Rate** | **21.4%** | 19.6% | 19.1% |

---

In fiscal year 2025, our effective tax rate was influenced by pre-tax charges of approximately $3.7 billion related to our decision to exit various projects and other cost reduction measures. These charges, which primarily related to our U.S. operations, resulted in an overall loss from continuing operations before taxes in fiscal year 2025. The related net tax benefit of these actions totaled $695.2, which includes an $11.3 cost for reserves established for uncertain tax positions related to the deductibility of certain costs in foreign subsidiaries. We also recorded a net tax cost of $197.4 resulting from a $364.9 increase in our valuation allowance net of $167.5 of deferred tax assets related to the future disposal of certain foreign subsidiaries.

The approximately $3.7 billion of business and asset actions inflated the presentation of regular, recurring effective tax rate reconciling items. The sale of our LNG business in the prior year resulted in a gain of approximately $1.6 billion. This gain diluted the impact of recurring effective tax rate reconciling items for fiscal year 2024.

Pre-tax charges for business and asset actions in fiscal year 2023 totaled $244.6. These charges included certain losses for which we could not recognize an income tax benefit and were subject to a valuation allowance of $36.0. Partially offsetting the valuation allowance cost was a $15.9 income tax benefit from a tax election related to a non-U.S. subsidiary. Fiscal year 2024 includes business and asset actions recorded at applicable statutory income tax rates.

The reconciling item for "State taxes, net of federal benefit" in fiscal year 2025 reflects the net state tax benefit recorded on our overall U.S. loss for the year.

<u>Shareholder Activism-Related Costs</u>

In fiscal year 2025, we incurred costs of $86.3 related to a proxy contest led by an activist shareholder as further discussed in Note 25, *Supplemental Information*. The related net tax benefit recorded in fiscal year 2025 was $14.6. Tax costs related to non-deductible amounts are included within "Business and asset actions" in our effective tax rate reconciliation.

<u>Tax on Repatriation of Foreign Earnings</u>

"Tax on foreign repatriated earnings" includes costs related to U.S. taxation of foreign operations (net of foreign tax credits) and foreign taxation on the repatriation of foreign earnings. Our fiscal year 2025 includes an income tax expense of $31.4 recorded in our second quarter related to withholding taxes on foreign earnings that we no longer intend to indefinitely reinvest. There were no other changes to our assumptions regarding the reinvestment of foreign earnings during fiscal year 2025. Our fiscal year 2025 also includes a net income tax benefit of $34.9 related to our intent to file a refund claim after a review of several U.S. Tax Court cases regarding the U.S. taxation of deemed foreign dividends in the transition year of the U.S. Tax Cuts and Jobs Act (our fiscal year 2018). While we were not a party to these cases, the opinions resulted in a change to our intent to pursue a refund claim. The $34.9 income tax benefit is net of a $67.8 reserve for an uncertain tax position related to the calculation of the refund amount.

<u>Income from Equity Affiliates</u>

Equity affiliates' income, which is primarily presented net of income taxes on our consolidated income statements, favorably impacts our effective tax rate. See Note 10, *Equity Affiliates*, for additional information.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

<u>Foreign Tax Differentials</u>

"Foreign tax differentials" represent the differences between foreign earnings subject to foreign tax rates that are different than the U.S. federal statutory rate and include tax holidays, credits, and other incentives. Our income tax holidays relate to operations in jurisdictions that provide reduced income tax rates for certain qualifying activities and are conditioned upon us satisfying certain requirements. These holidays are effective through fiscal years 2030 and 2033, and may be extended. The impact of these tax holidays decreased foreign taxes by $30.3, $25.7, and $24.8 for fiscal years 2025, 2024, and 2023, respectively. The benefit of the tax holidays on net income per share was $0.14, $0.12, and $0.11 per diluted share for fiscal years 2025, 2024, and 2023, respectively.

Fiscal year 2025 includes an overall net benefit for foreign tax differentials primarily due to business and asset actions that reduced our overall earnings in foreign jurisdictions with higher tax rates.

**Deferred Tax Assets and Liabilities**

The significant components of deferred tax assets and liabilities are as follows:

---

| | | |
|:---|:---|:---|
| **30 September** | **2025** | 2024 |
| **Gross Deferred Tax Assets** |  |  |
| Basis difference in foreign subsidiaries | **$182.3** | $— |
| Revenue recognition | **148.5** | 100.3 |
| Tax loss carryforwards | **137.5** | 132.2 |
| Reserves and accruals | **115.6** | 83.1 |
| Currency losses | **60.3** | 12.6 |
| Retirement benefits and compensation accruals | **59.2** | 62.5 |
| Tax credits and other tax carryforwards | **49.9** | 45.5 |
| Other | **76.2** | 44.6 |
| Valuation allowance | **(506.3)** | (158.4) |
| **Deferred Tax Assets** | **$323.2** | $322.4 |
| **Gross Deferred Tax Liabilities** |  |  |
| Plant and equipment | **$623.5** | $1205.8 |
| Unremitted earnings of foreign entities | **125.4** | 103.4 |
| Partnership and other investments | **18.1** | 19.2 |
| Intangible assets | **5.2** | 17.3 |
| Other | **2.7** | 8.8 |
| **Deferred Tax Liabilities** | **$774.9** | $1354.5 |
| **Net Deferred Income Tax Liability** | **$451.7** | $1032.1 |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

Deferred tax assets and liabilities are included within the consolidated balance sheets as follows:

---

| | | |
|:---|:---|:---|
| | **2025** | 2024 |
| **Deferred Tax Assets** |  |  |
| Other noncurrent assets | **$127.9** | $127.8 |
| **Deferred Tax Liabilities** |  |  |
| Deferred income taxes | **579.6** | 1159.9 |
| **Net Deferred Income Tax Liability** | **$451.7** | $1032.1 |

---

Deferred tax assets for "Revenue recognition" were impacted by increases in revenue recognized for income tax purposes in advance of GAAP. The deferred tax assets for "Reserves and accruals" were impacted by changes in tax deferred deductions, including business and asset actions, which impacted our accounts receivable and severance accruals. The deferred tax assets for "Basis difference in foreign subsidiaries" were the result of recognizing assets related to our tax investment basis in excess of U.S. GAAP for certain foreign subsidiaries where we have moved the corresponding assets and liabilities to held for sale on our consolidated balance sheet. Deferred tax assets for "Currency losses" changed primarily due to movements in unrealized foreign currency losses for income tax purposes.

Deferred tax liabilities related to "Plant and equipment" decreased primarily due to the impact of business and asset action charges recorded during the current fiscal year. "Unremitted earnings of foreign entities" increased primarily due to accruals for future foreign withholding taxes upon earnings' repatriation.

A significant portion of the $3.7 billion business and asset actions charges were not recognized in the current year for income tax purposes and resulted in a significant reduction in our net deferred tax liabilities. The majority of these deferred deductions impacted plant and equipment within the United States. We believe it is more likely than not that future earnings and the reversal of deferred tax liabilities will be sufficient to recognize the benefit of these deductions in the future.

As of 30 September 2025, we had the following deferred tax assets for certain tax credits:

---

| | | |
|:---|:---|:---|
| Jurisdiction | Gross Tax Asset | Expiration Period |
| U.S. State | $1.8 | 2028 - 2039 |
| U.S. Federal | 27.6 | 2030 - 2034 |
| Credits in Foreign Jurisdictions | 16.2 | Indefinite |

---

All of our $16.2 credits in foreign jurisdictions have indefinite carryforward periods.

As of 30 September 2025, we had the following loss carryforwards:

---

| | | |
|:---|:---|:---|
| Jurisdiction | Gross Loss Carryforward | Expiration Period |
| U.S. State Net Operating Loss | $207.2 | 2027 - 2045 |
| Foreign Net Operating Loss | 371.1 | 2026 - 2035; Indefinite |
| Foreign Capital Loss | 208.4 | Indefinite |

---

Of the $371.1 of foreign net operating loss carryforwards, $202.8 have indefinite carryforward periods.

The valuation allowance was $506.3 and $158.4 as of 30 September 2025 and 2024, respectively. As of 30 September 2025, the balance primarily related to deferred tax assets of $392.0, including those established from foreign business and asset actions, $55.3 related to foreign capital losses, $44.6 of foreign loss carryforwards and credits, and $10.8 of U.S. federal foreign income tax credits. If events warrant the reversal of the valuation allowance, it would result in a reduction of tax expense. We believe it is more likely than not that future earnings and reversal of deferred tax liabilities will be sufficient to utilize our deferred tax assets, net of existing valuation allowance, as of 30 September 2025.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

We record income taxes on the undistributed earnings of our foreign subsidiaries and corporate joint ventures unless those earnings are indefinitely reinvested. Such earnings may be subject to foreign withholding and other taxes. The cumulative undistributed earnings that are considered to be indefinitely reinvested in foreign subsidiaries and corporate joint ventures are included in retained earnings on the consolidated balance sheets and amounted to $9.8 billion as of 30 September 2025. An estimated $923.1 in additional foreign withholding and other income taxes would be due if these earnings were remitted as dividends.

**Unrecognized Tax Benefits**

A reconciliation of the beginning and ending amount of unrecognized tax benefits, which excludes interest and penalties, is as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | 2024 | 2023 |
| Unrecognized tax benefits balance at beginning of year | **$101.0** | $96.5 | $103.5 |
| Additions for tax positions of the current year | **21.2** | 14.6 | 10.9 |
| Additions for tax positions of prior years | **92.6** | 1.4 | 1.2 |
| Reductions for tax positions of prior years | **(0.6)** | (0.3) | (6.0) |
| Settlements | **—** | (3.7) | (3.9) |
| Statute of limitations expiration | **(20.0)** | (9.9) | (10.6) |
| Foreign currency translation | **0.6** | 2.4 | 1.4 |
| **Unrecognized tax benefits balance at end of year** | **$194.8** | $101.0 | $96.5 |

---

Of our unrecognized tax benefits as of 30 September 2025, $150.5 would impact the effective tax rate from continuing operations if recognized.

In fiscal year 2025 we recorded a $67.8 reserve related to our intent to file a refund claim after a review of several U.S. Tax Court cases regarding the U.S. taxation of deemed foreign dividends in the transition year of the U.S. Tax Cuts and Jobs Act. We also recorded a total of $11.3 in reserves for uncertain tax positions related to the deductibility of business and asset actions incurred in foreign subsidiaries.

Interest and penalties related to unrecognized tax benefits are recorded as a component of income tax expense and totaled ($0.2), $1.8, and $5.0 in fiscal years 2025, 2024, and 2023, respectively, and include benefits when reserves are released, typically due to the expiration of various statutes of limitation. Our accrued balance for interest and penalties was $27.8 and $28.5 as of 30 September 2025 and 2024, respectively.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Income Tax Examinations**

We are currently under examination in a number of tax jurisdictions. It is reasonably possible that a change in our unrecognized tax benefits may occur in fiscal year 2026 if any of these examinations are resolved during the next twelve months. However, quantification of an estimated range cannot be made as of the date of this report.

We generally remain subject to examination in the following major tax jurisdictions for the years indicated below:

---

| | |
|:---|:---|
| Major Tax Jurisdiction | Open Tax Years |
| **North America** |  |
| &nbsp;&nbsp;&nbsp;United States – Federal | 2022 - 2025 |
| &nbsp;&nbsp;&nbsp;United States – State | 2015 - 2025 |
| &nbsp;&nbsp;&nbsp;Canada | 2018 - 2025 |
| **Europe** |  |
| &nbsp;&nbsp;&nbsp;France | 2022 - 2025 |
| &nbsp;&nbsp;&nbsp;Netherlands | 2020 - 2025 |
| &nbsp;&nbsp;&nbsp;Spain | 2017 - 2025 |
| &nbsp;&nbsp;&nbsp;United Kingdom | 2021 - 2025 |
| **Middle East** |  |
| &nbsp;&nbsp;&nbsp;Saudi Arabia | 2020 - 2025 |
| **Asia** |  |
| &nbsp;&nbsp;&nbsp;China | 2011 - 2025 |
| &nbsp;&nbsp;&nbsp;South Korea | 2015 - 2025 |
| &nbsp;&nbsp;&nbsp;Taiwan | 2020 - 2025 |
| **Latin America** |  |
| &nbsp;&nbsp;&nbsp;Chile | 2020 - 2025 |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**25. SUPPLEMENTAL INFORMATION** 

**Related Party Transactions**

We have related party sales to some of our equity affiliates and joint venture partners as well as other income primarily from fees charged for use of Air Products' patents and technology. Sales to and other income from related parties totaled approximately $355, $350, and $380 in fiscal years 2025, 2024, and 2023, respectively. Sales agreements with related parties include terms that are consistent with those that we believe would have been negotiated at an arm's length with an independent party. As of 30 September 2025 and 2024, our consolidated balance sheets included related party trade receivables of approximately $105 and $120, respectively.

During the third quarter of fiscal year 2025, we reimbursed $24.7 to Mantle Ridge LP and certain of its affiliated entities (collectively, "Mantle Ridge") for costs they incurred in connection with the proxy contest that concluded in January 2025. Refer to "Shareholder Activism-Related Costs" below for additional information.

Refer to Note 17, *Debt*, for information concerning debt owed to related parties.

**Shareholder Activism-Related Costs**

Our consolidated income statement for fiscal year 2025 includes shareholder activism-related costs totaling $86.3 ($71.7 after tax) recorded in connection with a proxy contest that concluded in January 2025 following certification of the election of directors at the 2025 Annual Meeting of Shareholders.

Of the total, $31.9 was incurred directly by Air Products for legal and other professional service fees and proxy solicitation expenses, primarily during the first quarter. An additional $29.7 was recorded due to the departure of our former chief executive officer following the Board of Directors' appointment of a new chief executive officer. These separation costs included a noncash expense of $22.4 to accelerate vesting of share-based awards and $7.3 in severance and other cash benefits paid during the second quarter. The remaining $24.7 relates to a cash reimbursement paid to Mantle Ridge, an investor in Air Products, who nominated three of the nine directors elected in 2025, including Paul C. Hilal, Mantle Ridge's founder and chief executive officer.

The Board of Directors voted to authorize the cash reimbursement during the third quarter, with Mr. Hilal abstaining from the vote. Reimbursed costs included those incurred by Mantle Ridge for legal counsel, proxy engagement services, governance advisors, communication expenses, and other out-of-pocket costs related to its engagement with Air Products. The Board members who voted on this matter unanimously concluded that these expenses were incurred in the interest of enhancing long-term value for all shareholders and that the election of three of Mantle Ridge's nominees reflected strong shareholder support for Mantle Ridge's engagement. Accordingly, the Board determined that such expenses should be shared pro rata among all shareholders.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Supplemental Balance Sheet Information**

---

| | | |
|:---|:---|:---|
| <u>Other Receivables and Current Assets</u> |  |  |
| **30 September** | **2025** | 2024 |
| Derivative instruments | **$81.6** | $93.9 |
| Value added tax receivable | **243.4** | 195.9 |
| Contract fulfillment costs | **85.4** | 103.7 |
| Contract assets | **152.6** | 76.2 |
| Current lease receivables | **49.4** | 74.5 |
| Other | **77.1** | 66.6 |
| **Other receivables and current assets** | **$689.5** | $610.8 |

---

---

| | | |
|:---|:---|:---|
| <u>Other Noncurrent Assets</u> |  |  |
| **30 September** | **2025** | 2024 |
| Pension benefits | **$210.9** | $200.0 |
| Derivative instruments | **162.8** | 48.7 |
| Deferred tax assets | **127.9** | 127.8 |
| Prepaid tax | **100.4** | 41.0 |
| Contract assets | **82.3** |  |
| Contract fulfillment costs | **33.8** |  |
| Investments other than equity method | **17.4** | 67.1 |
| Deferred financing fees | **3.8** | 4.6 |
| World Energy deferred project costs<sup>(A)</sup> | **—** | 329.4 |
| Other | **282.0** | 352.9 |
| **Other noncurrent assets** | **$1021.3** | $1171.5 |

---

<sup>(A)</sup>Prior year balance includes assets that were subsequently written off in fiscal year 2025 as part of our exit from the sustainable aviation fuel expansion project with World Energy. Refer to Note 5, *Business and Asset Actions*, for additional information.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

---

| | | |
|:---|:---|:---|
| <u>Payables and Accrued Liabilities</u> |  |  |
| **30 September** | **2025** | 2024 |
| Trade creditors | **$1437.0** | $1451.6 |
| Dividends payable | **398.4** | 393.6 |
| Accrued payroll and employee benefits | **303.3** | 257.2 |
| Contract liabilities | **253.4** | 240.0 |
| Project exit costs | **178.3** |  |
| Accrued interest | **138.8** | 120.6 |
| Severance and other postemployment benefits | **101.6** | 34.0 |
| Current lease obligations | **91.8** | 100.3 |
| Derivative instruments | **35.9** | 44.6 |
| Pension and postretirement benefits | **15.8** | 11.3 |
| Other | **283.4** | 273.0 |
| **Payables and accrued liabilities** | **$3237.7** | $2926.2 |

---

---

| | | |
|:---|:---|:---|
| <u>Other Noncurrent Liabilities</u> |  |  |
| **30 September** | **2025** | 2024 |
| Asset retirement obligations | **$328.8** | $322.9 |
| Contract liabilities | **283.6** | 290.0 |
| Pension benefits | **266.1** | 236.1 |
| Postretirement benefits | **5.0** | 8.9 |
| Contingencies related to uncertain tax positions | **120.7** | 98.5 |
| Environmental liabilities | **71.8** | 67.2 |
| Derivative instruments | **57.7** | 56.0 |
| Long-term accrued income taxes related to U.S. tax reform | **—** | 60.8 |
| Other | **214.4** | 210.1 |
| **Other noncurrent liabilities** | **$1348.1** | $1350.5 |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**26. BUSINESS SEGMENT AND GEOGRAPHIC INFORMATION** 

We determine our reportable segments based on the manner in which our Chief Operating Decision Maker ("CODM") reviews financial results and allocates resources. The accounting policies applied to our reportable segments are consistent with those used in the preparation of our consolidated financial statements. Our reportable segments are as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Americas;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Asia;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Europe;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Middle East and India; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Corporate and other

The Americas, Asia, Europe, and Middle East and India segments represent the operations of our regional industrial gases business. Each of these segments qualifies as an individual operating segment and does not reflect the aggregation of multiple operating segments. Corporate and other consists of two operating segments that meet the aggregation criteria under GAAP. All segments also include our share of results from several equity method joint ventures, the largest of which operate in Algeria, China, India, Italy, Mexico, and Saudi Arabia.

Our CODM, who is our Chief Executive Officer, evaluates the performance of our reportable segments through segment operating income. This measure is reviewed regularly in internal management reports and serves as a key metric to monitor actual results against forecasts and prior periods. Segment operating income informs decisions related to resource allocation, including capital investments and employees, and supports strategic planning and long-term project development.

Segment operating income does not include gains or losses that we do not consider to be indicative of our underlying business performance, such as charges related to business or asset actions.

**Regional Industrial Gases**

The industrial gases business in the regional segments produces and sells gases to diversified customers in dozens of industries, including those in refining, chemicals, metals, electronics, manufacturing, medical, and food. Our industrial gas portfolio includes atmospheric gases such as oxygen, nitrogen, and argon; process gases such as hydrogen, helium, carbon dioxide, carbon monoxide, and syngas (a mixture of hydrogen and carbon monoxide), and specialty gases. We offer our industrial gas products through either the on-site gases supply mode or the merchant gases supply mode, both of which are described in Note 7, *Revenue Recognition*.

This business also develops, builds, and operates equipment for the production or processing of gases. Electricity is the largest cost component in the production of atmospheric gases. To produce hydrogen, carbon monoxide, and syngas, steam methane reformers use natural gas as the primary raw material, while gasifiers use liquid and solid hydrocarbons. We mitigate electricity, natural gas, and hydrocarbon price fluctuations contractually through pricing formulas, surcharges, cost pass-through provisions, and tolling arrangements.

Each of the regional industrial gases segments competes against global industrial gas companies as well as regional competitors. Competition in industrial gases is based primarily on price, reliability of supply, and the development of industrial gas applications. We derive a competitive advantage in locations where we have pipeline networks, which enable us to provide a reliable and economic supply of products to our larger customers.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Corporate and other**

The Corporate and other segment includes sales of cryogenic and gas processing equipment for air separation that is sold worldwide to customers in a variety of industries, including chemical and petrochemical manufacturing, oil and gas recovery and processing, and steel and primary metals processing. Our Corporate and other segment also includes the results of our turbo machinery and distribution sale of equipment businesses. Competition for our sale of equipment businesses is based primarily on plant efficiency and technological performance, service, technical know-how, and price, as well as schedule and plant performance guarantees.

Our Corporate and other segment also incurs costs to provide corporate support functions and global management activities that benefit all segments. These costs include those for product development, research and development, and administrative support. The results of our Corporate and other segment also include income and expense not directly associated with the regional segments, such as foreign exchange gains and losses.

In addition to assets of the global businesses included in this segment, other assets include cash and cash items, short-term investments, deferred tax assets, and financial instruments.

Through the end of fiscal year 2024, our Corporate and other segment also included the liquefied natural gas ("LNG") process technology and equipment business, which was sold to Honeywell International Inc. on 30 September 2024. Refer to Note 4, *Gain on Sale of Business*, to the consolidated financial statements for additional information regarding the sale.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Business Segment Information**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | Americas | Asia | Europe | Middle East and India | Corporate and other | Total |
| **2025** |  |  |  |  |  |  |
| Sales<sup>(A)</sup> | $5125.9 | $3271.0 | $2984.5 | $135.9 | $520.0 | $12037.3 |
| Cost of sales | (3423.5) | (2323.3) | (1893.2) | (107.4) | (508.6) | (8256.0) |
| Selling and administrative expense | (206.6) | (118.3) | (254.0) | (24.1) | (303.1) | (906.1) |
| Other segment items<sup>(B)</sup> | 23.8 | 21.7 | 7.4 | 5.2 | (75.6) | (17.5) |
| Operating income (loss)<sup>(C)</sup> | $1519.6 | $851.1 | $844.7 | $9.6 | ($367.3) | $2857.7 |
| <u>Other segment information:</u> |  |  |  |  |  |  |
| &nbsp;&nbsp;Depreciation and amortization | 732.1 | 518.9 | 247.4 | 25.9 | 39.9 | 1564.2 |
| &nbsp;&nbsp;Equity affiliates' income<sup>(D)</sup> | 157.0 | 42.3 | 101.9 | 340.9 | 12.4 | 654.5 |
| &nbsp;&nbsp;Investments in net assets of and advances to equity affiliates | 555.2 | 331.3 | 649.9 | 3713.2 | 116.5 | 5366.1 |
| &nbsp;&nbsp;Total assets | 12058.7 | 6712.2 | 6916.8 | 10919.4 | 4452.4 | 41059.5 |
| &nbsp;&nbsp;Expenditures for long-lived assets | 2610.7 | 406.6 | 1010.6 | 2868.6 | 126.1 | 7022.6 |
| **2024** |  |  |  |  |  |  |
| Sales<sup>(A)</sup> | $5040.1 | $3224.3 | $2823.4 | $134.4 | $878.4 | $12100.6 |
| Cost of sales | (3284.8) | (2255.8) | (1783.7) | (101.0) | (743.4) | (8168.7) |
| Selling and administrative expense | (212.5) | (122.0) | (243.2) | (28.2) | (336.5) | (942.4) |
| Other segment items<sup>(B)</sup> | 22.3 | 12.7 | 13.5 | 0.7 | (91.2) | (42.0) |
| Operating income (loss)<sup>(C)</sup> | $1565.1 | $859.2 | $810.0 | $5.9 | ($292.7) | $2947.5 |
| <u>Other segment information:</u> |  |  |  |  |  |  |
| &nbsp;&nbsp;Depreciation and amortization | 699.3 | 471.0 | 207.1 | 26.6 | 47.1 | 1451.1 |
| &nbsp;&nbsp;Equity affiliates' income | 158.8 | 32.9 | 88.1 | 347.5 | 20.4 | 647.7 |
| &nbsp;&nbsp;Investments in net assets of and advances to equity affiliates | 472.9 | 322.9 | 573.8 | 3317.7 | 105.2 | 4792.5 |
| &nbsp;&nbsp;Total assets | 12383.8 | 7436.5 | 5849.2 | 8477.4 | 5427.7 | 39574.6 |
| &nbsp;&nbsp;Expenditures for long-lived assets | 2733.1 | 574.8 | 865.2 | 2517.5 | 106.1 | 6796.7 |
| **2023** |  |  |  |  |  |  |
| Sales<sup>(A)</sup> | $5369.3 | $3216.1 | $2963.1 | $162.5 | $889.0 | $12600.0 |
| Cost of sales | (3715.5) | (2194.6) | (2080.1) | (120.0) | (722.8) | (8833.0) |
| Selling and administrative expense | (222.4) | (123.7) | (224.0) | (26.9) | (360.0) | (957.0) |
| Other segment items<sup>(B)</sup> | 8.3 | 8.7 | 4.4 | 1.3 | (93.5) | (70.8) |
| Operating income (loss)<sup>(C)</sup> | $1439.7 | $906.5 | $663.4 | $16.9 | ($287.3) | $2739.2 |
| <u>Other segment information:</u> |  |  |  |  |  |  |
| &nbsp;&nbsp;Depreciation and amortization | 649.3 | 433.5 | 196.2 | 27.5 | 51.8 | 1358.3 |
| &nbsp;&nbsp;Equity affiliates' income | 109.2 | 29.7 | 102.5 | 349.8 | 13.1 | 604.3 |
| &nbsp;&nbsp;Expenditures for long-lived assets | 2033.7 | 663.4 | 482.4 | 1312.7 | 134.2 | 4626.4 |

---

<sup>(A)</sup>Sales relate to external customers only. We do not have a homogeneous customer base or end market, and no single customer accounts for more than 10% of our consolidated sales. All intersegment sales are eliminated in consolidation.

<sup>(B)</sup>For the regional segments, other segment items primarily include impacts from transactions not directly related to our principal earnings activities, such as technology and royalty income and gains and losses on asset sales. For the Corporate and other segment, other segment items primarily include research and development expense and the net impact of gains and losses on foreign currency transactions.

<sup>(C)</sup>Refer to the *Reconciliation of Segment Operating Income to Consolidated Results* section below.

<sup>(D)</sup>Segment equity affiliates' income in fiscal year 2025 excludes a $6.8 impairment charge related to a joint venture in China, which was recorded as part of our business and asset actions during the second quarter. As a result, total segment equity affiliates' income does not reconcile to equity affiliates' income for the total company as reported on the consolidated income statement for the fiscal year ended 30 September 2025.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Reconciliation of Segment Operating Income to Consolidated Results**

The table below reconciles segment operating income to income (loss) from continuing operations before taxes as reflected on our consolidated income statements:

---

| | | | |
|:---|:---|:---|:---|
| **Fiscal Year Ended 30 September** | **2025** | 2024 | 2023 |
| **Segment Operating Income** | **$2857.7** | $2947.5 | $2739.2 |
| Business and asset actions | **(3747.0)** | (57.0) | (244.6) |
| Shareholder activism-related costs | **(86.3)** |  |  |
| Gain on sale of business | **67.3** | 1575.6 |  |
| Gain on sale of other assets <sup>(A)</sup> | **31.3** |  |  |
| **Consolidated Operating Income (Loss)** | **($877.0)** | $4466.1 | $2494.6 |
| Equity affiliates' income | **647.7** | 647.7 | 604.3 |
| Interest expense | **214.0** | 218.8 | 177.5 |
| Other non-operating income (expense), net | **2.6** | (73.8) | (39.0) |
| **Income (Loss) From Continuing Operations Before Taxes** | **($440.7)** | $4821.2 | $2882.4 |

---

<sup>(A)</sup> Reflected on the consolidated income statements within "Other income (expense), net."

**Geographic Information**

The geographic information presented below is based on country of origin.

<u>Sales to External Customers</u>

---

| | | | |
|:---|:---|:---|:---|
| Fiscal Year Ended 30 September | **2025** | 2024 | 2023 |
| United States | **$4692.5** | $4914.0 | $5234.2 |
| China | **1933.5** | 1951.5 | 1988.1 |
| Other foreign operations | **5411.3** | 5235.1 | 5377.7 |
| Total | **$12037.3** | $12100.6 | $12600.0 |
| <u>Long-Lived Assets</u><sup>(A)</sup> *(Plant and equipment, net)* |  |  |  |
| 30 September | **2025** | 2024 | 2023 |
| United States | **$8909.1** | $9159.3 | $7431.0 |
| Saudi Arabia<sup>(B)</sup> | **6910.6** | 5080.2 | 1818.1 |
| China | **2654.6** | 3845.7 | 3744.7 |
| Other foreign operations | **6863.5** | 5285.7 | 4478.3 |
| Total | **$25337.8** | $23370.9 | $17472.1 |

---

<sup>(A)</sup>In fiscal year 2025, we recorded impairment charges to long-lived assets associated with various project exits, as described in Note 5, *Business and Asset Actions*. These charges impacted all regions, with the majority related to projects in the United States.

<sup>(B)</sup>Long-lived assets in Saudi Arabia primarily relate to the NEOM Green Hydrogen Project as discussed in Note 3, *Variable Interest Entities*.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure**

Not applicable.

**Item 9A. Controls and Procedures**

**Disclosure Controls and Procedures**

We maintain a comprehensive set of disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15(e) under the Exchange Act). Under the supervision of the Chief Executive Officer and Chief Financial Officer, our management conducted an evaluation of the effectiveness of our disclosure controls and procedures as of 30 September 2025. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that, as of 30 September 2025, the disclosure controls and procedures were effective.

**Internal Control Over Financial Reporting**

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act). Management has evaluated the effectiveness of our internal control over financial reporting as of 30 September 2025 based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO"). Based on that evaluation, management concluded that, as of 30 September 2025, our internal control over financial reporting was effective. Management's Report on Internal Control over Financial Reporting is provided under Part II, Item 8, of this Annual Report on Form 10-K.

There was no change in our internal control over financial reporting during the fourth quarter of fiscal year 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Deloitte & Touche LLP, our independent registered public accounting firm, has audited our internal control over financial reporting as of 30 September 2025. The Report of the Independent Registered Public Accounting Firm is provided under Part II, Item 8, of this Annual Report on Form 10-K.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**Item 9B. Other Information**

**Amendment and Restatement of Bylaws**

On 19 November 2025, the Board of Directors approved the amendment and restatement of the Company's Amended and Restated Bylaws (as further amended and restated, the "Bylaws"), which took effect immediately. The Bylaws supersede the previously existing Amended and Restated Bylaws of the Company, which took effect on 31 January 2025.

The Bylaws were amended to make certain procedural changes to Board and Board committee functions, including revising Article II, Section 2(a) to permit the Chairman of the Board to serve on Board committees and revising Article II, Section 10 and Article II, Section 15 to provide that a majority of the directors must be present to establish a quorum of the Board or a committee, respectively. The amendments also provide that the Vice Chairman may call meetings of directors and modify the role of the President to reflect that if the office is filled, he or she will have responsibilities as assigned by the Board. The amendments also make a number of changes to reflect updates to the Delaware General Corporation Law and the SEC's adoption of Rule 14a-19 under the Exchange Act. The revisions also make a number of minor updating and conforming changes to remove ambiguity and improve readability.

This summary of the amendment to the Bylaws is qualified in its entirety by reference to the full text of the Bylaws, which are filed as Exhibit 3.2 to this Annual Report on Form 10-K and are incorporated by reference herein.

**Rule 10b5-1 Trading Plans**

None of the Company's directors or Section 16 reporting officers adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K) during the fourth quarter of fiscal year 2025.

**Item 9C. Disclosure Regarding Foreign Jurisdictions That Prevent Inspections**

Not applicable.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**PART III**

**Item 10. Directors, Executive Officers and Corporate Governance**

The information required by this item relating to our directors and nominees is incorporated herein by reference to the section captioned "The Board of Directors" in the Proxy Statement for the 2026 Annual Meeting of Shareholders. The information required by this item relating to our executive officers is set forth in Part I, Item 1. *Business* of this Annual Report on Form 10-K.

The information required by this item relating to our Audit and Finance Committee and our Audit and Finance Committee Financial Expert is incorporated herein by reference to the sections captioned "Board Structure–Standing Committees of the Board" in the Proxy Statement for the 2026 Annual Meeting of Shareholders.

The information required by this item relating to our procedures regarding the consideration of candidates recommended by shareholders and a procedure for submission of such candidates is incorporated herein by reference to the section captioned "The Board of Directors–Selection of Directors" in the Proxy Statement for the 2026 Annual Meeting of Shareholders.

The information required by this item relating to Section 16(a) Beneficial Ownership Reporting Compliance is incorporated herein by reference to the section captioned "Section 16(a) Beneficial Ownership Reporting" in the Proxy Statement for the 2026 Annual Meeting of Shareholders.

The information required by this item relating to our insider trading policies and procedures is incorporated herein by reference to the section captioned "Insider Trading Policy" in the Proxy Statement for the 2026 Annual Meeting of Shareholders.

We have adopted a Code of Conduct that applies to all employees, including the Chief Executive Officer, the Chief Financial Officer, and the Principal Accounting Officer. The Code of Conduct can be found at our website at www.airproducts.com/company/governance/code-of-conduct.

**Item 11. Executive Compensation**

The information required by this item is incorporated herein by reference to the sections captioned "Executive Compensation" and "Compensation of Directors" in the Proxy Statement for the 2026 Annual Meeting of Shareholders.

**Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters**

The information required by this item is incorporated herein by reference to the sections captioned "Information About Stock Ownership" and "Equity Compensation Plan Information" in the Proxy Statement for the 2026 Annual Meeting of Shareholders.

**Item 13. Certain Relationships and Related Transactions, and Director Independence**

The information required by this item is incorporated herein by reference to the sections captioned "The Board of Directors–Director Independence" and "Board Practices, Processes and Policies–Transactions with Related Persons" in the Proxy Statement for the 2026 Annual Meeting of Shareholders.

**Item 14. Principal Accountant Fees and Services**

The information required by this item is incorporated herein by reference to the section captioned "Fees of Independent Registered Public Accounting Firm" in the Proxy Statement for the 2026 Annual Meeting of Shareholders.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**PART IV**

**Item 15. Exhibits and Financial Statement Schedules**

---

| | |
|:---|:---|
| (a) The following documents are filed as a part of this report: |  |
| (1) *Financial Statements.*<br>The following is a list of the Consolidated Financial Statements of Air Products and Chemicals, Inc. and its subsidiaries included in Part II, Item 8. *Financial Statements and Supplementary Data*: |  |
| <u>[Report of Deloitte & Touche LLP, Independent Registered Public Accounting Firm](#i6c5d80e205be49368cbb0bd080310540_94)</u> | [67](#i6c5d80e205be49368cbb0bd080310540_94) |
| <u>[Consolidated Income Statements – Fiscal Years Ended 30 September 2025, 2024, and 2023](#i6c5d80e205be49368cbb0bd080310540_97)</u> | [69](#i6c5d80e205be49368cbb0bd080310540_97) |
| <u>[Consolidated Comprehensive Income Statements – Fiscal Years Ended 30 September 2025, 2024, and 2023](#i6c5d80e205be49368cbb0bd080310540_100)</u> | [70](#i6c5d80e205be49368cbb0bd080310540_100) |
| <u>[Consolidated Balance Sheets – 30 September 2025 and 2024](#i6c5d80e205be49368cbb0bd080310540_103)</u> | [71](#i6c5d80e205be49368cbb0bd080310540_103) |
| <u>[Consolidated Statements of Cash Flows – Fiscal Years Ended 30 September 2025, 2024, and 2023](#i6c5d80e205be49368cbb0bd080310540_106)</u> | [72](#i6c5d80e205be49368cbb0bd080310540_106) |
| <u>[Consolidated Statements of Equity – Fiscal Years Ended 30 September 2025, 2024, and 2023](#i6c5d80e205be49368cbb0bd080310540_109)</u> | [73](#i6c5d80e205be49368cbb0bd080310540_109) |
| (2) *Financial Statement Schedules.*<br>Financial statement schedules are omitted as they are either not required or the information is otherwise included in the consolidated financial statements or notes thereto. |  |
| (3) *Exhibits.*<br>The exhibits filed as a part of this report as required by Item 601 of Regulation S-K are listed in the <u>[Index to Exhibits](#i6c5d80e205be49368cbb0bd080310540_250)</u> beginning on page <u>[152](#i6c5d80e205be49368cbb0bd080310540_250)</u>. |  |

---

**Item 16. Form 10-K Summary**

None.

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

---

| | |
|:---|:---|
| **INDEX TO EXHIBITS** | **INDEX TO EXHIBITS** |
| **Exhibit No.** | **Description** |
| (3) | Articles of Incorporation and Bylaws. |
| 3.1 | <u>[Restated Certificate of Incorporation of the Company. (Filed as Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended 30 June 2023.)](https://www.sec.gov/Archives/edgar/data/2969/000000296923000037/apd-exhibit31x30jun23.htm)</u>\* |
| 3.2 | <u>[Amended and Restated Bylaws of the Company](apd-exhibit32x30sep25.htm)[, dated November](apd-exhibit32x30sep25.htm)[19](apd-exhibit32x30sep25.htm)[, 2025](apd-exhibit32x30sep25.htm)[.](apd-exhibit32x30sep25.htm)</u> |
| (4) | Instruments defining the rights of security holders, including indentures. Upon request of the Securities and Exchange Commission, the Company hereby undertakes to furnish copies of the instruments with respect to its long-term debt.\*\* |
| 4.1 | <u>[Indenture, dated as of 10 January 1995, between the Company and The Bank of New York Trust, N.A. (formerly Wachovia Bank, National Association and initially First Fidelity Bank Company, National Association), as Trustee. (Filed as Exhibit 4(a) to the Company's Registration Statement on Form S-3 filed 19 January 1995, File No. 033-57357.)](https://www.sec.gov/Archives/edgar/data/2969/0000950123-95-000077.txt)</u>\* |
| 4.2 | <u>[Indenture, dated as of 30 April 2020, between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee. (Filed as Exhibit 4.1 to the Company's Current Report on Form 8-K filed 30 April 2020.)](https://www.sec.gov/Archives/edgar/data/2969/000119312520127771/d923351dex41.htm)</u>\* |
| 4.3 | <u>[Description of Securities.](apd-exhibit43x30sep25.htm)</u> |
| (10) | Material Contracts. |
| 10.1 | <u>[Air Products and Chemicals, Inc. 2021 Long-Term Incentive Plan. (Filed as Exhibit 4.5 to the Company's Registration Statement on Form S-8 (File No. 333-252722) filed on 4 February 2021.)](https://www.sec.gov/Archives/edgar/data/2969/000119312521028500/d114338dex45.htm)</u>\*† |
| 10.1(a) | <u>[Form of Restricted Stock Unit Award Agreement under the Long-Term Incentive Plan of the Company, used for FY2022 awards. (Filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 December 2021.)](https://www.sec.gov/Archives/edgar/data/2969/000000296922000010/apd-exhibit101x31dec21.htm)</u>\*† |
| 10.1(b) | <u>[Form of Restricted Stock Unit Award Agreement under the Long-Term Incentive Plan of the Company, used for FY2023 Awards. (Filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 December 2022.)](https://www.sec.gov/Archives/edgar/data/2969/000000296923000014/apd-exhibit101x31dec22.htm)</u>\*† |
| 10.1(c) | <u>[Form of Performance Share Award Agreement under the Long-Term Incentive Plan of the Company, used for FY2023 Awards. (Filed as Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 December 2022.)](https://www.sec.gov/Archives/edgar/data/2969/000000296923000014/apd-exhibit102x31dec22.htm)</u>\*† |
| 10.1(d) | <u>[Form of Restricted Stock Unit Award Agreement under the Long-Term Incentive Plan of the Company, used for FY2024 Awards. (Filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 December 2023.)](https://www.sec.gov/Archives/edgar/data/2969/000000296924000010/apd-exhibit101x31dec23.htm)</u>\*† |
| 10.1(e) | <u>[Form of Performance Share Award Agreement under the Long-Term Incentive Plan of the Company, used for FY2024 Awards. (Filed as Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 December 2023.)](https://www.sec.gov/Archives/edgar/data/2969/000000296924000010/apd-exhibit102x31dec23.htm)</u>\*† |
| 10.1(f) | <u>[Form of Restricted Stock Unit Award Agreement under the Long-Term Incentive Plan of the Company, used for FY2025 Awards. (Filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 December 2024.)](https://www.sec.gov/Archives/edgar/data/2969/000000296925000013/apd-exhibit101x31dec24.htm)</u>\*† |
| 10.1(g) | <u>[Form of Performance Share Award Agreement under the Long-Term Incentive Plan of the Company, used for FY2025 Awards. (Filed as Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 December 2024.)](https://www.sec.gov/Archives/edgar/data/2969/000000296925000013/apd-exhibit102x31dec24.htm)</u>\*† |
| 10.2 | <u>[Air Products and Chemicals, Inc. Retirement Savings Plan as amended and restated effective 1 January 2022. (Filed as Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 December 2021.)](https://www.sec.gov/Archives/edgar/data/2969/000000296922000010/apd-exhibit103x31dec21.htm)</u>\*† |
| 10.2(a) | <u>[Amendment No. 1 to the Air Products and Chemicals, Inc. Retirement Savings Plan as amended and restated effective 1 January 2022. (Filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended 30 June 2022.)](https://www.sec.gov/Archives/edgar/data/2969/000000296922000038/apd-exhibit101x30jun22.htm)</u>\*† |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

---

| | |
|:---|:---|
| **INDEX TO EXHIBITS** | **INDEX TO EXHIBITS** |
| **Exhibit No.** | **Description** |
| 10.2(b) | <u>[Amendment No. 2 to the Air Products and Chemicals, Inc. Retirement Savings Plan as amended and restated effective 1 January 2022. (Filed as Exhibit 10.3(b) to the Company's Annual Report on Form 10-K for the fiscal year ended 30 September 2024.)](https://www.sec.gov/Archives/edgar/data/2969/000000296924000056/apd-exhibit103bx30sep24.htm)</u>\*† |
| 10.2(c) | <u>[Amendment No. 3 to the Air Products and Chemicals, Inc. Retirement Savings Plan as amended and restated effective 1 January 2022. (Filed as Exhibit 10.3 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 December 2023.)](https://www.sec.gov/Archives/edgar/data/2969/000000296924000010/apd-exhibit103x31dec23.htm)</u>\*† |
| 10.3 | <u>[Supplementary Pension Plan of Air Products and Chemicals, Inc. as Amended and Restated effective 1 August 2014. (Filed as Exhibit 10.10 to the Company's Annual Report on Form 10-K for the fiscal year ended 30 September 2014.)](https://www.sec.gov/Archives/edgar/data/2969/000119312514423115/d805038dex1010.htm)</u>\*† |
| 10.3(a) | <u>[Amendment No. 1 dated as of 30 September 2015 to the Supplementary Pension Plan of Air Products and Chemicals, Inc. as Amended and Restated effective 1 August 2014. (Filed as Exhibit 10.10(a) to the Company's Annual Report on Form 10-K for the fiscal year ended 30 September 2015.)](https://www.sec.gov/Archives/edgar/data/2969/000119312515386399/d69855dex1010a.htm)</u>\*† |
| 10.3(b) | <u>[Amendment No. 2 dated as of 30 September 2016 to the Supplementary Pension Plan of Air Products and Chemicals, Inc. as Amended and Restated effective 1 August 2014. (Filed as Exhibit 10.7(b) to the Company's Annual Report on Form 10-K for fiscal year ended 30 September 2016.)](https://www.sec.gov/Archives/edgar/data/2969/000119312516773346/d271291dex107b.htm)</u>\*† |
| 10.3(c) | <u>[Amendment No. 3 dated as of 26 July 2017 to the Supplementary Pension Plan of Air Products and Chemicals, Inc. as Amended and Restated effective 1 August 2017.(Filed as Exhibit 10.7(c) to the Company's Annual Report on Form 10-K for the fiscal year ended 30 September 2017.)](https://www.sec.gov/Archives/edgar/data/2969/000000296917000039/apd-exhibit107cx9302017.htm)</u>\*† |
| 10.4 | <u>[Deferred Compensation Plan as Amended and Restated effective 1 January 2018. (Filed as Exhibit 10.5 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 December 2017.)](https://www.sec.gov/Archives/edgar/data/2969/000000296918000014/apd-exhibit105x12312017.htm)</u>\*† |
| 10.5 | <u>[Air Products and Chemicals, Inc. Executive Separation Program as amended effective as of](apd-exhibit105x30sep25.htm)[19](apd-exhibit105x30sep25.htm)[November 2025.](apd-exhibit105x30sep25.htm)</u>† |
| 10.6 | <u>[Air Products and Chemicals, Inc. Senior Management Severance Plan and Summary Plan Description effective 1 August 2022. (Filed as Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for the quarter ended 30 June 2022.)](https://www.sec.gov/Archives/edgar/data/2969/000000296922000038/apd-exhibit102x30jun22.htm)</u>\*† |
| 10.7 | <u>[Form of Change in Control Severance Agreement for an Executive Officer. (](https://www.sec.gov/Archives/edgar/data/2969/000119312514350140/d793171dex102.htm)[F](https://www.sec.gov/Archives/edgar/data/2969/000119312514350140/d793171dex102.htm)[iled as Exhibit 10.2 of the Company's Current Report on Form 8-K dated 23 September 2014.)](https://www.sec.gov/Archives/edgar/data/2969/000119312514350140/d793171dex102.htm)</u>\*† |
| 10.8 | <u>[Compensation Programs for Nonemployee Directors amended and restated effective](apd-exhibit108x30sep25.htm)[19](apd-exhibit108x30sep25.htm)[November](apd-exhibit108x30sep25.htm)[2025.](apd-exhibit108x30sep25.htm)</u>† |
| 10.9 | <u>[Deferred Compensation Program for Directors, effective 7 October 2019. (Filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for quarter ended 31 December 2019.)](https://www.sec.gov/Archives/edgar/data/2969/000000296920000010/apd-exhibit101x31dec19.htm)</u>\*† |
| 10.10 | <u>[5-Year Revolving Credit Agreement dated as of March 28, 2024 for $3,000,000,000. (Filed as Exhibit 10.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 March 2024.)](https://www.sec.gov/Archives/edgar/data/2969/000000296924000026/apd-exhibit101x31mar24.htm)</u>\* |
| 10.10(a) | <u>[Amendment No.1 to Revolving Credit Agreement dated as of 22 August 2024. (Filed as Exhibit 10.12(a) to the Company's Annual Report on Form 10-K for the fiscal year ended 30 September 2024.)](https://www.sec.gov/Archives/edgar/data/2969/000000296924000056/apd-exhibit1012ax30sep24.htm)</u>\* |
| 10.11 | <u>[364-Day Revolving Credit Agreement dated as of March 28, 2024 for $500,000,000. (Filed as Exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 March 2024.)](https://www.sec.gov/Archives/edgar/data/2969/000000296924000026/apd-exhibit102x31mar24.htm)</u>\* |
| 10.11(a) | <u>[Amendment No.1 to 364-Day Revolving Credit Agreement dated as of 27 March 2025. (Filed as Exhibit 10.7 to the Company's Quarterly Report on Form 10-Q for the quarter ended 31 March 2025.)](https://www.sec.gov/Archives/edgar/data/2969/000000296925000027/apd-exhibit107x31mar25.htm)</u>\* |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

---

| | |
|:---|:---|
| **INDEX TO EXHIBITS** | **INDEX TO EXHIBITS** |
| **Exhibit No.** | **Description** |
| (19) | Insider Trading Policies and Procedures |
| 19.1 | <u>[Air Products and Chemicals, Inc. Insider Trading Policy. (Filed as Exhibit 19.1 to the Company's Annual Report on Form 10-K for the fiscal year ended 30 September 2024.)](https://www.sec.gov/Archives/edgar/data/2969/000000296924000056/apd-exhibit191x30sep24.htm)</u>\* |
| (21) | Subsidiaries of the Registrant. |
| 21.1 | <u>[Subsidiaries of the Registrant.](apd-exhibit211x30sep25.htm)</u> |
| (23) | Consents of Experts and Counsel. |
| 23.1 | <u>[Consent of Independent Registered Public Accounting Firm.](apd-exhibit231x30sep25.htm)</u> |
| (24) | Power of Attorney. |
| 24.1 | <u>[Power of Attorney.](apd-exhibit241x30sep25.htm)</u> |
| (31) | Rule 13a-14(a)/15d-14(a) Certifications. |
| 31.1 | <u>[Certification by the Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](apd-exhibit311x30sep25.htm)</u> |
| 31.2 | <u>[Certification by the Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](apd-exhibit312x30sep25.htm)</u> |
| (32) | Section 1350 Certifications. |
| 32.1 | <u>[Certification by the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](apd-exhibit321x30sep25.htm)</u>†† |
| (97) | Policy Relating to Recovery of Erroneously Awarded Compensation. |
| 97.1 | <u>[Air Products and Chemicals, Inc. Compensation Recoupment Policy and Supplemental Executive Officer Recoupment Policy, effective as of 1 October 2023. (Filed as Exhibit 97.1 to the Company's Annual Report on Form 10-K for the year ended 30 September 2023.)](https://www.sec.gov/Archives/edgar/data/2969/000000296923000047/apd-exhibit971x30sep23.htm)</u>\* |
| (101) | Interactive Data Files. |
| 101.INS | Inline XBRL Instance Document. The XBRL Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 104 | Cover Page Interactive Data File, formatted in Inline XBRL (included in Exhibit 101). |

---

---

| | |
|:---|:---|
| \* | Previously filed as indicated and incorporated herein by reference. Exhibits incorporated by reference are located in SEC File No. 001-04534 unless otherwise indicated. |
| \*\* | Long-term debt instruments under which the total amount of securities authorized does not exceed 10 percent of our consolidated total assets are not filed as exhibits to this Annual Report on Form 10-K. We will furnish a copy of these agreements to the Securities and Exchange Commission upon request. |
| † | Indicate management contract or compensatory arrangement. |
| †† | The certification attached as Exhibit 32.1 that accompanies this Annual Report on Form 10-K, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of Air Products and Chemicals, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing. |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

**SIGNATURES**

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| | AIR PRODUCTS AND CHEMICALS, INC. |
| | (Registrant) |
| By: | /s/ Melissa N. Schaeffer |
|  | Melissa N. Schaeffer<br>Executive Vice President and Chief Financial Officer<br>(Principal Financial Officer) |
| Date: | 20 November 2025 |

---

Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

---

| | |
|:---|:---|
| **Signature and Title** | **Date** |
| /s/ Eduardo F. Menezes | 20 November 2025 |
| Eduardo F. Menezes<br>Chief Executive Officer and Director<br>(Principal Executive Officer) |  |
| /s/ Melissa N. Schaeffer | 20 November 2025 |
| Melissa N. Schaeffer<br>Executive Vice President and Chief Financial Officer<br>(Principal Financial Officer) |  |
| /s/ William J. Pellicciotti | 20 November 2025 |
| William J. Pellicciotti<br>Vice President, Controller, and<br>Chief Accounting Officer<br>(Principal Accounting Officer) |  |
| \* | 20 November 2025 |
| Tonit M. Calaway<br>Director |  |
| \* | 20 November 2025 |
| Lisa A. Davis<br>Director |  |
| \* | 20 November 2025 |
| Andrew W. Evans<br>Director |  |

---

------

<u>[**Table of Contents**](#i6c5d80e205be49368cbb0bd080310540_7)</u>

---

| | |
|:---|:---|
| **Signature and Title** | **Date** |
| \* | 20 November 2025 |
| Jessica Trocchi Graziano<br>Director |  |
| \* | 20 November 2025 |
| Paul C. Hilal<br>Director |  |
| \* | 20 November 2025 |
| Bhavesh V. Patel<br>Director |  |
| \* | 20 November 2025 |
| Dennis H. Reilley<br>Director<br>Vice Chairman of the Board of Directors |  |
| \* | 20 November 2025 |
| Wayne T. Smith<br>Director<br>Chairman of the Board of Directors |  |
| \* | 20 November 2025 |
| Alfred Stern<br>Director |  |
| \* | 20 November 2025 |
| Howard Ungerleider<br>Director |  |

---

\* Matthew Lepore, Executive Vice President, General Counsel, Chief Compliance Officer and Secretary, by signing his name hereto, does sign this document on behalf of the above noted individuals, pursuant to a power of attorney duly executed by such individuals, which is filed with the Securities and Exchange Commission herewith.

---

| |
|:---|
| /s/ Matthew Lepore |
| Matthew Lepore |
| Executive Vice President, General Counsel, Chief Compliance Officer and Secretary |
| Date: 20 November 2025 |

---

## Exhibit 3.2

Exhibit 3.2

**AIR PRODUCTS AND CHEMICALS, INC.**

 

**AMENDED AND RESTATED BYLAWS**

Effective November 19, 2025

 

**ARTICLE I** 

**<u>MEETINGS OF STOCKHOLDERS</u>**

Section 1. <u>Annual Meetings</u>. (a) The annual meeting of the stockholders of Air Products and Chemicals, Inc. (the "<u>Corporation</u>") for the election of directors and for the transaction of any other business as may be properly brought before the meeting, shall be held at such place, if any, on such date, and at such time as the Board of Directors (the "<u>Board</u>") shall each year fix, which date shall be within 13 months subsequent to the last annual meeting of stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)To be properly brought before an annual meeting, business must be (i) specified in the notice of the meeting (or any supplement thereto) given by or at the direction of the Board, (ii) otherwise properly brought before the meeting by or at the direction of the Board, or (iii) otherwise properly brought before the meeting by a stockholder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)For business to be properly brought before an annual meeting by a stockholder, the stockholder must have given written notice thereof, either by personal delivery or by United States mail, postage prepaid, to the Secretary at the principal executive offices of the Corporation, not more than 120 calendar days or fewer than 90 calendar days in advance of the anniversary date of the immediately preceding annual meeting; <u>provided</u>, <u>however</u>, that in the event that the date of the annual meeting is more than 30 calendar days before or more than 60 calendar days after such anniversary date, notice by the stockholder to be timely must be so delivered not earlier than the close of business on the 120th calendar day prior to such annual meeting and not later than the close of business on the later of the 90th calendar day prior to such annual meeting or the 10th calendar day following the day on which public announcement of the date of such annual meeting is first made. In no event shall any adjournment or postponement of an annual meeting or the announcement of such adjournment or postponement commence a new time period (or change the existing time period) for the giving of a stockholder's notice as described above. Any such notice by the stockholder shall include: (i) a brief description of each item of business proposed to be brought before the meeting and the reasons for conducting such business at the meeting, and, in the event that such business includes a proposal to amend the Bylaws of the Corporation (these "<u>Bylaws</u>"), the language of the proposed amendment; (ii) the

------

name and address of the stockholder proposing such business and each other Covered Person (as defined below); (iii) a representation that the stockholder is a holder of record of stock of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to propose such business; (iv) the name of each person with whom such stockholder or any other Covered Person (as defined below) has any agreement, arrangement, or understanding (whether written or oral) for the purpose of acquiring, holding, voting (except pursuant to a revocable proxy given to such person in response to a public proxy or consent solicitation made generally by such person to all holders of shares of capital stock of the Corporation), or disposing of any shares of capital stock of the Corporation, or to cooperate in obtaining, changing, or influencing the control of the Corporation (except independent financial, legal, and other advisors acting in the ordinary course of their respective businesses) or related to any item of business described pursuant to clause (i) above, and a description of each such agreement, arrangement, or understanding; (v) a description of the material interest of the stockholder, each affiliate (as defined under the rules and regulations promulgated under the Securities Exchange Act of 1934, as amended (the "<u>Exchange Act</u>")) of such stockholder, each person described under clause (iv) above and each person (if any) nominated by such stockholder in accordance with <u>Article II</u>, <u>Section 3</u> of these Bylaws for election as a director to the Board (each person described in this clause (v), a "<u>Covered Person</u>") in each item of business described pursuant to clause (i) above; (vi) a list of the class or series and number of shares of capital stock of the Corporation that are owned of record or beneficially by each Covered Person and documentary evidence of such record or beneficial ownership; (vii) a list of all derivative securities (as defined under Rule 16a-1 under the Exchange Act) and other derivatives or similar arrangements to which any Covered Person is a counterparty and which relate to any shares of capital stock of the Corporation, a description of all economic terms of each such derivative security and other derivatives or similar arrangements, and copies of all agreements and other documents relating to each such derivative security and other derivatives or similar arrangements; (viii) a list of all transactions by any Covered Person involving any shares of capital stock of the Corporation or any derivative securities (as defined under Rule 16a-1 under the Exchange Act) or other derivatives or similar arrangements related to any shares of capital stock of the Corporation occurring within 60 calendar days of the date of the notice; (ix) all other information that, as of the date of the notice, would be required to be (A) filed on Schedule 13D (including the exhibits thereto) under the Exchange Act by any Covered Person, regardless of whether such Covered Person has publicly filed or is required to file a Schedule 13D containing such information or (B) disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies by any Covered Person in support of any item of business described pursuant to clause (i) above pursuant to Section 14(a) of the Exchange Act; (x) a description of any direct or indirect interest of any Covered Person in any contract with the Corporation, any affiliate of the Corporation or any principal competitor of the Corporation (including, in any such case, any employment agreement, collective bargaining agreement, or consulting agreement); (xi) a list of

------

any equity interest held by any Covered Person in any principal competitor of the Corporation or any derivative securities (as defined under Rule 16a-1 under the Exchange Act) held by any Covered Person and other derivatives or similar arrangements to which any Covered Person is a counterparty and which relate to any shares of capital stock of any principal competitor of the Corporation, a description of all economic terms of all such derivative securities and other derivatives or similar arrangements, and copies of all agreements and other documents relating to each such derivative security and other derivatives or similar arrangements; (xii) a description of any pending or threatened litigation in which any Covered Person is a party or material participant involving the Corporation or any of its officers or directors, or any affiliate of the Corporation; and (xiii) if the stockholder intends to solicit proxies in support of any of such stockholder's proposals, a representation to that effect. If, after the stockholder has delivered such notice, any information required to be contained in such notice as described in clauses (i) through (xiii) above changes prior to the date of the relevant annual meeting, such notice shall be deemed to be not in compliance with this <u>Section 1(c)</u> and not effective unless such stockholder, within three New York Stock Exchange business days of the date of the event causing such change in information, delivers to the Secretary an updated notice containing such change. No business brought by a stockholder shall be conducted at an annual meeting of stockholders except in accordance with this <u>Section 1(c)</u>, and the chairman of any annual meeting of stockholders may refuse to permit any business to be brought before an annual meeting without compliance with the foregoing procedures or if the stockholder solicits proxies in support of such stockholder's proposal without such stockholder having made the representation required by clause (xiii) of the second preceding sentence.

Section 2. <u>Special Meetings</u>. (a) Special meetings of the stockholders for any purpose or purposes prescribed in the notice of the meeting may be called at any time by (i) the Chairman of the Board, (ii) a majority of the whole Board, or (iii) in accordance with <u>Section 2(b)</u> of this <u>Article I</u>, the Secretary, and shall be held at the place, if any, on such date, and at such time as shall be designated in the notice thereof. At any special meeting of the stockholders, only such business shall be conducted or considered as shall have been specified in the Corporation's notice of meeting (or any supplement thereto).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Subject to the provisions of this <u>Section 2(b)</u> and all other applicable sections of these Bylaws, a special meeting shall be called by the Secretary upon written request (a "<u>Special Meeting Request</u>") of one or more stockholders of record of the Corporation representing not less than 10% of the outstanding shares of the Corporation that are entitled to vote; <u>provided</u>, <u>however</u>, that each such stockholder of record must have owned such shares continuously for the one-year period ending on the date of the Special Meeting Request and must continue to own such shares through the conclusion of the special meeting (the "<u>Requisite Percentage</u>"). The Board shall determine in good faith whether all requirements set forth in this

------

<u>Section 2(b)</u> have been satisfied and such determination shall be binding on the Corporation and its stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)A Special Meeting Request must be given in writing, either by personal delivery or by United States mail, postage prepaid, to the Secretary at the principal executive offices of the Corporation. A Special Meeting Request shall be valid only if it is signed and dated by each holder of record submitting the Special Meeting Request, or such stockholder's duly authorized agent (each, a "<u>Requesting Stockholder</u>"), collectively representing the Requisite Percentage, and includes (A) a statement of the specific purpose(s) of the special meeting and the reasons for conducting such business at the special meeting; (B) as to any director nominations proposed to be presented at the special meeting, and any matter (other than a director nomination) proposed to be conducted at the special meeting, and as to each Requesting Stockholder, the information, statements, representations, agreements and other documents that would be required to be set forth in or included with a stockholder's notice of a nomination pursuant to <u>Article II</u>, <u>Section 3</u> of these Bylaws and/or a stockholder's notice of business proposed to be brought before a meeting pursuant to <u>Section 1(c)</u> of this <u>Article I</u>, as applicable; (C) a representation that each Requesting Stockholder, or one or more representatives of each such stockholder, intends to appear in person or by proxy at the special meeting to present the proposal(s) or business to be brought before the special meeting; (D) an agreement by each Requesting Stockholder to notify the Corporation promptly in the event of any disposition prior to the record date for the special meeting of any shares of capital stock of the Corporation owned of record and an acknowledgement that any such disposition shall be deemed to be a revocation of such Special Meeting Request with respect to such disposed shares; (E) the number of shares of capital stock of the Corporation owned of record by each such Requesting Stockholder; and (F) documentary evidence that the Requesting Stockholders in the aggregate own the Requisite Percentage as of the date on which the Special Meeting Request is delivered to the Secretary, which will include evidence of the number of shares owned by the beneficial owners on whose behalf the Special Meeting Request is made as of the date of such Special Meeting Request. In addition, the Requesting Stockholders shall (x) further update and supplement the information provided in the Special Meeting Request, if necessary, so that all information provided or required to be provided therein shall be true and correct as of the record date for the special meeting, and such update and supplement (or a written certification that no such updates or supplements are necessary and that the information previously provided remains true and correct as of the record date) must be given in writing, either by personal delivery or by United States mail, postage prepaid, to the Secretary at the principal executive offices of the Corporation not later than five business days after the record date for the special meeting and (y) promptly provide any other information reasonably requested by the Corporation.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)A Special Meeting Request shall not be valid, and a special meeting requested by stockholders shall not be held, if (A) the Special Meeting Request does not comply with this <u>Section 2(b)</u>; (B) the Special Meeting Request relates to an item of business that is not a proper subject for stockholder action under applicable law (as determined in good faith by the Board); (C) the Special Meeting Request is delivered during the period commencing 120 calendar days prior to the first anniversary of the date of the immediately preceding annual meeting and ending on the earlier of 30 calendar days after (x) the date of the next annual meeting and (y) the first anniversary of the date of the previous annual meeting; (D) an identical or substantially similar item (as determined in good faith by the Board, a "<u>Similar Item</u>"), other than the election of directors, was presented at an annual meeting or special meeting held not more than 12 months before the Special Meeting Request is delivered; (E) a Similar Item was presented at an annual meeting or special meeting held not more than 120 calendar days before the Special Meeting Request is delivered (and, for purposes of this clause (E), the election of directors shall be deemed to be a "Similar Item" with respect to all items of business involving the election or removal of directors, changing the size of the Board and the filling of vacancies and/or newly created directorships resulting from any increase in the authorized number of directors); (F) a Similar Item is included in the Corporation's notice of meeting as an item of business to be brought before an annual meeting or special meeting that has been called but not yet held or that is called for a date within 120 calendar days of the receipt by the Corporation of a Special Meeting Request; or (G) the Special Meeting Request was made in a manner that involved a violation of Regulation 14A under the Exchange Act, or other applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Special meetings called pursuant to this <u>Section 2(b)</u> shall be held at such place, if any, on such date, and at such time as the Board shall fix; <u>provided</u>, <u>however</u>, that the special meeting shall not be held more than 120 calendar days after receipt by the Corporation of a valid Special Meeting Request.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) The Requesting Stockholders may revoke a Special Meeting Request by written revocation delivered to the Secretary at any time prior to the special meeting. If, at any point following the earliest dated Special Meeting Request, the unrevoked requests from Requesting Stockholders (whether by specific written revocation or deemed revocation pursuant to clause (D) of <u>Section 2(b)(i)</u> of this <u>Article I</u>), represent in the aggregate less than the Requisite Percentage, the Board, in its discretion, may cancel the special meeting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)In determining whether a special meeting has been requested by the Requesting Stockholders representing in the aggregate at the least the Requisite Percentage, multiple Special Meeting Requests delivered to the Secretary will be considered together only if (A) each Special Meeting Request identifies substantially the same purpose or purposes of the Special Meeting and substantially the same matters proposed to be acted on at the special

------

meeting, in each case as determined by the Board (which, if such purpose is the election or removal of directors, changing the size of the Board and/or the filling of vacancies and/or newly-created directorships resulting from any increase in the authorized number of directors, will mean that the exact same person or persons are proposed for election or removal in each relevant Special Meeting Request), and (B) such Special Meeting Requests have been dated and delivered to the Secretary within 60 calendar days of the earliest dated Special Meeting Request. For purposes of this <u>Section 2(b)</u> and references to a special meeting called pursuant hereto, a person shall be deemed to "own" only the outstanding shares of capital stock of the Corporation as described in <u>Article II</u>, <u>Section 4(b)(iii)</u> of these Bylaws (provided that ownership of loaned shares shall be deemed to continue during any period in which the person has the power to recall such loaned shares on not more than five business days' notice, has recalled such loaned shares as of the date of the Special Meeting Request and holds such shares (and the voting power of such shares) through the date of the special meeting described in the applicable Special Meeting Request).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) If none of the Requesting Stockholders appear or send a duly authorized agent to present the business to be presented for consideration specified in the Special Meeting Request, the Corporation need not present such business for a vote at the special meeting, notwithstanding that proxies in respect of such vote may have been received by the Corporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) Business transacted at any special meeting called pursuant to this <u>Section 2(b)</u> shall be limited to (A) the purpose(s) stated in the valid Special Meeting Request received from the Requisite Percentage of stockholders of record, and (B) any additional matters that the Board of Directors determines to include in the Corporation's notice of the Special Meeting.

Section 3. <u>Notice of Meetings</u>. Each stockholder of record shall be given written notice of each meeting of stockholders, which notice shall state: the place, if any, date, and time of the meeting; the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such meeting; and in the case of a special meeting, the purpose or purposes for which the meeting is called. Except as otherwise provided by law, the notice of any meeting shall be given not less than 10 or more than 60 calendar days before the date of the meeting to each stockholder entitled to vote at such meeting. Notice shall be deemed to have been given to all stockholders of record who share an address if notice is given in accordance with the "householding" rules set forth in Rule 14a-3(e) under the Exchange Act.

When a meeting of stockholders is adjourned to another time or place (including an adjournment taken to address a technical failure to convene or continue a meeting using remote communication), notice need not be given of the adjourned meeting if the time or place, if any,

------

thereof, and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in person and vote at such adjourned meeting are (a) announced at the meeting at which the adjournment is taken, (b) displayed, during the time scheduled for the meeting, on the same electronic network used to enable stockholders and proxy holders to participate in the meeting by means of remote communication, or (c) set forth in the notice of meeting; <u>provided</u>, <u>however</u>, that if the date of any adjourned meeting is more than 30 calendar days after the date for which the meeting was originally noticed, or if a new record date is fixed for the adjourned meeting, written notice of the place, if any, date, and time of the adjourned meeting shall be given in conformity herewith. At any adjourned meeting, any business may be transacted which might have been transacted at the meeting as originally noticed.

Section 4. <u>Meetings by Means of Remote Communication</u>. The Board may, in its sole discretion, determine that stockholder meetings shall not be held at any place, but may instead be held solely by means of remote communication in accordance with Section 211(a)(2) of the General Corporation Law of the State of Delaware (the "<u>DGCL</u>"). If authorized by the Board in its sole discretion, and subject to such guidelines and procedures as the Board may adopt, stockholders and proxy holders not physically present at a meeting of stockholders may, to the extent authorized by Section 211(a)(2) of the DGCL, by means of remote communication (i) participate in a meeting of stockholders and (ii) be deemed present in person and vote at a meeting of stockholders whether such meeting is to be held at a designated place or solely by means of remote communication.

Section 5. <u>List of Stockholders</u>. The officer who has charge of the stock ledger of the Corporation shall prepare and make, not later than the 10th calendar day before each meeting of stockholders, a complete list of the stockholders entitled to vote at the meeting, arranged in alphabetical order, showing the address of each stockholder and the number of shares registered in the name of each stockholder; <u>provided</u>, <u>however</u>, that the Corporation shall not be required to include electronic mail addresses or other electronic contact information on such list; and <u>provided</u>, <u>however</u>, that if the record date for determining the stockholders entitled to vote is less than 10 calendar days before the meeting date, the list shall reflect the stockholders entitled to vote as of the 10th calendar day before the meeting date. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting, for a period of at least 10 calendar days ending on the day before the meeting date (a) on a reasonably accessible electronic network, <u>provided</u>, <u>however</u>, that the information required to gain access to such list is provided with the notice of the meeting, or (b) at the principal place of business of the Corporation during normal business hours. In the event the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation. The list shall

------

presumptively determine the identity of the stockholders entitled to vote at the meeting and the number of shares held by each of them.

Section 6. <u>Quorum; Adjournment</u>. The holders of a majority of all of the shares of the stock entitled to vote at the meeting, present in person or represented by proxy, shall constitute a quorum for all purposes at all meetings of the stockholders for the transaction of business unless and except that the presence of a larger number may be required by law. Where a separate vote by a class or classes is required, a majority of the shares of such class or classes present in person or represented by proxy shall constitute a quorum entitled to take action with respect to that vote on that matter. The chairman of the meeting or the holders of a majority of the votes entitled to be cast by the stockholders who are present in person or by proxy may adjourn the meeting from time to time whether or not a quorum is present. At any such adjourned meeting at which a quorum may be present, any business may be transacted which might have been transacted at the meeting as originally called. If the adjournment is for more than 30 calendar days, or if after the adjournment a new record date is fixed for the adjourned meeting, a notice of the adjourned meeting shall be given to each stockholder entitled to vote at the meeting not less than 10 nor more than 60 calendar days before the date of the meeting, unless a different period is prescribed by applicable law.

Section 7. <u>Organization</u>. Meetings of stockholders shall be presided over by the Chairman of the Board; or, in the absence of the Chairman, by the Vice Chairman of the Board, if any; or, in the absence of both the Chairman and the Vice Chairman, if any, by the Chief Executive Officer; or, in the absence of the foregoing persons, by a chairman designated by the Board. The Secretary shall act as secretary of the meeting; or, in the absence of the Secretary, an assistant secretary shall so act; or, in their absence, the chairman of the meeting may appoint any person to act as secretary of the meeting.

Section 8. <u>Conduct of Business</u>. The chairman of any meeting of stockholders shall determine the order of business and the procedure at the meeting, including such regulation of the manner of voting and the conduct of discussion as seem to him or her in order.

Section 9. <u>Voting and Proxies</u>. Subject to the provisions of the Certificate of Incorporation of the Corporation (the "<u>Certificate of Incorporation</u>"), at every meeting of the stockholders each stockholder shall be entitled to one vote in person or by proxy for each share of the capital stock having voting power held by such stockholder. No proxy shall be voted on after three years from its date, unless the proxy provides for a longer period. All voting, except on the election of directors and where otherwise required by law, may be by a voice vote; <u>provided</u>, <u>however</u>, that upon demand therefor by a stockholder entitled to vote or the holder of a proxy of such person, a stock vote shall be taken. Every stock vote shall be taken by ballots, each

------

of which shall state the name of the stockholder or proxy voting and such other information as may be required under the procedure established for the meeting.

Unless a greater number of affirmative votes is required by the Certificate of Incorporation, elsewhere in these Bylaws, or by the rules or regulations of any stock exchange applicable to the Corporation, or as otherwise required by law or pursuant to any regulation applicable to the Corporation, if a quorum exists at any meeting of stockholders, stockholders shall have approved any matter, other than the election of directors, if the votes cast by stockholders present in person or represented by proxy at the meeting and entitled to vote on the matter in favor of such matter exceed the votes cast by such stockholders against such matter. A nominee for director shall be elected to the Board only upon the vote of a majority of the votes cast at a meeting at which a quorum is present, except that a nominee for director shall be elected by a plurality of the votes cast at any meeting of stockholders for which the Secretary determines, as of the record date for such meeting, that the number of nominees exceeds the number of directors to be elected. For purposes of the foregoing sentence, a majority of the votes cast means that votes cast for such nominee's election exceed the votes cast against such nominee's election.

Section 10. <u>Inspectors of Election</u>. The Corporation may, and shall if required by law, in advance of any meeting of stockholders, appoint one or more inspectors of election, who may be employees of the Corporation, to act at the meeting or any adjournment thereof and to make a written report thereof. The Corporation may designate one or more persons as alternate inspectors to replace any inspector who fails to act. In the event that no inspector so appointed or designated is able to act at a meeting of stockholders, the chairman of the meeting shall appoint one or more inspectors to act at the meeting. Each inspector, before entering upon the discharge of his or her duties, shall take and sign an oath to execute faithfully the duties of inspector with strict impartiality and according to the best of his or her ability. The inspector or inspectors so appointed or designated shall (i) ascertain the number of shares of capital stock of the Corporation outstanding and the voting power of each such share, (ii) determine the shares of capital stock of the Corporation represented at the meeting and the validity of proxies and ballots, (iii) count all votes and ballots, (iv) determine and retain for a reasonable period a record of the disposition of any challenges made to any determination by the inspectors, and (v) certify their determination of the number of shares of capital stock of the Corporation represented at the meeting and such inspectors' count of all votes and ballots. Such certification and report shall specify such other information as may be required by law. In determining the validity and counting of proxies and ballots cast at any meeting of stockholders of the Corporation, the inspectors may consider such information as is permitted by applicable law. No person who is a candidate for an office at an election may serve as an inspector at such election.

------

**ARTICLE II**

**<u>BOARD OF DIRECTORS</u>**

Section 1. <u>General Powers</u>. The business and affairs of the Corporation shall be managed by or under the direction of the Board, which may exercise all such powers of the Corporation and do all such lawful acts and things as are not by law or by the Certificate of Incorporation directed or required to be exercised or done by the stockholders.

Section 2. <u>Chairman of the Board; Vice Chairman of the Board</u>. There shall be a Chairman of the Board and, if determined by the Board, a Vice Chairman of the Board, who shall each be elected from among the directors of the Corporation. The Chairman of the Board and the Vice Chairman of the Board, if any, shall have the respective powers and duties set forth below, and shall also have such other powers and duties as may be conferred by the Board from time to time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Chairman of the Board</u>. The Chairman of the Board may be, but need not be, a person other than the Chief Executive Officer of the Corporation or another officer or employee of the Corporation. The Chairman of the Board shall preside at all meetings of the stockholders and of the Board. The Chairman of the Board shall, in consultation with the Vice Chairman of the Board, if any, and the Chief Executive Officer, if separate, establish and oversee the preparation of agendas for meetings of the Board. The Chairman of the Board shall perform such other duties as shall be determined by the Board.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Vice Chairman of the Board</u>. The Vice Chairman of the Board, if any, shall consult with, advise and assist the Chairman of the Board in the performance of the duties of the Chairman of the Board. The Vice Chairman of the Board shall preside at all meetings of the stockholders and of the Board in the absence or at the request of the Chairman of the Board. The Vice Chairman of the Board shall perform such other duties as shall be determined by the Board.

Section 3. <u>Number; Nomination; Qualifications</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Number of Directors</u>. The number of directors which shall constitute the whole Board shall be fixed from time to time by a vote of the majority of the whole Board. (The term "<u>whole Board</u>" as used in these Bylaws shall mean the total number of authorized directors, whether or not there exist any vacancies or unfilled previously authorized directorships.)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Nomination of Director Candidates</u>. Nominations of persons for election as directors at any annual meeting of stockholders, or at any special meeting of stockholders

------

called for the purpose of electing directors as set forth in the Corporation's notice of such special meeting may be made by the Board or by any stockholder who is a stockholder of record at the time of giving of the notice of nomination and who complies with the procedures for such nomination specified in this <u>Section 3</u> and Rule 14a-19 under the Exchange Act. Any stockholder of record entitled to vote for the election of directors may nominate a person or persons for election as directors (i) if written notice of such stockholder's intent to make such nomination is given in accordance with the procedures for bringing business before an annual meeting set forth in <u>Article I</u>, <u>Section 1(c)</u> of these Bylaws, or (ii) if such Eligible Stockholder submits one or more Stockholder Nominees pursuant to the proxy access requirements of <u>Section 4</u> of this <u>Article II</u>.

Each notice of stockholder nomination pursuant to this <u>Section 3</u> must also comply with <u>Article I</u>, <u>Section 1(c)</u> of these Bylaws and must include, in addition to all of the information required under such section: (A) the name and address of the person or persons to be nominated for election as directors by the stockholder; (B) a representation that the stockholder is a holder of record of stock of the Corporation entitled to vote at such meeting and intends to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice; (C) a description of all agreements, arrangements, or understandings (whether written or oral) between any Covered Person, each nominee, and any other person or persons (naming such person or persons) related to the nomination of each nominee that is to be made by the stockholder and all direct and indirect material relationships or other compensation and other material monetary agreements, arrangements, and understandings during the past three years between any Covered Person, each nominee, and any other such person or persons (naming such person or persons); (D) all information that would be reasonably relevant to a determination by the Board as to whether each nominee proposed by such stockholder is "independent" within the meaning of all applicable securities law and stock exchange requirements; (E) all information that would be relevant to a determination by the Board (or any relevant committee thereof) as to whether each nominee proposed by such stockholder meets any standards for Board membership set forth by the Board (or any committee thereof) in any publicly available documents; (F) such other information regarding each nominee proposed by such stockholder as would have been required to be included in a proxy statement had such nominee been nominated, or intended to be nominated, by the Board; (G) the consent of each nominee to serve as a director if so elected; and (H) a completed and signed questionnaire, representation and agreement for each nominee as required by the immediately succeeding paragraph. If, after the stockholder has delivered such notice, any information required to be contained in such notice as described in clauses (A) through (H) above changes prior to the date of the relevant meeting of stockholders, such notice shall be deemed to be not in compliance with this <u>Section 3</u> and not effective unless such stockholder, within three New York Stock Exchange business days of the date of the event causing such change in information, delivers to the Secretary an updated notice containing such

------

change. The chairman of any meeting of stockholders to elect directors may refuse to acknowledge the nomination of any person if not made in compliance with the foregoing procedure or if the stockholder solicits proxies in support of such stockholder's nominee(s) without such stockholder having made the representation required by clause (13) of <u>Article I</u>, <u>Section 1(c)</u> of these Bylaws or if such stockholder fails to comply with Rule 14a-19 under the Exchange Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Qualification of Director Nominees</u>. To be eligible to be a nominee for election or reelection as a director of the Corporation, a proposed nominee must deliver to the Secretary at the principal executive offices of the Corporation a written questionnaire with respect to the background and qualification of such proposed nominee (which questionnaire shall be provided by the Secretary upon written request), and a written representation and agreement (in form provided by the Secretary upon written request) that such proposed nominee: (i) is not and will not become a party to (A) any agreement, arrangement or understanding with, and has not given any commitment or assurance to, any person as to how such proposed nominee, if elected as a director of the Corporation, will act or vote on any issue or question (a "<u>Voting Commitment</u>") that has not been fully disclosed to the Corporation or (B) any Voting Commitment that could limit or interfere with such proposed nominee's ability to comply, if elected as a director of the Corporation, with such proposed nominee's fiduciary duties under applicable law; (ii) is not, and will not become a party to, any agreement, arrangement or understanding with any person other than the Corporation with respect to any direct or indirect compensation, reimbursement, or indemnification in connection with service or action as a director of the Corporation that has not been fully disclosed to the Corporation; and (iii) in such proposed nominee's individual capacity and on behalf of any person on whose behalf the nomination is made, would be in compliance, if elected as a director of the Corporation, and will comply, with the Corporation's Corporate Governance Guidelines and Code of Conduct and Business Ethics, and all other applicable, publicly disclosed conflict of interest, confidentiality, stock ownership, and insider trading policies and guidelines of the Corporation.

Section 4. <u>Proxy Access for Director Nominations</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Eligibility</u>. Subject to the terms and conditions of these Bylaws, in connection with an annual meeting of stockholders at which directors are to be elected, the Corporation shall include in its proxy materials the name(s) and "Additional Information" (as defined below) relating to nominees for election to the Board submitted pursuant to this <u>Section 4</u> (each, a "<u>Stockholder Nominee</u>"), if:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the Stockholder Nominee satisfies the eligibility requirements in this <u>Section 4</u>;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)the Stockholder Nominee is identified in a timely notice (the "<u>Stockholder Notice</u>") that satisfies this <u>Section 4</u> and is delivered by a stockholder that qualifies as, or is acting on behalf of, an Eligible Stockholder (as defined below); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)the Eligible Stockholder satisfies the requirements in this <u>Section 4</u> and expressly elects at the time of the delivery of the Stockholder Notice to have the Stockholder Nominee included in the Corporation's proxy materials.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain Definitions</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)The maximum number of Stockholder Nominees appearing in the Corporation's proxy materials with respect to an annual meeting of stockholders shall not exceed the greater of (A) two or (B) 20% of the number of directors in office as of the last day on which a Stockholder Notice may be delivered pursuant to this <u>Section 4</u> with respect to the annual meeting, or if such amount is not a whole number, the closest whole number (rounding down) below 20% (the "<u>Authorized Number</u>"); <u>provided</u>, <u>however</u>, that the Authorized Number shall be reduced by (A) the number of individuals (if any) included in the Corporation's proxy materials as nominees recommended by the Board pursuant to an agreement, arrangement, or other understanding with a stockholder or group of stockholders (other than any such agreement, arrangement, or other understanding entered into in connection with an acquisition of stock from the Corporation by such stockholder or group of stockholders) and (B) the number of nominees (if any) who were previously elected to the Board as Stockholder Nominees at any of the preceding two annual meetings and who are nominated for election at the annual meeting by the Board as a Board nominee. For purposes of determining when the Authorized Number has been reached, any individual nominated by an Eligible Stockholder for inclusion in the Corporation's proxy materials pursuant to this <u>Section 4</u> whose nomination is subsequently withdrawn or whom the Board decides to nominate for election to the Board shall be counted as one of the Stockholder Nominees. In the event that one or more vacancies for any reason occurs after the date of the Stockholder Notice but before the annual meeting and the Board resolves to reduce the size of the Board in connection therewith, the Authorized Number shall be calculated based on the number of directors in office as so reduced.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)To qualify as an "<u>Eligible Stockholder</u>," a stockholder or a group as described in this <u>Section 4</u> must:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)as of the date of the Stockholder Notice, have continuously Owned (as defined below) for at least three years a number of shares (as adjusted to account for any stock dividend, stock split, subdivision, combination, reclassification, or recapitalization of

------

shares of the Corporation that are entitled to vote in the election of directors) that represents at least three percent of the outstanding shares of the Corporation that are entitled to vote in the election of directors as of the date of the Stockholder Notice (the "<u>Required Shares</u>"); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)thereafter continue to Own the Required Shares through such annual meeting of stockholders.

For purposes of satisfying the ownership requirements of <u>Section 4(b)(ii)</u> of this <u>Article II</u>, a group of not more than 20 stockholders may aggregate the number of shares of the Corporation that are entitled to vote in the election of directors that each group member, as of the date of the Stockholder Notice, has individually Owned continuously for at least three years if all of the other requirements and obligations for an Eligible Stockholder set forth in this <u>Section 4</u> are satisfied by and as to each stockholder comprising the group whose shares are aggregated. No shares may be attributed to more than one Eligible Stockholder, and no stockholder, alone or together with any of its affiliates, may individually or as a member of a group qualify as or constitute more than one Eligible Stockholder under this <u>Section 4</u>. A group of any two or more funds shall be treated as one stockholder for this purpose if they are (1) under common management and investment control, (2) under common management and funded primarily by a single employer, or (3) part of a family of funds, meaning a group of publicly offered investment companies (whether organized within or outside the United States) that hold themselves out to investors as related companies for purposes of investment and investor services. For purposes of this <u>Section 4</u>, the term "<u>affiliate</u>" or "<u>affiliates</u>" shall have the meanings ascribed thereto under the rules and regulations promulgated under the Exchange Act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) For purposes of this <u>Section 4</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)A stockholder is deemed to "<u>Own</u>" only those outstanding shares of the Corporation that are entitled to vote in the election of directors as to which the person possesses both (1) the full voting and investment rights pertaining to the shares and (2) the full economic interest in (including the opportunity for profit and risk of loss on) such shares, except that the number of shares calculated in accordance with clauses (1) and (2) shall not include any shares (x) sold by such person in any transaction that has not been settled or closed, (y) borrowed by the person for any purposes or purchased by the person pursuant to an agreement to resell, or (z) subject to any option, warrant, forward contract, swap, contract of sale, or other derivative or similar agreement entered into by the person, whether the instrument or agreement is to be settled with shares or with cash based on the notional amount or value of outstanding shares of the Corporation that are entitled to vote in the election of directors, if the instrument or agreement has, or is intended to have, or if exercised would have, the purpose or effect of (a) reducing in any manner, to any extent or at any time in the future, the person's full right to vote

------

or direct the voting of the shares and/or (b) hedging, offsetting or altering to any degree any gain or loss arising from the full economic ownership of the shares by the person. The terms "<u>Owned</u>," "<u>Owning</u>" and other variations of the word "<u>Own</u>," when used with respect to a stockholder, have correlative meanings. For purposes of clauses (x) through (z), the term "<u>person</u>" includes its affiliates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)A stockholder is deemed to "<u>Own</u>" shares held in the name of a nominee or other intermediary so long as the person retains both (1) the full voting and investment rights pertaining to the shares and (2) the full economic interest in the shares. The person's Ownership of shares is deemed to continue during any period in which the person has delegated any voting power by means of a proxy, power of attorney, or other instrument or arrangement that is revocable at any time by the stockholder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)A stockholder's Ownership of shares shall be deemed to continue during any period in which the person has loaned the shares if the person has the power to recall the loaned shares on not more than five business days' notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) For purposes of this <u>Section 4</u>, the "<u>Additional Information</u>" referred to in <u>Section 4(a)</u> of this <u>Article II</u> that the Corporation will include in its proxy statement is:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)the information set forth in the Schedule 14N provided with the Stockholder Notice concerning each Stockholder Nominee and the Eligible Stockholder that is required to be disclosed in the Corporation's proxy statement by the applicable requirements of the Exchange Act and the rules and regulations thereunder; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)if the Eligible Stockholder so elects, a written statement of the Eligible Stockholder (or, in the case of a group, a written statement of the group), not to exceed 500 words, in support of its Stockholder Nominee(s), which must be provided at the same time as the Stockholder Notice for inclusion in the Corporation's proxy statement for the annual meeting of stockholders.

Notwithstanding anything to the contrary contained in this <u>Section 4(b)(iv)</u>, the Corporation may omit from its proxy materials any information that it, in good faith, believes is untrue in any material respect (or omits a material fact necessary in order to make the statements made, in light of the circumstances under which they are made, not misleading) or would violate any applicable law, rule, regulation, or listing standard. Furthermore, nothing in this <u>Section 4</u> shall limit the Corporation's ability to solicit against and include in its proxy materials its own statements relating to any Eligible Stockholder or Stockholder Nominee.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Stockholder Notice and Other Informational Requirements</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)The Stockholder Notice shall set forth all information, representations and agreements required under <u>Section 3(b)</u> of this <u>Article II</u> and <u>Article I</u>, <u>Section 1(c)</u> of these Bylaws, including the information required with respect to (x) any nominee for election as a director, (y) any stockholder giving notice of an intent to nominate a candidate for election, and (z) any stockholder on whose behalf the nomination is made under this <u>Section 4</u>. In addition, such Stockholder Notice shall include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)a copy of the Schedule 14N that has been or concurrently is filed with the United States Securities and Exchange Commission (the "<u>Commission</u>") under the Exchange Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)a written statement of the Eligible Stockholder (and in the case of a group, the written statement of each stockholder whose shares are aggregated for purposes of constituting an Eligible Stockholder), which statement(s) shall also be included in the Schedule 14N filed with the Commission, (1) setting forth and certifying to the number of shares of the Corporation entitled to vote in the election of directors that the Eligible Stockholder has Owned (as defined in <u>Section 4(b)(iii)</u> of this <u>Article II</u>) continuously for at least three years as of the date of the Stockholder Notice, (2) agreeing to continue to Own such shares through the annual meeting of stockholders and (3) indicating whether it intends to continue to Own such shares for at least one year following the annual meeting;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)the written agreement of the Eligible Stockholder (and in the case of a group, the written agreement of each stockholder or whose shares are aggregated for purposes of constituting an Eligible Stockholder) addressed to the Corporation, setting forth the following additional agreements, representations, and warranties:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;&nbsp;&nbsp;&nbsp;the Eligible Stockholder shall provide (a) within five business days after the date of the Stockholder Notice, one or more written statements from the record holder(s) of the Required Shares and from each intermediary through which the Required Shares are or have been held, in each case during the requisite three-year holding period, specifying the number of shares that it has Owned continuously in compliance with this <u>Section 4</u>, (b) within five business days after the record date for the annual meeting of stockholders both the information required under <u>Article I</u>, <u>Section 1(c)</u> of these Bylaws and notification in writing verifying its continuous Ownership of the Required Shares, in each case, as of such date, and (c) immediate notice to the Corporation if it ceases to own any of the Required Shares prior to the annual meeting;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;&nbsp;&nbsp;&nbsp;the Eligible Stockholder (a) acquired the Required Shares in the ordinary course of business and not with the intent to change or influence control of the Corporation and does not presently intend to change or influence control of the Corporation, (b) has not nominated and shall not nominate for election to the Board at the annual meeting of stockholders any person other than the Stockholder Nominee(s) being nominated pursuant to this <u>Section 4</u>, (c) has not engaged and shall not engage in, and has not been and shall not be a participant (as defined in Item 4 of Exchange Act Schedule 14A) in, a solicitation within the meaning of Exchange Act Rule 14a-1(l) in support of the election of any individual as a director at the annual meeting other than its Stockholder Nominee(s) or any Board nominee, and (d) shall not distribute to any stockholder any form of proxy for the annual meeting of stockholders other than the form of proxy distributed by the Corporation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;&nbsp;&nbsp;&nbsp;the Eligible Stockholder will (a) assume all liability stemming from any legal or regulatory violation arising out of its communications with the Corporation's stockholders or out of the information that it provided to the Corporation, (b) indemnify and hold harmless the Corporation and each of its directors, officers, and employees individually against any liability, loss, or damages in connection with any threatened or pending action, suit, or proceeding, whether legal, administrative, or investigative, against the Corporation or any of its directors, officers or employees arising out of its communications with the Corporation's stockholders or out of the information that it provided to the Corporation, (c) comply with all laws, rules, regulations, and listing standards applicable to its nomination or any solicitation in connection with the annual meeting of stockholders, (d) file with the Commission any solicitation or other communication by or on behalf of the Eligible Stockholder relating to the Corporation's annual meeting, one or more of the Corporation's directors or director nominees or any Stockholder Nominee, regardless of whether the filing is required under Exchange Act Regulation 14A, or whether any exemption from filing is available for the materials under Exchange Act Regulation 14A, and (e) at the request of the Corporation, promptly, but in any event within five business days after such request (or by the day prior to the date of the annual meeting, if earlier), provide to the Corporation such additional information as reasonably requested by the Corporation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D)in the case of a nomination by a group, the designation by all group members of one group member that is authorized to act on behalf of all members of the group with respect to the nomination and matters related thereto, including withdrawal of the nomination, and the written agreement, representation, and warranty of the Eligible Stockholder that it shall provide, within five business days after the date of the Stockholder Notice, documentation reasonably satisfactory to the Corporation demonstrating that the number of stockholders within such group does not exceed 20, including whether a group of funds qualifies as one stockholder within the meaning of <u>Section 4(b)(ii)</u> of this <u>Article II</u>.

------

All information provided pursuant to this <u>Section 4(c)(i)</u> shall be deemed part of the Stockholder Notice for purposes of this <u>Section 4</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)To be timely under this <u>Section 4</u>, the Stockholder Notice must be delivered to, or mailed to and received by, the Secretary at the principal executive offices of the Corporation not earlier than the close of business on the 150th calendar day prior to the anniversary date on which the Corporation first distributed its definitive proxy materials for the prior year's annual meeting of stockholders and not later than the close of business on the 120th calendar day prior to such anniversary date; <u>provided</u>, <u>however</u>, that in the event that the date of the annual meeting is more than 30 calendar days before or more than 60 calendar days after such anniversary date, notice by the stockholder to be timely must be so delivered to, or mailed and received by, not earlier than the close of business on the 150th calendar day prior to such annual meeting and not later than the close of business on the later of the 120th calendar day prior to such annual meeting or the 10th calendar day following the date on which public announcement of the date of such annual meeting is first made. In no event shall the adjournment or a postponement of an annual meeting commence a new time period (or extend any time period) for the giving of the Stockholder Notice as described above.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Within the time period for delivery of the Stockholder Notice, a written representation and agreement of each Stockholder Nominee shall be delivered to the Secretary at the principal executive offices of the Corporation, which shall be signed by each Stockholder Nominee and shall represent and agree (A) as to the matters set forth in <u>Section 3(b)</u> of this <u>Article II</u> and (B) that such Stockholder Nominee consents to being named in the Corporation's proxy materials as a nominee and to serving as a director if elected. At the request of the Corporation, the Stockholder Nominee must promptly, but in any event within five business days after such request, submit the information required by <u>Section 3(c)</u> of this <u>Article II</u>. The Corporation may request such additional information as the Secretary determines may be necessary to permit the Board to determine if each Stockholder Nominee satisfies the requirements of this <u>Section 4</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) In the event that any information or communications provided by the Eligible Stockholder or any Stockholder Nominees to the Corporation or its stockholders is not, when provided, or thereafter ceases to be, true, correct, and complete in all material respects (including omitting a material fact necessary to make the statements made, in light of the circumstances under which they were made, not misleading), such Eligible Stockholder or Stockholder Nominee, as the case may be, shall promptly notify the Secretary and provide the information that is required to make such information or communication true, correct, complete, and not misleading; it being understood that providing any such notification shall not be deemed

------

to cure any defect or limit the Corporation's right to omit a Stockholder Nominee from its proxy materials as provided in this <u>Section 4</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Proxy Access Procedures</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)Notwithstanding anything to the contrary contained in this <u>Section 4</u>, the Corporation may omit from its proxy materials any Stockholder Nominee, and such nomination shall be disregarded and no vote on such Stockholder Nominee shall occur, notwithstanding that proxies in respect of such vote may have been received by the Corporation, if:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)the Eligible Stockholder or Stockholder Nominee breaches any of its agreements, representations, or warranties set forth in the Stockholder Notice or otherwise submitted pursuant to this <u>Section 4</u>, any of the information in the Stockholder Notice or otherwise submitted pursuant to this <u>Section 4</u> was not, when provided, true, correct, and complete (or omitted a material fact necessary to make the statements made, in light of the circumstances under which they were made, not misleading), or the Eligible Stockholder or applicable Stockholder Nominee otherwise fails to comply with its obligations pursuant to these Bylaws, including, but not limited to, its obligations under this <u>Section 4</u>;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)the Stockholder Nominee (1) is not independent under any applicable listing standards, any applicable rules of the Commission or any publicly disclosed standards used by the Board in determining and disclosing the independence of the Corporation's directors, (2) is or has been, within the past three years, an officer or director of a competitor, as defined in Section 8 of the Clayton Antitrust Act of 1914, as amended, (3) is a named subject of a pending criminal proceeding (excluding traffic violations and other minor offenses) or has been convicted in a criminal proceeding (excluding traffic violations and other minor offenses) within the past 10 years, (4) is subject to any order of the type specified in Rule 506(d) of Regulation D promulgated under the Securities Act of 1933, as amended, or (5) shall have provided any information to the Corporation or its stockholders that was untrue in any material respect or that omitted to state a material fact necessary to make the statements made, in light of the circumstances in which they were made, not misleading;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)the Corporation has received a notice (whether or not subsequently withdrawn) that a stockholder intends to nominate any candidate for election to the Board pursuant to the advance notice requirements for stockholder nominees for director in <u>Section 3</u> of this <u>Article II</u>; or

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D)the election of the Stockholder Nominee to the Board would cause the Corporation to violate the Certificate of Incorporation, these Bylaws, or any applicable law, rule, regulation, or listing standard.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)An Eligible Stockholder submitting more than one Stockholder Nominee for inclusion in the Corporation's proxy materials pursuant to this <u>Section 4</u> shall rank such Stockholder Nominees based on the order that the Eligible Stockholder desires such Stockholder Nominees to be selected for inclusion in the Corporation's proxy materials and include such assigned rank in its Stockholder Notice submitted to the Corporation. In the event that the number of Stockholder Nominees submitted by Eligible Stockholders pursuant to this <u>Section 4</u> exceeds the Authorized Number, the Stockholder Nominees to be included in the Corporation's proxy materials shall be determined in accordance with the following provisions: one Stockholder Nominee who satisfies the eligibility requirements in this <u>Section 4</u> shall be selected from each Eligible Stockholder for inclusion in the Corporation's proxy materials until the Authorized Number is reached, going in order of the number (most to fewest) of shares of the Corporation each Eligible Stockholder disclosed as Owned in its Stockholder Notice submitted to the Corporation and going in the order of the rank (highest to lowest) assigned to each Stockholder Nominee by such Eligible Stockholder. If the Authorized Number is not reached after one Stockholder Nominee who satisfies the eligibility requirements in this <u>Section 4</u> has been selected from each Eligible Stockholder, this selection process shall continue as many times as necessary, following the same order each time, until the Authorized Number is reached. Following such determination, if any Stockholder Nominee who satisfies the eligibility requirements in this <u>Section 4</u> thereafter is nominated by the Board, thereafter is not included in the Corporation's proxy materials or thereafter is not submitted for director election for any reason (including the Eligible Stockholder's or Stockholder Nominee's failure to comply with this <u>Section 4</u>), no other nominee or nominees shall be included in the Corporation's proxy materials or otherwise submitted for election as a director at the applicable annual meeting of stockholders in substitution for such Stockholder Nominee.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Any Stockholder Nominee who is included in the Corporation's proxy materials pursuant to this <u>Section 4</u> for a particular annual meeting of stockholders but either (A) withdraws from or becomes ineligible or unavailable for election at the annual meeting for any reason, including for the failure to comply with any provision of these Bylaws (<u>provided</u>, <u>however</u>, that in no event shall any such withdrawal, ineligibility or unavailability commence a new time period (or extend any time period) for the giving of a Stockholder Notice) or (B) does not receive in favor of such Stockholder Nominee's election at least 25% of the votes cast with respect to such Stockholder Nominee's election, shall be ineligible to be a Stockholder Nominee pursuant to this <u>Section 4</u> for the next two annual meetings.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Notwithstanding the foregoing provisions of this <u>Section 4</u>, unless otherwise required by law or otherwise determined by the chairman of the meeting, if the stockholder delivering the Stockholder Notice (or a qualified representative of the stockholder, as defined in <u>Article I</u>, <u>Section 1(c)</u> of these Bylaws) does not appear at the annual meeting of stockholders of the Corporation to present its Stockholder Nominee or Stockholder Nominees, such nomination or nominations shall be disregarded, notwithstanding that proxies in respect of the election of the Stockholder Nominee or Stockholder Nominees may have been received by the Corporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)The Board (and any other person or body authorized by the Board) shall have the power and authority to interpret this <u>Section 4</u> and to make any and all determinations necessary or advisable to apply this <u>Section 4</u> to any persons, facts or circumstances, including, without limitation, the power to determine (A) whether one or more stockholders qualifies as an Eligible Stockholder, (B) whether a Stockholder Notice complies with this <u>Section 4</u> and has otherwise met the requirements of this <u>Section 4</u>, (C) whether a Stockholder Nominee satisfies the qualifications and requirements in this <u>Section 4</u>, and (D) whether any and all requirements of this <u>Section 4</u> or any applicable requirements of <u>Article I</u>, <u>Section 1(c)</u> of these Bylaws have been satisfied. Any such interpretation or determination adopted in good faith by the Board (or any other person or body authorized by the Board) shall be binding on all persons, including, without limitation, the Corporation and its stockholders.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) For the avoidance of doubt, nothing in this <u>Section 4</u> shall limit the Corporation's ability to solicit against any Stockholder Nominee or include in its proxy materials the Corporation's own statements or other information relating to any Eligible Stockholder or Stockholder Nominee, including any information provided to the Corporation pursuant to this <u>Section 4</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) Other than pursuant to Rule 14a-19 under the Exchange Act, this <u>Section 4</u> shall be the exclusive method for stockholders to include director nominees for election in the Corporation's proxy materials.

Section 5. <u>Resignation</u>. Any director may resign at any time by giving written notice of his or her resignation to the Board, the Chairman of the Board, the Chief Executive Officer, or the Secretary. Any such resignation shall take effect at the time specified therein, or, if the time when it is to become effective shall not be specified therein, then it shall take effect when received.

Section 6. <u>Newly-Created Directorships and Vacancies</u>. Newly-created directorships resulting from any increase in the number of directors and any vacancies on the Board resulting

------

from death, resignation, removal, or other cause shall only be filled as provided in the Certificate of Incorporation.

**MEETINGS OF THE BOARD**

Section 7. <u>Regular Meetings</u>. Regular meetings of the Board shall be held at such place or places, on such date or dates, and at such time or times as shall have been established by the Board and publicized among all directors. A further notice of each regular meeting shall not be required.

Section 8. <u>Special Meetings</u>. Special meetings of the Board may be called by the Chairman of the Board, by one-third of the directors then in office, or by the Vice Chairman of the Board, if any; and shall be held at such place, on such date, and at such time as such person(s) shall fix. Notice of the place, date, and time of each such special meeting shall be given to each director by whom it is not waived by providing written notice not less than four hours before the scheduled time of such meeting. Unless otherwise indicated in the notice thereof, any and all business may be transacted at a special meeting.

Section 9. <u>Telephonic Meetings Permitted</u>. Members of the Board, or any committee designated by the Board, may participate in a meeting thereof by means of conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other, and participation in a meeting pursuant to this <u>Section 9</u> shall constitute presence in person at such meeting.

Section 10. <u>Quorum</u>. At all meetings of the Board a majority of the directors then in office shall constitute a quorum for the transaction of business and the act of a majority of the directors present at any meeting at which there is a quorum shall be the act of the Board, except as may be otherwise provided herein or be required by law. If a quorum shall not be present at any meeting of the Board, the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum shall be present.

Section 11. <u>Organization and Order of Business</u>. At each meeting of the Board, the Chairman of the Board shall act as chairman of and preside at the meeting. If the Chairman is not present, the Vice Chairman of the Board, if any, shall act as chairman of and preside at the meeting. If the Chairman of the Board or the Vice Chairman of the Board, if any, is not the Chief Executive Officer, in the absence of the Chairman and the Vice Chairman, the Chief Executive Officer shall act as chairman of and preside at the meeting. If the Chairman of the Board, the Vice Chairman of the Board, if any, and the Chief Executive Officer are not present, any director chosen by a majority of the directors present shall act as chairman of and preside at the meeting.

------

The Secretary or, if he or she shall be absent from such meeting, any person whom the chairman of such meeting shall appoint, shall act as secretary of such meeting and keep the minutes thereof. The order of business at each meeting shall be determined by the chairman of such meeting.

Section 12. <u>Director Consent in Lieu of Meeting</u>. Any action required or permitted to be taken at any meeting of the Board or of any committee thereof may be taken without a meeting, if all members of the Board or of such committee as the case may be, consent thereto in writing, or by electronic transmission, and such writing or transmission is filed with the minutes of proceedings of the Board or committee.

**COMMITTEES OF DIRECTORS**

Section 13. <u>Committees of the Board</u>. The Board may, by resolution passed by a majority of the whole Board, create one or more committees including, but not limited to, an Executive Committee, which, to the extent provided in the resolution or a committee charter adopted by the Board, shall have and may exercise all of the delegable powers of the Board in the management of the business and affairs of the Corporation. Such committee or committees shall have such name or names as may be determined from time to time by resolution adopted by the Board. The Board shall also determine the membership of each such committee.

Section 14. <u>Executive Committee</u>. There shall be an Executive Committee, whose membership shall include the Chairman of the Board, the Vice Chairman of the Board, if any, and, if separate, the Chief Executive Officer, which during the intervals between meetings of the Board shall have all the delegable powers and duties of the Board, except with respect to matters delegated to another committee and except as shall have been otherwise provided by the Board. All action taken by the Executive Committee since the last meeting of the Board shall be reported to the Board at its next meeting.

Section 15. <u>Conduct of Business</u>. Each committee may determine the procedural rules for meeting and conducting its business and shall act in accordance therewith, except as otherwise provided herein, required by law, or provided in the resolution creating such committee. Adequate provision shall be made for notice to members of all meetings; a majority of directors then serving on any committee shall constitute a quorum (provided that if a committee has an even number of members, one-half of the members shall constitute a quorum); and all matters shall be determined by a majority vote of the members present.

------

Section 16. <u>Emergency Bylaws</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)This <u>Section 16</u> shall be applicable during any emergency condition as a result of which a quorum of the Board cannot readily be convened in accordance with the procedures prescribed therefor above (any such event, an "emergency"). To the extent not in conflict with this <u>Section 16</u>, the remaining provisions of these Bylaws shall remain in effect during the emergency.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)During any emergency, a special meeting of the Board may be called by any officer or director by any means feasible at the time. In the event a quorum of the Board cannot be obtained for such a meeting, an emergency committee of the Board may be convened.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)An emergency committee of the Board shall consist of any members of the Board who are available and able to act and, in the event fewer than three members of the Board are available and able to act, one or more persons standing highest on the following list who are available and able to act, but not to exceed the number of persons needed to comprise an emergency committee of three:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)President, if not a member of the Board;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)Chief Financial Officer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) General Counsel; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Any other Executive Officer (as defined below) in order of seniority.

Each member of the emergency committee thus constituted who is not a director shall continue to act in such capacity until a director or an individual standing higher on the list is available to replace them. The emergency committee shall continue to act until a quorum of the Board is available and able to act. If, at the conclusion of the emergency, the Corporation has fewer than three directors able to act, the emergency committee shall cause a special meeting of stockholders for the election of directors to be called and held as soon as practicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)The emergency committee shall have and may exercise all of the powers and authority of the Board, including the power to implement any emergency succession plan for the Chief Executive Officer previously adopted by the Board, to fill a vacancy in any other office of the Corporation or to designate a temporary replacement for any officer of the Corporation who is unavailable, but shall not have the power to fill vacancies in the Board.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)A majority of the members of the emergency committee shall constitute a quorum.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)Each member of the emergency committee who is not a director shall, during his or her service as such, be entitled to the rights and immunities conferred by the DGCL, the Certificate of Incorporation, and these Bylaws upon directors of the Corporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)Upon the termination of the emergency, the foregoing emergency bylaw provisions shall cease to be operative.

**COMPENSATION OF DIRECTORS**

Section 17. <u>Compensation</u>. The directors may be reimbursed for their expenses, if any, of attendance at each meeting of the Board, of special and standing committees thereof, and in connection with other business of the Corporation and may be paid for their services as directors and as members of such committees as may be determined by resolutions adopted by the Board from time to time. No such payment shall preclude any director from serving the Corporation in any other capacity and receiving compensation therefor.

**ARTICLE III** 

**<u>NOTICES</u>**

Section 1. <u>Notices</u>. Whenever notice is required to be given to any stockholder, director, officer, or agent, such requirement shall not be construed to mean personal notice. Whenever notice is required to be given to any stockholder, such notice may in every instance be effectively given by regular or expedited United States mail, recognized courier service for overnight delivery, telegram, cable, telex, or telecopier, facsimile transmission, or by electronic mail or other electronic transmission (if such stockholder has consented to such form of electronic transmission) addressed to such stockholder at his or her address as the same appears on the books of the Corporation, including an electronic mail address at which the stockholder has consented to receive notice. Notice shall be deemed given (a) if by facsimile telecommunication, when directed to the number at which the stockholder has consented to receive notice, (b) if by electronic mail, when directed to an electronic mail address at which the stockholder has consented to receive notice, (c) if by a posting on an electronic network together with separate notice to the stockholder of such specific posting, upon the later of (i) such posting and (ii) the giving of such separate notice, and (d) in all other instances, when such notice is dispatched.

------

Any notice required to be given to any director may be given by any of the methods in the foregoing paragraph. Any such notice, other than one which is delivered personally, shall be sent to such post office address, facsimile number, or electronic mail address as such director shall have filed in writing with the Secretary, or, in the absence of such filing, to the last known such address or number of such director. It shall not be necessary that the same method of giving notice be employed in respect of all directors, but one permissible method may be employed in respect of any one or more, and any other permissible method or methods may be employed in respect of any other or others.

Section 2. <u>Waivers</u>. A written waiver of any notice, signed by a stockholder, director, officer, or agent, whether before or after the time of the event for which notice is to be given, shall be deemed equivalent to the notice required to be given to such stockholder, director, officer, or agent. Neither the business nor the purpose of any meeting need be specified in such a waiver.

**ARTICLE IV** 

**<u>OFFICERS</u>**

Section 1. <u>Officers</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The officers of the Corporation shall be a Chief Executive Officer, who shall be a member of the Board; a President; a Chief Financial Officer; one or more Vice Presidents including Executive Vice Presidents; a Secretary; a General Counsel; a Treasurer; and such other officers as the Board or the Chief Executive Officer may deem expedient. Any one person may hold any number of offices of the Corporation at any one time unless specifically prohibited therefrom by law. Any office of the Corporation may be left vacant from time to time at the discretion of the Board.

&nbsp;&nbsp;&nbsp;&nbsp;Any officer who is subject to Section 16 of the Exchange Act (an "<u>Executive Officer</u>") must be elected by the Board and shall hold office for such term as the Board may prescribe. All other officers designated by this <u>Section 1(a)</u> may be appointed by the Chief Executive Officer and shall hold office for such term as the Chief Executive Officer may prescribe. The Chief Executive Officer may, from time to time, in his or her discretion, assign titles, powers, duties, and reporting arrangements for any officer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)In addition to the officers designated in <u>Section 1(a)</u> of this <u>Article IV</u>, the Corporation may have one or more appointed Vice Presidents and Executive Vice Presidents, Assistant Secretaries, Assistant Treasurers, or other officers, who shall also be officers of the Corporation (each an "<u>Appointed Officer</u>"). Any Appointed Officer may be appointed by the

------

Chief Executive Officer. The Chief Executive Officer may from time to time, in his or her discretion, assign titles, powers, duties, scope of job responsibilities, and reporting arrangements for any Appointed Officer. Appointed Officers shall hold office for such term as the Chief Executive Officer shall prescribe.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Any Executive Officer may be removed at any time by the Board. If the office of any such Executive Officer becomes vacant for any reason, the vacancy may be left vacant or be filled by the Board. Any other officer, including any Appointed Officer, may be removed at any time by the Chief Executive Officer. If the office of any such officer becomes vacant for any reason, the vacancy may be left vacant or be filled by the Chief Executive Officer. Nothing in these Bylaws shall be construed as creating any kind of contractual right to employment with the Corporation.

Section 2. <u>Chief Executive Officer</u>. Subject to the provisions of these Bylaws and to the direction of the Board, the Chief Executive Officer shall have the responsibility for the general management and control of the business and affairs of the Corporation and shall have such other powers and perform such other duties as are incident to his or her office or as may be properly required of him or her by the Board. He or she may sign, execute, and deliver in the name of the Corporation, certificates for shares of the capital stock of the Corporation any deeds, mortgages, bonds, contracts, or other instruments which the Board shall have authorized to be executed, except in cases where the signing and execution thereof shall be expressly delegated by the Board or by these Bylaws to some other officer or agent of the Corporation or shall be required by law otherwise to be signed or executed. He or she may delegate his or her powers to the President of the Corporation, if any, or otherwise to the extent determined by the Board. He or she may from time to time appoint, remove, or change members of and discharge one or more advisory committees, each of which shall consist of such number of persons (who may, but need not, be directors or officers of the Corporation), and have such advisory duties as he or she shall determine.

Section 3. <u>President</u>. Unless the President of the Corporation is the Chief Executive Officer, the President of the Corporation shall have such powers and shall perform such duties as shall be assigned to him or her by the Board or the Chief Executive Officer.

Section 4. <u>Chief Financial Officer</u>. The Chief Financial Officer shall be the head of the finance functions of the Corporation and shall consider the adequacy of, and make recommendations to the Board and the Chief Executive Officer concerning, the capital resources available to the Corporation to meet its projected obligations and business plans; report to the Board and the Chief Executive Officer on financial results and trends affecting the business; and

------

have such other powers and perform such other duties as may from time to time be granted or assigned to him or her by the Board or the Chief Executive Officer.

Section 5. <u>Vice Presidents</u>. The Vice Presidents including Executive Vice Presidents shall perform such duties as from time to time shall be assigned by the Chief Executive Officer and have such powers as may be prescribed from time to time by the Board or the Chief Executive Officer.

Section 6. <u>General Counsel</u>. The General Counsel shall be the chief legal officer of the Corporation and the head of its legal department. He or she shall, in general, perform the duties incident to the office of General Counsel and all such other duties as from time to time may be assigned to him or her by the Chief Executive Officer. In case one or more Associate or Assistant General Counsels shall be appointed, the General Counsel may delegate to them authority to perform such of his or her duties as he or she may determine.

Section 7. <u>Secretary</u>. The Secretary shall keep records of all of the meetings of the Corporation and of the Board and shall perform like duties for the standing committees when required. He or she shall give, or cause to be given, notice of all meetings of the stockholders and special meetings of the Board, and shall perform all the duties incident to the office of Secretary and all such other duties as may be assigned to him or her by the Chief Executive Officer. He or she shall keep, or cause to be kept, at the principal office or at the office of the Corporation's transfer agent or registrar, a share register, or a duplicate share register, showing the names of all stockholders and their addresses, the number and classes of shares held by each, the number and date of certificates issued for the same, and the number and date of cancellation of every certificate surrendered for cancellation. He or she shall have custody of the corporate seal of the Corporation and he or she, or an Assistant Secretary, shall have authority to affix the same to any instrument requiring it and when so affixed, it may be attested by his or her signature or by the signature of such Assistant Secretary. In case one or more Assistant Secretaries shall be appointed, the Secretary may delegate to them authority to perform such of his or her duties as he or she may determine.

Section 8. <u>Treasurer</u>. The Treasurer shall have custody of the funds and securities of the Corporation and shall keep regular accounts of receipts and disbursements. He or she shall deposit all moneys and other valuable effects belonging to the Corporation in accounts established in such depositories as may be designated by the Corporation pursuant to authority granted by the Board. He or she shall make such disbursement of the funds of the Corporation as are proper and shall render to the Chairman of the Board and the Board, at its regular meetings, or when the Board so requires, an account of all his or her transactions as Treasurer and of the financial condition of the Corporation. He or she shall perform all the duties incident to the office

------

of Treasurer and all such other duties as may be assigned to him or her by the Chief Executive Officer. In case one or more Assistant Treasurers shall be appointed, the Treasurer may delegate to them authority to perform such of his or her duties as he or she may determine.

**ARTICLE V**

**<u>INDEMNIFICATION OF DIRECTORS AND OFFICERS</u>**

Section 1. <u>Interpretation, Amendment, and Survival of this Article</u>. The indemnification and advancement rights provided by this <u>Article V</u> shall each be enforceable by each present and former officer and director of the Corporation (hereinafter, an "<u>indemnitee</u>"), shall vest as of the date an indemnitee first performs or performed service as an officer or director, and are contract rights upon which the indemnitee shall be presumed to have relied in determining to serve or continuing to serve in his or her capacity with the Corporation. Neither the amendment or repeal of the indemnification and/or the advancement rights, nor the adoption of any new provision of the Certificate of Incorporation or these Bylaws, nor, to the fullest extent permitted by Delaware law, any modification of law, shall eliminate or reduce the effect of the indemnification and/or advancement rights in respect of any acts or omissions occurring prior to such amendment, repeal, adoption or modification.

Section 2. <u>Power to Indemnify in Actions, Suits, or Proceedings Other Than</u> <u>Those by or in the Right of the Corporation</u>. Subject to <u>Section 4</u> of this <u>Article V</u>, the Corporation shall indemnify, to the fullest extent authorized by the DGCL, any indemnitee who was or is a party or is threatened to be made a party to any threatened, pending, or completed action, suit, or proceeding, whether civil, criminal, administrative, or investigative (other than an action by or in the right of the Corporation) by reason of the fact that he or she is or was a director or officer of the Corporation, or is or was a director or officer of the Corporation serving at the request of the Corporation as a director or officer, or agent of another corporation, partnership, joint venture, trust, employee benefit plan, or other enterprise, against expenses (including attorneys' fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit, or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The termination of any action, suit, or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create a presumption that the indemnitee did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the Corporation, or, with respect to any criminal action or proceeding, had reasonable cause to believe that his or her conduct was unlawful.

------

Section 3. <u>Power to Indemnify in Actions, Suits, or Proceedings by or in the Right of the Corporation</u>. Subject to <u>Section 4</u> of this <u>Article V</u>, the Corporation shall indemnify any indemnitee who was or is a party or is threatened to be made a party to any threatened, pending, or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that he or she is or was a director or officer of the Corporation, or is or was a director or officer of the Corporation serving at the request of the Corporation as a director or officer, or agent of another corporation, partnership, joint venture, trust, employee benefit plan, or other enterprise against expenses (including attorneys' fees) actually and reasonably incurred by him or her in connection with the defense or settlement of such action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Corporation; except that no indemnification shall be made in respect of any claim, issue, or matter as to which such indemnitee shall have been adjudged to be liable to the Corporation unless the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity, and only to the extent of such expenses which the Court of Chancery or such other court shall deem proper.

Section 4. <u>Authorization of Indemnification</u>. Any indemnification under this <u>Article V</u> (unless ordered by a court) shall be made by the Corporation only as authorized in the specific case upon a determination that indemnification of the director or officer is proper in the circumstances because he or she has met the applicable standard of conduct set forth in <u>Section 2</u> or <u>Section 3</u> of this <u>Article V</u>, as the case may be. Such determination shall be made: (a) by the Board by a majority vote of directors who were not parties to such action, suit, or proceeding ("<u>disinterested directors</u>"); (b) if there are no disinterested directors or if such disinterested directors so direct, by independent legal counsel in a written opinion; or (c) by the stockholders; <u>provided</u>, <u>however</u>, that in the event of a Change in Control (as defined below) of the Corporation, any such determination made with respect to conduct occurring before the Change in Control shall be made by independent legal counsel. Notwithstanding the above, to the extent that an indemnitee has been successful on the merits or otherwise in defense of any action, suit, or proceeding described above, or in defense of any claim, issue, or matter therein, he or she shall be indemnified against expenses (including attorneys' fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by him or her in connection therewith, without the necessity of authorization in the specific case.

Section 5. <u>Indemnification by a Court</u>. Notwithstanding any contrary determination in the specific case under <u>Section 4</u> of this <u>Article V</u>, and notwithstanding the absence of any determination thereunder, any director or officer may apply to the Court of Chancery of the State of Delaware for indemnification to the extent otherwise permissible under <u>Section 2</u> and <u>Section 3</u> of this <u>Article V</u>. The basis of such indemnification by a court shall be a determination by such

------

court that indemnification of the indemnitee is proper in the circumstances because such indemnitee has met the applicable standards of conduct set forth in <u>Section 2</u> or <u>Section 3</u> of this <u>Article V</u>, as the case may be. Neither a contrary determination in the specific case under <u>Section 4</u> of this <u>Article V</u> nor the absence of any determination thereunder shall be a defense to such application or create a presumption that the indemnitee seeking indemnification has not met any applicable standard of conduct. Notice of any application for indemnification pursuant to this <u>Section 5</u> shall be given to the Corporation promptly upon the filing of such application. If successful, in whole or in part, the director or officer seeking indemnification shall also be entitled to be paid the expense of prosecuting such application.

Section 6. <u>Successful Defense; Partial Indemnification</u>. If any action, suit or proceeding is disposed of, on the merits or otherwise (including a disposition without prejudice), without: (a) the disposition being adverse to an indemnitee; (b) an adjudication that the indemnitee was liable to the Corporation; (c) a plea of guilty or nolo contendere by the indemnitee; (d) an adjudication that the indemnitee did not act in good faith and in a manner the indemnitee reasonably believed to be in or not opposed to the best interests of the Corporation; or (e) with respect to any criminal proceeding, an adjudication that the indemnitee had reasonable cause to believe his or her conduct was unlawful, the indemnitee shall be considered for the purposes of this <u>Article V</u> to have been successful with respect thereto.

If an indemnitee is entitled under any provision of this <u>Article V</u> to indemnification by the Corporation for a portion of the expenses (including attorneys' fees), judgments, fines, or amounts paid in settlement actually and reasonably incurred by the indemnitee or on the indemnitee's behalf in connection with any action, suit, proceeding, or investigation, or in defense of any claim, issue or matter therein, and any appeal therefrom but not for the total amount thereof, the Corporation shall nevertheless indemnify the indemnitee for the portion of such expenses (including attorneys' fees), judgments, fines, or amounts paid in settlement actually and reasonably incurred to which the indemnitee is entitled.

Section 7. <u>Advance Payment of Expenses</u>. Expenses (including attorneys' fees) reasonably incurred by the indemnitee in defending a threatened or pending civil, criminal, administrative, or investigative action, suit, or proceeding, or in connection with an enforcement action pursuant to <u>Section 8(b)</u> of this <u>Article V</u>, shall be paid by the Corporation in advance of the final disposition of such action, suit, or proceeding within 10 calendar days after receipt by the Corporation of (a) the statement or statements described in <u>Section 8(a)</u> of this <u>Article V</u> from the indemnitee requesting such advance or advances from time to time and (b) an undertaking by or on behalf of the indemnitee to repay such amount or amounts, only if, and to the extent that, it shall ultimately be determined that he or she is not entitled to be indemnified by the Corporation or, in the case of an enforcement action pursuant to <u>Section 8(b)</u> of this <u>Article</u> 

------

<u>V</u>, the indemnitee is not successful in such action. Such undertaking shall be accepted without reference to the financial ability of the indemnitee to make such repayment. Advances shall be made without regard to whether a determination that indemnification is proper has been made in accordance with <u>Section 4</u> of this <u>Article V</u>. Advances shall be unsecured and interest-free.

Section 8. <u>Procedure</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)To obtain an advance or final indemnification, an indemnitee shall promptly submit to the Secretary a written request, including therein or therewith such documentation and information as is reasonably available to the indemnitee and is reasonably necessary to determine whether and to what extent the indemnitee is entitled to indemnification. The Secretary shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that the indemnitee has requested indemnification.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The Corporation's determination whether to grant the indemnitee's advance or final indemnification request shall be made promptly, and in any event within 10 calendar days following receipt of a request for advancement pursuant to <u>Section 7</u> of this <u>Article V</u> or within 30 calendar days of any other indemnification request. The rights to indemnification and advancement as granted by <u>Section 2</u>, <u>Section 3</u>, or <u>Section 7</u> of this <u>Article V</u> shall be enforceable by the indemnitee in any court of competent jurisdiction if the Corporation denies such request, in whole or in part, or fails to respond within such 10-calendar day period or 30-calendar day period, respectively. It shall be a defense to any such action (other than an action brought to enforce a claim for the advance of costs, charges, and expenses under <u>Section 7</u> of this <u>Article V</u>) that the indemnitee has not met the standard of conduct set forth in <u>Section 2</u> or <u>Section 3</u> of this <u>Article V</u>, as applicable, but the burden of proving such defense shall be on the Corporation. Neither the failure of the Corporation (including its Board or one of its committees, its independent legal counsel, and its stockholders) to have made a determination prior to the commencement of such action that indemnification of the indemnitee is proper in the circumstances because the indemnitee has met the applicable standard of conduct set forth in <u>Section 2</u> or <u>Section 3</u> of this <u>Article V</u>, nor the fact that there has been an actual determination by the Corporation (including its Board or one of its committees, its independent legal counsel, or its stockholders) that the indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that the indemnitee has or has not met the applicable standard of conduct. An indemnitee's expenses (including attorneys' fees) reasonably incurred in connection with successfully establishing the indemnitee's rights to indemnification and advancement, in whole or in part, in any such proceeding or otherwise shall also be indemnified by the Corporation.

------

Section 9. <u>Insurance</u>. The Corporation may purchase and maintain insurance on behalf of any person who is or was a director or officer of the Corporation, or is or was a director or officer of the Corporation serving at the request of the Corporation as a director, officer, or agent of another corporation, partnership, joint venture, trust, employee benefit plan, or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person's status as such, whether or not the Corporation would have the power or the obligation to indemnify such person against such liability under the provisions of this <u>Article V</u>.

Section 10. <u>Certain Definitions</u>. For purposes of this <u>Article V</u>, the following definitions shall apply:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The term "<u>action, suit, or proceeding</u>" shall be broadly construed and shall include, without limitation, the investigation, preparation, prosecution, defense, settlement, arbitration and appeal of, and the giving of testimony in, any threatened, pending, or completed claim, action, suit, or proceeding, whether civil, criminal, administrative, or investigative.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The term "<u>by reason of the fact that he or she is or was a director or officer of the Corporation</u>," shall be broadly construed and shall include, without limitation, any actual or alleged act or omission to act.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The term "<u>expenses</u>" shall be broadly and reasonably construed and shall include, without limitation, all direct and indirect costs of any type or nature whatsoever including, without limitation, all attorneys' fees and related disbursements, appeal bonds, and other out-of-pocket costs actually and reasonably incurred by the indemnitee in connection with either the investigation, defense, or appeal of an action, suit, or proceeding or establishing or enforcing a right to indemnification under this <u>Article V</u>, Section 145 of the DGCL, or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)The term "<u>judgments, fines, and amounts paid in settlement</u>" shall be broadly construed and shall include, without limitation, all direct and indirect payments of any type or nature whatsoever (including, without limitation, all penalties and amounts required to be forfeited or reimbursed to the Corporation), as well as any penalties or excise taxes assessed on a person with respect to an employee benefit plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)The term "<u>Corporation</u>" shall include, without limitation and in addition to the resulting corporation, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger which, if its separate existence had continued, would have had power and authority to indemnify its directors, officers, or agents, so that any person who is or was a director, officer, or agent of such constituent corporation, or is or was serving at the

------

request of such constituent corporation as a director, officer, or agent of another corporation, partnership, joint venture, trust, employee benefit plan, or other enterprise, shall stand in the same position under the provisions of this <u>Article V</u> with respect to the resulting or surviving corporation as he or she would have with respect to such constituent corporation if its separate existence had continued.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)The term "<u>other enterprises</u>" shall include, without limitation, employee benefit plans.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)The term "<u>serving at the request of the Corporation</u>" shall include, without limitation, any service as a director or officer of the Corporation which imposes duties on, or involves services by, such director or officer with respect to an employee benefit plan or its participants or beneficiaries.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)The term "<u>Change in Control</u>" of the Corporation shall mean any event or series of events which results in individuals who were members of the Corporation's Board at the beginning of a two-year period no longer constituting the majority of the Board at the end of the two-year period.

Section 11. <u>Limitation on Indemnification</u>. Notwithstanding any other provision herein to the contrary, the Corporation shall not be obligated pursuant to this <u>Article V</u>:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)To indemnify or advance expenses to an indemnitee with respect to an action, suit, or proceeding (or part thereof) initiated by the indemnitee, except with respect to an action, suit, or proceeding brought to establish or enforce a right to indemnification (which shall be governed by the provisions of <u>Section 8(b)</u> and <u>Section 11(b)</u> of this <u>Article V</u>), unless such action, suit, or proceeding (or part thereof) was authorized or consented to by the Board of the Corporation.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)To indemnify an indemnitee for any expenses incurred by the indemnitee with respect to any action, suit, or proceeding instituted by the indemnitee to enforce or interpret this <u>Article V</u> or any other right to indemnification, unless the indemnitee is successful in establishing the indemnitee's right to indemnification in such action, suit, or proceeding, in whole or in part, or unless and to the extent that the court in such action, suit, or proceeding shall determine that, despite the indemnitee's failure to establish their right to indemnification, the indemnitee is entitled to indemnity for such expenses; <u>provided</u>, <u>however</u>, that nothing in this <u>Section 11(b)</u> is intended to limit the Corporation's obligation with respect to the advancement of expenses to an indemnitee in connection with any such action, suit, or proceeding.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)To indemnify an indemnitee on account of any proceeding with respect to which final judgment is rendered against the indemnitee for payment or an accounting of profits arising from the purchase or sale by the indemnitee of securities in violation of Section 16(b) of the Exchange Act or any similar successor statute.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)To indemnify or to advance expenses to any indemnitee with respect to service at the request of the Corporation as a director, officer, employee, or agent of another corporation, partnership, joint venture, trust, or other enterprise to the extent of any amount the indemnitee receives as indemnification or advancement of expenses from such other corporation, partnership, joint venture, trust, or other enterprise.

Section 12. <u>Certain Settlement Provisions</u>. The Corporation shall have no obligation to indemnify an indemnitee under this <u>Article V</u> for amounts paid in settlement of any action, suit, or proceeding without the Corporation's prior written consent, which shall not be unreasonably withheld. The Corporation shall not settle any action, suit, or proceeding in any manner that would impose any fine or other obligation on the indemnitee without the indemnitee's prior written consent, which shall not be unreasonably withheld.

Section 13. <u>Nonexclusivity</u>. The provisions for indemnification and advancement of expenses set forth in this <u>Article V</u> shall not be deemed exclusive of any other rights which an indemnitee may have under any provision of law, the Certificate of Incorporation, in any court in which a proceeding is brought, the vote of the Corporation's stockholders or disinterested directors, agreements, or otherwise, and the indemnitee's rights hereunder shall continue after the indemnitee has ceased acting as a director or officer of the Corporation and shall inure to the benefit of the heirs, executors, and administrators of the indemnitee.

**ARTICLE VI**

**<u>DELEGATION OF AUTHORITY</u>**

Section 1. <u>Execution of Documents</u>. The Board shall designate the officers, employees, and agents of the Corporation who shall have power to execute and deliver deeds, contracts, mortgages, bonds, debentures, checks, drafts, and other orders for the payment of money and other documents for and in the name of the Corporation and may authorize such officers, employees, and agents to delegate such power (including authority to redelegate) by written instrument to other officers, employees, or agents of the Corporation. Such designation may be by resolution or otherwise, and the authority granted may be general or confined to specific instances, all as the Board may determine.

------

Section 2. <u>Proxies in Respect of Stock or Other Securities of Other</u> <u>Corporations</u>. The Board shall designate the officers of the Corporation who shall have authority to appoint from time to time an agent or agents of the Corporation to exercise in the name and on behalf of the Corporation the powers and rights which the Corporation may have as the holder of stock or other securities or interests in any other corporation or business entity and to vote or consent in respect of such stock securities or interests; such designated officers may instruct the person or persons so appointed as to the manner of exercising such powers and rights; and such designated officers may execute or cause to be executed in the name and on behalf of the Corporation and under its corporate seal, or otherwise, such written proxies, powers of attorney, or other instruments as they may deem necessary or proper in order that the Corporation may exercise such powers and rights.

**ARTICLE VII** 

**<u>STOCK</u>**

Section 1. <u>Certificates of Stock</u>. Every holder of stock in the Corporation shall be entitled to have a certificate signed by, or in the name of the Corporation by, the Chairman of the Board, Chief Executive Officer, President, or a Vice President and the Treasurer and/or Assistant Treasurer, or the Secretary or an Assistant Secretary, certifying the number of shares owned by him or her in the Corporation. Where a certificate is countersigned (a) by a transfer agent other than the Corporation or its employee or (b) by a registrar other than the Corporation or its employee, any other signature on the certificate may be a facsimile. In case an officer, transfer agent, or registrar who has signed, or whose facsimile signature has been placed upon a certificate shall have ceased to be such officer, transfer agent, or registrar, whether because of death, resignation, or otherwise, before such certificate has been issued or delivered by the Corporation, such certificate may nevertheless be issued and delivered by the Corporation as though the person or persons who signed such certificate or whose facsimile signature has been used thereon had not ceased to be such officer, transfer agent, or registrar. Notwithstanding the foregoing provisions regarding share certificates, the Corporation may provide that, subject to the rights of stockholders under applicable law, some or all of any or all classes or series of the stock may be uncertificated shares.

Section 2. <u>Lost, Stolen, or Destroyed Certificates</u>. In the event of loss, theft, or destruction of any certificate of stock, another may be issued in its place pursuant to such regulations as the Board may establish concerning proof of such loss, theft, or destruction and concerning the giving of a satisfactory bond or bonds of indemnity.

Section 3. <u>Transfers of Stock</u>. Transfers of stock shall be made only upon the transfer books of the Corporation kept at an office of the Corporation or by transfer agents designated to

------

transfer shares of the stock of the Corporation. Except where a certificate is issued in accordance with <u>Section 2</u> of this <u>Article VII</u>, an outstanding certificate for the number of shares involved shall be surrendered for cancellation before a new certificate is issued therefor.

Section 4. <u>Record Date</u>. In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders, or to receive payment of any dividend or other distribution or allotment of any rights or to exercise any rights in respect of any change, conversion, or exchange of stock or for the purpose of any other lawful action, the Board may fix a record date, which record date shall not precede the date on which the resolution fixing the record date is adopted and which record date shall not be more than 60 nor fewer than 10 calendar days before the date of any meeting of stockholders, nor more than 60 calendar days prior to the time for such other action as hereinbefore described; <u>provided</u>, <u>however</u>, that if no record date is fixed by the Board, the record date for determining stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day next preceding the day on which notice is given; and, for determining stockholders entitled to receive payment of any dividend or other distribution or allotment of rights or to exercise any rights of change, conversion, or exchange of stock or for any other purpose, the record date shall be at the close of business on the day on which the Board adopts a resolution relating thereto.

Section 5. <u>Registered Stockholders</u>. The Corporation shall be entitled to recognize the exclusive right of a person registered on its books as the owner of shares and shall not be bound to recognize any equitable or other claim to or interest in such share or shares on the part of any other person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of Delaware.

**ARTICLE VIII**

**<u>GENERAL PROVISIONS</u>**

Section 1. <u>Dividends</u>. Dividends upon the capital stock of the Corporation, subject to the provisions, if any, of the Certificate of Incorporation, may be declared by the Board at any regular or special meeting, pursuant to law. Dividends may be paid in cash, in property, or in shares of the capital stock, subject to the provisions of the Certificate of Incorporation. Before payment of any dividend, there may be set aside out of any funds of the Corporation available for dividends such sum or sums as the directors from time to time, in their absolute discretion, think proper as a reserve or reserves to meet contingencies, or for equalizing dividends, or for repairing or maintaining any property of the Corporation, or for such other purpose as the directors shall think conducive to the interest of the Corporation, and the directors may modify or abolish any such reserve in the manner in which it was created.

------

Section 2. <u>Reliance Upon Books, Reports, and Records</u>. Each director, each member of any committee designated by the Board, and each officer of the Corporation shall, in the performance of his or her duties, be fully protected in relying in good faith upon the books of account or other records of the Corporation and upon such information, opinions, reports, or statements presented to the Corporation by any of its officers or employees, or committees of the Board so designated, or by any other person as to matters which such director or committee member reasonably believes are within such other person's professional or expert competence and who has been selected with reasonable care by or on behalf of the Corporation.

Section 3. <u>Checks</u>. All checks or demands for money and notes of the Corporation shall be signed by such officer or officers or such other person or persons as the Board may from time to time designate.

Section 4. <u>Fiscal Year</u>. The fiscal year of the Corporation shall be fixed by resolution of the Board.

Section 5. <u>Seal</u>. The corporate seal shall have inscribed thereon the name of the Corporation, the year of its organization, and the words "Corporate Seal, Delaware." The Board may give general authority to any officer to affix the seal of the Corporation and to attest the affixing by his or her signature. The seal may be used by causing it or a facsimile thereof to be impressed, affixed, reproduced, or otherwise.

Section 6. <u>Forum for Adjudication of Disputes</u>. Unless the Corporation consents in writing to the selection of an alternative forum, the sole and exclusive forum for (a) any derivative action or proceeding brought on behalf of the Corporation; (b) any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer or other employee of the Corporation to the Corporation or the Corporation's stockholders; (c) any action asserting a claim arising pursuant to any provision of the DGCL, the Certificate of Incorporation or these Bylaws (each as in effect from time to time); or (d) any action asserting a claim governed by the internal affairs doctrine shall be the Court of Chancery of the State of Delaware, or, if the Court of Chancery of the State of Delaware does not have jurisdiction, the Superior Court of the State of Delaware, or, if the Superior Court of the State of Delaware does not have jurisdiction, the United States District Court for the District of Delaware, in each case, subject to said court having personal jurisdiction over the indispensable parties named as defendants therein. If any action the subject matter of which is within the scope of this <u>Section 6</u> is filed in a court other than a court located within the State of Delaware (a "<u>Foreign Action</u>") in the name of any stockholder, such stockholder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce this Section 6 (an "<u>Enforcement Action</u>"),

------

and (y) having service of process made upon such stockholder in any such Enforcement Action by service upon such stockholder's counsel in the Foreign Action as agent for such stockholder. Any person or entity purchasing or otherwise acquiring any interest in shares of capital stock of the Corporation shall be deemed to have notice of and consented to the provisions of this <u>Section 6</u>. The existence of any prior consent pursuant to this <u>Section 6</u> shall not constitute a waiver of the Corporation's ongoing consent right as set forth herein with respect to any current or future actions, proceedings, or claims.

**ARTICLE IX** 

**<u>OFFICES AND RECORDS</u>**

Section 1. <u>Delaware Office</u>. The registered office of the Corporation in the State of Delaware shall be located in the City of Wilmington, County of New Castle, and the name and address of its registered agent is The Corporation Trust Company, 1209 Orange Street, Wilmington, Delaware 19801.

Section 2. <u>Other Offices</u>. The Corporation may have such other offices, either within or without the State of Delaware, as the Board may designate or as the business of the Corporation may from time to time require.

Section 3. <u>Books and Records</u>. The books and records of the Corporation may be kept outside the State of Delaware, except as otherwise required by law, at such place or places as may from time to time be designated by the Board.

**ARTICLE X**

**<u>AMENDMENTS</u>**

Section 1. <u>Amendments</u>. These Bylaws may be altered or repealed by the vote of a majority of the whole Board, subject to the power of the stockholders to alter or repeal any Bylaw made by the Board. Unless otherwise provided in the Certificate of Incorporation, these Bylaws may also be repealed, altered, or amended, and new Bylaws may be adopted, at any meeting of the stockholders, either annual or special, by the affirmative vote of a majority of the stock entitled to vote at such meeting.

## Exhibit 4.3

**Exhibit 4.3**

**AIR PRODUCTS AND CHEMICALS, INC.**

**DESCRIPTION OF SECURITIES REGISTERED** 

**UNDER SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934** 

As of November 20, 2025, Air Products and Chemicals, Inc. (the "Company") has seven classes of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"): (1) our common stock; (2) our 0.500% Euro Notes due 2028; (3) 2.950% Euro Notes due 2031; (4) 0.800% Euro Notes due 2032; (5) 3.250% Euro Notes due 2032; (6) 4.000% Euro Notes due 2035; and (7) 3.450% Euro Notes due 2037.

**Description of Common Stock**

The following is a description of the general terms of the shares of our common stock. This description does not include all of the terms of our common stock and should be read together with our Restated Certificate of Incorporation (our "Certificate of Incorporation"), and our Amended and Restated Bylaws (our "Bylaws"), each of which are included or incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit is a part, and applicable provisions of the General Corporation Law of the State of Delaware (the "DGCL"). We encourage you to read our Certificate of Incorporation, our Bylaws and the applicable provisions of the DGCL, for additional information.

**General** 

We are authorized to issue up to 300,000,000 shares of common stock, par value $1.00 per share ("common stock"), and up to 25,000,000 shares of preferred stock, par value $1.00 per share. Our common stock is listed on the New York Stock Exchange under the symbol "APD."

**Voting**

Each holder of common stock is entitled to one vote per share on all matters requiring a vote of the stockholders. A majority of the votes cast is required for stockholders to elect directors in uncontested elections, while in contested elections directors are elected by a plurality of the votes cast. All other matters put to a stockholder vote generally require the approval of a majority of the shares entitled to vote on the matter and present in person or represented by proxy unless a higher threshold is required by the DGCL. Stockholders do not have cumulative voting rights.

**Dividends**

Holders of common stock are entitled to receive dividends, in cash, securities, or property, as may from time to time be declared by our board of directors, subject to the rights of the holders of any outstanding preferred stock.

**Rights Upon Liquidation**

In the event of our voluntary or involuntary liquidation, dissolution, or winding up, the holders of common stock would be entitled to share equally in our assets available for distribution after payment in full of all debts and

------

after the holders of any outstanding preferred stock have received their liquidation preferences (including accrued and unpaid dividends) in full.

**Statutory Provisions** 

Section 203 of the DGCL prohibits a defined set of transactions between a Delaware corporation and an interested stockholder. An interested stockholder is generally defined as a person who, together with any affiliates or associates of such person, beneficially owns, directly or indirectly, 15% or more of the outstanding voting shares of a corporation. This provision may prohibit business combinations between an interested stockholder and a corporation for a period of three years after the date the interested stockholder becomes an interested stockholder. The term business combination is broadly defined to include mergers, consolidations, sales or other dispositions of assets of the corporation or of any direct or indirect majority-owned subsidiary which assets have an aggregate market value equal to 10% or more of either the aggregate market value of all the assets of the corporation determined on a consolidated basis or the aggregate market value of all the outstanding stock of the corporation, and some other transactions that would increase the interested stockholder's proportionate share ownership in the corporation.

This prohibition is effective unless:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the business combination or the transaction which resulted in the stockholder becoming an interested stockholder is approved by the corporation's board of directors prior to the time the interested stockholder becomes an interested stockholder;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the interested stockholder acquired at least 85% of the voting stock of the corporation, other than stock held by directors who are also officers or by qualified employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer, in the transaction in which it becomes an interested stockholder; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the business combination is approved by a majority of the board of directors and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock which is not owned by the interested stockholder.

**Certificate of Incorporation and Bylaw Provisions** 

Vacancies, and newly-created directorships resulting from any increase in the size of our board, may be filled by a majority vote of all remaining directors, even if the directors then on the board do not constitute a quorum or only one director is left in office. In addition, the board of directors is authorized to issue preferred stock without stockholder approval. These provisions, together with the provisions of Section 203 of the DGCL (as discussed above), could have the effect of delaying, deferring or preventing a change in control or the removal of existing management, of deterring potential acquirers from making an offer to our stockholders and of limiting any opportunity to realize premiums over prevailing market prices for our common stock in connection therewith. This could be the case notwithstanding that a majority of our stockholders might benefit from such a change in control or offer.

------

In addition, our Bylaws contain a forum selection provision for the adjudication of certain disputes. Unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum for (a) any derivative action or proceeding brought on our behalf; (b) any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders; (c) any action asserting a claim arising pursuant to any provision of the DGCL, our Certificate of Incorporation or Bylaws; or (d) any action asserting a claim governed by the internal affairs doctrine will be the Court of Chancery of the State of Delaware, or, if the Court of Chancery of the State of Delaware does not have jurisdiction, the Superior Court of the State of Delaware, or, if the Superior Court of the State of Delaware does not have jurisdiction, the United States District Court for the District of Delaware, in each case, subject to said court having personal jurisdiction over the indispensable parties named as defendants. If any action the subject matter of which is within the scope of the forgoing is filed in a court other than a court located within the State of Delaware in the name of any stockholder, such stockholder shall be deemed to have consented to (i) the personal jurisdiction of the state and federal courts located within the State of Delaware in connection with any action brought in any such court to enforce our forum selection clause and (ii) having service of process made upon such stockholder in any such enforcement action by service upon such stockholder's counsel in such action as agent for such stockholder. Any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock will be deemed to have notice of and consented to the forum selection provision of our Bylaws.

As discussed above, our Certificate of Incorporation authorizes the issuance of undesignated preferred stock, in one or more classes or series. Undesignated preferred stock may enable our board of directors to render it more difficult or to discourage an attempt to obtain control of us by means of a tender offer, proxy contest, merger or otherwise, and to thereby protect the continuity of our management. The issuance of shares of preferred stock may adversely affect the rights of the holders of our common stock. For example, any preferred stock issued may rank prior to our common stock as to dividend rights, liquidation preference or both, may have full or limited voting rights and may be convertible into shares of common stock. As a result, the issuance of shares of preferred stock may discourage bids for our common stock or may otherwise adversely affect the market price of our common stock or any existing preferred stock. In some instances the preferred stock could be issued and have the effect of preventing a merger, tender offer or other takeover attempt that our board of directors opposes.

&nbsp;&nbsp;&nbsp;&nbsp;

**Miscellaneous**

Shares of our common stock are non-assessable and not redeemable and have no sinking fund provisions or subscription, conversion or preemptive rights.

The rights, preferences and privileges of holders of our common stock are subject to the rights of the holders of shares of any series of preferred stock which we may issue.

**Transfer Agent**

The transfer agent for our common stock is Broadridge Corporate Issuer Solutions, Inc.

------

**Description of Notes**

The following description of our 0.500% Euro Notes due 2028 (the "2028 Notes"), our 2.950% Euro Notes due 2031 (the "2031 Notes"), our 0.800% Euro Notes due 2032 (the "2032 Notes"), our 3.250% Euro Notes due 2032 (the "2032B Notes"), our 4.000% Euro Notes due 2035 (the "2035 Notes"), and our 3.450% Euro Notes due 2037 (the "2037 Notes" and, together with the 2028 Notes, the 2031 Notes, the 2032 Notes, the 2032B Notes and the 2035 Notes, the "Notes") is a summary and does not purport to be complete. The description of the Notes is subject to and qualified in its entirety by reference to the Indenture, dated as of April 30, 2020, between the Company and The Bank of New York Mellon Trust Company, N.A. (the "Indenture").

The terms of the 2028 Notes and the 2032 Notes are governed by the Indenture, as supplemented by the Officer's Certificate, dated May 5, 2020 (the "2020 Certificate"). The terms of the 2035 Notes are governed by the Indenture, as supplemented by the Officer's Certificate, dated March 3, 2023 (the "2023 Certificate"). The terms of the 2031 Notes and the 2037 Notes are governed by the Indenture, as supplemented by the Officer's Certificate, dated February 14, 2025 (the "February 2025 Certificate"). The terms of the 2032B Notes are governed by the Indenture, as supplemented by the Officer's Certificate, dated June 16, 2025 (the "June 2025 Certificate" and, together with the 2020 Certificate, the 2023 Certificate and the February 2025 Certificate, the "Certificates"). We encourage you to read the above referenced Indenture, as supplemented by the Certificates, for additional information.

**General**

The following table briefly summarizes certain key terms of the Notes.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2028 Notes** | **2031 Notes** | **2032 Notes** | **2032B Notes** | **2035 Notes** | **2037 Notes** |
| **Principal** | €500,000,000 | €500,000,000 | €500,000,000 | €500,000,000 | €700,000,000 | €500,000,000 |
| **Interest Rate per year** | 0.500% | 2.950% | 0.800% | 3.250% | 4.000% | 3.450% |
| **Issuance Date** | May 5, 2020 | February 14, 2025 | May 5, 2020 | June 16, 2025 | March 3, 2023 | February 14, 2025 |
| **Interest Payment Date** | Annually on May 5, commencing <br>May 5, 2021 | Annually on May 14, commencing May 14, 2025 | Annually on May 5, commencing <br>May 5, 2021 | Annually on June 16, commencing June 16, 2026 | Annually on March 3, commencing March 3, 2024 | Annually on February 14, commencing February 14, 2026 |
| **Maturity Date** | May 5, 2028 | May 14, 2031 | May 5, 2032 | June 16, 2032 | March 3, 2035 | February 14, 2037 |
| **Trading Symbol** | APD28 | APD31 | APD32 | APD32B | APD35 | APD37 |

---

The Notes were issued on the dates, in the amounts and subject to the terms stated in the table above. Each series of Notes was issued in a form of one or more fully registered global securities, without coupons, in denominations of €100,000 in principal amount and integral multiples of €1,000 in excess thereof.

------

Each series of Notes represents our senior unsecured obligations and rank equally with our other unsecured and unsubordinated debt from time to time outstanding. The Notes will not benefit from any sinking fund.

We are permitted to issue additional Notes of each series without the consent of the holders of that series of Notes. As of November 20, 2025 no such additional Notes have been issued.

Each series of Notes is listed on The New York Stock Exchange under the bond trading symbols stated in the table above.

**Interest and Principal**

Each series of Notes bears interest from the date of initial issuance at the fixed rate and on the dates stated in the table above. Interest on the 2028 Notes and the 2032 Notes is payable to the person in whose name such Note is registered at the close of business on the 15th calendar day prior to the applicable interest payment date. Interest on the 2031 Notes, the 2032B Notes, the 2035 Notes and the 2037 Notes is payable to the person in whose name such Note is registered at the close of business on the clearing system business day immediately preceding each interest payment date.

Interest is computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the Notes (or the original issuance date, if no interest has been paid), to but excluding the next scheduled interest payment date. This payment convention is referred to as ACTUAL/ACTUAL (ICMA) as defined in the rulebook of the International Capital Markets Association.

If any interest payment date falls on a day that is not a business day, the interest payment will be postponed to the next day that is a business day, and no interest on such payment will accrue for the period from and after such interest payment date. If the maturity date or date fixed for redemption of any series of Notes falls on a day that is not a business day, the payment of interest and principal shall be made on the next succeeding business day, and no interest on such payment will accrue for the period from and after the maturity date.

**Optional Redemption** 

*2028 Notes*

We may redeem the 2028 Notes, in whole or in part, prior to February 5, 2028 at a redemption price equal to the greater of (i) 100% of the principal amount of the 2028 Notes being redeemed or (ii) the sum of the present values of the remaining scheduled payments of principal and interest thereon that would be due if the 2028 Notes matured on February 5, 2028 (exclusive of any accrued interest) discounted to the redemption date on an annual basis (Actual/Actual (ICMA)) using a discount rate equal to the Comparable Government Bond Rate (as defined in the 2020 Officer's Certificate) plus 20 basis points, plus, in each case, any interest accrued but not paid to the date of redemption.

On or after February 5, 2028, the 2028 Notes will be redeemable at our option at a redemption price equal to 100% of the principal amount of the 2028 Notes being redeemed plus accrued and unpaid interest on the principal amount being redeemed to, but excluding, the redemption date.

------

*2031 Notes*

We may redeem the 2031 Notes, in whole or in part, prior to March 14, 2031 at a redemption price equal to the greater of (i) 100% of the principal amount of the 2031 Notes being redeemed or (ii) the sum of the present values of the remaining scheduled payments of principal and interest thereon that would be due if the 2031 Notes matured on March 14, 2031 (exclusive of any accrued interest) discounted to the redemption date on an annual basis (Actual/Actual (ICMA)) using a discount rate equal to the Comparable Government Bond Rate (as defined in the February 2025 Officer's Certificate) plus 15 basis points, plus, in each case, any interest accrued but not paid to the date of redemption.

On or after March 14, 2031, the 2031 Notes will be redeemable at our option at a redemption price equal to 100% of the principal amount of the 2031 Notes being redeemed plus accrued and unpaid interest on the principal amount being redeemed to, but excluding, the redemption date.

*2032 Notes*

We may redeem the 2032 Notes, in whole or in part, prior to February 5, 2032 at a redemption price equal to the greater of (i) 100% of the principal amount of the 2032 Notes being redeemed or (ii) the sum of the present values of the remaining scheduled payments of principal and interest thereon that would be due if the 2032 Notes matured on February 5, 2032 (exclusive of any accrued interest) discounted to the redemption date on an annual basis (Actual/Actual (ICMA)) using a discount rate equal to the Comparable Government Bond Rate (as defined in the 2020 Officer's Certificate) plus 20 basis points, plus, in each case, any interest accrued but not paid to the date of redemption.

On or after February 5, 2032, the 2032 Notes will be redeemable at our option at a redemption price equal to 100% of the principal amount of the 2032 Notes being redeemed plus accrued and unpaid interest on the principal amount being redeemed to, but excluding, the redemption date.

*2032B Notes*

We may redeem the 2032B Notes, in whole or in part, prior to April 16, 2032 at a redemption price equal to the greater of (i) 100% of the principal amount of the 2032B Notes being redeemed or (ii) the sum of the present values of the remaining scheduled payments of principal and interest thereon that would be due if the 2032B Notes matured on April 16, 2032 (exclusive of any accrued interest) discounted to the redemption date on an annual basis (Actual/Actual (ICMA)) using a discount rate equal to the Comparable Government Bond Rate (as defined in the June 2025 Officer's Certificate) plus 15 basis points, plus, in each case, any interest accrued but not paid to the date of redemption.

On or after April 16, 2032, the 2032B Notes will be redeemable at our option at a redemption price equal to 100% of the principal amount of the 2032B Notes being redeemed plus accrued and unpaid interest on the principal amount being redeemed to, but excluding, the redemption date.

*2035 Notes*

We may redeem the 2035 Notes, in whole or in part, prior to December 3, 2034 at a redemption price equal to the greater of (i) 100% of the principal amount of the 2035 Notes being redeemed or (ii) the sum of the present

------

values of the remaining scheduled payments of principal and interest thereon that would be due if the 2035 Notes matured on December 3, 2034 (exclusive of any accrued interest) discounted to the redemption date on an annual basis (Actual/Actual (ICMA)) using a discount rate equal to the Comparable Government Bond Rate (as defined in the 2023 Officer's Certificate) plus 25 basis points, plus, in each case, any interest accrued but not paid to the date of redemption.

On or after December 3, 2034, the 2035 Notes will be redeemable at our option at a redemption price equal to 100% of the principal amount of the 2035 Notes being redeemed plus accrued and unpaid interest on the principal amount being redeemed to, but excluding, the redemption date.

*2037 Notes*

We may redeem the 2037 Notes, in whole or in part, prior to November 14, 2036 at a redemption price equal to the greater of (i) 100% of the principal amount of the 2037 Notes being redeemed or (ii) the sum of the present values of the remaining scheduled payments of principal and interest thereon that would be due if the 2037 Notes matured on November 14, 2036 (exclusive of any accrued interest) discounted to the redemption date on an annual basis (Actual/Actual (ICMA)) using a discount rate equal to the Comparable Government Bond Rate (as defined in the February 2025 Officer's Certificate) plus 15 basis points, plus, in each case, any interest accrued but not paid to the date of redemption.

On or after November 14, 2036, the 2037 Notes will be redeemable at our option at a redemption price equal to 100% of the principal amount of the 2037 Notes being redeemed plus accrued and unpaid interest on the principal amount being redeemed to, but excluding, the redemption date.

**Redemption Upon Tax Event** 

If, as a result of any change in, or amendment to, the laws of the United States or the official interpretation thereof that is announced or becomes effective, we become or, based upon a written opinion of independent counsel selected by us, there is a substantial probability that we will become obligated to pay certain additional amounts with respect to a series of Notes, then we may redeem, in whole, but not in part, the Notes of the affected series at a redemption price equal to 100% of their principal amount, together with accrued and unpaid interest on such Notes to, but excluding, the redemption date.

**Redemption on Change of Control Triggering Event** 

With respect to each series of Notes, a "*Change of Control Triggering Event*" will be deemed to have occurred in the event of both a Change of Control and a Ratings Decline, as each term is defined in the applicable Certificate. Upon the occurrence of a Change of Control Triggering Event with respect to a series of Notes, we will be required to make an offer (a "Change of Control Offer") to the holders of such series to repurchase all or any part of such series at a purchase price equal to 101% of the aggregate principal amount thereof, together with accrued and unpaid interest thereon to the date of repurchase.

Except as described with respect to a Change of Control Triggering Event, the Indenture does not contain any provisions that permit the holders of the Notes to require that we repurchase or redeem the Notes in the event of a takeover, recapitalization or similar transaction.

------

**Payment of Additional Amounts**

We will, subject to certain exceptions and limitations, pay additional amounts on each series of Notes as is necessary in order that the net payment of the principal of and interest on such Notes to a holder who is not a United States person, after withholding or deduction for any present or future tax, assessment or other governmental charge imposed by the United States or a taxing authority in the United States, will not be less than the amount provided in such Notes to be then due and payable.

&nbsp;&nbsp;&nbsp;&nbsp;

**Events of Default** 

An "event of default" is defined in the Indenture as being any of the following events: (i) default for 30 days in the payment of any interest on the Notes of such series; (ii) default in the payment of principal or premium, if any, due on the Notes of any series; (iii) default for 30 days in the payment of any sinking fund installment on the securities of such series, when due; (iv) default for 90 days in the performance of any other of the covenants or agreements in the Indenture (other than those set forth exclusively in the terms of any other series of securities); or (v) certain events of bankruptcy, insolvency and reorganization.

No event of default with respect to any particular series of Notes necessarily constitutes an event of default with respect to any other series of Notes.

The trustee must give notice of a default to the holders of the series of Notes on which the default exists within 90 days unless the default is cured or waived. However, except in the case of a default in the payment of the principal of, premium on, if any, or interest on any of the securities of such series or in the making of any sinking fund payment with respect to such series, the trustee may withhold this notice if the trustee considers it in the interest of the holders of the Notes of such series to do so. The trustee may not withhold notice in the event of a payment default with regard to principal, interest or a sinking fund.

If an event of default has occurred and is continuing and the event of default is as described in clause (i), (ii), (iii) or (iv) above, either the trustee or the holders of at least 25% in principal amount of the Notes of such series then outstanding may declare the principal of all such securities to be due and payable immediately. If an event of default as described in clause (v) above applies, then all securities issued under the Indenture shall automatically and without acceleration or other action on the part of the trustee or any holder, become immediately due and payable.

However, upon the occurrence of certain conditions specified in the applicable Indenture, past events of default may be waived by the holders of a majority of the aggregate principal amount of the affected securities, except for defaults in the payment of principal of, or any premium or interest on, such Notes or with respect to any covenant or provision which may not be amended without the approval of each holder affected.

The holders of a majority in principal amount of the Notes of each series affected, voting as a separate class, may direct the time, method and place of conducting any proceeding for any remedy available to the trustee under the respective Indenture, subject to certain limitations specified in such Indenture, provided that the holders of securities shall have offered to the trustee reasonable indemnity against costs, expenses and liabilities.

We must certify to the trustee on a yearly basis as to the absence of certain defaults.

------

**Modification of the Indenture**

Together with the trustee, and subject to the consent of the holders of a majority of the outstanding principal amount of the outstanding Notes of all affected series (voting separately), we may modify the respective Indenture or any supplement to such Indenture. Without the consent of each affected Note holder, we may not: (i) extend the final maturity; (ii) reduce the principal amount or rate of interest; (iii) extend the time of payment of interest; (iv) reduce the amount payable upon redemption; (v) reduce the amount of the principal of a discounted security payable upon acceleration of the maturity of the security or in the event of bankruptcy; (vi) impair the right to institute suit to enforce payment or repayment; or (vii) change the provisions in the Indenture that relate to its modification or amendment. Notwithstanding the foregoing, the Indenture permits us, together with the trustee, to make certain specified changes to the Indenture without obtaining the consent of the holders of any series of Notes issued thereunder.

**Discharge and Defeasance**

We may discharge certain obligations to holders with respect to each series of the Notes by irrevocably depositing money or certain securities with the trustee in an amount to pay the entire indebtedness on such securities when due and by satisfying certain additional conditions set forth in the Indenture.

**Trustee, Paying Agents and Security Registrar** 

The Bank of New York Mellon Trust Company, N.A. is the trustee under the Indenture governing the Notes. The Bank of New York Mellon, London Branch, is the paying agent for the notes in London.

We maintain deposit accounts and conduct other banking transactions with the trustee or an affiliate of the trustee in the ordinary course of business.

**Governing Law** 

The Indenture and the Notes are governed by, and construed in accordance with, the laws of the State of New York.

## Exhibit 10.5

Exhibit 10.5

**AIR PRODUCTS AND CHEMICALS, INC.<br>EXECUTIVE<br>SEPARATION PROGRAM**

As Amended Effective as of November 19, 2025

------

ARTICLE I<br>PURPOSE AND TERM OF PLAN

Section 1.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Purpose</u>. Air Products and Chemicals, Inc. hereby establishes the Air Products and Chemicals, Inc. Executive Separation Program (the "<u>Plan</u>") for the purpose of retaining Covered Executives (as defined below), maintaining a stable work environment and providing severance benefits to Covered Executives in the event of certain qualifying terminations of employment.

Section 1.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Term of the Plan</u>. This amendment and restatement of the Plan shall be effective for a Termination of Employment occurring on or after November 19, 2025 (the "<u>Effective Date</u>"). The Plan will continue until such time as the Committee (as defined below) acting in its sole discretion, elects to modify, supersede or terminate the Plan in accordance with, and subject to, the provisions of Article V.

ARTICLE II

DEFINITIONS

Section 2.01&nbsp;&nbsp;&nbsp;&nbsp;"<u>Administrator</u>" shall mean the Committee or, to the extent the Committee delegates its powers in accordance with Section 4.01, its delegate with respect to matters so delegated.

Section 2.02&nbsp;&nbsp;&nbsp;&nbsp;"<u>Air Products</u>" shall mean Air Products and Chemicals, Inc.

Section 2.03&nbsp;&nbsp;&nbsp;&nbsp;"<u>Annual Incentive Plan</u>" shall mean the Air Products and Chemicals, Inc. Annual Incentive Plan and/or any similar, successor or substitute short-term bonus plan, program or pay practice.

Section 2.04&nbsp;&nbsp;&nbsp;&nbsp;"<u>Benefit</u>" or "<u>Benefits</u>" shall mean any or all of the benefits that a Covered Executive is entitled to receive pursuant to Sections 3.02, 3.03 and 3.04.

Section 2.05&nbsp;&nbsp;&nbsp;&nbsp;"<u>Board</u>" means the Board of Directors of Air Products.

Section 2.06&nbsp;&nbsp;&nbsp;&nbsp;"<u>Cause</u>" shall mean (a) the willful failure of a Covered Executive to substantially perform the Covered Executive's duties (other than any such failure due to Disability), after a demand for substantial performance is delivered, which demand shall identify the manner in which the Company believes that the Covered Executive has not substantially performed the Covered Executive's duties, (b) a Covered Executive's engaging in willful and serious misconduct that has caused or would reasonably be expected to result in material injury to the Company or any of its affiliates, (c) a Covered Executive's conviction of, or entering a plea of <u>nolo</u> <u>contendere</u> to, a crime that constitutes a felony, or (d) violation by the Covered Executive of any provision of Air Product's Code of Conduct.

Section 2.07&nbsp;&nbsp;&nbsp;&nbsp;"<u>CEO</u>" shall mean the Chief Executive Officer of Air Products, or a former chief executive officer of Air Products whose removal from such position constituted Good Reason.

------

Section 2.08&nbsp;&nbsp;&nbsp;&nbsp;"<u>Change in Control</u>" shall mean the first to occur of any one of the events described below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Stock Acquisition</u>. Any "person" (as such term is used in Sections 13(d) and 14(d)(2) of the Securities Exchange Act of 1934), other than the Company or a corporation, a majority of whose outstanding stock entitled to vote is owned, directly or indirectly, by the Company, or a trustee of an employee benefit plan or trust sponsored solely by the Company and/or such a corporation, is or becomes, other than by purchase from the Company or such a corporation, the "beneficial owner" (as such term is defined in Rule 13d-3 under the Securities Exchange Act of 1934), directly or indirectly, of securities of the Company representing 30% or more of the combined voting power of the Company's then outstanding voting securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Change in Board</u>. During any period of two consecutive years commencing on or after the Effective Date, individuals who at the beginning of such period were members of the Board cease for any reason to constitute at least a majority of the Board, unless the election or nomination for election by the Company's shareholders of each new director was approved by a vote of at least two-thirds of the directors then still in office who were directors at the beginning of the period. Such a Change in Control shall be deemed to have occurred on the date upon which the requisite majority of directors fail to be elected by the shareholders of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Business Combination</u>. Consummation of a reorganization, merger, consolidation, or other corporate transaction involving the Company (a "<u>Transaction</u>"), in each case, with respect to which the shareholders of the Company immediately prior to such Transaction do not, immediately after the Transaction, own more than 50% of the combined voting power of the Company or other corporation resulting from such Transaction in substantially the same respective proportions as such shareholders' ownership of the voting power of the Company immediately before such Transaction; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Sale or Liquidation</u>. The shareholders of the Company approve a plan of complete liquidation or dissolution of the Company or a sale or disposition of all or substantially all of the Company's assets.

Notwithstanding the foregoing or anything in this Agreement to the contrary, if any payment under this Agreement is "deferred compensation" for purposes of Section 409A, the foregoing definition shall be modified to the extent necessary to avoid the imposition of an excise tax under Section 409A.

Section 2.09&nbsp;&nbsp;&nbsp;&nbsp;"<u>Change in Control Termination of Employment</u>" shall mean termination of the active employment relationship between a Covered Executive and the Company (a) by the Company for reasons other than the Covered Executive's death, Disability or Cause or (b) by the Covered Executive for Good Reason, in each case, within the two years following the effective date of a Change in Control; <u>provided</u> that, if ownership of any subsidiary, unit, division or business of Air Products is divested, spun off, sold or otherwise transferred to a third party or third parties, including the stockholders of Air Products, and the Covered Executive's employment within such divested or transferred subsidiary, unit, division or business continues, the termination of the employment relationship between the Covered Executive and Air Products shall not be a Change in Control Termination of Employment.

Section 2.10&nbsp;&nbsp;&nbsp;&nbsp;"<u>COBRA</u>" shall mean the Consolidated Omnibus Budget Reconciliation Act of 1985.

------

Section 2.11&nbsp;&nbsp;&nbsp;&nbsp;"<u>Code</u>" shall mean the Internal Revenue Code of 1986, as amended.

Section 2.12&nbsp;&nbsp;&nbsp;&nbsp;"<u>Committee</u>" shall mean the Management Development and Compensation Committee of the Board, or other person or persons appointed by the Board, to act on behalf of the Company with respect to the Plan as provided in the Plan.

Section 2.13&nbsp;&nbsp;&nbsp;&nbsp;"<u>Company</u>" shall mean Air Products and any of its wholly or majority owned subsidiaries and affiliates. The term "Company" shall include any successor to Air Products such as a corporation succeeding to the business of Air Products or any subsidiary, by merger, consolidation or liquidation, or purchase of assets or stock or similar transaction.

Section 2.14&nbsp;&nbsp;&nbsp;&nbsp;"<u>Company Officer</u>" shall mean any individual serving as an officer of the Company at executive grade level 218 and above who directly reports to the CEO; <u>provided</u>, <u>however</u>, that any such individual serving in such a capacity on an interim basis of less than six months shall not be a "Company Officer" unless otherwise determined by the Committee, upon the recommendation of the CEO.

Section 2.15&nbsp;&nbsp;&nbsp;&nbsp;"<u>Company Plan</u>" shall mean this Plan or any other plan, policy, arrangement or agreement of or with the Company or any of its affiliates.

Section 2.16&nbsp;&nbsp;&nbsp;&nbsp;"<u>Covered Executive</u>" shall mean any individual serving as an Executive Officer or as a Company Officer at the time of a Termination of Employment; <u>provided</u> that any individual who is an Executive Officer or a Company Officer on or following the Effective Date but who ceases to be designated as an Executive Officer or as a Company Officer during the six-month period preceding a Termination of Employment shall be treated as a Covered Executive for purposes of the Plan.

Section 2.17&nbsp;&nbsp;&nbsp;&nbsp;"<u>Disability</u>" shall be as defined under the Company's long-term disability plan.

Section 2.18&nbsp;&nbsp;&nbsp;&nbsp;"<u>Employment Termination Date</u>" shall mean the date on which a Covered Executive undergoes a Termination of Employment.

Section 2.19&nbsp;&nbsp;&nbsp;&nbsp;"<u>ERISA</u>" shall mean the Employee Retirement Income Security Act of 1974, as amended.

Section 2.20&nbsp;&nbsp;&nbsp;&nbsp;"<u>Executive Officer</u>" shall mean each "executive officer" so designated by the Board pursuant to Rule 3b-7 under the Securities Exchange Act of 1934.

Section 2.21&nbsp;&nbsp;&nbsp;&nbsp;"<u>Fiscal Year</u>" shall mean each period commencing on October 1 and ending on the subsequent September 30.

Section 2.22&nbsp;&nbsp;&nbsp;&nbsp;"<u>Good Reason</u>" shall mean the occurrence of any of the following without a Covered Executive's consent:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;a material adverse change in the Covered Executive's position or office with the Company, including, without limitation, a material diminution in the Covered Executive's duties, reporting responsibilities and authority with the Company; or an assignment to the Covered Executive of duties or responsibilities, which are materially inconsistent with the Covered Executive's status or position with the Company; <u>provided</u> that, any of the foregoing in connection with termination of a Covered Executive's employment for Cause, Retirement or Disability shall not constitute Good Reason;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;reduction of the Covered Executive's Salary or failure by the Company to pay, in substantially equal installments conforming with the Company's normal pay practices, the Covered Executive's Salary; <u>provided</u>, <u>however</u>, that the Company may reduce a Covered Executive's Salary if such reduction is no less favorable to the Covered Executive than the average annual percentage reduction during the applicable Fiscal Year for all Highly Compensated Employees; <u>provided</u>, <u>further</u>, that the Company may adjust its normal payroll practices with respect to the payment of a Covered Executive's Salary; <u>provided</u> that such adjustment is applicable to all Highly Compensated Employees;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;a material reduction in a Covered Executive's annual incentive opportunities under the Annual Incentive Plan without a corresponding increase in other incentive compensation payable by the Company; <u>provided</u>, <u>however</u>, that the Company may reduce a Covered Executive's annual incentive opportunities under the Annual Incentive Plan if such reduction is on a basis no less favorable to the Covered Executive than the basis upon which the Company reduces the annual incentive opportunities payable to all Highly Compensated Employees during the applicable Fiscal Year;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;a material reduction in a Covered Executive's aggregate Company provided benefits under the Company's employee pension benefit, life insurance, medical, dental, health and accident, disability, severance and paid vacation plans, programs and practices; <u>provided</u>, <u>however</u>, that the Company may reduce or adjust the aggregate benefits payable to a Covered Executive if such reduction is on a basis no less favorable to the Covered Executive than the basis on which the Company reduces aggregate benefits payable with respect to Highly Compensated Employees; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;a requirement by the Company that a Covered Executive relocate the Covered Executive's principal place of employment by more than 50 miles from the location in effect immediately prior to the relocation.

Notwithstanding anything to the contrary contained herein, a Covered Executive's termination of employment will not be treated as for Good Reason as the result of the occurrence of any event specified <u>in the foregoing clauses (a) through (e) (each such event, a "Good Reason Event</u>") unless, within 90 days following the occurrence of such Good Reason Event, the Covered Executive provides written notice to the Company of the occurrence of such Good Reason Event, which notice sets forth the exact nature of the Good Reason Event and the conduct required to cure such Good Reason Event. The Company will have 30 days from the receipt of such notice within which to cure such Good Reason Event (such period, the "<u>Cure Period</u>"). If, during the Cure Period, such Good Reason Event is remedied, the Covered Executive will not be permitted to terminate the Covered Executive's employment for Good Reason. If, at the end of the Cure Period, the Good Reason Event has not been remedied, a Covered Executive's voluntary termination will be treated as for Good Reason during the 90-day period that follows the end of the Cure Period. If a Covered Executive does not terminate employment during such 90-day period, the Covered Executive will not be permitted to terminate employment and receive the payments and benefits set forth under this Agreement as a result of such Good Reason Event.

Section 2.23&nbsp;&nbsp;&nbsp;&nbsp;"<u>Grandfathered Covered Executive</u>" shall mean the individuals set forth on Exhibit A.

Section 2.24&nbsp;&nbsp;&nbsp;&nbsp;"<u>Highly Compensated Employees</u>" shall mean the highest paid one percent of employees of the Company together with all corporations, partnerships, trusts or other entities controlling, controlled by or under common control with, the Company.

------

Section 2.25&nbsp;&nbsp;&nbsp;&nbsp;"<u>Long-Term Incentive Plan</u>" shall mean the Air Products and Chemicals, Inc. 2021 Long-Term Incentive Plan, together with all predecessor and similar successor or substitute intermediate and/or long-term incentive compensation plan or program.

Section 2.26&nbsp;&nbsp;&nbsp;&nbsp;"<u>Non-Change in Control Termination of Employment</u>" shall mean termination of the active employment relationship between a Covered Executive and the Company (a) by the Company for reasons other than the Covered Executive's death, Disability or Cause or (b) by the Covered Executive for Good Reason, in each case, other than within the two years following the effective date of a Change in Control; <u>provided</u> that, if ownership of any subsidiary, unit, division or business of Air Products is divested, spun off, sold or otherwise transferred to a third party or third parties, including the stockholders of Air Products, and the Covered Executive's employment within such divested or transferred subsidiary, unit, division or business continues, the termination of the employment relationship between the Covered Executive and Air Products shall not be a Non-Change in Control Termination of Employment.

Section 2.27&nbsp;&nbsp;&nbsp;&nbsp;"<u>Pension Plans</u>" shall mean, the Air Products and Chemicals, Inc. Pension Plan for Salaried Employees, as amended from time to time, together with any similar, succeeding or substitute plan, and the Supplementary Pension Plan of Air Products and Chemicals, Inc. as amended from time to time, together with any similar, succeeding or substitute plan, and any private annuity or pension agreement between the Grandfathered Covered Executive and the Company.

Section 2.28&nbsp;&nbsp;&nbsp;&nbsp;"<u>Plan</u>" shall mean the Air Products and Chemicals, Inc. Executive Separation Program, as set forth herein, and as the same may from time to time be amended.

Section 2.29&nbsp;&nbsp;&nbsp;&nbsp;"<u>Retirement</u>" shall be as defined under the Long-Term Incentive Plan.

Section 2.30&nbsp;&nbsp;&nbsp;&nbsp;"<u>Retirement Savings Plan</u>" shall mean the Air Products and Chemicals, Inc. Retirement Savings Plan, as amended from time to time, together with any similar, succeeding or substitute plan.

Section 2.31&nbsp;&nbsp;&nbsp;&nbsp;"<u>Salary</u>" shall mean an amount equal to the annual rate of a Covered Executive's base salary payable to the Covered Executive in all capacities with the Company and its subsidiaries or affiliates on the Covered Executive's Employment Termination Date.

Section 2.32&nbsp;&nbsp;&nbsp;&nbsp;"<u>Savings Plans</u>" shall mean the Retirement Savings Plan and the Air Products and Chemicals, Inc. Deferred Compensation Plan, as each is amended from time to time, together with any similar, succeeding or substitute plan(s).

Section 2.33&nbsp;&nbsp;&nbsp;&nbsp;"<u>Section 409A</u>" shall mean Section 409A of the Code, and the regulations thereunder as in effect from time to time.

Section 2.34&nbsp;&nbsp;&nbsp;&nbsp;"<u>Severance Multiple</u>" shall mean the number listed in such Covered Executive's applicable tier level in the Schedule of Benefits attached hereto as Exhibit B.

Section 2.35&nbsp;&nbsp;&nbsp;&nbsp;"<u>Statutory Benefits</u>" shall mean any severance or notice payments or benefits provided for by any federal, state, local, foreign or supranational law, statute, regulation, ordinance or rule in connection with an individual's Termination of Employment.

Section 2.36&nbsp;&nbsp;&nbsp;&nbsp;"<u>Target Bonus</u>" shall mean a Covered Executive's target bonus under the Annual Incentive Plan that is approved by the Committee for the applicable Fiscal Year or, if no such target bonus has been determined for such Fiscal Year, such target bonus for the most recent Fiscal Year for which one was determined.

------

Section 2.37&nbsp;&nbsp;&nbsp;&nbsp;"<u>Termination of Employment</u>" shall mean either a Change in Control Termination of Employment or a Non-Change in Control Termination of Employment.

ARTICLE III<br>ENTITLEMENT TO AND DESCRIPTION OF BENEFITS

Section 3.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Earned Salary; Accrued Vacation</u>. Upon a Covered Executive's Termination of Employment, the Company shall pay to the Covered Executive, as soon as practicable but no later than 30 days after the Covered Executive's Employment Termination Date, the Covered Executive's (a) Salary, to the extent earned but unpaid as of the Employment Termination Date, and (b) vacation pay accrued through the Employment Termination Date. The Covered Executive shall also be entitled to business expenses incurred but unreimbursed as of the Employment Termination Date, earned but unpaid bonuses and other benefits accrued under the Company's benefit plans as of the Employment Termination Date; <u>provided</u> that such amounts shall be paid to the Covered Executive in accordance with the applicable Company Plan.

Section 3.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Cash Benefits</u>. Upon a Covered Executive's Termination of Employment and the Covered Executive's satisfaction of the conditions specified in Section 3.05, the Covered Executive shall be entitled to receive the following Benefits, as well as the Benefits specified in Sections 3.03 and 3.04:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;A lump sum cash severance payment equal to (i) the Severance Multiple set forth in the Schedule of Benefits attached hereto as Exhibit B, *multiplied by* (ii) the sum of (A) the Covered Executive's Salary *plus* (B) the Covered Executive's Target Bonus for the Fiscal Year in which the Termination of Employment occurs.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;A lump sum cash payment which shall be equal to the product of (i) (A) the Covered Executive's Target Bonus, *multiplied by* (B) the Annual Incentive Plan payout factor for the corporate organization determined by the Committee for the Fiscal Year in which the Termination of Employment occurs *and* (ii) a fraction, the numerator of which is the number of days in the current Fiscal Year through the Covered Executive's Employment Termination Date and the denominator of which is 365. Payment under this subsection 3.02(b) shall be in lieu of annual incentive opportunities under the Annual Incentive Plan for the Fiscal Year in which the Employment Termination Date occurs. In the event the Covered Executive is determined by the Committee to be entitled to annual incentive opportunities under the Annual Incentive Plan for the Fiscal Year in which the Employment Termination Date occurs, no payment will be made under this subsection 3.02(b).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;If a Grandfathered Covered Executive is a participant in the Pension Plans and is not a Core Contribution Participant under the Retirement Savings Plan, a lump sum cash payment equal to the difference between the actuarial present values as of the Employment Termination Date of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)&nbsp;&nbsp;&nbsp;&nbsp;The Grandfathered Covered Executive's accrued vested pension benefits under the Pension Plans, calculated assuming that payment of the benefits will commence in the form of a straight life annuity on the earliest date on which the Grandfathered Covered Executive could commence payment if the Grandfathered Covered Executive is eligible for an early retirement subsidy on any portion of the Grandfathered Covered Executive's accrued benefits on the Employment Termination Date, or on the

------

first day of the month after the Grandfathered Covered Executive attains age 65 if the Grandfathered Covered Executive is not; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)&nbsp;&nbsp;&nbsp;&nbsp;The Grandfathered Covered Executive's accrued vested pension benefits under the Pension Plans calculated by adding one year (in the case of the CEO, two years) of service to the actual service credited under such plans for benefit accrual and vesting purposes and including any early retirement subsidy available under the Pension Plans for which the Grandfathered Covered Executive is not eligible due to termination before satisfying age and service requirements for such subsidy, and assuming that the Grandfathered Covered Executive's benefit will commence in the form of a straight life annuity on the earliest date on which the Grandfathered Covered Executive could retire and commence a benefit under the Pension Plans.

For purposes of calculating the actuarial present values of (A) and (B) above, the interest rate shall be the average of the average monthly yields for municipal bonds published monthly by Moody's Investors' Service Inc. for the three months immediately preceding the Employment Termination Date and the life expectancy assumptions shall be those most frequently used by the Pension Plans' actuaries for other purposes. The calculation of the pension payment described in this subparagraph shall be made by a nationally recognized firm of enrolled actuaries acceptable to the Grandfathered Covered Executive and the Company. The Company shall pay the reasonable fees and expenses of such actuarial firm. The calculation made by such actuarial firm shall be binding on the Grandfathered Covered Executive and the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;If a Grandfathered Covered Executive is a Core Contribution Participant in the Retirement Savings Plan, a lump sum cash payment (or, in lieu of the payment described in clause (i) above) equal to the Company Core Contributions and Core Credits (as defined in the Savings Plans) that the Grandfathered Covered Executive would have received under the Savings Plans during the one-year period (in the case of the CEO, two-year period) following the Employment Termination Date assuming that (A) the Grandfathered Covered Executive remained actively employed by the Company during such period, (B) the Grandfathered Covered Executive's Salary continued at the higher of the rate in effect on the Employment Termination Date or the rate in effect immediately prior to any purported reduction in the Grandfathered Covered Executive's Salary constituting Good Reason, and (C) the Grandfathered Covered Executive's Annual Incentive Plan awards were equal in amount to the higher of the most recent award received prior to the Employment Termination Date and the average of the awards available to the Grandfathered Covered Executive under the Annual Incentive Plan during and/or for each of the three immediately preceding Fiscal Years; <u>provided</u> that the amount payable to the Grandfathered Covered Executive under this clause (c)(ii) shall in no event include any Company matching contributions or credits on such Company Core Contributions or Core Credits.

Section 3.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-Cash Benefits</u>. In addition to the Benefits provided under Section 3.02, a Covered Executive shall receive, subject to the Covered Executive's satisfaction of the conditions specified in Section 3.05, the following additional benefits:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;If the Covered Executive is covered under any of the Company's group medical and dental plans as of the Employment Termination Date, and the Covered Executive is eligible for and timely elects continuation coverage under such plans pursuant to COBRA, the Company will pay the cost of such COBRA coverage on behalf

------

of the Covered Executive, and each of the Covered Executive's dependents who were covered under such medical and dental plans as of the Employment Termination Date and who are qualified beneficiaries under COBRA, for the amount of time following the Employment Termination Date set forth in such Covered Executive's applicable tier level in the Schedule of Benefits attached hereto as Exhibit B (the "<u>COBRA Continuation Period</u>"); <u>provided</u>, <u>however</u>, that if the duration of the COBRA Continuation Period exceeds the maximum number of months that continuation coverage may be provided under COBRA, the Company shall pay to the Covered Executive within 30 days following the last day on which COBRA continuation benefits may be provided a lump sum cash payment equal to (x) the number of months in the COBRA Continuation Period less the number of months of COBRA continuation coverage previously provided as of such date, *multiplied by* (y) the amount of the COBRA premiums paid by the Company in the last month during which COBRA continuation coverage was provided to the Covered Executive. Notwithstanding the preceding sentence, to the extent that any Covered Executive is eligible to commence retiree medical benefits under the Company's group medical plan on the Employment Termination Date, the preceding sentence shall not apply to such Covered Executive with respect to such plan and shall not affect the Covered Executive's entitlement to retiree medical benefits under the terms and conditions of such plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Outplacement assistance at times and locations that are convenient to the Covered Executive; <u>provided</u> that such outplacement services will be provided for a period of no more than 12 months following the Employment Termination Date.

Section 3.04&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Long-Term Incentive Plan Benefits</u>. In addition to the Benefits payable under Sections 3.02 and 3.03, in the event of a Non-Change in Control Termination of Employment, a Covered Executive's Long-Term Incentive Plan awards shall, subject to the Covered Executive's satisfaction of the conditions specified in Section 3.05, be treated in accordance with this Section 3.04.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;All stock options and stock appreciation rights that are exercisable as of the Covered Executive's Employment Termination Date shall continue to be exercisable following such Employment Termination Date and shall remain exercisable for the remainder of the term applicable to the stock option or stock appreciation right. All stock options and stock appreciation rights that are not exercisable as of the Covered Executive's Employment Termination Date shall automatically terminate as of the Employment Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp;All unearned performance shares and other awards with performance-based vesting shall vest as of the Covered Executive's Employment Termination Date in an amount to be determined by *multiplying* (A) the number of shares or units that would have been earned by the Covered Executive under each such award at the level of performance determined by the Committee at the end of the applicable performance cycle for other senior executives of the Company *by* (B) a fraction, the numerator of which is the number of full months that have elapsed between the beginning of the applicable performance period and the Covered Executive's Employment Termination Date and the denominator of which is the number of full months in such performance period. Payments in respect of such vested awards shall be made within 30 days of the Committee's determination, or, if later, as soon as permissible under Section 409A.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;All other awards, including restricted stock units (other than deferred stock units that vest under the Long-Term Incentive Plan or the applicable award agreement upon a Covered Executive's death, Disability or Retirement) and restricted

------

stock, that are subject to time-based vesting or other non-performance based conditions shall vest as of the Covered Executive's Employment Termination Date in an amount determined by multiplying (A) the number of shares or units that are subject to the award by (B) a fraction, the numerator of which is the number of full months that shall have elapsed since the beginning of the applicable vesting period and the denominator of which is the number of full months in the vesting period. Deferred stock units and restricted stock that become vested under the Long-Term Incentive Plan or applicable award agreement upon a Covered Executive's death, Disability or Retirement shall become fully vested on the Covered Executive's Employment Termination Date. Payments in respect of such vested awards shall be made as soon as practicable after the Release Effective Date (as defined below) or, if later, as soon as permissible under Section 409A.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Section 3.04, fractional shares of the common stock, par value $1.00 per share, of Air Products shall be rounded up to the next highest whole share of stock.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything herein to the contrary, the treatment of Long-Term Incentive Plan awards held by a Covered Executive whose Termination of Employment is a Retirement or as a result of death or Disability shall be determined under the Long-Term Incentive Plan and applicable award agreement (and not under this Section 3.04) to the extent determined by the Committee on the Covered Executive's Employment Termination Date to be more favorable to the Covered Executive.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;The treatment of Long-Term Incentive Plan awards held by a Covered Executive whose Termination of Employment is a Change in Control Termination of Employment shall be treated in connection with a Change in Control in the manner provided under the Long-Term Incentive Plan and applicable award agreements thereunder.

Section 3.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditions to Entitlement to Benefit</u>. To be eligible to receive any Benefits under the Plan after the Covered Executive's Employment Termination Date has been set, a Covered Executive must (a) continue in the Covered Executive's then-current office and perform such duties for the Company as are typically related to the Covered Executive's position (or such other position as the Board reasonably requests) including identifying, recruiting and/or transitioning the Covered Executive's successor, in all events performing all assigned duties in the manner reasonably directed by the CEO in the CEO's sole discretion, or if the CEO is the Covered Executive, by the Board in its sole discretion, and cease the Covered Executive's employment on the Employment Termination Date; (b) on or after the Employment Termination Date, but prior to the 30<sup>th</sup> day following the Employment Termination Date, execute and provide to the Company a release and discharge of the Company from any and all claims, demands or causes of action, in such form as the Administrator shall determine, in its discretion, acting on behalf of the Company, and such release must not be revoked before becoming effective and irrevocable (the date on which the release becomes effective and irrevocable shall be the "<u>Release Effective Date</u>"); and (c) prior to the Release Effective Date, execute a noncompetition, nonsolicitation and nondisparagement agreement that extends for the two-year period following the Covered Executive's Employment Termination Date in substantially the form attached hereto as Exhibit C, with such changes therein as the Administrator shall determine, in its discretion, acting on behalf of the Company. No Benefits due hereunder shall be paid to a Covered Executive who has not complied in all respects with the requirements of this Section 3.05. On or after the Release Effective Date, the Company shall provide the Covered Executive with a release of claims against the Covered Executive.

------

Section 3.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Method of Payment</u>. Benefits under the Plan shall be paid as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;The cash Benefits determined pursuant to Section 3.02 hereof shall be paid in a lump sum, subject to all employment and withholding taxes applicable to the type of payments made. Such payments shall be made as soon as practicable after the Covered Executive's Release Effective Date, or, if later, as soon as permissible under Section 409A. In the event the permitted time between the Employment Termination Date and the Release Effective Date could span two taxable years, payment will be made in the second taxable year.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;The non-cash Benefits described in Section 3.03 shall be provided after the Employment Termination Date in accordance with the applicable Company Plan or as permitted by Section 409A if later; <u>provided</u> that if the Covered Executive fails to comply with all of the conditions set forth in Section 3.05, the Covered Executive shall be required to repay to the Company in cash within five business days after written demand is made therefor by the Company, an amount equal to the value of any Benefit received under Section 3.03.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;Long-Term Incentive Plan awards referred to in Section 3.04 will be paid on the later of the date contemplated under the applicable award agreement and the date (if any) provided for under Section 3.04; <u>provided</u> that payment shall be made in accordance with the applicable award agreement to the extent required to avoid taxes or penalties under Section 409A.

Section 3.07&nbsp;&nbsp;&nbsp;&nbsp;<u>Death or Disability</u>. If a Covered Executive, incurs Disability or dies before the Employment Termination Date has been set, no Plan payments or other benefits will be due and owing to the Covered Executive or, in the case of the Covered Executive's death, to the Covered Executive's estate or beneficiary. If a Covered Executive incurs Disability or dies after the Covered Executive's Employment Termination Date has been set but not attained, the Administrator shall cause any Benefits due under the Plan to be paid to the Covered Executive or, in the case of the Covered Executive's death, to the Covered Executive's Designated Beneficiary as defined in the Long-Term Incentive Plan.

ARTICLE IV<br>ADMINISTRATION

Section 4.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Authority and Duties</u>. It shall be the duty of the Administrator, on the basis of information supplied by the Company, to determine the entitlement of each Covered Executive to Benefits under the Plan. The Administrator shall have the full power and authority to (a) determine whether a Covered Executive's termination of employment with the Company constitutes a Termination of Employment for purposes of the Plan and (b) construe, interpret and administer the Plan, to correct deficiencies therein and to supply omissions. All decisions, actions, and interpretations of the Administrator shall be final, binding, and conclusive upon the parties. The Committee may delegate to appropriate Company officers its authority and its duties as it shall deem appropriate in its sole discretion, and the actions of such person or persons shall have the same force and effect as any action of the Committee in respect of the Plan (other than any action by such person or persons to delegate the Committee's duties or authority hereunder); <u>provided</u>, <u>however</u>, that the Committee shall approve the eligibility for Benefits.

Section 4.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Expenses of the Administrator</u>. All reasonable expenses of the Administrator shall be paid or reimbursed by the Company upon proper documentation. The Company shall indemnify and defend the Administrator against personal liability for actions taken in good faith in the discharge of its duties hereunder.

------

Section 4.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Actions of the Administrator</u>. Whenever a determination is required of the Administrator under the Plan, such determination shall be made solely at the discretion of the Administrator. In addition, the exercise of discretion by the Administrator need not be uniformly applied to similarly situated Covered Executives and shall be final and binding on each Covered Executive or beneficiary(ies) to whom the determination is directed.

ARTICLE V<br>AMENDMENT AND TERMINATION

The Company, acting through the Committee, retains the right, at any time and from time to time, to amend, suspend or terminate the Plan in whole or in part, for any reason, and, except as provided below, without either the consent of or the prior notification to any Covered Executive. Notwithstanding the foregoing and except as specifically provided under Section 7.12(d), no such amendment, suspension or termination shall (a) give the Company the right to recover any amount paid to a Covered Executive prior to the date of such action, (b) cause the cessation and discontinuance of payments of Benefits to any person or persons under the Plan already receiving Benefits, or (c) be effective to terminate or reduce the Benefits or prospective Benefits of any Covered Executive whose Employment Termination Date has been set as of the date of such amendment, suspension or termination (unless the express written consent of the Covered Executive has been obtained with respect thereto). Further, notwithstanding the foregoing and except as specifically provided under Section 7.12(d), during the period commencing on a Change in Control and ending on the second anniversary of the Change in Control, no Covered Executive's participation hereunder may be terminated and the Plan may not be terminated or amended in any manner which is materially adverse to the interest of any Covered Executive without the prior written consent of such Covered Executive.

ARTICLE VI<br>DUTIES OF THE COMPANY

Section 6.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Records</u>. The Company shall supply to the Administrator all records and information necessary to the performance of the Administrator's duties.

Section 6.02&nbsp;&nbsp;&nbsp;&nbsp;<u>Discretion</u>. Any decisions, actions or interpretations to be made under the Plan by the Board, the Committee, the Company, or the Administrator, acting on behalf of the Company, shall be made in its or their respective sole discretion, not in any fiduciary capacity and need not be uniformly applied to similarly situated individuals and shall be final, binding and conclusive upon all parties.

ARTICLE VII<br>MISCELLANEOUS

Section 7.01&nbsp;&nbsp;&nbsp;&nbsp;<u>Nonalienation of Benefits</u>. None of the payments, Benefits or rights of any Covered Executive shall be subject to any claim of any creditor, and, in particular, to the fullest extent permitted by law, all such payments, Benefits and rights shall be free from attachment, garnishment, trustee's process or any other legal or equitable process available to any creditor of such Covered Executive. No Covered Executive shall have the right to alienate, anticipate, commute, pledge, encumber or assign any of the Benefits or payments which the Covered Executive may expect to receive, contingently or otherwise, under the Plan.

------

Section 7.02&nbsp;&nbsp;&nbsp;&nbsp;<u>No Contract of Employment</u>. Neither the establishment of the Plan, nor any modification thereof, nor the creation of any fund, trust or account nor the payment of any Benefits shall be construed as giving any Covered Executive, or any person whosoever, the right to be retained in the service of the Company, and all Covered Executives shall remain subject to discharge to the same extent as if the Plan had never been adopted.

Section 7.03&nbsp;&nbsp;&nbsp;&nbsp;<u>Entire Agreement</u>. This Plan document, as it may be amended by the Committee, and the documents specifically referenced herein, or in such amendment, shall constitute the entire agreement between the Company and the Covered Executive with respect to the Benefits promised hereunder and no other agreements, representations, oral or otherwise, express or implied, with respect to such Benefits or any severance benefits shall be binding on the Company; <u>provided</u> that, (a) if an individual is party to an Executive Officer Change in Control Severance Agreement or a "covered employee" under the Air Products and Chemicals, Inc. Special Severance Plan, as amended, such individual will not be a Covered Executive for purposes of any payments or benefits in connection with a Change in Control Termination of Employment hereunder to the extent treatment under such agreement or plan, as applicable, is more favorable to such individual than under the Plan, and (b) if a Covered Executive is party to an employment agreement subject to laws outside the United States that provides for Statutory Benefits or other severance amounts or notice pay or is otherwise entitled to receive any Statutory Benefits (collectively, "<u>Local Benefits</u>"), any payments or benefits under the Plan payable to the Covered Executive will be reduced by any such Local Benefits.

Section 7.04&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability of Provisions</u>. If any provision of the Plan shall be held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provisions hereof, and the Plan shall be construed and enforced as if such provisions had not been included.

Section 7.05&nbsp;&nbsp;&nbsp;&nbsp;<u>Successors, Heirs, Assigns, and Personal Representatives</u>. The Plan shall be binding upon the heirs, executors, administrators, successors and assigns of the parties, including each Covered Executive, present and future.

Section 7.06&nbsp;&nbsp;&nbsp;&nbsp;<u>Headings and Captions</u>. The headings and captions herein are provided for reference and convenience only, shall not be considered part of the Plan, and shall not be employed in the construction of the Plan.

Section 7.07&nbsp;&nbsp;&nbsp;&nbsp;<u>Gender and Number</u>. Except where otherwise clearly indicated by context, the masculine and the neuter shall include the feminine and the neuter, the singular shall include the plural and vice-versa.

Section 7.08&nbsp;&nbsp;&nbsp;&nbsp;<u>Unfunded Plan</u>. The Plan shall not be funded. The Company may, but shall not be required to, set aside or earmark an amount necessary to provide the Benefits specified herein (including the establishment of trusts). In any event, no Covered Executive shall have any right to, or interest in, any assets of the Company.

Section 7.09&nbsp;&nbsp;&nbsp;&nbsp;<u>Payments to Incompetent Persons, Etc.</u> Any Benefit payable to or for the Benefit of a minor, an incompetent person or other person incapable of receipting therefor shall be deemed paid when paid to such person's guardian or to the party providing or reasonably appearing to provide for the care of such person, and such payment shall fully discharge the Company, the Administrator and all other parties with respect thereto.

Section 7.10&nbsp;&nbsp;&nbsp;&nbsp;<u>Lost Payees</u>. A Benefit shall be deemed forfeited if the Administrator is unable to locate a Covered Executive to whom a Benefit is due. Such Benefit shall be reinstated if application is made by the Covered Executive for the forfeited Benefit while the Plan is in operation.

------

Section 7.11&nbsp;&nbsp;&nbsp;&nbsp;<u>Controlling Law and Nature of Plan</u>. The Plan shall be construed and enforced according to the laws of the Commonwealth of Pennsylvania to the extent not preempted by Federal law. The Plan is not intended to be included in the definitions of "employee pension benefit plan" and "pension plan" set forth under Section 3(2) of ERISA. Rather, the Plan is intended to meet the descriptive requirements of a plan constituting a "severance pay plan" within the meaning of regulations published by the Secretary of Labor at Title 29, Code of Federal Regulations, Section 2510.3-2(b). Notwithstanding the foregoing, if and to the extent that the Plan is deemed to be an "employee pension benefit plan" or "pension plan" as set forth under Section 3(2) of ERISA, then the Plan is intended, for all purposes under ERISA, to constitute a plan that is unfunded and maintained by the Company primarily for the purposes of providing deferred compensation for a select group of management or Highly Compensated Employees.

Section 7.12&nbsp;&nbsp;&nbsp;&nbsp;<u>Section 409A</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;It is intended that the provisions of this Plan comply with Section 409A, and all provisions of this Plan shall be construed and interpreted in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Covered Executive nor any of the Covered Executive's creditors or beneficiaries shall have the right to subject any deferred compensation (within the meaning of Section 409A) payable under any Company Plan to any anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment or garnishment. Except as permitted under Section 409A, any deferred compensation (within the meaning of Section 409A) payable to the Covered Executive or for the Covered Executive's benefit under any Company Plan may not be reduced by, or offset against, any amount owing by the Covered Executive to the Company or any of its affiliates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;If, at the time of the Covered Executive's separation from service (within the meaning of Section 409A), (i) the Covered Executive shall be a specified employee (within the meaning of Section 409A and using the indemnification methodology selected by the Company from time to time) and (ii) the Company shall make a good faith determination that an amount payable under a Company Plan constitutes deferred compensation (within the meaning of Section 409A) the payment of which is required to be delayed pursuant to the six-month delay rule as set forth in Section 409A in order to avoid taxes or penalties under Section 409A, then the Company shall not pay such amount on the otherwise scheduled payment date but shall instead accumulate such amount and pay it, without interest, on the first business day after such six-month period.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any provision of this Plan or any Company Plan to the contrary, the Company reserves the right to make amendments to this Plan and any Company Plan as the Company deems necessary or desirable to avoid the imposition of taxes or penalties under Section 409A. In any case, the Covered Executive is solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on the Covered Executive for the Covered Executive's account in connection with any Company Plan (including any taxes and penalties under Section 409A), and neither the Company nor any affiliate shall have any obligation to indemnify or otherwise hold the Covered Executive harmless from any or all of such taxes or penalties.

Section 7.13&nbsp;&nbsp;&nbsp;&nbsp;<u>Potential Limit on Payments</u>. Notwithstanding any provision of this Plan to the contrary, in the event that an excise tax under Section 4999 of the Code would be assessed on payments or other benefits to be received by the Covered Executive upon a Change in Control, the Covered Executive will be entitled to receive whichever of the following amounts

------

that would result in the largest aggregate amount being retained by the Covered Executive after the application of all applicable federal, state and local taxes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;All payments and other benefits described under Article III; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;Reduced payments and other benefits described in Article III that have an aggregate value equal to the highest amount that, together with all other payments and benefits to be received by the Covered Executive that are parachute payments within the meaning of Section 4999 of the Code, does not exceed three times the Covered Executive's "base amount" (within the meaning of Section 280G of the Code).

The determination of whether (a) or (b) above would result in the largest aggregate amount being retained by the Covered Executive after taxes and the calculation of the amount described in (b) shall be made, at the Company's expense, by a nationally recognized public accounting firm. If a reduced amount is to be paid under clause (b) above, the Covered Executive will be notified no later than the fifth day following the Employment Termination Date.

In the case of a reduction in payments and benefits pursuant to this Section 7.13, such payments and benefits will be reduced in the following order: (i) payments that are payable in cash that are valued at full value under Treasury Regulation Section 1.280G-1, Q&A 24(a) will be reduced (if necessary, to zero), with amounts that are payable last reduced first; (ii) payments and benefits due in respect of any equity valued at full value under Treasury Regulation Section 1.280G-1, Q&A 24(a), with the highest values reduced first (as such values are determined under Treasury Regulation Section 1.280G-1, Q&A 24) will next be reduced; (iii) payments that are payable in cash that are valued at less than full value under Treasury Regulation Section 1.280G-1, Q&A 24, with amounts that are payable last reduced first, will next be reduced; (iv) payments and benefits due in respect of any equity valued at less than full value under Treasury Regulation Section 1.280G-1, Q&A 24, with the highest values reduced first (as such values are determined under Treasury Regulation Section 1.280G-1, Q&A 24) will next be reduced; and (v) all other non-cash benefits not otherwise described in clauses (ii) or (iv) will be next reduced pro-rata.

------

**EXHIBIT A**

**<u>GRANDFATHERED COVERED EXECUTIVES</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Eduardo Menezes

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Melissa Schaeffer

------

**EXHIBIT B**

**<u>SCHEDULE OF BENEFITS</u>**

---

| | | | | |
|:---|:---|:---|:---|:---|
| Covered Executive | Non-Change in Control Termination of Employment Severance Multiple | Non-Change in Control Termination of Employment COBRA Coverage Period | Change in Control Termination of Employment Severance Multiple | Change in Control Termination of Employment COBRA Coverage Period |
| CEO | 2x | 12 months | 3x | 36 months |
| Non-CEO Executive Officer or Company Officer | 1x | 12 months | 2x | 24 months |

---

------

**EXHIBIT C**

**NONCOMPETITION, NONSOLICITATION,** 

**<u>AND NONDISPARAGEMENT AGREEMENT</u>**

I, ____________________ (the "<u>Executive</u>"), for and in consideration of (a) certain severance benefits to be paid and provided to me by Air Products and Chemicals, Inc. (the "<u>Company</u>") under the Air Products and Chemicals, Inc. Executive Separation Program (the "<u>Plan</u>"), and (b) the Company's execution of a release in favor of the Executive, I, the Executive, hereby covenant and agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;The Executive acknowledges that the Company is generally engaged in business throughout the world. During the Executive's employment by the Company and for two years after the Executive's Employment Termination Date (as defined in the Plan), the Executive agrees that the Executive will not, unless acting with the prior written consent of the Company, directly or indirectly, own, manage, control, or participate in the ownership, management or control of, or be employed or engaged by, or be otherwise affiliated or associated with, as an officer, director, employee, consultant, independent contractor or otherwise: (a) any person who is engaged, in any manner anywhere, in any business which, as of the Employment Termination Date, is engaged in by the Company or has been reviewed with the Board for development to be owned or managed by the Company (together "<u>competitive businesses</u>"), or (b) any person who has an ownership interest in a competitive business or an affiliate of such a person. Executive's passive ownership of not more than 5% of the equity of a publicly traded entity shall not be deemed to be a violation of this paragraph.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;The Executive also agrees that the Executive will not, directly or indirectly, during the period described in paragraph 1, induce any person who is an employee, officer, director, or agent of the Company, to terminate such relationship, or employ, assist in employing or otherwise be associated in business with any present or former employee or officer of the Company, including, without limitation, those who commence such positions with the Company after the Employment Termination Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;For the purposes of this Agreement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;the term "<u>Company</u>" shall be deemed to include Air Products and Chemicals, Inc. and the subsidiaries and affiliates of Air Products and Chemicals, Inc.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;the term "<u>person</u>" shall include an individual, a publicly-traded or privately-held corporation or equivalent thereof under foreign law, a partnership, an association, a joint stock company, a trust, any unincorporated association, or any business organization; and may include an affiliate of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;the term "<u>affiliate</u>" of a specified person shall mean any corporation, partnership, joint venture, business organization, trust, or other non-natural person in which the specified person directly or indirectly holds an interest, which is under common control with the specified person, or of which the specified person is an executive officer, manager, trustee, executor or similar controlling person.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;The Executive acknowledges and agrees that the restrictions contained in this Agreement are reasonable and necessary to protect and preserve the legitimate interests, properties, goodwill and business of the Company, that the Company would not have entered into this Agreement in the absence of such restrictions and that irreparable injury will be suffered by the Company should the Executive breach the provisions of this Section. The Executive represents and acknowledges that (a) the Executive has been advised by the Company to consult the Executive's own legal counsel in respect of this Agreement, (b) the Executive has consulted with and been advised by the Executive's own counsel in respect of this Agreement, and (c) the Executive has had full opportunity, prior to execution of this Agreement, to review thoroughly this Agreement with the Executive's counsel.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;The Executive further acknowledges and agrees that a breach of the restrictions in this Agreement will not be adequately compensated by monetary damages. The Executive agrees that the Company shall be entitled to (a) preliminary and permanent injunctive relief, without the necessity of proving actual damages, or posting of a bond, (b) an equitable accounting of all earnings, profits and other benefits arising from any violation of this Agreement, and (c) enforce the terms, including requiring forfeitures, under other plans, programs and agreements under which the Executive has been granted a benefit contingent on a covenant similar to those contained in this Agreement, which rights shall be cumulative and in addition to any other rights or remedies to which the Company may be entitled. In the event that the provisions of this Agreement should ever be adjudicated to exceed the limitations permitted by applicable law in any jurisdiction, it is the intention of the parties that the provision shall be amended to the extent of the maximum limitations permitted by applicable law, that such amendment shall apply only within the jurisdiction of the court that made such adjudication and that the provision otherwise shall be enforced to the maximum extent permitted by law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;If the Executive breaches the Executive's obligations under this Agreement, the Executive agrees that suit may be brought, and that the Executive consents to personal jurisdiction, in the United States District Court for the Eastern District of Pennsylvania, or in any court of general jurisdiction in Allentown, Pennsylvania; consents to the non-exclusive jurisdiction of any such court in any such suit, action or proceeding; and waives any objection which the Executive may have to the laying of venue of any such suit, action or proceeding in any such court. The Executive also irrevocably and unconditionally consents to the service of any process, pleadings, notices, or other papers with respect thereto. EACH PARTY HERETO IRREVOCABLY AGREES TO WAIVE TRIAL BY JURY IN ANY ACTION, PROCEEDING, CLAIM, OR COUNTERCLAIM BROUGHT BY OR ON BEHALF OF ANY PARTY RELATED TO OR ARISING OUT OF THIS NONCOMPETITION AGREEMENT.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;Executive further agrees, covenants, and promises that the Executive will not in any way communicate the terms of this Agreement to any person other than the Executive's immediate family and the Executive's attorney and financial consultant or when necessary to advise a third party of the Executive's obligations under this Agreement. Notwithstanding the foregoing, the Company and Executive also agree that for a period of two years following the Employment Termination Date, Executive will provide and that at all times after the date hereof the Company may similarly provide, with prior written notice to Executive, a copy of this Agreement to any business or enterprise (a) which Executive may directly or indirectly own, manage, operate, finance, join, control or of which the Executive may participate in the ownership, management, operation, financing or control, or (b) with which Executive may be connected as an officer, director, employee, partner, principal, agent, representative, consultant or otherwise or in connection with which Executive may use or permit to be used Executive's name. Executive agrees not to disparage the name, business reputation or business practices of

------

the Company or its subsidiaries or affiliates or its or their officers, employees or directors, and the Company agrees not to disparage the name or business reputation of Executive.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;&nbsp;&nbsp;&nbsp;The Executive hereby expressly acknowledges and agrees that (a) the provisions of the Employee Patent and Confidential Information Agreement entered into by the Executive on _______________, shall continue to apply in accordance with its terms, and (b) the provisions of the Executive's outstanding incentive award agreements granted under the Company's Long-Term Incentive Plan, as defined in the Plan, shall continue to apply in accordance with their terms except as otherwise provided in Section 3.04 of the Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9.&nbsp;&nbsp;&nbsp;&nbsp;No failure or delay on the part of the Company in exercising any power or right hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right or power preclude any further or other exercise thereof or the exercise of any other right or power hereunder. No modification or waiver of any provision of this Agreement or consent to any departure by any party therefrom shall in any event be effective until the same shall be in writing and then such waiver or consent shall be effective only in the specific instance and for the purpose for which given. No notice to or demand on any party in any case shall entitle such party to any other or further notice or demand in similar or other circumstances.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10.&nbsp;&nbsp;&nbsp;&nbsp;Notices under this Agreement shall be in writing and sent via overnight mail as follows:

To:&nbsp;&nbsp;&nbsp;&nbsp;Company's General Counsel&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To:&nbsp;&nbsp;&nbsp;&nbsp;Executive

1940 Air Products Boulevard &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;At the address on file

Allentown, PA 18106-5500&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with the Company

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;11.&nbsp;&nbsp;&nbsp;&nbsp;This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Pennsylvania without reference to its principles of conflict of law. This Agreement shall extend to and ensure to the benefit of the respective successors and assigns of the Company.

Intending to be legally bound hereby, I execute the Noncompetition, Nonsolicitation, and Nondisparagement Agreement this ___ day of _____________, 20 ___.

 <br> Witness Executive

## Exhibit 10.8

Exhibit 10.8 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;![image_0.jpg](image_0.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***Compensation Program***<br>***for Nonemployee Directors***<br>**Amended and Restated Effective November 19, 2025**<br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Each director shall be paid an annual retainer of $140,000 for serving as a member of the Board of Directors and any Board Committee(s), which retainer shall be payable in quarterly installments at the end of each quarter. Payment of this retainer may be deferred under the Deferred Compensation Program for Directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.The chair of the Audit and Finance Committee shall be paid an additional annual retainer of $25,000. The chair of the Corporate Governance and Nominating Committee shall be paid an annual retainer of $20,000. The chair of the Management Development and Compensation Committee shall be paid an annual retainer of $20,000. Such retainers shall be payable in quarterly installments. Payment may be deferred under the Deferred Compensation Program for Directors.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Deferred stock units with a targeted dollar value of $190,000 shall be credited annually to the Air Products Stock Account under the Deferred Compensation Program for Directors for each director who is continuing in office after the Annual Meeting of Shareholders, effective as of the day of the Annual Meeting. The Chairman of the Board shall be credited with additional deferred stock units with a targeted dollar value of $250,000 and the Vice Chairman of the Board shall be credited with additional deferred stock units with a targeted dollar value of $200,000. The number of units to be credited will be

------

determined based on the Fair Market Value of a share of common stock of the Company as determined under the Program.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Deferred stock units shall be credited to the Air Products Stock Account under the Deferred Compensation Program for Directors for each newly-elected director effective as of the date the director first serves on the Board. The targeted dollar value of such units shall be the amount specified in paragraph (d) above multiplied by a fraction, the numerator of which shall be the number of full or partial months remaining until the next Annual Meeting of Shareholders and the denominator of which shall be twelve. The number of units to be credited will be determined based on the Fair Market Value of a share of common stock of the Company as determined under the Program.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e.Directors shall be reimbursed for out-of-pocket expenses incurred in attending regular and special meetings of the Board and Board Committees and any other business function of the Company at the request of the Chairman of the Board. Expenses will be reimbursed as submitted.<sup>\*</sup><sup>/</sup>

 <sup>\*</sup><sup>/</sup>&nbsp;&nbsp;&nbsp;&nbsp;Directors are reimbursed at the rate of $.58 per mile or the current rate published by the Internal Revenue Service for use of their personal cars in connection with Company business. Directors using personal aircraft or private carrier will be reimbursed for such expenses at a rate equivalent to first-class airfare of scheduled carriers.

------

**AIR PRODUCTS AND CHEMICALS, INC.**

**NON-EMPLOYEE DIRECTORS**

**EXPENSE REPORT**

---

| | |
|:---|:---|
| EVENT(S) AND DATE(S) | |
| COMMERCIAL AIRFARE | |
| (Attach Ticket) | |
| HOTEL ACCOMMODATIONS | |
| MEALS | |
| MILEAGE | |
| CHAUFFEUR SERVICE | |
| TELEPHONE TOLLS | |
| MISCELLANEOUS | |
| (Please Specify) | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;TOTAL | |
| | Signature / Date |
| | Address |

---

**Please submit this form with attached receipts to Darlene Reimert, Corporate Secretary's Office**

## Exhibit 21.1

Exhibit 21.1

**Subsidiaries of Air Products and Chemicals, Inc.**

Registrant -- Air Products and Chemicals, Inc.

---

| |
|:---|
| **UNITED STATES** |
| All companies are incorporated in the State of Delaware unless otherwise indicated. |
| Air Products Advanced Materials LLC |
| Air Products Ammonia Distribution, LLC |
| Air Products Ammonia Holdings, LLC |
| Air Products and Chemicals, Inc. of Utah (Utah) |
| Air Products Asia, Inc. |
| Air Products Blue Energy LLC |
| Air Products Caribbean Holdings, Inc. |
| Air Products China, Inc. |
| Air Products Clean Ammonia LLC |
| Air Products Helium, Inc. |
| Air Products Hydrogen Company, Inc. |
| Air Products Industrial Gas LLC |
| Air Products International, LLC |
| Air Products Investments Holdings, LLC |
| Air Products Investments, LLC |
| Air Products LLC |
| Air Products Manufacturing Corporation |
| Air Products Manufacturing LLC |
| Air Products West Coast Hydrogen LLC |
| APCI (U.K.), Inc. |
| APMTG Helium LLC |
| East Coast Nitrogen Company LLC |
| East Coast Oxygen Co. |
| EPCO Carbondioxide Products, Inc. (Illinois) |
| Felix 4, LLC |
| Felix DevCo, LLC |
| Felix Holding Company II, LLC |
| Gardner Cryogenics, Inc. (Pennsylvania) |
| Indura Holdings Colombia, LLC |
| Olin - DNT Limited Partnership |
| Permea, Inc. |
| ProCal (California) |
| Prodair Corporation |
| SCWC Corp. |
| The Former SR Manufacturers Inc. (Colorado) |
| **ALGERIA** |
| Helios S.p.A. |

---

------

---

| |
|:---|
| **ARGENTINA** |
| Indura Argentina S.A. |
| **BAHRAIN** |
| Air Products Bahrain W.L.L |
| Middle East Carbon Dioxide W.L.L. (MECD) |
| **BELGIUM** |
| ACP Zolder Invest NV |
| Air Products Management BV/SRL |
| Air Products NV/SA |
| Ijsfabriek Strombeek N.V. |
| Napro S.A. |
| **BERMUDA** |
| Asia Industrial Gas Company Ltd. |
| **BRAZIL** |
| Air Products Brasil Ltda. |
| **CANADA** |
| Air Products Canada Ltd./Prodair Canada Ltee |
| Air Products Ammonia Distribution Ltd. |
| **CHILE** |
| AP Services South America SpA |
| Centro Técnico Indura Limitada |
| Indura Inversiones Limitada |
| Indura S.A. |
| Indura Sociedad Comercial Limitada |
| Inversiones Air Products Holdings Limitada |
| Oxigeno Medicinal Domiciliario Limitada |
| Servicios Indura Limitada |
| **CHINA** |
| Air Products (Beijing) Hydrogen Energy Technology Co., Ltd. |
| Air Products (Cangzhou) Co., Ltd. |
| Air Products (Changsha) Co., Ltd. |
| Air Products (Chongqing) Chem-Materials Co., Ltd. |
| Air Products (Dongguan) Gases Co., Ltd. |
| Air Products (Guangzhou) Electronics Gases Co., Ltd. |
| Air Products (Hangjin Qi) Co., Ltd. |
| Air Products (Hefei) Electronics Gases Co., Ltd |
| Air Products (Huaibei) Gases Co., Ltd. |
| Air Products (Jiangxi) Co., Ltd. |
| Air Products (Jincheng) Co., Ltd. |
| Air Products (Jinjiang) Electronics Gases Co., Ltd. |
| Air Products (Kunshan) Gases Co., Ltd. |
| Air Products (Kunshan) Gases Co., Ltd. FuChunjiang Road Branch |
| Air Products (Linfen) Co., Ltd. |
| Air Products (Longkou) Gases Co., Ltd. |
| Air Products (Nanjing) Electronics Gases Co., Ltd |
| Air Products (Ningbo) Hi-Tech Gases Co., Ltd. |

---

------

---

| |
|:---|
| Air Products (Qingdao) Gases Co., Ltd. |
| Air Products (Shandong) Engineering Co., Ltd. |
| Air Products (Shandong) Engineering Co., Ltd. Nanjing Branch |
| Air Products (Shanghai) Electronics Gases Co., Ltd. |
| Air Products (Shanxi) Co., Ltd. |
| Air Products (Shenyang) Gases Co., Ltd. |
| Air Products (Shenzhen) Electronics Gases Co., Ltd. |
| Air Products (Tianjin) Co., Ltd. |
| Air Products (Wuhan) Gases Co., Ltd. |
| Air Products (Xia'men) Electronics Gases Co., Ltd. |
| Air Products (Xi'an) Gases Co., Ltd |
| Air Products (Zhengzhou) Hydrogen Energy Technology Co., Ltd. |
| Air Products (Zhongshan) Gases Co., Ltd. |
| Air Products (Zhumadian) Gases Co., Ltd. |
| Air Products and Chemicals (Anhui) Co., Ltd. |
| Air Products and Chemicals (Banan) Gases Co., Ltd. |
| Air Products and Chemicals (Beijing) Distribution Co., Ltd. |
| Air Products and Chemicals (Binzhou) Co., Ltd. |
| Air Products and Chemicals (Chengdu) Co., Ltd. |
| Air Products and Chemicals (China) Investment Co., Ltd. |
| Air Products and Chemicals (China) Investment Co., Ltd. Nanjing Branch |
| Air Products and Chemicals (China) Investment Co., Ltd. Xi'an Branch |
| Air Products and Chemicals (Chongqing) Co., Ltd. |
| Air Products and Chemicals (Chongqing) Co., Ltd. Chang Shou Branch |
| Air Products and Chemicals (Dalian) Co., Ltd. |
| Air Products and Chemicals (Guangzhou) Co., Ltd. |
| Air Products and Chemicals (Guiyang) Co., Ltd. |
| Air Products and Chemicals (Hefei) Co., Ltd. |
| Air Products and Chemicals (Hohhot) Co., Ltd. |
| Air Products and Chemicals (Nanjing) Co., Ltd. |
| Air Products and Chemicals (Nanjing) Gases Co., Ltd. |
| Air Products and Chemicals (Pengzhou) Co., Ltd. |
| Air Products and Chemicals (Putian) Co., Ltd. |
| Air Products and Chemicals (Shaanxi Pucheng) Co., Ltd. |
| Air Products and Chemicals (Shaanxi) Co., Ltd. |
| Air Products and Chemicals (Shanghai) Co., Ltd. |
| Air Products and Chemicals (Shanghai) Electronics Gases Co., Ltd. |
| Air Products and Chemicals (Shanghai) Gases Co., Ltd. |
| Air Products and Chemicals (Shanghai) Gases Production Co., Ltd. |
| Air Products and Chemicals (Shanghai) Gasification Technology Co., Ltd. |
| Air Products and Chemicals (Shanghai) On-Site Gases Co., Ltd. |
| Air Products and Chemicals (Shanghai) Systems Co. Ltd. |
| Air Products and Chemicals (Shanghai) Systems Co. Ltd. Qingpu Branch |
| Air Products and Chemicals (Shangluo) Co., Ltd. |
| Air Products and Chemicals (Shenzhen) Co., Ltd. |
| Air Products and Chemicals (Shenzhen) Gases Co., Ltd. |
| Air Products and Chemicals (Shenzhen) Gases Co., Ltd. Guangming Branch |
| Air Products and Chemicals (Shenzhen) Gases Co., Ltd. Longhua Branch |
| Air Products and Chemicals (Tangshan) Co., Ltd. |

---

------

---

| |
|:---|
| Air Products and Chemicals (Tianjin) Co., Ltd. |
| Air Products and Chemicals (Tongxiang) Co., Ltd. |
| Air Products and Chemicals (Weifang) Co., Ltd. |
| Air Products and Chemicals (Wuxi) Co., Ltd. |
| Air Products and Chemicals (WuXi) Gases Co., Ltd. |
| Air Products and Chemicals (Xiâ€™an) Co., Ltd. First Branch |
| Air Products and Chemicals (Xi'an) Co., Ltd. |
| Air Products and Chemicals (Xingtai) Co., Ltd. |
| Air Products and Chemicals (Xinxiang) Co., Ltd. |
| Air Products and Chemicals (Xuzhou) Co., Ltd. |
| Air Products and Chemicals (Yichun) Co., Ltd. |
| Air Products and Chemicals (Yulin) Co., Ltd. |
| Air Products and Chemicals (Zhangjiagang) Co., Ltd. |
| Air Products and Chemicals (Zhejiang) Co., Ltd. |
| Air Products and Chemicals (Zhejiang) Co., Ltd. Haiyan Economic Development Zone Hydrogen Refueling Station |
| Air Products and Chemicals (Zhejiang) Co., Ltd. Hangzhou Branch |
| Air Products and Chemicals (Zhuhai) Co., Ltd. |
| Air Products and Chemicals (Zibo) Co., Ltd. |
| Air Products and Chemicals Tech Development (Beijing) Co., Ltd. |
| Air Products Debang (Lianyungang) Co., Ltd. |
| Air Products (Hong Kong) Co., Ltd. |
| Air Products Hydrogen Energy Technology (Zibo) Co., Ltd. |
| Air Products Hydrogen Energy Technology (Zibo) Co., Ltd. Kunlun Service Area North Branch of Jiwei Expressway Branch |
| Air Products Hydrogen Energy Technology (Zibo) Co., Ltd. Kunlun Service Area South Branch of Jiwei Expressway Branch |
| Air Products Jiutai (Inner Mongolia) Hydrogen Technology Co., Ltd. |
| Air Products Logistics (Zhejiang) Co., Ltd. |
| Air Products Lu An (Changzhi) Co., Ltd. |
| Air Products SinoHytec (Beijing) Hydrogen Energy Technology Co., Ltd. |
| Beijing AP BAIF Gases Industry Co., Ltd. |
| Chengdu Air & Gas Products Ltd. |
| Chengzhi Air Products Hydrogen Energy Technology Co., Ltd., |
| CNOOC Air Products and Chemicals (Fujian) Co., Ltd. |
| Gaolu Air Products and Chemicals (Shanghai) Energy Technology Co.,Ltd. |
| New Energy Air Products (Liaoning) Co., Ltd. |
| Permea China, Ltd. |
| WuXi Hi-Tech Gas Co., Ltd. |

---

---

| |
|:---|
| **COLOMBIA** |
| Gases Industriales de Colombia S.A. – Cryogas |
| **CZECH REPUBLIC** |
| Air Products spol s.r.o. |
| **ECUADOR** |
| Air Products Ecuador S.A. |
| **EGYPT** |
| Air Products Gases S.A.E. |
| **FRANCE** |
| Air Products SAS |

---

------

---

| |
|:---|
| Air Products Transport SAS |
| Helap SAS |
| Lida SAS |
| Prodair et Cie S.C.S. |
| Prodair S.A.S. |
| Soprogaz SNC |
| **GERMANY** |
| Air Products Renewable Hydrogen GmbH |
| Air Products GmbH |
| Air Products Holdings GmbH |
| **INDIA** |
| Prodair Air Products India Private Limited |
| INOX Air Products Pvt. Ltd. |
| **HUNGARY** |
| Air Products Hungary Kft. |
| **INDONESIA** |
| PT Air Products East Kalimantan |
| PT Air Products Indonesia |
| PT Air Products Indonesia Gases |
| PT Air Products Indonesia Services |
| **IRELAND** |
| Air Products Ireland Limited |
| **ISRAEL** |
| Air Products Israel Ltd. |
| Gas Technologies O.B. Ltd. |
| Oxygen & Argon Works, Ltd. |
| **ITALY** |
| Air Products Italia S.r.l. |
| Sapio Produzione Idrogeno Ossigeno S.r.l. |
| **JAPAN** |
| Air Products Japan K.K. |
| **KOREA** |
| Air Products Korea Inc. |
| Korea Industrial Gases, Ltd. |
| **LUXEMBOURG** |
| ACP Europe SA |
| **MALAYSIA** |
| Air Products Malaysia Sdn Bhd |
| Air Products Shared Services Sdn. Bhd |
| Air Products Specialized Process Equipment SDN |
| Kulim Industrial Gases Sdn Bhd |
| **MEXICO** |

---

------

---

| |
|:---|
| Air Products and Chemicals de Mexico, S.A. de C.V. |
| Grupo INFRA |
| Promotora Mexcolom S.A. de C.V. |
| **MOROCCO** |
| Air Products Maghreb S.A.R.L. |
| **NETHERLANDS** |
| Air Products Eurasia Investments B.V. |
| Air Products Gases Holdings B.V. |
| Air Products Holdings B.V. |
| Air Products Investments B.V. |
| Air Products Leasing B.V. |
| Air Products Nederland B.V. |
| Air Products Netherlands Gases B.V. |
| Air Products Renewable Hydrogen B.V. |
| Carbolim B.V. |
| KRIG Holdings B.V. |
| **NIGERIA** |
| Prodair Escravos Limited |
| **NORWAY** |
| Air Products A/S |
| **OMAN** |
| Air Products Majan LLC |
| AJWAA Gases LLC |
| **PERU** |
| Air Products Peru S.A. |
| **POLAND** |
| Air Products Sp. z o.o. |
| STP & DIN Chemicals sp. z o.o. |
| **PORTUGAL** |
| CVA Portugal LDA |
| Gasin II Unipessoal LDA |
| Sociedade Portuguesa de Oxigenio, Lda. |
| **QATAR** |
| Air Products Helium Inc. – Qatar Branch |
| Air Products PLC, Britain – Qatar Branch |
| **ROMANIA** |
| Air Products Romania SRL |
| **SAUDI ARABIA** |
| Abdulla Hashim Gases & Equipment Co. Limited |
| Air Products (BR) Ltd. P.E. Branch |
| Air Products Middle East and Regional Headquarters (RHQ) Company |
| Air Products Middle East Industrial Gases LLC |
| Air Products PLC Branch |
| Air Products Qudra for Energy |

---

------

---

| |
|:---|
| Air Products Qudra for Industrial Gases |
| Air Products Saudi Arabia Investment Company |
| Blue Hydrogen Industrial Gases Company |
| Jazan Gas Projects Company (JGPC) |
| Jazan Integrated Gasification and Power Company (JIGPC) |
| NEOM Green Hydrogen Company |
| **SINGAPORE** |
| Air Products (Singapore) Energy Pte. Ltd. |
| **SLOVAKIA** |
| Air Products Slovakia s.r.o. |
| **SOUTH AFRICA** |
| Air Products South Africa (Proprietary) Limited |
| **SPAIN** |
| Air Products Iberica, S.L.U. |
| Air Products Services Europe, S.A. |
| Andaluza de Gases, S.A. |
| Carb-IQA de Tarragona, S.L. |
| Carburos Via Augusta Logistics, S.L. |
| Iberica del Carbonico, S.A. |
| Matgas 2000 A.I.E. |
| Oxigeno de Sagunto, S.L. |
| Sociedad Espanola de Carburos Metalicos S.A. |
| Vitalox Industrial S.L.U. |
| **SWITZERLAND** |
| Air Products Switzerland Sàrl |
| **TAIWAN, CHINA** |
| Air Products Asia Inc., Taiwan Branch |
| Air Products San Fu Co., Ltd. |
| Air Products Taiwan Holdings Co., Ltd. |
| Blue Ocean Industrial Gas Co., Ltd. |
| **THAILAND** |
| Bangkok Industrial Gas Co., Ltd. |
| Bangkok Cogeneration Company Limited |
| **TRINIDAD AND TOBAGO** |
| Caribbean Industrial Gases Unlimited |
| **UKRAINE** |
| Air Products Ukraina LLC |
| KRYVYI RIH Industrial Gas |
| PQ Ammonia |
| **UNITED ARAB EMIRATES** |
| AJWAA Emirates Gases Company LLC |
| Air Products Arabia for Industrial Gases LLC |
| Air Products (Middle East) FZE |
| Air Products Emirates Gases LLC |

---

------

---

| |
|:---|
| Air Products Gulf Gas LLC |
| ALEMIR Jebil Ali FTZ (Branch) |
| ALEMIR Sharjah FTZ (Branch) |
| **UNITED KINGDOM** |
| Air Products (BR) Limited |
| Air Products Equipment Limited |
| Air Products Group Limited |
| Air Products Llanwern Limited |
| Air Products PLC |
| Air Products Renewable Energy Limited |
| Cryoservice Limited |
| Gas Direct Cymru Cyf |
| Gas Direct Limited |
| SIG Industrial Gases Limited |
| **UZBEKISTAN** |
| Air Products Bukhara LLC |
| Air Products Central Asia Group LLC |
| Air Products Fergana FE LLC |
| Air Products Netherlands Gases P.E. (Branch) |

---

## Exhibit 23.1

Exhibit 23.1

**Consent of Independent Registered Public Accounting Firm**

We consent to the incorporation by reference in Registration Statement Nos. 333-141336, 333-141337, 333-149813, 333-158101, 333-158102, 333-165563, 333-172889, 333-172890, 333-180122, 333-180123, 333-188643, 333-196000, 333-204387, 333-204388, 333-211476, 333-225016, 333-232847, 333-240038, and 333-252722 on Form S-8 and No. 333-275663 on Form S-3 of our report dated November 20, 2025, relating to the consolidated financial statements of Air Products and Chemicals, Inc. and subsidiaries, and the effectiveness of Air Products and Chemicals, Inc.'s internal control over financial reporting appearing in this Annual Report on Form 10-K of Air Products and Chemicals, Inc. for the year ended September 30, 2025.

/s/ Deloitte & Touche LLP

Philadelphia, Pennsylvania

November 20, 2025

## Exhibit 24.1

Exhibit 24.1

**POWER OF ATTORNEY**

KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints EDUARDO F. MENEZES, MELISSA N. SCHAEFFER, and MATTHEW LEPORE, and each of them acting severally, his/her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him/her and in his/her name, place and stead, in any and all capacities, to sign the Form 10-K Annual Report for the fiscal year ended 30 September 2025 and all amendments thereto and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he/she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities and Exchange Act of 1934, this Power of Attorney has been signed below by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Eduardo F. Menezes | Chief Executive Officer and Director<br>(Principal Executive Officer) | November 20, 2025 |
| Eduardo F. Menezes |  |  |
| /s/ Tonit M. Calaway | Director | November 20, 2025 |
| Tonit M. Calaway |  |  |
| /s/ Lisa A. Davis | Director | November 20, 2025 |
| Lisa A. Davis |  |  |
| /s/ Andrew W. Evans | Director | November 20, 2025 |
| Andrew W. Evans |  |  |
| /s/ Jessica Trocchi Graziano | Director | November 20, 2025 |
| Jessica Trocchi Graziano |  |  |
| /s/ Paul C. Hilal | Director | November 20, 2025 |
| Paul C. Hilal |  |  |
| /s/ Bhavesh V. Patel | Director | November 20, 2025 |
| Bhavesh V. Patel |  |  |
| /s/ Dennis H. Reilley | Director<br>Vice Chairman of the Board of Directors | November 20, 2025 |
| Dennis H. Reilley |  |  |
| /s/ Wayne T. Smith | Director<br>Chairman of the Board of Directors | November 20, 2025 |
| Wayne T. Smith |  |  |
| /s/ Alfred Stern | Director | November 20, 2025 |
| Alfred Stern |  |  |
| /s/ Howard Ungerleider | Director | November 20, 2025 |
| Howard Ungerleider |  |  |

---

## Exhibit 31.1

Exhibit 31.1

**<u>PRINCIPAL EXECUTIVE OFFICER'S CERTIFICATION</u>**

I, Eduardo F. Menezes, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Annual Report on Form 10-K of Air Products and Chemicals, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: 20 November 2025

---

| |
|:---|
| /s/ Eduardo F. Menezes |
| Eduardo F. Menezes |
| Chief Executive Officer and Director |

---

## Exhibit 31.2

Exhibit 31.2

**<u>PRINCIPAL FINANCIAL OFFICER'S CERTIFICATION</u>**

I, Melissa N. Schaeffer, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Annual Report on Form 10-K of Air Products and Chemicals, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: 20 November 2025

---

| |
|:---|
| /s/ Melissa N. Schaeffer |
| Melissa N. Schaeffer |
| Executive Vice President and Chief Financial Officer |

---

## Exhibit 32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report on Form 10-K of Air Products and Chemicals, Inc. (the "Company") for the period ending 30 September 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Eduardo F. Menezes, Chief Executive Officer of the Company, and Melissa N. Schaeffer, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| | /s/ Eduardo F. Menezes |
| Date: 20 November 2025 | Eduardo F. Menezes |
| | Chief Executive Officer and Director |
| | /s/ Melissa N. Schaeffer |
| | Melissa N. Schaeffer |
| | Executive Vice President and Chief Financial Officer |

---

<br>